{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "65464cb1-f3cd-42cd-9f89-9aa323196250",
   "metadata": {},
   "source": [
    "# Extraction des NCTIds dans ClinicalTrial:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "338bf2ef-bbcc-427a-8840-0f2b91b17292",
   "metadata": {},
   "source": [
    "## API v1:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "548c1a1f-38fd-455f-abd2-6111b492a446",
   "metadata": {},
   "source": [
    "Pour faciliter la récupération des données via l'API v1 de ClinicalTrial, on utilise le wrapper Python: [pytrials](https://github.com/jvfe/pytrials)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7de1cbc9-3b95-40cf-8ceb-73efdc8e9661",
   "metadata": {},
   "source": [
    "Installer ***pytrials***:\n",
    "- Dans Conda Navigator, se placer dans le meme environnement que celui qui execute Jupyter\n",
    "- Lancer Powershell Prompt dans cet environnement\n",
    "- Taper: `pip install pytrials`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "2ae35742-d8a3-448b-b616-636604a16a50",
   "metadata": {},
   "outputs": [
    {
     "ename": "ModuleNotFoundError",
     "evalue": "No module named 'pytrials'",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mModuleNotFoundError\u001b[0m                       Traceback (most recent call last)",
      "Cell \u001b[1;32mIn[1], line 1\u001b[0m\n\u001b[1;32m----> 1\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01mpytrials\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mclient\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m ClinicalTrials\n\u001b[0;32m      2\u001b[0m \u001b[38;5;28;01mimport\u001b[39;00m \u001b[38;5;21;01murllib\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mparse\u001b[39;00m\n",
      "\u001b[1;31mModuleNotFoundError\u001b[0m: No module named 'pytrials'"
     ]
    }
   ],
   "source": [
    "from pytrials.client import ClinicalTrials\n",
    "import urllib.parse"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e22ac03f-cafe-4757-9c41-4bf21940f058",
   "metadata": {},
   "outputs": [],
   "source": [
    "ct = ClinicalTrials()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f5f94dc3-f00c-4a26-b360-63d46912aab4",
   "metadata": {},
   "source": [
    "### Création de la requête:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "479b8333-7891-4eac-a718-775fb3da2616",
   "metadata": {},
   "source": [
    "On crée la requête qui sera envoyé à l'API de ClinicalTrial"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "979cef8b-2f59-4ffc-b8e1-713c2df54f7d",
   "metadata": {},
   "source": [
    "#### Sponsors:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "fa86d5bc-e8ba-498a-a20d-ba223e05ef89",
   "metadata": {},
   "outputs": [],
   "source": [
    "sponsors = [\n",
    "    \"anrs\",\n",
    "    \"inserm\",\n",
    "    \"institut national de la santé et de la recherche médicale\",\n",
    "    \"french national agency for research on aids and viral hepatitis\",\n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "11a94424-1569-4107-ba6d-6310db1079ea",
   "metadata": {},
   "outputs": [],
   "source": [
    "sponsors_expr = [f\"AREA[LeadSponsorName]{sponsor}\" for sponsor in sponsors]\n",
    "\n",
    "# Add OR keyword\n",
    "sponsors_expr = \" OR \".join(sponsors_expr)\n",
    "\n",
    "# Add parenthesis for correct interpretation of OR expression\n",
    "sponsors_expr = f\"({sponsors_expr})\"\n",
    "\n",
    "sponsors_expr"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f673c610-bd07-4441-8954-bb9471b3eb4d",
   "metadata": {},
   "source": [
    "#### Status:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b7faf8d7-45d7-42c9-8769-05b4b161b0d8",
   "metadata": {},
   "outputs": [],
   "source": [
    "status = \"completed\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "718888a1-e9b7-48e6-bb19-d40adbeb12a2",
   "metadata": {},
   "outputs": [],
   "source": [
    "status_expr = f\"AREA[OverallStatus]{status}\"\n",
    "status_expr"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a0fba5e7-f5ac-4522-87f4-59750f158c9c",
   "metadata": {},
   "source": [
    "#### Search Expression:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2a93eed1-3da5-483b-9641-93e073d72eb3",
   "metadata": {},
   "outputs": [],
   "source": [
    "search_expr = \" AND \".join([sponsors_expr, status_expr])\n",
    "search_expr"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5317cc15-f232-43d2-84a0-dffd039866ff",
   "metadata": {},
   "source": [
    "#### URL encode: "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "74564518-2bff-4de8-854e-5690d8b3be95",
   "metadata": {},
   "outputs": [],
   "source": [
    "search_expr_url_encode = urllib.parse.quote_plus(search_expr)\n",
    "search_expr_url_encode"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4ba1adce-a84f-494b-8724-ee555d5c7d57",
   "metadata": {},
   "source": [
    "#### Fields:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c5114e6f-8606-4109-ac13-62d2cf22975a",
   "metadata": {},
   "source": [
    "Les champs que l'on veut récupérer:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "af5a1984-b35d-4af6-85ca-d276ffe37af5",
   "metadata": {},
   "outputs": [],
   "source": [
    "fields = [\n",
    "    \"NCTId\",\n",
    "    \"BriefTitle\",\n",
    "    \"OverallStatus\",\n",
    "    \"StudyType\",\n",
    "    \"LeadSponsorName\",\n",
    "    \"CollaboratorName\",\n",
    "    \"OrgStudyId\",\n",
    "    \"SecondaryId\",\n",
    "    \"StudyFirstPostDate\",\n",
    "    \"ReferencePMID\",\n",
    "    \"ReferenceCitation\",\n",
    "    \"ReferenceType\",\n",
    "]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "67d2fde1-5386-4773-b10a-90a8ff153dc5",
   "metadata": {},
   "source": [
    "### Envoi de la requête :"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ee115e0b-e412-4465-994e-b25dd746c5f9",
   "metadata": {},
   "outputs": [],
   "source": [
    "study_fields = ct.get_study_fields(\n",
    "    search_expr=search_expr_url_encode,\n",
    "    fields=fields,\n",
    "    max_studies=1000,\n",
    "    fmt=\"csv\",\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0a86dcfc-d52b-4d7c-8041-b3ffac03b982",
   "metadata": {},
   "outputs": [],
   "source": [
    "print(f\"NStudiesReturned: {len(study_fields[1:])}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "17dec420-05d4-4724-b626-931f5f23c115",
   "metadata": {},
   "source": [
    "### Lire le résultat de la requête dans Pandas :"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "3de5e52f-2e18-4c00-85f2-75b4c3249706",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "34aced60-0e4c-4fec-8379-37026be31837",
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.DataFrame.from_records(study_fields[1:], index=\"Rank\", columns=study_fields[0])"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "21b09539-cd2a-44e6-85bd-fd1a77c2eac7",
   "metadata": {},
   "source": [
    "## API v2:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e47cc848-f6eb-4c27-8f79-c31d2b6f6a27",
   "metadata": {},
   "source": [
    "L'API v1 ne sera plus supporté a partir de mi-2024"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ccb8b923-cd0d-4704-af4d-537bc9ff9448",
   "metadata": {},
   "source": [
    ">***Notice to API users:  \n",
    ">The new ClinicalTrials.gov API, version 2.0 is available. Classic API users are strongly encouraged to switch to the modernized API. We will continue to support the classic API until mid-2024 and are planning blackouts for the spring to help with the transition to the modernized API.***"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4760cf2e-125c-4961-bde4-5939a55a9159",
   "metadata": {},
   "source": [
    "De plus, l'API v2 supporte un nouveau champs **\"HasResults\"**, qui pour l'instant n'est que très peu utilisé mais qui pourrait être utile à l'avenir.\n",
    "\n",
    "En contre-partie, l'export des données sous forme de CSV est limité à un certain nombre de champs visible sur cette page: https://clinicaltrials.gov/data-api/about-api/csv-download\n",
    "\n",
    "On est donc obligé d'utiliser l'export de données sous forme de JSON."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cc42bfa7-3115-410a-8244-d1ad36551a3f",
   "metadata": {},
   "source": [
    "### Création de la requête:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0f8d8cb3-4485-4899-9080-09fa01fa4e46",
   "metadata": {},
   "source": [
    "`pytrials` n'étant pas compatible avec la v2, on envoie la requête manuellement en utilisant [Requests](https://requests.readthedocs.io/en/latest/) "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a5fed10d-6587-43fd-8e93-9dfd937db9e0",
   "metadata": {},
   "source": [
    "#### Format:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c9c74f1a-8345-44a7-8a5e-e034ed6bac96",
   "metadata": {},
   "outputs": [],
   "source": [
    "format = \"json\""
   ]
  },
  {
   "cell_type": "markdown",
   "id": "00b5564b-8a48-4fba-b0eb-f396af6c2f93",
   "metadata": {},
   "source": [
    "#### Sponsors:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "28745196-a342-47e7-9b95-d1f214ba4372",
   "metadata": {},
   "outputs": [],
   "source": [
    "sponsors"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "97255a51-e80a-4ded-878e-116f62b761d9",
   "metadata": {},
   "outputs": [],
   "source": [
    "sponsors_expr_v2 = \" OR \".join(sponsors)\n",
    "sponsors_expr_v2 = urllib.parse.quote_plus(sponsors_expr_v2)\n",
    "sponsors_expr_v2"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f2014ccb-b5ba-4bdb-90e0-040900c08c87",
   "metadata": {},
   "source": [
    "#### Overall_status:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "380fae7f-a745-4cfc-93f2-53d64f75717c",
   "metadata": {},
   "outputs": [],
   "source": [
    "overall_status = \"COMPLETED\""
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7a1431ad-b7a8-4c7c-8f97-cfa13cc1aa61",
   "metadata": {},
   "source": [
    "#### Fields:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "98e9a105-7e78-47cc-b572-b42a67b3aaa7",
   "metadata": {},
   "outputs": [],
   "source": [
    "fields_v2 = [\n",
    "    'NCTId',\n",
    "    'BriefTitle',\n",
    "    'OverallStatus',\n",
    "    'StudyType',\n",
    "    'LeadSponsorName',\n",
    "    'CollaboratorName',\n",
    "    # 'OrgStudyId',\n",
    "    # 'SecondaryId',\n",
    "    'StudyFirstPostDate',\n",
    "    'ReferencePMID',\n",
    "    'ReferenceCitation',\n",
    "    'ReferenceType',\n",
    "    'hasResults'\n",
    "]\n",
    "fields_v2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7830602f-81b0-425c-bc69-f4f96db82948",
   "metadata": {},
   "outputs": [],
   "source": [
    "fields_expr_v2 = \",\".join(fields_v2)\n",
    "fields_expr_v2 = urllib.parse.quote_plus(fields_expr_v2)\n",
    "fields_expr_v2"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fcd86e2b-ebad-4806-b5f4-c9e283db79f4",
   "metadata": {},
   "source": [
    "#### Nombre de résultats:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "fd0b7d3d-0a8b-43bc-a078-00464b940972",
   "metadata": {},
   "outputs": [],
   "source": [
    "count_total = \"true\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "46cc35ff-1519-4433-a6bc-a49bc4c28e1a",
   "metadata": {},
   "outputs": [],
   "source": [
    "page_size = 1000"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c6c28d63-9bcf-4de6-bea0-4d143fcc002d",
   "metadata": {},
   "source": [
    "#### URL api:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "42d61bdd-b160-45b2-a782-d3b1f887d631",
   "metadata": {},
   "outputs": [],
   "source": [
    "query_url = f\"https://clinicaltrials.gov/api/v2/studies?format={format}&query.lead={sponsors_expr_v2}&filter.overallStatus={overall_status}&fields={fields_expr_v2}&countTotal={count_total}&pageSize={page_size}\"\n",
    "query_url"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "da875083-d048-4247-bba1-e71f88d23d6b",
   "metadata": {},
   "source": [
    "### Envoi de la requête :"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "5c83ef54-aa5b-417b-9948-0917421dbb92",
   "metadata": {},
   "outputs": [],
   "source": [
    "import requests"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "bfa9259e-3c18-458b-9286-9e16a08123da",
   "metadata": {},
   "outputs": [],
   "source": [
    "response = requests.get(query_url)\n",
    "response.raise_for_status()\n",
    "response"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "83cb6e68-fe6d-4fd8-90f8-bcd57450af69",
   "metadata": {},
   "outputs": [],
   "source": [
    "print(f'Studies returned: {response.json()[\"totalCount\"]}')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "044debef-36e1-4a84-a483-1e2804c4f79d",
   "metadata": {},
   "source": [
    "### Traitement du JSON retourné:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9032d2aa-2d5c-4b9f-ba47-a0e591129dc9",
   "metadata": {},
   "outputs": [],
   "source": [
    "import json"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e105fd04-80ac-436b-846c-def4df8c2591",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "print(json.dumps(response.json(), indent=2))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f8239b23-3a6b-4541-a657-98ee97e80ea5",
   "metadata": {},
   "source": [
    "***La structure du JSON est bien trop imbriquée pour le normaliser avec Pandas, du coup on l'applatit à la main:***"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1de1fc10-a370-4b0d-8dfc-eaa17dfab0f2",
   "metadata": {},
   "source": [
    "A partir du JSON on construit un dictionnaire équivalent mais beaucoup plus \"plat\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0abd0476-5bc8-44d7-bcf2-a83fd3917852",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Si la liste des collaborateurs est vide on renvoie None, sinon on concatène les valeurs de la liste\n",
    "# sous la forme \"collaborateur_0 | collaborateur_1 | ...\"\n",
    "def concatenate_collaborator_list(collaborator_list):\n",
    "    if collaborator_list == []:\n",
    "        return None\n",
    "    else:\n",
    "        return \" | \".join(collaborator_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c0192b08-9e25-4254-a542-b5b8d55d1388",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "studies_list = []\n",
    "for study in response.json()[\"studies\"]:\n",
    "    study_dict = {\n",
    "        'NCTId' : study[\"protocolSection\"][\"identificationModule\"][\"nctId\"],\n",
    "        'BriefTitle' : study[\"protocolSection\"][\"identificationModule\"][\"briefTitle\"],\n",
    "        'LeadSponsorName' : study[\"protocolSection\"][\"sponsorCollaboratorsModule\"][\"leadSponsor\"][\"name\"],\n",
    "        \"CollaboratorName\": concatenate_collaborator_list(\n",
    "            [c[\"name\"] for c in (\n",
    "                    study[\"protocolSection\"][\"sponsorCollaboratorsModule\"].get(\"collaborators\", [])  # can be missing\n",
    "                )\n",
    "            ]\n",
    "        ),    \n",
    "        'OverallStatus' : study[\"protocolSection\"][\"statusModule\"][\"overallStatus\"],\n",
    "        'StudyType' : study[\"protocolSection\"][\"designModule\"][\"studyType\"],    \n",
    "        'HasResults' : study[\"hasResults\"],\n",
    "        'StudyFirstPostDate' : study[\"protocolSection\"][\"statusModule\"][\"studyFirstPostDateStruct\"][\"date\"],\n",
    "        'Reference' : study[\"protocolSection\"].get(\"referencesModule\", {}).get(\"references\"), # can be missing       \n",
    "    }\n",
    "    studies_list.append(study_dict)\n",
    "print(json.dumps(studies_list, indent=2))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "79beae31-da09-4108-8900-26d423062495",
   "metadata": {},
   "source": [
    "On vérifie que l'on n'a pas perdu de NCTId en route:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "591c6902-e73c-4db6-b27c-89d68e06e2c0",
   "metadata": {},
   "outputs": [],
   "source": [
    "print(f\"Nombre de NCTId: {len(studies_list)}\")\n",
    "assert(response.json()[\"totalCount\"] == len(studies_list))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2536328d-746c-4fab-8245-d498eaa2fc55",
   "metadata": {},
   "source": [
    "### Import dans Pandas"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "a6866a1d-8c4a-4992-815c-66faf4a42a46",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_ct = pd.json_normalize(data = studies_list)\n",
    "df_ct"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bcf7da5f-f67d-4cf6-ab62-136eae59d865",
   "metadata": {},
   "source": [
    "#### On \"explose\" la colonne \"Reference\":\n",
    "\n",
    "Pour chaque NCTId, la colonne réference contient potentiellement une liste de plusieurs références.  \n",
    "Si par exemple, on a 3 références, on veut se retrouver avec 3 lignes, chacune indexée par le même NCTId et contenant une unique réference.  \n",
    "\n",
    "*Avant*:  \n",
    "**`NCTId    Reference`**  \n",
    "`NCT0001, [Ref1, Ref2, Ref3]`   \n",
    "\n",
    "*Après*:  \n",
    "**`NCTId    Reference`**  \n",
    "`NCT0001,   Ref1`  \n",
    "`NCT0001,   Ref2`  \n",
    "`NCT0001,   Ref3`   "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "3af5b2f7-9a14-4d85-823f-5335ec9d66e7",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_ct = df_ct.explode('Reference', ignore_index = True)\n",
    "df_ct"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8a141674-4974-432d-8c4a-4b1c0b9f9970",
   "metadata": {},
   "source": [
    "Pour chaque NCTId, la colonne réference contient maintenant un dictionnaire de la forme:  \n",
    "`{  \n",
    "\"pmid\": \"17545707\",  \n",
    "\"type\": \"BACKGROUND\",  \n",
    "\"citation\": \"...\",  \n",
    "}`\n",
    "\n",
    "Dont on veut extraire de nouvelles colonnes en utilant les clés du dictionnaire:  \n",
    "**`pmid     type        citation`**  \n",
    "`17545707, BACKGROUND, \"...\"`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0b7f8365-bbf5-4e6a-96b0-23946df93a8b",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_ct_references = pd.json_normalize(df_ct.pop('Reference'))\n",
    "df_ct_references"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cb7ea35e-3816-48f8-b91a-526e99768b8e",
   "metadata": {},
   "source": [
    "On réassemble la dataFrame complète:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0f55da6b-f2f3-4554-88b0-dac5850614d4",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_ct = df_ct.join(df_references)\n",
    "df_ct"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0e42f325-90f5-415a-a500-e4caea12146a",
   "metadata": {},
   "source": [
    "***On reconstruit l'index :***"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "a76d82bd-7c03-4a42-bca1-1d56efa90532",
   "metadata": {},
   "outputs": [],
   "source": [
    "# df_studies_v2.set_index('NCTId', inplace = True)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cd0416a3-4af4-45d2-b4a0-167004409a31",
   "metadata": {},
   "source": [
    "***On précise les types :***"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b191aeb2-c4cb-431d-a7d1-074f30454ad7",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_ct = df_ct.convert_dtypes()\n",
    "# df_ct = df_ct.astype({\"OverallStatus\" : 'category', \"StudyType\" : 'category', \"type\": 'category',})\n",
    "df_ct = df_ct.astype({\"OverallStatus\" : 'category', \"StudyType\" : 'category'})\n",
    "df_ct.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 338,
   "id": "c5c3a664-539b-40d0-af12-fdc0d7f7f3ff",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>pmid</th>\n",
       "      <th>type</th>\n",
       "      <th>citation</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT01895920</td>\n",
       "      <td>Viral Biofilms: Hijacking T Cell Extracellular...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2013-07-11</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02486731</td>\n",
       "      <td>Hormonal Sensitivity in Patients With Noonan a...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2015-07-01</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02116374</td>\n",
       "      <td>Physiopathology Study of the Microbiota Biodiv...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2014-04-16</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT03537196</td>\n",
       "      <td>DRug Use &amp; Infections in ViEtnam - Hepatitis C...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2018-05-25</td>\n",
       "      <td>25086286</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Gower E, Estes C, Blach S, Razavi-Shearer K, R...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT03537196</td>\n",
       "      <td>DRug Use &amp; Infections in ViEtnam - Hepatitis C...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2018-05-25</td>\n",
       "      <td>23172780</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersm...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT03537196</td>\n",
       "      <td>DRug Use &amp; Infections in ViEtnam - Hepatitis C...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2018-05-25</td>\n",
       "      <td>22828983</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Sereno L, Mesquita F, Kato M, Jacka D, Nguyen ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>NCT03537196</td>\n",
       "      <td>DRug Use &amp; Infections in ViEtnam - Hepatitis C...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2018-05-25</td>\n",
       "      <td>20041309</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Clatts MC, Colon-Lopez V, Giang LM, Goldsamt L...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT03537196</td>\n",
       "      <td>DRug Use &amp; Infections in ViEtnam - Hepatitis C...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2018-05-25</td>\n",
       "      <td>22098550</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Gish RG, Bui TD, Nguyen CT, Nguyen DT, Tran HV...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT03537196</td>\n",
       "      <td>DRug Use &amp; Infections in ViEtnam - Hepatitis C...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2018-05-25</td>\n",
       "      <td>20196807</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Kallman JB, Tran S, Arsalla A, Haddad D, Stepa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>NCT03537196</td>\n",
       "      <td>DRug Use &amp; Infections in ViEtnam - Hepatitis C...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2018-05-25</td>\n",
       "      <td>19839502</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Pham DA, Leuangwutiwong P, Jittmittraphap A, L...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         NCTId                                         BriefTitle  \\\n",
       "0  NCT01895920  Viral Biofilms: Hijacking T Cell Extracellular...   \n",
       "1  NCT02486731  Hormonal Sensitivity in Patients With Noonan a...   \n",
       "2  NCT02116374  Physiopathology Study of the Microbiota Biodiv...   \n",
       "3  NCT03537196  DRug Use & Infections in ViEtnam - Hepatitis C...   \n",
       "4  NCT03537196  DRug Use & Infections in ViEtnam - Hepatitis C...   \n",
       "5  NCT03537196  DRug Use & Infections in ViEtnam - Hepatitis C...   \n",
       "6  NCT03537196  DRug Use & Infections in ViEtnam - Hepatitis C...   \n",
       "7  NCT03537196  DRug Use & Infections in ViEtnam - Hepatitis C...   \n",
       "8  NCT03537196  DRug Use & Infections in ViEtnam - Hepatitis C...   \n",
       "9  NCT03537196  DRug Use & Infections in ViEtnam - Hepatitis C...   \n",
       "\n",
       "                                     LeadSponsorName CollaboratorName  \\\n",
       "0                 ANRS, Emerging Infectious Diseases             <NA>   \n",
       "1  Institut National de la Santé Et de la Recherc...             <NA>   \n",
       "2                 ANRS, Emerging Infectious Diseases             <NA>   \n",
       "3                 ANRS, Emerging Infectious Diseases             <NA>   \n",
       "4                 ANRS, Emerging Infectious Diseases             <NA>   \n",
       "5                 ANRS, Emerging Infectious Diseases             <NA>   \n",
       "6                 ANRS, Emerging Infectious Diseases             <NA>   \n",
       "7                 ANRS, Emerging Infectious Diseases             <NA>   \n",
       "8                 ANRS, Emerging Infectious Diseases             <NA>   \n",
       "9                 ANRS, Emerging Infectious Diseases             <NA>   \n",
       "\n",
       "  OverallStatus       StudyType  HasResults StudyFirstPostDate      pmid  \\\n",
       "0     COMPLETED  INTERVENTIONAL       False         2013-07-11      <NA>   \n",
       "1     COMPLETED   OBSERVATIONAL       False         2015-07-01      <NA>   \n",
       "2     COMPLETED   OBSERVATIONAL       False         2014-04-16      <NA>   \n",
       "3     COMPLETED  INTERVENTIONAL       False         2018-05-25  25086286   \n",
       "4     COMPLETED  INTERVENTIONAL       False         2018-05-25  23172780   \n",
       "5     COMPLETED  INTERVENTIONAL       False         2018-05-25  22828983   \n",
       "6     COMPLETED  INTERVENTIONAL       False         2018-05-25  20041309   \n",
       "7     COMPLETED  INTERVENTIONAL       False         2018-05-25  22098550   \n",
       "8     COMPLETED  INTERVENTIONAL       False         2018-05-25  20196807   \n",
       "9     COMPLETED  INTERVENTIONAL       False         2018-05-25  19839502   \n",
       "\n",
       "         type                                           citation  \n",
       "0        <NA>                                               <NA>  \n",
       "1        <NA>                                               <NA>  \n",
       "2        <NA>                                               <NA>  \n",
       "3  BACKGROUND  Gower E, Estes C, Blach S, Razavi-Shearer K, R...  \n",
       "4  BACKGROUND  Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersm...  \n",
       "5  BACKGROUND  Sereno L, Mesquita F, Kato M, Jacka D, Nguyen ...  \n",
       "6  BACKGROUND  Clatts MC, Colon-Lopez V, Giang LM, Goldsamt L...  \n",
       "7  BACKGROUND  Gish RG, Bui TD, Nguyen CT, Nguyen DT, Tran HV...  \n",
       "8  BACKGROUND  Kallman JB, Tran S, Arsalla A, Haddad D, Stepa...  \n",
       "9  BACKGROUND  Pham DA, Leuangwutiwong P, Jittmittraphap A, L...  "
      ]
     },
     "execution_count": 338,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_ct.head(10)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a7b5fc9d-ac46-475b-b842-6fb462dd4860",
   "metadata": {},
   "source": [
    "#### Export en CSV :"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 263,
   "id": "48250189-42cc-4bc8-ab9d-f143850c541d",
   "metadata": {},
   "outputs": [],
   "source": [
    "# df_studies_v2.to_csv('Data/outputs/extract_CT_api_v2.csv', sep=\";\", encoding='utf-8-sig')\n",
    "df_ct.to_csv('Data/outputs/extract_CT_api_v2.csv', sep=\";\", index=False, encoding='utf-8-sig')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f4754b32-ee8e-4b1c-b634-7177c4e273ab",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "5dc82c20-529d-463f-a5ae-7a8ba6a07684",
   "metadata": {},
   "source": [
    "# PubMed"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cde7add4-bea7-4155-a522-a4bc75979ebd",
   "metadata": {},
   "source": [
    "### Utilisation d'une clé pour l'API Pubmed : "
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "id": "9679e4c2-6f3c-4754-bd37-44646d6f7633",
   "metadata": {},
   "source": [
    "Il est recommandé d'utiliser une clé pour accéder à l'API Pubmed, ce qui permet de lancer jusqu'à 10 requêtes par seconde.  \n",
    "Sans clé, la limite est de 3 requêtes par seconde.  \n",
    "\n",
    "> E-utils users are allowed 3 requests/second without an API key. Create an API key to increase your e-utils limit to 10 requests/second.\n",
    "\n",
    "**En pratique, l'API Pubmed étant beaucoup plus lente (~1 requête par seconde), cela ne semble pas changer grand chose.**\n",
    "\n",
    "Pour récupérer sa clé, se rendre sur la page en étant loggué:\n",
    "https://account.ncbi.nlm.nih.gov/settings/\n",
    "\n",
    "Une fois la clé récupérée, l'ajouter aux variables d'environnement avec la commande suivante:\n",
    "\n",
    "**Windows :** \n",
    "\n",
    "`setx NCBI_API_KEY “123456\"`\n",
    "\n",
    "**Linux/MacOS :**\n",
    "\n",
    "`export NCBI_API_KEY = 123456`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 264,
   "id": "ccc06834-ea85-48c2-b66b-f9ef01329ec7",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "\n",
    "assert(os.getenv('NCBI_API_KEY', None) is not None)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "494cb7ad-b0c7-4cc5-86fe-c0e40f9a1ff5",
   "metadata": {},
   "source": [
    "### Installer metapub :\n",
    "- Dans Conda Navigator, se placer dans le meme environnement que celui qui execute Jupyter  \n",
    "- Lancer Powershell Prompt dans cet environnement  \n",
    "- Taper la commande suivante :  `pip install metapub`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "id": "1f910a19-7c98-4f30-ba71-2e9b5364a267",
   "metadata": {},
   "outputs": [],
   "source": [
    "from metapub import PubMedFetcher\n",
    "from metapub.exceptions import InvalidPMID\n",
    "\n",
    "fetch = PubMedFetcher(cachedir='./.cache/')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7103b475-2af0-4a49-9581-4f8196e29d87",
   "metadata": {},
   "source": [
    "#### Récupération des PMIDs via PubMed:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9bc92598-3bee-4975-8fd2-efe55de4050d",
   "metadata": {},
   "source": [
    "Pour chaque NCTId de CT, on récupère les PMIDs des publications associées via PubMed:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "id": "36a9a2dc-fa3b-4959-96e1-2ca4146c4427",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "286/286..."
     ]
    }
   ],
   "source": [
    "# Liste unique des NCTId extraits de ClinicalTrial\n",
    "nctid_array = df_ct.loc[:, \"NCTId\"].unique()\n",
    "\n",
    "pmids_pubmed_dict = {}\n",
    "for i, nctid in enumerate(nctid_array):\n",
    "    # Display the progress on a single line\n",
    "    print(f\"\\r{i+1}/{len(nctid_array)}...\", end=\"\", flush=True)\n",
    "    \n",
    "    pmids = [pmid for pmid in fetch.pmids_for_query(nctid)]\n",
    "    pmids_pubmed_dict[nctid] = set(pmids)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "id": "6724fc4b-eff7-4c44-b5c8-63a4045f9507",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'NCT01895920': set(),\n",
       " 'NCT02486731': set(),\n",
       " 'NCT02116374': set(),\n",
       " 'NCT03537196': {'33208326'},\n",
       " 'NCT01899196': set(),\n",
       " 'NCT04631224': set(),\n",
       " 'NCT01579435': set(),\n",
       " 'NCT03235258': set(),\n",
       " 'NCT00383734': {'23432777'},\n",
       " 'NCT00901524': {'24905490'},\n",
       " 'NCT01493934': set(),\n",
       " 'NCT03078439': {'38408861'},\n",
       " 'NCT04808986': set(),\n",
       " 'NCT01207986': set(),\n",
       " 'NCT02626286': {'33753460', '34022820', '34352834'},\n",
       " 'NCT02527096': set(),\n",
       " 'NCT00121758': {'20625264', '23759749'},\n",
       " 'NCT04684758': set(),\n",
       " 'NCT02057796': {'32558469', '36883573'},\n",
       " 'NCT03071458': set(),\n",
       " 'NCT02192658': {'26846895'},\n",
       " 'NCT01713335': set(),\n",
       " 'NCT00158522': set(),\n",
       " 'NCT00640263': {'23039034',\n",
       "  '26603917',\n",
       "  '27895016',\n",
       "  '28469697',\n",
       "  '30814028',\n",
       "  '31633158',\n",
       "  '31994250',\n",
       "  '32067040',\n",
       "  '32228542',\n",
       "  '32991450',\n",
       "  '34425825'},\n",
       " 'NCT02428816': set(),\n",
       " 'NCT00122616': {'23800784'},\n",
       " 'NCT00196586': set(),\n",
       " 'NCT00148863': {'23190183'},\n",
       " 'NCT03150290': set(),\n",
       " 'NCT01514890': {'23669289', '24704719', '25556540'},\n",
       " 'NCT03652090': set(),\n",
       " 'NCT02738502': set(),\n",
       " 'NCT02212379': {'31269208'},\n",
       " 'NCT00465790': set(),\n",
       " 'NCT01605890': {'29590335'},\n",
       " 'NCT00196664': set(),\n",
       " 'NCT00122603': {'19420019'},\n",
       " 'NCT02992184': {'29615488'},\n",
       " 'NCT02071784': set(),\n",
       " 'NCT01432821': set(),\n",
       " 'NCT00121121': {'17712402'},\n",
       " 'NCT02126384': set(),\n",
       " 'NCT02323308': set(),\n",
       " 'NCT02314208': set(),\n",
       " 'NCT01348308': {'32040959'},\n",
       " 'NCT02113943': set(),\n",
       " 'NCT00299143': set(),\n",
       " 'NCT04824638': set(),\n",
       " 'NCT00120367': {'21738597'},\n",
       " 'NCT00323804': set(),\n",
       " 'NCT03642704': set(),\n",
       " 'NCT04849767': {'34916316'},\n",
       " 'NCT00573001': set(),\n",
       " 'NCT02267304': set(),\n",
       " 'NCT01525472': set(),\n",
       " 'NCT02073604': set(),\n",
       " 'NCT01127204': {'27015798',\n",
       "  '28434406',\n",
       "  '28453240',\n",
       "  '28483965',\n",
       "  '28800382',\n",
       "  '31334298',\n",
       "  '34723858'},\n",
       " 'NCT01473472': {'26624850', '28747274', '29229440', '31784343', '36601747'},\n",
       " 'NCT00122538': {'20516271', '21857286', '23719348'},\n",
       " 'NCT01555450': {'28823681', '29909873'},\n",
       " 'NCT01696708': {'25568297'},\n",
       " 'NCT01100281': set(),\n",
       " 'NCT00424814': {'23766338', '25838291'},\n",
       " 'NCT00946595': {'29767684', '30968368'},\n",
       " 'NCT02488395': set(),\n",
       " 'NCT03335995': {'32026446', '37497675'},\n",
       " 'NCT01647295': set(),\n",
       " 'NCT01226446': {'25987791'},\n",
       " 'NCT00658346': {'31063537'},\n",
       " 'NCT01874808': set(),\n",
       " 'NCT01509508': {'23880306',\n",
       "  '25880823',\n",
       "  '27504637',\n",
       "  '28329393',\n",
       "  '29199100',\n",
       "  '29890048',\n",
       "  '30027600',\n",
       "  '30321314',\n",
       "  '30412926',\n",
       "  '31637821',\n",
       "  '32970730'},\n",
       " 'NCT00391638': set(),\n",
       " 'NCT01426243': {'26314624', '30096071'},\n",
       " 'NCT02496312': set(),\n",
       " 'NCT03519503': set(),\n",
       " 'NCT00196612': set(),\n",
       " 'NCT04133012': set(),\n",
       " 'NCT03298360': set(),\n",
       " 'NCT01490489': set(),\n",
       " 'NCT04780191': set(),\n",
       " 'NCT01164462': set(),\n",
       " 'NCT02051413': set(),\n",
       " 'NCT01531036': set(),\n",
       " 'NCT01164436': set(),\n",
       " 'NCT00870649': {'30532268'},\n",
       " 'NCT01842919': set(),\n",
       " 'NCT06260319': set(),\n",
       " 'NCT01569399': set(),\n",
       " 'NCT03193099': set(),\n",
       " 'NCT01094899': set(),\n",
       " 'NCT01038999': {'22829920', '23285253'},\n",
       " 'NCT03831906': {'32853411', '33743621', '36395782'},\n",
       " 'NCT01008813': set(),\n",
       " 'NCT00604149': set(),\n",
       " 'NCT01779713': {'30354977'},\n",
       " 'NCT02160119': set(),\n",
       " 'NCT01207349': {'22030240'},\n",
       " 'NCT00944541': set(),\n",
       " 'NCT02102737': set(),\n",
       " 'NCT01942655': set(),\n",
       " 'NCT03870438': set(),\n",
       " 'NCT04945655': {'35332045'},\n",
       " 'NCT01188512': {'24261996', '24421886', '24793938'},\n",
       " 'NCT01038401': set(),\n",
       " 'NCT01086904': set(),\n",
       " 'NCT01332955': {'25139963'},\n",
       " 'NCT02469350': {'29636105'},\n",
       " 'NCT00480792': {'21486976', '27064975'},\n",
       " 'NCT04484740': set(),\n",
       " 'NCT01095744': set(),\n",
       " 'NCT00236340': set(),\n",
       " 'NCT02384967': {'29905808'},\n",
       " 'NCT03109067': set(),\n",
       " 'NCT00988767': {'20090916'},\n",
       " 'NCT01552044': set(),\n",
       " 'NCT03047967': set(),\n",
       " 'NCT05199831': set(),\n",
       " 'NCT00113282': set(),\n",
       " 'NCT01039220': set(),\n",
       " 'NCT04265742': set(),\n",
       " 'NCT01089400': {'24646009'},\n",
       " 'NCT00445575': set(),\n",
       " 'NCT00158496': set(),\n",
       " 'NCT01271842': {'22948576'},\n",
       " 'NCT01917175': set(),\n",
       " 'NCT01905059': {'28566227'},\n",
       " 'NCT01592175': set(),\n",
       " 'NCT00574652': {'22129253'},\n",
       " 'NCT02236832': set(),\n",
       " 'NCT01269632': set(),\n",
       " 'NCT01024400': {'22147712'},\n",
       " 'NCT02542800': set(),\n",
       " 'NCT00158470': set(),\n",
       " 'NCT01779752': set(),\n",
       " 'NCT03005652': {'33873195', '35853750', '36068621', '38100477'},\n",
       " 'NCT01311752': set(),\n",
       " 'NCT02916732': {'29539287', '33657112'},\n",
       " 'NCT03215732': {'31320358', '37143029'},\n",
       " 'NCT02405013': {'36686592'},\n",
       " 'NCT00820118': {'26568566'},\n",
       " 'NCT01952587': set(),\n",
       " 'NCT00640887': {'25406657', '26482301'},\n",
       " 'NCT01725542': {'25977266'},\n",
       " 'NCT02038842': set(),\n",
       " 'NCT00115609': set(),\n",
       " 'NCT04120415': set(),\n",
       " 'NCT01192737': set(),\n",
       " 'NCT00265642': set(),\n",
       " 'NCT00918307': {'29329763', '34611902'},\n",
       " 'NCT01089387': {'25974235', '26439886', '28753830'},\n",
       " 'NCT00928187': {'31273686'},\n",
       " 'NCT03324633': {'30570526', '32798585', '34212476'},\n",
       " 'NCT02027051': set(),\n",
       " 'NCT02027233': set(),\n",
       " 'NCT00136630': {'22491195', '24780882'},\n",
       " 'NCT03459157': {'34048794'},\n",
       " 'NCT05040048': set(),\n",
       " 'NCT04470648': set(),\n",
       " 'NCT02497274': set(),\n",
       " 'NCT05311865': {'36438274', '37795682'},\n",
       " 'NCT00158457': set(),\n",
       " 'NCT04315948': {'32304640',\n",
       "  '32958495',\n",
       "  '33264556',\n",
       "  '34048876',\n",
       "  '34350582',\n",
       "  '34473343',\n",
       "  '34534511',\n",
       "  '35233617',\n",
       "  '35512728',\n",
       "  '36695483',\n",
       "  '37728045'},\n",
       " 'NCT01620957': set(),\n",
       " 'NCT01693848': set(),\n",
       " 'NCT02107365': set(),\n",
       " 'NCT00196625': set(),\n",
       " 'NCT01359774': set(),\n",
       " 'NCT02273765': {'33667406'},\n",
       " 'NCT00490074': set(),\n",
       " 'NCT02081066': set(),\n",
       " 'NCT00651066': {'24465443'},\n",
       " 'NCT02566148': {'29307383', '29437866', '29982518'},\n",
       " 'NCT02073630': set(),\n",
       " 'NCT02573948': set(),\n",
       " 'NCT00339157': {'21173013'},\n",
       " 'NCT02453048': {'31945015', '32687804'},\n",
       " 'NCT03446430': set(),\n",
       " 'NCT00120757': {'22353022'},\n",
       " 'NCT02987530': set(),\n",
       " 'NCT02100774': {'24808487', '26063065', '27798339'},\n",
       " 'NCT00460382': set(),\n",
       " 'NCT00820820': set(),\n",
       " 'NCT01066962': {'25103176', '26520926', '30365452', '33794182'},\n",
       " 'NCT03671291': set(),\n",
       " 'NCT00117494': {'22318219', '22739396'},\n",
       " 'NCT01771562': {'27881690', '30081838'},\n",
       " 'NCT02542891': {'27488181', '34874888'},\n",
       " 'NCT01508494': set(),\n",
       " 'NCT05349162': {'36735263'},\n",
       " 'NCT01882062': {'25568297'},\n",
       " 'NCT01489592': set(),\n",
       " 'NCT01453192': {'30688008'},\n",
       " 'NCT01033760': {'25701561', '28708873'},\n",
       " 'NCT00545194': set(),\n",
       " 'NCT00528060': {'23459496'},\n",
       " 'NCT02650427': set(),\n",
       " 'NCT04008927': {'35774932'},\n",
       " 'NCT01022476': set(),\n",
       " 'NCT01335529': {'27077673'},\n",
       " 'NCT02014727': {'28947345'},\n",
       " 'NCT00536627': {'24394187', '24555998'},\n",
       " 'NCT02078076': set(),\n",
       " 'NCT02777229': {'31339676', '33010241', '33355914', '37851566', '38156046'},\n",
       " 'NCT01703962': {'37668523'},\n",
       " 'NCT03546127': set(),\n",
       " 'NCT01331876': set(),\n",
       " 'NCT02886416': set(),\n",
       " 'NCT01188525': set(),\n",
       " 'NCT00302822': set(),\n",
       " 'NCT01693835': set(),\n",
       " 'NCT02978924': set(),\n",
       " 'NCT00226434': {'24096631', '24759827'},\n",
       " 'NCT00148824': {'20210645'},\n",
       " 'NCT00670839': {'26257021'},\n",
       " 'NCT01548586': set(),\n",
       " 'NCT01801618': {'29662875'},\n",
       " 'NCT01055873': {'22427678'},\n",
       " 'NCT00495326': {'23433590', '24663014'},\n",
       " 'NCT02099474': {'32661003'},\n",
       " 'NCT02592174': {'31755936'},\n",
       " 'NCT00334256': set(),\n",
       " 'NCT01492985': {'33568510'},\n",
       " 'NCT02125500': set(),\n",
       " 'NCT00196599': set(),\n",
       " 'NCT02906137': set(),\n",
       " 'NCT02647632': {'29077864'},\n",
       " 'NCT00822315': {'24726095'},\n",
       " 'NCT01413152': set(),\n",
       " 'NCT01463956': set(),\n",
       " 'NCT00454337': {'19757993', '21712241', '27042193'},\n",
       " 'NCT01698411': set(),\n",
       " 'NCT02214511': set(),\n",
       " 'NCT01331811': {'26908804', '29174612', '30689814', '31455612'},\n",
       " 'NCT05090956': set(),\n",
       " 'NCT00120185': {'19508157'},\n",
       " 'NCT04392388': {'34293141'},\n",
       " 'NCT01065207': set(),\n",
       " 'NCT02082171': set(),\n",
       " 'NCT02052271': set(),\n",
       " 'NCT00158509': {'17314338', '18593294', '18596069'},\n",
       " 'NCT02346409': set(),\n",
       " 'NCT02656407': set(),\n",
       " 'NCT02150993': set(),\n",
       " 'NCT00657397': {'22741944',\n",
       "  '24268548',\n",
       "  '25209306',\n",
       "  '25393311',\n",
       "  '27048152',\n",
       "  '27770695'},\n",
       " 'NCT03137797': set(),\n",
       " 'NCT01167283': set(),\n",
       " 'NCT02014883': {'26536893'},\n",
       " 'NCT02931097': set(),\n",
       " 'NCT02093754': set(),\n",
       " 'NCT00116454': set(),\n",
       " 'NCT03954054': {'35012570'},\n",
       " 'NCT02329054': {'26930627', '28231247'},\n",
       " 'NCT04842851': set(),\n",
       " 'NCT00118677': {'20657770'},\n",
       " 'NCT01880151': set(),\n",
       " 'NCT00495651': {'23639243',\n",
       "  '24985779',\n",
       "  '25330161',\n",
       "  '26193126',\n",
       "  '29020361',\n",
       "  '29297443',\n",
       "  '35093007'},\n",
       " 'NCT02481453': {'38273639'},\n",
       " 'NCT00421551': {'20802297', '22848481', '29767684'},\n",
       " 'NCT02658253': {'32032566', '33717176'},\n",
       " 'NCT01688453': {'29696179',\n",
       "  '29776897',\n",
       "  '29934380',\n",
       "  '32097754',\n",
       "  '34087324',\n",
       "  '35272723'},\n",
       " 'NCT02408354': {'28969699'},\n",
       " 'NCT02157311': {'29186458'},\n",
       " 'NCT04288128': {'38419144', '38421662'},\n",
       " 'NCT02721745': set(),\n",
       " 'NCT01494961': {'23343912', '29178852', '34329355'},\n",
       " 'NCT02833961': {'36318030'},\n",
       " 'NCT02567071': set(),\n",
       " 'NCT02453061': {'31381524'},\n",
       " 'NCT01693861': set(),\n",
       " 'NCT00272428': {'19491388',\n",
       "  '19828715',\n",
       "  '20176858',\n",
       "  '20431391',\n",
       "  '20605091',\n",
       "  '21106918',\n",
       "  '21490142',\n",
       "  '21775560',\n",
       "  '21955649',\n",
       "  '22158670',\n",
       "  '22378736',\n",
       "  '22633793',\n",
       "  '23082222',\n",
       "  '23283500',\n",
       "  '23284983',\n",
       "  '24027184',\n",
       "  '24089418',\n",
       "  '24527713',\n",
       "  '24553693',\n",
       "  '25651444',\n",
       "  '25994566',\n",
       "  '26156743',\n",
       "  '26409628',\n",
       "  '26447153',\n",
       "  '26812508',\n",
       "  '26817718',\n",
       "  '26864363',\n",
       "  '26962176',\n",
       "  '27000099',\n",
       "  '27055851',\n",
       "  '28033414',\n",
       "  '28356432',\n",
       "  '28494135',\n",
       "  '29546305',\n",
       "  '29649036',\n",
       "  '30517725',\n",
       "  '31164347',\n",
       "  '31927670',\n",
       "  '33738534'},\n",
       " 'NCT01534728': set(),\n",
       " 'NCT04409405': {'38043556'},\n",
       " 'NCT02976298': set(),\n",
       " 'NCT00647205': set(),\n",
       " 'NCT02960698': set(),\n",
       " 'NCT01842477': set(),\n",
       " 'NCT01037777': {'23707147', '24780882', '32822634', '35264424'},\n",
       " 'NCT02172677': set(),\n",
       " 'NCT02101398': set(),\n",
       " 'NCT01495897': set(),\n",
       " 'NCT00463983': {'22379151'},\n",
       " 'NCT00158483': {'19530940'},\n",
       " 'NCT00301561': {'21831714', '35248123'},\n",
       " 'NCT01075061': set(),\n",
       " 'NCT00158405': {'16782488', '18986246'},\n",
       " 'NCT00623051': set()}"
      ]
     },
     "execution_count": 71,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pmids_pubmed_dict"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "351d2549-e3c2-4331-b90b-3ea14530008e",
   "metadata": {},
   "source": [
    "**On veut fusionner la liste PMIDs que l'on vient de récupérer sur PubMed, à la liste des PMIDs déjà récupérés via CT.**"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4c8b94f1-2851-40b8-9ed2-77348b74477e",
   "metadata": {},
   "source": [
    "On met les PMIDs de CT sous la même forme:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "id": "6ddaabb3-f3ce-4a4d-9ef9-4d391c7205df",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'NCT01895920': set(),\n",
       " 'NCT02486731': set(),\n",
       " 'NCT02116374': set(),\n",
       " 'NCT03537196': {'19839502',\n",
       "  '20041309',\n",
       "  '20196807',\n",
       "  '20572071',\n",
       "  '22098550',\n",
       "  '22564041',\n",
       "  '22828983',\n",
       "  '23172780',\n",
       "  '23553643',\n",
       "  '23675659',\n",
       "  '23728143',\n",
       "  '23884064',\n",
       "  '25086286',\n",
       "  '25245939',\n",
       "  '25920094',\n",
       "  '26298331',\n",
       "  '27148964',\n",
       "  '27178119',\n",
       "  '27227200',\n",
       "  '27349488',\n",
       "  '27427455',\n",
       "  '27667367',\n",
       "  '33208326'},\n",
       " 'NCT01899196': set(),\n",
       " 'NCT04631224': set(),\n",
       " 'NCT01579435': set(),\n",
       " 'NCT03235258': {'17712765',\n",
       "  '18614870',\n",
       "  '19194272',\n",
       "  '20536367',\n",
       "  '21511330',\n",
       "  '21971357',\n",
       "  '22198788',\n",
       "  '22427678',\n",
       "  '24253249',\n",
       "  '24705410',\n",
       "  '24945880',\n",
       "  '26762993'},\n",
       " 'NCT00383734': {'23432777'},\n",
       " 'NCT00901524': {'24905490'},\n",
       " 'NCT01493934': set(),\n",
       " 'NCT03078439': set(),\n",
       " 'NCT04808986': set(),\n",
       " 'NCT01207986': set(),\n",
       " 'NCT02626286': {'33753460', '34022820', '34352834'},\n",
       " 'NCT02527096': set(),\n",
       " 'NCT00121758': {'20625264', '23759749'},\n",
       " 'NCT04684758': set(),\n",
       " 'NCT02057796': {'32558469'},\n",
       " 'NCT03071458': set(),\n",
       " 'NCT02192658': {'26846895'},\n",
       " 'NCT01713335': set(),\n",
       " 'NCT00158522': {'15977225', '16434426'},\n",
       " 'NCT00640263': {'17825642',\n",
       "  '23039034',\n",
       "  '26603917',\n",
       "  '27895016',\n",
       "  '28469697',\n",
       "  '30814028',\n",
       "  '31633158',\n",
       "  '31994250',\n",
       "  '32067040',\n",
       "  '32228542',\n",
       "  '32991450'},\n",
       " 'NCT02428816': set(),\n",
       " 'NCT00122616': {'23800784'},\n",
       " 'NCT00196586': set(),\n",
       " 'NCT00148863': {'23190183'},\n",
       " 'NCT03150290': set(),\n",
       " 'NCT01514890': {'23669289', '24704719', '25556540'},\n",
       " 'NCT03652090': set(),\n",
       " 'NCT02738502': {'22160145',\n",
       "  '22848481',\n",
       "  '23559464',\n",
       "  '23766338',\n",
       "  '26197844',\n",
       "  '26709605',\n",
       "  '26854809'},\n",
       " 'NCT02212379': set(),\n",
       " 'NCT00465790': set(),\n",
       " 'NCT01605890': {'29590335'},\n",
       " 'NCT00196664': set(),\n",
       " 'NCT00122603': {'19420019'},\n",
       " 'NCT02992184': {'29615488'},\n",
       " 'NCT02071784': set(),\n",
       " 'NCT01432821': {'12914551', '15037514', '15249613', '15777732', '2271377'},\n",
       " 'NCT00121121': {'17712402'},\n",
       " 'NCT02126384': set(),\n",
       " 'NCT02323308': set(),\n",
       " 'NCT02314208': set(),\n",
       " 'NCT01348308': {'32040959'},\n",
       " 'NCT02113943': set(),\n",
       " 'NCT00299143': set(),\n",
       " 'NCT04824638': set(),\n",
       " 'NCT00120367': {'21738597'},\n",
       " 'NCT00323804': set(),\n",
       " 'NCT03642704': set(),\n",
       " 'NCT04849767': {'34916316'},\n",
       " 'NCT00573001': set(),\n",
       " 'NCT02267304': set(),\n",
       " 'NCT01525472': set(),\n",
       " 'NCT02073604': set(),\n",
       " 'NCT01127204': {'27015798',\n",
       "  '28434406',\n",
       "  '28453240',\n",
       "  '28483965',\n",
       "  '28800382',\n",
       "  '31334298',\n",
       "  '34723858'},\n",
       " 'NCT01473472': {'26624850', '28747274', '29229440', '31784343'},\n",
       " 'NCT00122538': {'20516271', '21857286', '23719348'},\n",
       " 'NCT01555450': {'21256688', '28823681', '29909873'},\n",
       " 'NCT01696708': {'25568297'},\n",
       " 'NCT01100281': set(),\n",
       " 'NCT00424814': {'23766338', '25838291'},\n",
       " 'NCT00946595': {'29767684', '30968368'},\n",
       " 'NCT02488395': {'22639796', '23916713', '6774653'},\n",
       " 'NCT03335995': {'32026446'},\n",
       " 'NCT01647295': set(),\n",
       " 'NCT01226446': {'25987791'},\n",
       " 'NCT00658346': {'31063537'},\n",
       " 'NCT01874808': set(),\n",
       " 'NCT01509508': {'23880306',\n",
       "  '25880823',\n",
       "  '27504637',\n",
       "  '28329393',\n",
       "  '29199100',\n",
       "  '29890048',\n",
       "  '30027600',\n",
       "  '30321314',\n",
       "  '30412926',\n",
       "  '31637821',\n",
       "  '32970730'},\n",
       " 'NCT00391638': set(),\n",
       " 'NCT01426243': {'30096071'},\n",
       " 'NCT02496312': {'10436334',\n",
       "  '10678322',\n",
       "  '10941190',\n",
       "  '12461757',\n",
       "  '15897497',\n",
       "  '16207933',\n",
       "  '16421064',\n",
       "  '17027767',\n",
       "  '17131230',\n",
       "  '1821241',\n",
       "  '18307266',\n",
       "  '19533496',\n",
       "  '19713543',\n",
       "  '19933975',\n",
       "  '21895376'},\n",
       " 'NCT03519503': {'21602695', '22814853', '26603917'},\n",
       " 'NCT00196612': {'15717256'},\n",
       " 'NCT04133012': set(),\n",
       " 'NCT03298360': set(),\n",
       " 'NCT01490489': {'16384869', '17531315', '19602057'},\n",
       " 'NCT04780191': {'32232101'},\n",
       " 'NCT01164462': set(),\n",
       " 'NCT02051413': set(),\n",
       " 'NCT01531036': {'20505064'},\n",
       " 'NCT01164436': set(),\n",
       " 'NCT00870649': {'30532268'},\n",
       " 'NCT01842919': set(),\n",
       " 'NCT06260319': set(),\n",
       " 'NCT01569399': set(),\n",
       " 'NCT03193099': set(),\n",
       " 'NCT01094899': set(),\n",
       " 'NCT01038999': {'22829920', '23285253'},\n",
       " 'NCT03831906': {'32853411', '33743621', '36395782'},\n",
       " 'NCT01008813': set(),\n",
       " 'NCT00604149': set(),\n",
       " 'NCT01779713': {'30354977'},\n",
       " 'NCT02160119': set(),\n",
       " 'NCT01207349': {'22030240'},\n",
       " 'NCT00944541': set(),\n",
       " 'NCT02102737': set(),\n",
       " 'NCT01942655': set(),\n",
       " 'NCT03870438': {'26603917', '33872801'},\n",
       " 'NCT04945655': {'35332045'},\n",
       " 'NCT01188512': {'16839199',\n",
       "  '18762220',\n",
       "  '19625486',\n",
       "  '20107007',\n",
       "  '20184606',\n",
       "  '24261996',\n",
       "  '24421886',\n",
       "  '24793938'},\n",
       " 'NCT01038401': set(),\n",
       " 'NCT01086904': set(),\n",
       " 'NCT01332955': {'25139963'},\n",
       " 'NCT02469350': {'29636105'},\n",
       " 'NCT00480792': {'21486976', '27064975'},\n",
       " 'NCT04484740': set(),\n",
       " 'NCT01095744': set(),\n",
       " 'NCT00236340': {'11438952', '14770396', '7970458', '9464739'},\n",
       " 'NCT02384967': {'29905808'},\n",
       " 'NCT03109067': set(),\n",
       " 'NCT00988767': {'15382173', '16310901', '20090916'},\n",
       " 'NCT01552044': set(),\n",
       " 'NCT03047967': set(),\n",
       " 'NCT05199831': set(),\n",
       " 'NCT00113282': set(),\n",
       " 'NCT01039220': set(),\n",
       " 'NCT04265742': set(),\n",
       " 'NCT01089400': {'24646009'},\n",
       " 'NCT00445575': set(),\n",
       " 'NCT00158496': {'16019104', '16434426', '16847958', '16956918'},\n",
       " 'NCT01271842': {'22948576'},\n",
       " 'NCT01917175': set(),\n",
       " 'NCT01905059': {'16249701',\n",
       "  '16549962',\n",
       "  '17545707',\n",
       "  '18097218',\n",
       "  '18540803',\n",
       "  '20010070',\n",
       "  '20802297',\n",
       "  '20802298',\n",
       "  '21811554',\n",
       "  '21886816',\n",
       "  '22441252',\n",
       "  '22814125',\n",
       "  '23075703',\n",
       "  '28566227'},\n",
       " 'NCT01592175': set(),\n",
       " 'NCT00574652': {'22129253'},\n",
       " 'NCT02236832': set(),\n",
       " 'NCT01269632': set(),\n",
       " 'NCT01024400': {'22147712'},\n",
       " 'NCT02542800': set(),\n",
       " 'NCT00158470': set(),\n",
       " 'NCT01779752': set(),\n",
       " 'NCT03005652': {'33873195', '35853750', '36068621'},\n",
       " 'NCT01311752': set(),\n",
       " 'NCT02916732': {'29539287', '33657112'},\n",
       " 'NCT03215732': {'31320358'},\n",
       " 'NCT02405013': set(),\n",
       " 'NCT00820118': {'26568566'},\n",
       " 'NCT01952587': set(),\n",
       " 'NCT00640887': {'25406657', '26482301'},\n",
       " 'NCT01725542': {'25977266'},\n",
       " 'NCT02038842': set(),\n",
       " 'NCT00115609': set(),\n",
       " 'NCT04120415': set(),\n",
       " 'NCT01192737': set(),\n",
       " 'NCT00265642': set(),\n",
       " 'NCT00918307': {'29329763', '34611902'},\n",
       " 'NCT01089387': {'25974235', '28753830'},\n",
       " 'NCT00928187': {'31273686'},\n",
       " 'NCT03324633': {'20493576',\n",
       "  '20876416',\n",
       "  '20969743',\n",
       "  '21239121',\n",
       "  '21692942',\n",
       "  '21819472',\n",
       "  '21888878',\n",
       "  '21920402',\n",
       "  '22173166',\n",
       "  '22285372',\n",
       "  '22409788',\n",
       "  '22535683',\n",
       "  '22781224',\n",
       "  '23052829',\n",
       "  '23226258',\n",
       "  '23421419',\n",
       "  '23461846',\n",
       "  '23978720',\n",
       "  '24166726',\n",
       "  '24499953',\n",
       "  '24580042',\n",
       "  '25015913',\n",
       "  '25778750',\n",
       "  '26372388',\n",
       "  '26528903',\n",
       "  '27073179',\n",
       "  '27177169',\n",
       "  '27317796',\n",
       "  '27339598',\n",
       "  '28235612',\n",
       "  '28418984',\n",
       "  '28430385',\n",
       "  '28780609',\n",
       "  '28942916',\n",
       "  '30570526',\n",
       "  '32798585',\n",
       "  '34212476'},\n",
       " 'NCT02027051': set(),\n",
       " 'NCT02027233': set(),\n",
       " 'NCT00136630': {'15313841',\n",
       "  '15365159',\n",
       "  '16055926',\n",
       "  '16193476',\n",
       "  '16501573',\n",
       "  '17098887',\n",
       "  '17597328',\n",
       "  '17605047',\n",
       "  '17957230',\n",
       "  '18378516',\n",
       "  '18853458',\n",
       "  '22491195',\n",
       "  '24780882'},\n",
       " 'NCT03459157': {'34048794'},\n",
       " 'NCT05040048': set(),\n",
       " 'NCT04470648': {'31978945',\n",
       "  '31995857',\n",
       "  '32046819',\n",
       "  '32070465',\n",
       "  '32109013',\n",
       "  '32224310',\n",
       "  '32338732',\n",
       "  '32371096'},\n",
       " 'NCT02497274': set(),\n",
       " 'NCT05311865': set(),\n",
       " 'NCT00158457': set(),\n",
       " 'NCT04315948': {'32304640',\n",
       "  '32473020',\n",
       "  '32958495',\n",
       "  '33089306',\n",
       "  '33264556',\n",
       "  '34048876',\n",
       "  '34350582',\n",
       "  '34473343',\n",
       "  '34534511',\n",
       "  '34763056',\n",
       "  '35233617',\n",
       "  '35512728',\n",
       "  '35533972',\n",
       "  '35623577',\n",
       "  '35643099',\n",
       "  '36680782',\n",
       "  '36828006',\n",
       "  '37269068',\n",
       "  '37302469',\n",
       "  '37728045'},\n",
       " 'NCT01620957': set(),\n",
       " 'NCT01693848': set(),\n",
       " 'NCT02107365': set(),\n",
       " 'NCT00196625': {'15060509', '15456093'},\n",
       " 'NCT01359774': {'17653274', '21285522', '21320997'},\n",
       " 'NCT02273765': {'33667406'},\n",
       " 'NCT00490074': set(),\n",
       " 'NCT02081066': set(),\n",
       " 'NCT00651066': {'24465443'},\n",
       " 'NCT02566148': {'29307383', '29437866', '29982518'},\n",
       " 'NCT02073630': set(),\n",
       " 'NCT02573948': {'25540950',\n",
       "  '26032121',\n",
       "  '26050614',\n",
       "  '26075647',\n",
       "  '26080690',\n",
       "  '27006257',\n",
       "  '27178119',\n",
       "  '28612212',\n",
       "  '28800503'},\n",
       " 'NCT00339157': {'21173013'},\n",
       " 'NCT02453048': {'18762220',\n",
       "  '19625486',\n",
       "  '20107007',\n",
       "  '20419113',\n",
       "  '20708998',\n",
       "  '21147936',\n",
       "  '21430219',\n",
       "  '22814407',\n",
       "  '24421886',\n",
       "  '24793938',\n",
       "  '24950361',\n",
       "  '31945015',\n",
       "  '32687804'},\n",
       " 'NCT03446430': set(),\n",
       " 'NCT00120757': {'22353022'},\n",
       " 'NCT02987530': set(),\n",
       " 'NCT02100774': {'21957063', '24808487', '26063065', '27798339'},\n",
       " 'NCT00460382': set(),\n",
       " 'NCT00820820': set(),\n",
       " 'NCT01066962': {'25103176', '26520926', '30365452', '33794182'},\n",
       " 'NCT03671291': set(),\n",
       " 'NCT00117494': {'22318219', '22739396'},\n",
       " 'NCT01771562': {'27881690', '30081838'},\n",
       " 'NCT02542891': {'27488181', '34874888'},\n",
       " 'NCT01508494': set(),\n",
       " 'NCT05349162': set(),\n",
       " 'NCT01882062': {'25568297'},\n",
       " 'NCT01489592': {'15501961', '15974953', '16946298', '18559556', '20169331'},\n",
       " 'NCT01453192': set(),\n",
       " 'NCT01033760': {'25701561', '28708873'},\n",
       " 'NCT00545194': {'11236117', '16553177', '17071427'},\n",
       " 'NCT00528060': {'23459496'},\n",
       " 'NCT02650427': set(),\n",
       " 'NCT04008927': {'22310560',\n",
       "  '26806260',\n",
       "  '27168667',\n",
       "  '27178119',\n",
       "  '27537841',\n",
       "  '28004616',\n",
       "  '29432973',\n",
       "  '35774932'},\n",
       " 'NCT01022476': set(),\n",
       " 'NCT01335529': {'27077673'},\n",
       " 'NCT02014727': {'28947345'},\n",
       " 'NCT00536627': {'15382173', '16310901', '24394187', '24555998'},\n",
       " 'NCT02078076': set(),\n",
       " 'NCT02777229': {'31339676', '33010241', '33355914'},\n",
       " 'NCT01703962': set(),\n",
       " 'NCT03546127': set(),\n",
       " 'NCT01331876': set(),\n",
       " 'NCT02886416': set(),\n",
       " 'NCT01188525': set(),\n",
       " 'NCT00302822': set(),\n",
       " 'NCT01693835': set(),\n",
       " 'NCT02978924': set(),\n",
       " 'NCT00226434': {'17624825',\n",
       "  '22010913',\n",
       "  '23237982',\n",
       "  '24096631',\n",
       "  '24608960',\n",
       "  '24759827'},\n",
       " 'NCT00148824': {'20210645'},\n",
       " 'NCT00670839': {'26257021'},\n",
       " 'NCT01548586': {'10990547',\n",
       "  '11723286',\n",
       "  '15272049',\n",
       "  '15634731',\n",
       "  '16002441',\n",
       "  '19805746',\n",
       "  '20161639',\n",
       "  '22085959',\n",
       "  '8756819'},\n",
       " 'NCT01801618': set(),\n",
       " 'NCT01055873': {'22427678'},\n",
       " 'NCT00495326': {'23433590', '24663014'},\n",
       " 'NCT02099474': {'32661003'},\n",
       " 'NCT02592174': {'31755936'},\n",
       " 'NCT00334256': {'18987623', '19104016', '19307941'},\n",
       " 'NCT01492985': {'33568510'},\n",
       " 'NCT02125500': set(),\n",
       " 'NCT00196599': {'10915095', '15012649'},\n",
       " 'NCT02906137': set(),\n",
       " 'NCT02647632': {'29077864'},\n",
       " 'NCT00822315': {'24726095'},\n",
       " 'NCT01413152': set(),\n",
       " 'NCT01463956': set(),\n",
       " 'NCT00454337': {'19757993',\n",
       "  '19995925',\n",
       "  '20683319',\n",
       "  '21126958',\n",
       "  '21326075',\n",
       "  '21576452',\n",
       "  '21712241',\n",
       "  '22416781',\n",
       "  '27042193'},\n",
       " 'NCT01698411': set(),\n",
       " 'NCT02214511': set(),\n",
       " 'NCT01331811': {'26908804', '29174612', '30689814', '31455612'},\n",
       " 'NCT05090956': set(),\n",
       " 'NCT00120185': {'19508157'},\n",
       " 'NCT04392388': set(),\n",
       " 'NCT01065207': set(),\n",
       " 'NCT02082171': set(),\n",
       " 'NCT02052271': set(),\n",
       " 'NCT00158509': {'16044019', '17314338', '18593294', '18596069'},\n",
       " 'NCT02346409': set(),\n",
       " 'NCT02656407': {'25955583'},\n",
       " 'NCT02150993': set(),\n",
       " 'NCT00657397': {'22741944',\n",
       "  '24268548',\n",
       "  '25209306',\n",
       "  '25393311',\n",
       "  '27048152',\n",
       "  '27770695'},\n",
       " 'NCT03137797': {'22008658',\n",
       "  '22267473',\n",
       "  '23079802',\n",
       "  '23936509',\n",
       "  '24058636',\n",
       "  '24465584',\n",
       "  '25573889',\n",
       "  '26636578',\n",
       "  '27509048'},\n",
       " 'NCT01167283': set(),\n",
       " 'NCT02014883': {'26536893'},\n",
       " 'NCT02931097': set(),\n",
       " 'NCT02093754': set(),\n",
       " 'NCT00116454': set(),\n",
       " 'NCT03954054': {'35012570'},\n",
       " 'NCT02329054': {'25435054', '26930627', '27046271', '28231247'},\n",
       " 'NCT04842851': set(),\n",
       " 'NCT00118677': {'20657770'},\n",
       " 'NCT01880151': set(),\n",
       " 'NCT00495651': {'23639243',\n",
       "  '24985779',\n",
       "  '25330161',\n",
       "  '26193126',\n",
       "  '29020361',\n",
       "  '29297443',\n",
       "  '35093007'},\n",
       " 'NCT02481453': {'20413309', '24975859'},\n",
       " 'NCT00421551': {'20802297', '22848481', '29767684'},\n",
       " 'NCT02658253': {'32032566', '33717176'},\n",
       " 'NCT01688453': {'29696179', '29776897', '29934380', '32097754', '34087324'},\n",
       " 'NCT02408354': {'28969699'},\n",
       " 'NCT02157311': {'29186458'},\n",
       " 'NCT04288128': set(),\n",
       " 'NCT02721745': set(),\n",
       " 'NCT01494961': {'20403152', '21857289', '23343912', '29178852', '34329355'},\n",
       " 'NCT02833961': set(),\n",
       " 'NCT02567071': set(),\n",
       " 'NCT02453061': {'31381524'},\n",
       " 'NCT01693861': set(),\n",
       " 'NCT00272428': {'15557412',\n",
       "  '19491388',\n",
       "  '19828715',\n",
       "  '20176858',\n",
       "  '20431391',\n",
       "  '20605091',\n",
       "  '21106918',\n",
       "  '21490142',\n",
       "  '21775560',\n",
       "  '21955649',\n",
       "  '22158670',\n",
       "  '22378736',\n",
       "  '22633793',\n",
       "  '23082222',\n",
       "  '23283500',\n",
       "  '23284983',\n",
       "  '24027184',\n",
       "  '24089418',\n",
       "  '24527713',\n",
       "  '24553693',\n",
       "  '25651444',\n",
       "  '25994566',\n",
       "  '26156743',\n",
       "  '26409628',\n",
       "  '26447153',\n",
       "  '26812508',\n",
       "  '26817718',\n",
       "  '26864363',\n",
       "  '26962176',\n",
       "  '27000099',\n",
       "  '27055851',\n",
       "  '28033414',\n",
       "  '28356432',\n",
       "  '28494135',\n",
       "  '29546305',\n",
       "  '29649036',\n",
       "  '30517725',\n",
       "  '31164347',\n",
       "  '31927670',\n",
       "  '33738534'},\n",
       " 'NCT01534728': set(),\n",
       " 'NCT04409405': set(),\n",
       " 'NCT02976298': set(),\n",
       " 'NCT00647205': set(),\n",
       " 'NCT02960698': set(),\n",
       " 'NCT01842477': set(),\n",
       " 'NCT01037777': {'23707147', '24780882', '32822634', '35264424'},\n",
       " 'NCT02172677': set(),\n",
       " 'NCT02101398': set(),\n",
       " 'NCT01495897': set(),\n",
       " 'NCT00463983': {'16883006', '22379151'},\n",
       " 'NCT00158483': {'16455895', '18385443', '19530940'},\n",
       " 'NCT00301561': {'21831714', '35248123'},\n",
       " 'NCT01075061': set(),\n",
       " 'NCT00158405': {'16152755', '16782488', '18986246'},\n",
       " 'NCT00623051': set()}"
      ]
     },
     "execution_count": 72,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pmids_ct_dict = {}\n",
    "for nctid in nctid_array:\n",
    "    pmids = df_studies_v2[df_studies_v2.loc[:, \"NCTId\"] == nctid].loc[:, \"pmid\"].dropna()\n",
    "    pmids_ct_dict[nctid] = set(pmids)\n",
    "pmids_ct_dict"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bead8f40-8dab-40f8-8650-87043c1c803a",
   "metadata": {},
   "source": [
    "Pour un NCTDId donné, on fait l'union des deux ensembles de PMIDs:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "id": "1d60a430-c91c-4094-8a93-7d948dc0c29c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'NCT01895920': set(),\n",
       " 'NCT02486731': set(),\n",
       " 'NCT02116374': set(),\n",
       " 'NCT03537196': {'19839502',\n",
       "  '20041309',\n",
       "  '20196807',\n",
       "  '20572071',\n",
       "  '22098550',\n",
       "  '22564041',\n",
       "  '22828983',\n",
       "  '23172780',\n",
       "  '23553643',\n",
       "  '23675659',\n",
       "  '23728143',\n",
       "  '23884064',\n",
       "  '25086286',\n",
       "  '25245939',\n",
       "  '25920094',\n",
       "  '26298331',\n",
       "  '27148964',\n",
       "  '27178119',\n",
       "  '27227200',\n",
       "  '27349488',\n",
       "  '27427455',\n",
       "  '27667367',\n",
       "  '33208326'},\n",
       " 'NCT01899196': set(),\n",
       " 'NCT04631224': set(),\n",
       " 'NCT01579435': set(),\n",
       " 'NCT03235258': {'17712765',\n",
       "  '18614870',\n",
       "  '19194272',\n",
       "  '20536367',\n",
       "  '21511330',\n",
       "  '21971357',\n",
       "  '22198788',\n",
       "  '22427678',\n",
       "  '24253249',\n",
       "  '24705410',\n",
       "  '24945880',\n",
       "  '26762993'},\n",
       " 'NCT00383734': {'23432777'},\n",
       " 'NCT00901524': {'24905490'},\n",
       " 'NCT01493934': set(),\n",
       " 'NCT03078439': {'38408861'},\n",
       " 'NCT04808986': set(),\n",
       " 'NCT01207986': set(),\n",
       " 'NCT02626286': {'33753460', '34022820', '34352834'},\n",
       " 'NCT02527096': set(),\n",
       " 'NCT00121758': {'20625264', '23759749'},\n",
       " 'NCT04684758': set(),\n",
       " 'NCT02057796': {'32558469', '36883573'},\n",
       " 'NCT03071458': set(),\n",
       " 'NCT02192658': {'26846895'},\n",
       " 'NCT01713335': set(),\n",
       " 'NCT00158522': {'15977225', '16434426'},\n",
       " 'NCT00640263': {'17825642',\n",
       "  '23039034',\n",
       "  '26603917',\n",
       "  '27895016',\n",
       "  '28469697',\n",
       "  '30814028',\n",
       "  '31633158',\n",
       "  '31994250',\n",
       "  '32067040',\n",
       "  '32228542',\n",
       "  '32991450',\n",
       "  '34425825'},\n",
       " 'NCT02428816': set(),\n",
       " 'NCT00122616': {'23800784'},\n",
       " 'NCT00196586': set(),\n",
       " 'NCT00148863': {'23190183'},\n",
       " 'NCT03150290': set(),\n",
       " 'NCT01514890': {'23669289', '24704719', '25556540'},\n",
       " 'NCT03652090': set(),\n",
       " 'NCT02738502': {'22160145',\n",
       "  '22848481',\n",
       "  '23559464',\n",
       "  '23766338',\n",
       "  '26197844',\n",
       "  '26709605',\n",
       "  '26854809'},\n",
       " 'NCT02212379': {'31269208'},\n",
       " 'NCT00465790': set(),\n",
       " 'NCT01605890': {'29590335'},\n",
       " 'NCT00196664': set(),\n",
       " 'NCT00122603': {'19420019'},\n",
       " 'NCT02992184': {'29615488'},\n",
       " 'NCT02071784': set(),\n",
       " 'NCT01432821': {'12914551', '15037514', '15249613', '15777732', '2271377'},\n",
       " 'NCT00121121': {'17712402'},\n",
       " 'NCT02126384': set(),\n",
       " 'NCT02323308': set(),\n",
       " 'NCT02314208': set(),\n",
       " 'NCT01348308': {'32040959'},\n",
       " 'NCT02113943': set(),\n",
       " 'NCT00299143': set(),\n",
       " 'NCT04824638': set(),\n",
       " 'NCT00120367': {'21738597'},\n",
       " 'NCT00323804': set(),\n",
       " 'NCT03642704': set(),\n",
       " 'NCT04849767': {'34916316'},\n",
       " 'NCT00573001': set(),\n",
       " 'NCT02267304': set(),\n",
       " 'NCT01525472': set(),\n",
       " 'NCT02073604': set(),\n",
       " 'NCT01127204': {'27015798',\n",
       "  '28434406',\n",
       "  '28453240',\n",
       "  '28483965',\n",
       "  '28800382',\n",
       "  '31334298',\n",
       "  '34723858'},\n",
       " 'NCT01473472': {'26624850', '28747274', '29229440', '31784343', '36601747'},\n",
       " 'NCT00122538': {'20516271', '21857286', '23719348'},\n",
       " 'NCT01555450': {'21256688', '28823681', '29909873'},\n",
       " 'NCT01696708': {'25568297'},\n",
       " 'NCT01100281': set(),\n",
       " 'NCT00424814': {'23766338', '25838291'},\n",
       " 'NCT00946595': {'29767684', '30968368'},\n",
       " 'NCT02488395': {'22639796', '23916713', '6774653'},\n",
       " 'NCT03335995': {'32026446', '37497675'},\n",
       " 'NCT01647295': set(),\n",
       " 'NCT01226446': {'25987791'},\n",
       " 'NCT00658346': {'31063537'},\n",
       " 'NCT01874808': set(),\n",
       " 'NCT01509508': {'23880306',\n",
       "  '25880823',\n",
       "  '27504637',\n",
       "  '28329393',\n",
       "  '29199100',\n",
       "  '29890048',\n",
       "  '30027600',\n",
       "  '30321314',\n",
       "  '30412926',\n",
       "  '31637821',\n",
       "  '32970730'},\n",
       " 'NCT00391638': set(),\n",
       " 'NCT01426243': {'26314624', '30096071'},\n",
       " 'NCT02496312': {'10436334',\n",
       "  '10678322',\n",
       "  '10941190',\n",
       "  '12461757',\n",
       "  '15897497',\n",
       "  '16207933',\n",
       "  '16421064',\n",
       "  '17027767',\n",
       "  '17131230',\n",
       "  '1821241',\n",
       "  '18307266',\n",
       "  '19533496',\n",
       "  '19713543',\n",
       "  '19933975',\n",
       "  '21895376'},\n",
       " 'NCT03519503': {'21602695', '22814853', '26603917'},\n",
       " 'NCT00196612': {'15717256'},\n",
       " 'NCT04133012': set(),\n",
       " 'NCT03298360': set(),\n",
       " 'NCT01490489': {'16384869', '17531315', '19602057'},\n",
       " 'NCT04780191': {'32232101'},\n",
       " 'NCT01164462': set(),\n",
       " 'NCT02051413': set(),\n",
       " 'NCT01531036': {'20505064'},\n",
       " 'NCT01164436': set(),\n",
       " 'NCT00870649': {'30532268'},\n",
       " 'NCT01842919': set(),\n",
       " 'NCT06260319': set(),\n",
       " 'NCT01569399': set(),\n",
       " 'NCT03193099': set(),\n",
       " 'NCT01094899': set(),\n",
       " 'NCT01038999': {'22829920', '23285253'},\n",
       " 'NCT03831906': {'32853411', '33743621', '36395782'},\n",
       " 'NCT01008813': set(),\n",
       " 'NCT00604149': set(),\n",
       " 'NCT01779713': {'30354977'},\n",
       " 'NCT02160119': set(),\n",
       " 'NCT01207349': {'22030240'},\n",
       " 'NCT00944541': set(),\n",
       " 'NCT02102737': set(),\n",
       " 'NCT01942655': set(),\n",
       " 'NCT03870438': {'26603917', '33872801'},\n",
       " 'NCT04945655': {'35332045'},\n",
       " 'NCT01188512': {'16839199',\n",
       "  '18762220',\n",
       "  '19625486',\n",
       "  '20107007',\n",
       "  '20184606',\n",
       "  '24261996',\n",
       "  '24421886',\n",
       "  '24793938'},\n",
       " 'NCT01038401': set(),\n",
       " 'NCT01086904': set(),\n",
       " 'NCT01332955': {'25139963'},\n",
       " 'NCT02469350': {'29636105'},\n",
       " 'NCT00480792': {'21486976', '27064975'},\n",
       " 'NCT04484740': set(),\n",
       " 'NCT01095744': set(),\n",
       " 'NCT00236340': {'11438952', '14770396', '7970458', '9464739'},\n",
       " 'NCT02384967': {'29905808'},\n",
       " 'NCT03109067': set(),\n",
       " 'NCT00988767': {'15382173', '16310901', '20090916'},\n",
       " 'NCT01552044': set(),\n",
       " 'NCT03047967': set(),\n",
       " 'NCT05199831': set(),\n",
       " 'NCT00113282': set(),\n",
       " 'NCT01039220': set(),\n",
       " 'NCT04265742': set(),\n",
       " 'NCT01089400': {'24646009'},\n",
       " 'NCT00445575': set(),\n",
       " 'NCT00158496': {'16019104', '16434426', '16847958', '16956918'},\n",
       " 'NCT01271842': {'22948576'},\n",
       " 'NCT01917175': set(),\n",
       " 'NCT01905059': {'16249701',\n",
       "  '16549962',\n",
       "  '17545707',\n",
       "  '18097218',\n",
       "  '18540803',\n",
       "  '20010070',\n",
       "  '20802297',\n",
       "  '20802298',\n",
       "  '21811554',\n",
       "  '21886816',\n",
       "  '22441252',\n",
       "  '22814125',\n",
       "  '23075703',\n",
       "  '28566227'},\n",
       " 'NCT01592175': set(),\n",
       " 'NCT00574652': {'22129253'},\n",
       " 'NCT02236832': set(),\n",
       " 'NCT01269632': set(),\n",
       " 'NCT01024400': {'22147712'},\n",
       " 'NCT02542800': set(),\n",
       " 'NCT00158470': set(),\n",
       " 'NCT01779752': set(),\n",
       " 'NCT03005652': {'33873195', '35853750', '36068621', '38100477'},\n",
       " 'NCT01311752': set(),\n",
       " 'NCT02916732': {'29539287', '33657112'},\n",
       " 'NCT03215732': {'31320358', '37143029'},\n",
       " 'NCT02405013': {'36686592'},\n",
       " 'NCT00820118': {'26568566'},\n",
       " 'NCT01952587': set(),\n",
       " 'NCT00640887': {'25406657', '26482301'},\n",
       " 'NCT01725542': {'25977266'},\n",
       " 'NCT02038842': set(),\n",
       " 'NCT00115609': set(),\n",
       " 'NCT04120415': set(),\n",
       " 'NCT01192737': set(),\n",
       " 'NCT00265642': set(),\n",
       " 'NCT00918307': {'29329763', '34611902'},\n",
       " 'NCT01089387': {'25974235', '26439886', '28753830'},\n",
       " 'NCT00928187': {'31273686'},\n",
       " 'NCT03324633': {'20493576',\n",
       "  '20876416',\n",
       "  '20969743',\n",
       "  '21239121',\n",
       "  '21692942',\n",
       "  '21819472',\n",
       "  '21888878',\n",
       "  '21920402',\n",
       "  '22173166',\n",
       "  '22285372',\n",
       "  '22409788',\n",
       "  '22535683',\n",
       "  '22781224',\n",
       "  '23052829',\n",
       "  '23226258',\n",
       "  '23421419',\n",
       "  '23461846',\n",
       "  '23978720',\n",
       "  '24166726',\n",
       "  '24499953',\n",
       "  '24580042',\n",
       "  '25015913',\n",
       "  '25778750',\n",
       "  '26372388',\n",
       "  '26528903',\n",
       "  '27073179',\n",
       "  '27177169',\n",
       "  '27317796',\n",
       "  '27339598',\n",
       "  '28235612',\n",
       "  '28418984',\n",
       "  '28430385',\n",
       "  '28780609',\n",
       "  '28942916',\n",
       "  '30570526',\n",
       "  '32798585',\n",
       "  '34212476'},\n",
       " 'NCT02027051': set(),\n",
       " 'NCT02027233': set(),\n",
       " 'NCT00136630': {'15313841',\n",
       "  '15365159',\n",
       "  '16055926',\n",
       "  '16193476',\n",
       "  '16501573',\n",
       "  '17098887',\n",
       "  '17597328',\n",
       "  '17605047',\n",
       "  '17957230',\n",
       "  '18378516',\n",
       "  '18853458',\n",
       "  '22491195',\n",
       "  '24780882'},\n",
       " 'NCT03459157': {'34048794'},\n",
       " 'NCT05040048': set(),\n",
       " 'NCT04470648': {'31978945',\n",
       "  '31995857',\n",
       "  '32046819',\n",
       "  '32070465',\n",
       "  '32109013',\n",
       "  '32224310',\n",
       "  '32338732',\n",
       "  '32371096'},\n",
       " 'NCT02497274': set(),\n",
       " 'NCT05311865': {'36438274', '37795682'},\n",
       " 'NCT00158457': set(),\n",
       " 'NCT04315948': {'32304640',\n",
       "  '32473020',\n",
       "  '32958495',\n",
       "  '33089306',\n",
       "  '33264556',\n",
       "  '34048876',\n",
       "  '34350582',\n",
       "  '34473343',\n",
       "  '34534511',\n",
       "  '34763056',\n",
       "  '35233617',\n",
       "  '35512728',\n",
       "  '35533972',\n",
       "  '35623577',\n",
       "  '35643099',\n",
       "  '36680782',\n",
       "  '36695483',\n",
       "  '36828006',\n",
       "  '37269068',\n",
       "  '37302469',\n",
       "  '37728045'},\n",
       " 'NCT01620957': set(),\n",
       " 'NCT01693848': set(),\n",
       " 'NCT02107365': set(),\n",
       " 'NCT00196625': {'15060509', '15456093'},\n",
       " 'NCT01359774': {'17653274', '21285522', '21320997'},\n",
       " 'NCT02273765': {'33667406'},\n",
       " 'NCT00490074': set(),\n",
       " 'NCT02081066': set(),\n",
       " 'NCT00651066': {'24465443'},\n",
       " 'NCT02566148': {'29307383', '29437866', '29982518'},\n",
       " 'NCT02073630': set(),\n",
       " 'NCT02573948': {'25540950',\n",
       "  '26032121',\n",
       "  '26050614',\n",
       "  '26075647',\n",
       "  '26080690',\n",
       "  '27006257',\n",
       "  '27178119',\n",
       "  '28612212',\n",
       "  '28800503'},\n",
       " 'NCT00339157': {'21173013'},\n",
       " 'NCT02453048': {'18762220',\n",
       "  '19625486',\n",
       "  '20107007',\n",
       "  '20419113',\n",
       "  '20708998',\n",
       "  '21147936',\n",
       "  '21430219',\n",
       "  '22814407',\n",
       "  '24421886',\n",
       "  '24793938',\n",
       "  '24950361',\n",
       "  '31945015',\n",
       "  '32687804'},\n",
       " 'NCT03446430': set(),\n",
       " 'NCT00120757': {'22353022'},\n",
       " 'NCT02987530': set(),\n",
       " 'NCT02100774': {'21957063', '24808487', '26063065', '27798339'},\n",
       " 'NCT00460382': set(),\n",
       " 'NCT00820820': set(),\n",
       " 'NCT01066962': {'25103176', '26520926', '30365452', '33794182'},\n",
       " 'NCT03671291': set(),\n",
       " 'NCT00117494': {'22318219', '22739396'},\n",
       " 'NCT01771562': {'27881690', '30081838'},\n",
       " 'NCT02542891': {'27488181', '34874888'},\n",
       " 'NCT01508494': set(),\n",
       " 'NCT05349162': {'36735263'},\n",
       " 'NCT01882062': {'25568297'},\n",
       " 'NCT01489592': {'15501961', '15974953', '16946298', '18559556', '20169331'},\n",
       " 'NCT01453192': {'30688008'},\n",
       " 'NCT01033760': {'25701561', '28708873'},\n",
       " 'NCT00545194': {'11236117', '16553177', '17071427'},\n",
       " 'NCT00528060': {'23459496'},\n",
       " 'NCT02650427': set(),\n",
       " 'NCT04008927': {'22310560',\n",
       "  '26806260',\n",
       "  '27168667',\n",
       "  '27178119',\n",
       "  '27537841',\n",
       "  '28004616',\n",
       "  '29432973',\n",
       "  '35774932'},\n",
       " 'NCT01022476': set(),\n",
       " 'NCT01335529': {'27077673'},\n",
       " 'NCT02014727': {'28947345'},\n",
       " 'NCT00536627': {'15382173', '16310901', '24394187', '24555998'},\n",
       " 'NCT02078076': set(),\n",
       " 'NCT02777229': {'31339676', '33010241', '33355914', '37851566', '38156046'},\n",
       " 'NCT01703962': {'37668523'},\n",
       " 'NCT03546127': set(),\n",
       " 'NCT01331876': set(),\n",
       " 'NCT02886416': set(),\n",
       " 'NCT01188525': set(),\n",
       " 'NCT00302822': set(),\n",
       " 'NCT01693835': set(),\n",
       " 'NCT02978924': set(),\n",
       " 'NCT00226434': {'17624825',\n",
       "  '22010913',\n",
       "  '23237982',\n",
       "  '24096631',\n",
       "  '24608960',\n",
       "  '24759827'},\n",
       " 'NCT00148824': {'20210645'},\n",
       " 'NCT00670839': {'26257021'},\n",
       " 'NCT01548586': {'10990547',\n",
       "  '11723286',\n",
       "  '15272049',\n",
       "  '15634731',\n",
       "  '16002441',\n",
       "  '19805746',\n",
       "  '20161639',\n",
       "  '22085959',\n",
       "  '8756819'},\n",
       " 'NCT01801618': {'29662875'},\n",
       " 'NCT01055873': {'22427678'},\n",
       " 'NCT00495326': {'23433590', '24663014'},\n",
       " 'NCT02099474': {'32661003'},\n",
       " 'NCT02592174': {'31755936'},\n",
       " 'NCT00334256': {'18987623', '19104016', '19307941'},\n",
       " 'NCT01492985': {'33568510'},\n",
       " 'NCT02125500': set(),\n",
       " 'NCT00196599': {'10915095', '15012649'},\n",
       " 'NCT02906137': set(),\n",
       " 'NCT02647632': {'29077864'},\n",
       " 'NCT00822315': {'24726095'},\n",
       " 'NCT01413152': set(),\n",
       " 'NCT01463956': set(),\n",
       " 'NCT00454337': {'19757993',\n",
       "  '19995925',\n",
       "  '20683319',\n",
       "  '21126958',\n",
       "  '21326075',\n",
       "  '21576452',\n",
       "  '21712241',\n",
       "  '22416781',\n",
       "  '27042193'},\n",
       " 'NCT01698411': set(),\n",
       " 'NCT02214511': set(),\n",
       " 'NCT01331811': {'26908804', '29174612', '30689814', '31455612'},\n",
       " 'NCT05090956': set(),\n",
       " 'NCT00120185': {'19508157'},\n",
       " 'NCT04392388': {'34293141'},\n",
       " 'NCT01065207': set(),\n",
       " 'NCT02082171': set(),\n",
       " 'NCT02052271': set(),\n",
       " 'NCT00158509': {'16044019', '17314338', '18593294', '18596069'},\n",
       " 'NCT02346409': set(),\n",
       " 'NCT02656407': {'25955583'},\n",
       " 'NCT02150993': set(),\n",
       " 'NCT00657397': {'22741944',\n",
       "  '24268548',\n",
       "  '25209306',\n",
       "  '25393311',\n",
       "  '27048152',\n",
       "  '27770695'},\n",
       " 'NCT03137797': {'22008658',\n",
       "  '22267473',\n",
       "  '23079802',\n",
       "  '23936509',\n",
       "  '24058636',\n",
       "  '24465584',\n",
       "  '25573889',\n",
       "  '26636578',\n",
       "  '27509048'},\n",
       " 'NCT01167283': set(),\n",
       " 'NCT02014883': {'26536893'},\n",
       " 'NCT02931097': set(),\n",
       " 'NCT02093754': set(),\n",
       " 'NCT00116454': set(),\n",
       " 'NCT03954054': {'35012570'},\n",
       " 'NCT02329054': {'25435054', '26930627', '27046271', '28231247'},\n",
       " 'NCT04842851': set(),\n",
       " 'NCT00118677': {'20657770'},\n",
       " 'NCT01880151': set(),\n",
       " 'NCT00495651': {'23639243',\n",
       "  '24985779',\n",
       "  '25330161',\n",
       "  '26193126',\n",
       "  '29020361',\n",
       "  '29297443',\n",
       "  '35093007'},\n",
       " 'NCT02481453': {'20413309', '24975859', '38273639'},\n",
       " 'NCT00421551': {'20802297', '22848481', '29767684'},\n",
       " 'NCT02658253': {'32032566', '33717176'},\n",
       " 'NCT01688453': {'29696179',\n",
       "  '29776897',\n",
       "  '29934380',\n",
       "  '32097754',\n",
       "  '34087324',\n",
       "  '35272723'},\n",
       " 'NCT02408354': {'28969699'},\n",
       " 'NCT02157311': {'29186458'},\n",
       " 'NCT04288128': {'38419144', '38421662'},\n",
       " 'NCT02721745': set(),\n",
       " 'NCT01494961': {'20403152', '21857289', '23343912', '29178852', '34329355'},\n",
       " 'NCT02833961': {'36318030'},\n",
       " 'NCT02567071': set(),\n",
       " 'NCT02453061': {'31381524'},\n",
       " 'NCT01693861': set(),\n",
       " 'NCT00272428': {'15557412',\n",
       "  '19491388',\n",
       "  '19828715',\n",
       "  '20176858',\n",
       "  '20431391',\n",
       "  '20605091',\n",
       "  '21106918',\n",
       "  '21490142',\n",
       "  '21775560',\n",
       "  '21955649',\n",
       "  '22158670',\n",
       "  '22378736',\n",
       "  '22633793',\n",
       "  '23082222',\n",
       "  '23283500',\n",
       "  '23284983',\n",
       "  '24027184',\n",
       "  '24089418',\n",
       "  '24527713',\n",
       "  '24553693',\n",
       "  '25651444',\n",
       "  '25994566',\n",
       "  '26156743',\n",
       "  '26409628',\n",
       "  '26447153',\n",
       "  '26812508',\n",
       "  '26817718',\n",
       "  '26864363',\n",
       "  '26962176',\n",
       "  '27000099',\n",
       "  '27055851',\n",
       "  '28033414',\n",
       "  '28356432',\n",
       "  '28494135',\n",
       "  '29546305',\n",
       "  '29649036',\n",
       "  '30517725',\n",
       "  '31164347',\n",
       "  '31927670',\n",
       "  '33738534'},\n",
       " 'NCT01534728': set(),\n",
       " 'NCT04409405': {'38043556'},\n",
       " 'NCT02976298': set(),\n",
       " 'NCT00647205': set(),\n",
       " 'NCT02960698': set(),\n",
       " 'NCT01842477': set(),\n",
       " 'NCT01037777': {'23707147', '24780882', '32822634', '35264424'},\n",
       " 'NCT02172677': set(),\n",
       " 'NCT02101398': set(),\n",
       " 'NCT01495897': set(),\n",
       " 'NCT00463983': {'16883006', '22379151'},\n",
       " 'NCT00158483': {'16455895', '18385443', '19530940'},\n",
       " 'NCT00301561': {'21831714', '35248123'},\n",
       " 'NCT01075061': set(),\n",
       " 'NCT00158405': {'16152755', '16782488', '18986246'},\n",
       " 'NCT00623051': set()}"
      ]
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pmids_complete_dict = {}\n",
    "for nctid in nctid_array:\n",
    "    # L'ensemble des PMIds présents dans PubMed et CT \n",
    "    pmids_complete_dict[nctid] = pmids_pubmed_dict[nctid] | pmids_ct_dict[nctid]\n",
    "pmids_complete_dict"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a808cce0-ad9a-4236-a7d7-5bf8a796eca9",
   "metadata": {},
   "source": [
    "#### Verifications:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 150,
   "id": "d181cb92-9626-406f-b36d-b15845b45b0d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nombre total de publications issus de CT: 521\n"
     ]
    }
   ],
   "source": [
    "num_pmids_ct = sum((len(v) for v in pmids_ct_dict.values()))\n",
    "print(f\"Nombre total de publications issus de CT: {num_pmids_ct}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 166,
   "id": "880fadf5-199b-49b8-b81b-99f7ba7b2343",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nombre total de publications après consultation PubMed: 548\n"
     ]
    }
   ],
   "source": [
    "num_pmids_complete = sum((len(v) for v in pmids_complete_dict.values()))\n",
    "print(f\"Nombre total de publications après consultation PubMed: {num_pmids_complete}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 173,
   "id": "ed3165a6-3f0a-4b95-b7c0-b2caf0167cc7",
   "metadata": {},
   "outputs": [],
   "source": [
    "pmids_pubmed_only_dict = {}\n",
    "for nctid in nctid_array:\n",
    "    # L'ensemble des PMIds présents dans PubMed uniquement \n",
    "    pmids_pubmed_only_dict[nctid] = pmids_pubmed_dict[nctid] - pmids_ct_dict[nctid]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 185,
   "id": "c9201565-039e-469b-979b-2a496d4a03ae",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nombre de nouveaux PMIDs trouvés via Pubmed: 27\n"
     ]
    }
   ],
   "source": [
    "num_pmids_pubmed_only = sum((len(v) for v in pmids_pubmed_only_dict.values()))\n",
    "print(f\"Nombre de nouveaux PMIDs trouvés via Pubmed: {num_pmids_pubmed_only}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 182,
   "id": "3dcf6bbb-ad35-4d3e-9224-f13dc3052571",
   "metadata": {},
   "outputs": [],
   "source": [
    "assert (num_pmids_complete - num_pmids_ct == num_pmids_pubmed_only)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 186,
   "id": "eab933fe-2aa5-4ece-a4e6-9a07bec66d04",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "NCTId des nouveaux PMIDs trouvés via Pubmed:\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'NCT03078439': {'38408861'},\n",
       " 'NCT02057796': {'36883573'},\n",
       " 'NCT00640263': {'34425825'},\n",
       " 'NCT02212379': {'31269208'},\n",
       " 'NCT01473472': {'36601747'},\n",
       " 'NCT03335995': {'37497675'},\n",
       " 'NCT01426243': {'26314624'},\n",
       " 'NCT03005652': {'38100477'},\n",
       " 'NCT03215732': {'37143029'},\n",
       " 'NCT02405013': {'36686592'},\n",
       " 'NCT01089387': {'26439886'},\n",
       " 'NCT05311865': {'36438274', '37795682'},\n",
       " 'NCT04315948': {'36695483'},\n",
       " 'NCT05349162': {'36735263'},\n",
       " 'NCT01453192': {'30688008'},\n",
       " 'NCT02777229': {'37851566', '38156046'},\n",
       " 'NCT01703962': {'37668523'},\n",
       " 'NCT01801618': {'29662875'},\n",
       " 'NCT04392388': {'34293141'},\n",
       " 'NCT02481453': {'38273639'},\n",
       " 'NCT01688453': {'35272723'},\n",
       " 'NCT04288128': {'38419144', '38421662'},\n",
       " 'NCT02833961': {'36318030'},\n",
       " 'NCT04409405': {'38043556'}}"
      ]
     },
     "execution_count": 186,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "print(\"NCTId des nouveaux PMIDs trouvés via Pubmed:\")\n",
    "{k: v for k, v in pmids_pubmed_only_dict.items() if v != set()}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 203,
   "id": "b28d3dd2-8dd8-4231-b29b-aa55563d4336",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nombre d'études sans PMIDs issus de CT: 148\n"
     ]
    }
   ],
   "source": [
    "num_nctid_empty_ct = sum((1 for v in pmids_ct_dict.values() if v == set()))\n",
    "print(f\"Nombre d'études sans PMIDs issus de CT: {num_nctid_empty_ct}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 204,
   "id": "0e4ba4ae-ce84-4b25-82ea-98e4c8972a7b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nombre d'études sans PMIDs après consultation PubMed: 136\n"
     ]
    }
   ],
   "source": [
    "num_nctid_empty_pubmed = sum((1 for v in pmids_complete_dict.values() if v == set()))\n",
    "print(f\"Nombre d'études sans PMIDs après consultation PubMed: {num_nctid_empty_pubmed}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 202,
   "id": "0f2f7862-2d98-4e8a-a707-fa4be829e133",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "NCTIds qui n'avait aucun PMIDs sous CT, mais enrichis via Pubmed:\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'NCT02405013': {'36686592'},\n",
       " 'NCT04392388': {'34293141'},\n",
       " 'NCT01703962': {'37668523'},\n",
       " 'NCT02833961': {'36318030'},\n",
       " 'NCT01801618': {'29662875'},\n",
       " 'NCT01453192': {'30688008'},\n",
       " 'NCT02212379': {'31269208'},\n",
       " 'NCT05311865': {'36438274', '37795682'},\n",
       " 'NCT04409405': {'38043556'},\n",
       " 'NCT05349162': {'36735263'},\n",
       " 'NCT03078439': {'38408861'},\n",
       " 'NCT04288128': {'38419144', '38421662'}}"
      ]
     },
     "execution_count": 202,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "print(\"NCTIds qui n'avait aucun PMIDs sous CT, mais enrichis via Pubmed:\")\n",
    "nctids_previously_empty = {k for k, v in pmids_ct_dict.items() if v == set()} - {k for k, v in pmids_complete_dict.items() if v == set()}\n",
    "{k : pmids_complete_dict[k] for k in nctids_previously_empty}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 241,
   "id": "a9f76a73-72da-4319-a441-365a7cd8f9db",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "12"
      ]
     },
     "execution_count": 241,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(nctids_previously_empty)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 201,
   "id": "9b818f69-9f1e-4778-9c2e-603ca9fd378e",
   "metadata": {},
   "outputs": [],
   "source": [
    "assert (num_nctid_empty_ct - num_nctid_empty_pubmed == len(nctids_previously_empty))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7ccd4072-b497-4a87-baf0-67b55c8a4845",
   "metadata": {},
   "source": [
    "### Enrichissement des PMIDs via l'API Pubmed"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6fffb32b-b3d8-4814-ae72-9d2656a6ecc0",
   "metadata": {},
   "source": [
    "Pour chaque PMID récupéré, on l'enrichit avec les données de PubMed tel que le titre, les auteurs, ...:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 265,
   "id": "7a8cd865-03da-49e2-88ac-13a3dbd3c5b9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "548 / 548..."
     ]
    }
   ],
   "source": [
    "counter = 0 # To keep track of progress\n",
    "book_counter = 0 # type different from 'article', get ignored\n",
    "total_publications_list = []\n",
    "\n",
    "#For each NTCID...\n",
    "for nctid, pmids in pmids_complete_dict.items():\n",
    "    pmids_list = []\n",
    "    \n",
    "    # We process each PMID...\n",
    "    for pmid in pmids:\n",
    "        \n",
    "        # Display the progress on a single line\n",
    "        print(f'\\r{counter+1} / {num_pmids_complete}...', end='', flush=True)\n",
    "\n",
    "        try:\n",
    "            # Fetch article details from Pubmed\n",
    "            article = fetch.article_by_pmid(pmid)\n",
    "\n",
    "            # We are not interested by articles with type 'book'\n",
    "            # TODO: book special case ?\n",
    "            if article.pubmed_type == 'article':\n",
    "                pmids_list.append(\n",
    "                    {\n",
    "                        'pmid': pmid,\n",
    "                        'title': article.title,\n",
    "                        'authors': article.authors_str.strip(),\n",
    "                        'doi': article.doi,\n",
    "                        'year': article.year,\n",
    "                        'publication_types': list(\n",
    "                            article.publication_types.values()\n",
    "                        ),\n",
    "                        'citation': article.citation,\n",
    "                    }\n",
    "                )\n",
    "            else:\n",
    "                book_counter += 1\n",
    "                book = (nctid, pmid)\n",
    "                \n",
    "            counter += 1\n",
    "        except InvalidPMID as e:\n",
    "            print(f'\\n{e}')\n",
    "\n",
    "    publication_dict = {'NCTId': nctid, 'publications': pmids_list}\n",
    "\n",
    "    total_publications_list.append(publication_dict)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 307,
   "id": "66dc9fed-b144-47c8-9637-0685aed7d3da",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nb de publications avec un type différent d\"article\": 1\n",
      "('NCT03537196', '27227200')\n"
     ]
    }
   ],
   "source": [
    "print(f'Nb de publications avec un type différent d\"article\": {book_counter}')\n",
    "print(book)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 278,
   "id": "3f26319c-fb30-4810-8f0e-2ee72592866e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[\n",
      "  {\n",
      "    \"NCTId\": \"NCT01895920\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02486731\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02116374\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03537196\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26298331\",\n",
      "        \"title\": \"Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis.\",\n",
      "        \"authors\": \"Smith DJ; Combellick J; Jordan AE; Hagan H\",\n",
      "        \"doi\": \"10.1016/j.drugpo.2015.07.004\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Meta-Analysis\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Review\",\n",
      "          \"Systematic Review\"\n",
      "        ],\n",
      "        \"citation\": \"Smith DJ, et al. Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis. Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis. 2015; 26:911-21. doi: 10.1016/j.drugpo.2015.07.004\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23172780\",\n",
      "        \"title\": \"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.\",\n",
      "        \"authors\": \"Mohd Hanafiah K; Groeger J; Flaxman AD; Wiersma ST\",\n",
      "        \"doi\": \"10.1002/hep.26141\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Meta-Analysis\",\n",
      "          \"Review\",\n",
      "          \"Systematic Review\"\n",
      "        ],\n",
      "        \"citation\": \"Mohd Hanafiah K, et al. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. 2013; 57:1333-42. doi: 10.1002/hep.26141\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20572071\",\n",
      "        \"title\": \"Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam.\",\n",
      "        \"authors\": \"Tanimoto T; Nguyen HC; Ishizaki A; Chung PT; Hoang TT; Nguyen VT; Kageyama S; Oka S; Pham VT; Ichimura H\",\n",
      "        \"doi\": \"10.1002/jmv.21787\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Tanimoto T, et al. Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam. Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam. 2010; 82:1355-63. doi: 10.1002/jmv.21787\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23553643\",\n",
      "        \"title\": \"Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals.\",\n",
      "        \"authors\": \"Martin NK; Vickerman P; Grebely J; Hellard M; Hutchinson SJ; Lima VD; Foster GR; Dillon JF; Goldberg DJ; Dore GJ; Hickman M\",\n",
      "        \"doi\": \"10.1002/hep.26431\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Martin NK, et al. Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. 2013; 58:1598-609. doi: 10.1002/hep.26431\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23884064\",\n",
      "        \"title\": \"Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy.\",\n",
      "        \"authors\": \"Martin NK; Hickman M; Hutchinson SJ; Goldberg DJ; Vickerman P\",\n",
      "        \"doi\": \"10.1093/cid/cit296\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Martin NK, et al. Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. 2013; 57 Suppl 2:S39-45. doi: 10.1093/cid/cit296\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20196807\",\n",
      "        \"title\": \"Vietnamese community screening for hepatitis B virus and hepatitis C virus.\",\n",
      "        \"authors\": \"Kallman JB; Tran S; Arsalla A; Haddad D; Stepanova M; Fang Y; Wrobel VJ; Srishord M; Younossi ZM\",\n",
      "        \"doi\": \"10.1111/j.1365-2893.2010.01278.x\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kallman JB, et al. Vietnamese community screening for hepatitis B virus and hepatitis C virus. Vietnamese community screening for hepatitis B virus and hepatitis C virus. 2011; 18:70-6. doi: 10.1111/j.1365-2893.2010.01278.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23728143\",\n",
      "        \"title\": \"Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements.\",\n",
      "        \"authors\": \"Grebely J; Matthews GV; Lloyd AR; Dore GJ\",\n",
      "        \"doi\": \"10.1093/cid/cit377\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Grebely J, et al. Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements. Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements. 2013; 57:1014-20. doi: 10.1093/cid/cit377\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27667367\",\n",
      "        \"title\": \"EASL Recommendations on Treatment of Hepatitis C 2016.\",\n",
      "        \"authors\": \"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu\",\n",
      "        \"doi\": \"10.1016/j.jhep.2016.09.001\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Practice Guideline\"\n",
      "        ],\n",
      "        \"citation\": \"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL Recommendations on Treatment of Hepatitis C 2016. EASL Recommendations on Treatment of Hepatitis C 2016. 2017; 66:153-194. doi: 10.1016/j.jhep.2016.09.001\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33208326\",\n",
      "        \"title\": \"Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C).\",\n",
      "        \"authors\": \"Rapoud D; Quillet C; Pham Minh K; Vu Hai V; Nguyen Thanh B; Nham Thi Tuyet T; Tran Thi H; Mol\\u00e8s JP; Vallo R; Michel L; Feelemyer J; Weiss L; Lemoine M; Vickerman P; Fraser H; Duong Thi H; Khuat Thi Hai O; Des Jarlais D; Nagot N; Laureillard D; DRIVE-C Study Group\",\n",
      "        \"doi\": \"10.1136/bmjopen-2020-039234\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Rapoud D, et al. Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C). Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C). 2020; 10:e039234. doi: 10.1136/bmjopen-2020-039234\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25920094\",\n",
      "        \"title\": \"From non-A, non-B hepatitis to hepatitis C virus cure.\",\n",
      "        \"authors\": \"Pawlotsky JM; Feld JJ; Zeuzem S; Hoofnagle JH\",\n",
      "        \"doi\": \"10.1016/j.jhep.2015.02.006\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Pawlotsky JM, et al. From non-A, non-B hepatitis to hepatitis C virus cure. From non-A, non-B hepatitis to hepatitis C virus cure. 2015; 62:S87-99. doi: 10.1016/j.jhep.2015.02.006\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22098550\",\n",
      "        \"title\": \"Liver disease in Viet Nam: screening, surveillance, management and education: a 5-year plan and call to action.\",\n",
      "        \"authors\": \"Gish RG; Bui TD; Nguyen CT; Nguyen DT; Tran HV; Tran DM; Trinh HN; International Group for Liver Health in Viet Nam\",\n",
      "        \"doi\": \"10.1111/j.1440-1746.2011.06974.x\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Gish RG, et al. Liver disease in Viet Nam: screening, surveillance, management and education: a 5-year plan and call to action. Liver disease in Viet Nam: screening, surveillance, management and education: a 5-year plan and call to action. 2012; 27:238-47. doi: 10.1111/j.1440-1746.2011.06974.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20041309\",\n",
      "        \"title\": \"Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection.\",\n",
      "        \"authors\": \"Clatts MC; Col\\u00f3n-L\\u00f3pez V; Giang LM; Goldsamt LA\",\n",
      "        \"doi\": \"10.1007/s11524-009-9417-9\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Clatts MC, et al. Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. 2010; 87:278-291. doi: 10.1007/s11524-009-9417-9\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27148964\",\n",
      "        \"title\": \"High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262).\",\n",
      "        \"authors\": \"Nguyen Truong T; Laureillard D; Lacombe K; Duong Thi H; Pham Thi Hanh P; Truong Thi Xuan L; Chu Thi N; Luong Que A; Vu Hai V; Nagot N; Tuaillon E; Dominguez S; Lemoine M\",\n",
      "        \"doi\": \"10.1371/journal.pone.0153744\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nguyen Truong T, et al. High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262). High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262). 2016; 11:e0153744. doi: 10.1371/journal.pone.0153744\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25086286\",\n",
      "        \"title\": \"Global epidemiology and genotype distribution of the hepatitis C virus infection.\",\n",
      "        \"authors\": \"Gower E; Estes C; Blach S; Razavi-Shearer K; Razavi H\",\n",
      "        \"doi\": \"10.1016/j.jhep.2014.07.027\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Gower E, et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. Global epidemiology and genotype distribution of the hepatitis C virus infection. 2014; 61:S45-57. doi: 10.1016/j.jhep.2014.07.027\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23675659\",\n",
      "        \"title\": \"Current and future therapies for hepatitis C virus infection.\",\n",
      "        \"authors\": \"Liang TJ; Ghany MG\",\n",
      "        \"doi\": \"10.1056/NEJMra1213651\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Liang TJ and Ghany MG. Current and future therapies for hepatitis C virus infection. Current and future therapies for hepatitis C virus infection. 2013; 368:1907-17. doi: 10.1056/NEJMra1213651\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19839502\",\n",
      "        \"title\": \"High prevalence of Hepatitis C virus genotype 6 in Vietnam.\",\n",
      "        \"authors\": \"Pham DA; Leuangwutiwong P; Jittmittraphap A; Luplertlop N; Bach HK; Akkarathamrongsin S; Theamboonlers A; Poovorawan Y\",\n",
      "        \"doi\": null,\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Pham DA, et al. High prevalence of Hepatitis C virus genotype 6 in Vietnam. High prevalence of Hepatitis C virus genotype 6 in Vietnam. 2009; 27:153-60.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22564041\",\n",
      "        \"title\": \"Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings.\",\n",
      "        \"authors\": \"Vickerman P; Martin N; Turner K; Hickman M\",\n",
      "        \"doi\": \"10.1111/j.1360-0443.2012.03932.x\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Vickerman P, et al. Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings. Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings. 2012; 107:1984-95. doi: 10.1111/j.1360-0443.2012.03932.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27427455\",\n",
      "        \"title\": \"The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.\",\n",
      "        \"authors\": \"Altice FL; Azbel L; Stone J; Brooks-Pollock E; Smyrnov P; Dvoriak S; Taxman FS; El-Bassel N; Martin NK; Booth R; St\\u00f6ver H; Dolan K; Vickerman P\",\n",
      "        \"doi\": \"10.1016/S0140-6736(16)30856-X\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, U.S. Gov't, Non-P.H.S.\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Altice FL, et al. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. 2016; 388:1228-48. doi: 10.1016/S0140-6736(16)30856-X\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27349488\",\n",
      "        \"title\": \"Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals.\",\n",
      "        \"authors\": \"Conti F; Buonfiglioli F; Scuteri A; Crespi C; Bolondi L; Caraceni P; Foschi FG; Lenzi M; Mazzella G; Verucchi G; Andreone P; Brillanti S\",\n",
      "        \"doi\": \"10.1016/j.jhep.2016.06.015\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Conti F, et al. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. 2016; 65:727-733. doi: 10.1016/j.jhep.2016.06.015\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22828983\",\n",
      "        \"title\": \"Epidemiology, responses, and way forward: the silent epidemic of viral hepatitis and HIV coinfection in Vietnam.\",\n",
      "        \"authors\": \"Sereno L; Mesquita F; Kato M; Jacka D; Nguyen TT; Nguyen TN\",\n",
      "        \"doi\": \"10.1177/1545109712453939\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Sereno L, et al. Epidemiology, responses, and way forward: the silent epidemic of viral hepatitis and HIV coinfection in Vietnam. Epidemiology, responses, and way forward: the silent epidemic of viral hepatitis and HIV coinfection in Vietnam. 2012; 11:311-20. doi: 10.1177/1545109712453939\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25245939\",\n",
      "        \"title\": \"Prevention, treatment and care of hepatitis C virus infection among people who inject drugs.\",\n",
      "        \"authors\": \"Bruggmann P; Grebely J\",\n",
      "        \"doi\": \"10.1016/j.drugpo.2014.08.014\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bruggmann P and Grebely J. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs. 2015; 26 Suppl 1:S22-6. doi: 10.1016/j.drugpo.2014.08.014\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27178119\",\n",
      "        \"title\": \"Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.\",\n",
      "        \"authors\": \"Des Jarlais D; Duong HT; Pham Minh K; Khuat OH; Nham TT; Arasteh K; Feelemyer J; Heckathorn DD; Peries M; Moles JP; Laureillard D; Nagot N; (The Drive Study Team)\",\n",
      "        \"doi\": \"10.1080/09540121.2016.1178698\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Des Jarlais D, et al. Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. 2016; 28:1312-5. doi: 10.1080/09540121.2016.1178698\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01899196\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04631224\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01579435\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03235258\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"21971357\",\n",
      "        \"title\": \"Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens.\",\n",
      "        \"authors\": \"Judd A; European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32834d614c\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Judd A and European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord. Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens. Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens. 2011; 25:2279-87. doi: 10.1097/QAD.0b013e32834d614c\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21511330\",\n",
      "        \"title\": \"Risk of triple-class virological failure in children with HIV: a retrospective cohort study.\",\n",
      "        \"authors\": \"Pursuing Later Treatment Options II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE); Castro H; Judd A; Gibb DM; Butler K; Lodwick RK; van Sighem A; Ramos JT; Warsawski J; Thorne C; Noguera-Julian A; Obel N; Costagliola D; Tookey PA; Colin C; Kjaer J; Grarup J; Chene G; Phillips A\",\n",
      "        \"doi\": \"10.1016/S0140-6736(11)60208-0\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Pursuing Later Treatment Options II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE), et al. Risk of triple-class virological failure in children with HIV: a retrospective cohort study. Risk of triple-class virological failure in children with HIV: a retrospective cohort study. 2011; 377:1580-7. doi: 10.1016/S0140-6736(11)60208-0\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24705410\",\n",
      "        \"title\": \"Low birth weight in perinatally HIV-exposed uninfected infants: observations in urban settings in Cameroon.\",\n",
      "        \"authors\": \"Sofeu CL; Warszawski J; Ateba Ndongo F; Penda IC; Tetang Ndiang S; Guemkam G; Makwet N; Owona F; Kfutwah A; Tchendjou P; Texier G; Tchuente M; Faye A; Tejiokem MC; ANRS-PEDIACAM Study Group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0093554\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sofeu CL, et al. Low birth weight in perinatally HIV-exposed uninfected infants: observations in urban settings in Cameroon. Low birth weight in perinatally HIV-exposed uninfected infants: observations in urban settings in Cameroon. 2014; 9:e93554. doi: 10.1371/journal.pone.0093554\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17712765\",\n",
      "        \"title\": \"Long-term nonprogression of HIV infection in children: evaluation of the ANRS prospective French Pediatric Cohort.\",\n",
      "        \"authors\": \"Warszawski J; Lechenadec J; Faye A; Dollfus C; Firtion G; Meyer L; Douard D; Monpoux F; Tricoire J; Benmebarek Y; Rouzioux C; Blanche S\",\n",
      "        \"doi\": \"10.1086/521165\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Warszawski J, et al. Long-term nonprogression of HIV infection in children: evaluation of the ANRS prospective French Pediatric Cohort. Long-term nonprogression of HIV infection in children: evaluation of the ANRS prospective French Pediatric Cohort. 2007; 45:785-94. doi: 10.1086/521165\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22198788\",\n",
      "        \"title\": \"Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation.\",\n",
      "        \"authors\": \"Goetghebuer T; Le Chenadec J; Haelterman E; Galli L; Dollfus C; Thorne C; Judd A; Keiser O; Ramos JT; Levy J; Warszawski J; European Infant Collaboration Group\",\n",
      "        \"doi\": \"10.1093/cid/cir950\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Goetghebuer T, et al. Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation. Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation. 2012; 54:878-81. doi: 10.1093/cid/cir950\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22427678\",\n",
      "        \"title\": \"Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study.\",\n",
      "        \"authors\": \"Avettand-Fenoel V; Blanche S; Le Chenadec J; Scott-Algara D; Dollfus C; Viard JP; Bouallag N; Benmebarek Y; Rivi\\u00e8re Y; Warszawski J; Rouzioux C; Buseyne F\",\n",
      "        \"doi\": \"10.1093/infdis/jis233\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Avettand-Fenoel V, et al. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study. 2012; 205:1520-8. doi: 10.1093/infdis/jis233\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26762993\",\n",
      "        \"title\": \"HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report.\",\n",
      "        \"authors\": \"Frange P; Faye A; Avettand-Feno\\u00ebl V; Bellaton E; Descamps D; Angin M; David A; Caillat-Zucman S; Peytavin G; Dollfus C; Le Chenadec J; Warszawski J; Rouzioux C; S\\u00e1ez-Ciri\\u00f3n A; ANRS EPF-CO10 Pediatric Cohort and the ANRS EP47 VISCONTI study group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(15)00232-5\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Case Reports\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Frange P, et al. HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report. HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report. 2016; 3:e49-54. doi: 10.1016/S2352-3018(15)00232-5\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20536367\",\n",
      "        \"title\": \"Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10).\",\n",
      "        \"authors\": \"Dollfus C; Le Chenadec J; Faye A; Blanche S; Briand N; Rouzioux C; Warszawski J\",\n",
      "        \"doi\": \"10.1086/653674\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Dollfus C, et al. Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10). Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10). 2010; 51:214-24. doi: 10.1086/653674\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18614870\",\n",
      "        \"title\": \"Response to combination antiretroviral therapy: variation by age.\",\n",
      "        \"authors\": \"Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group; Sabin CA; Smith CJ; d'Arminio Monforte A; Battegay M; Gabiano C; Galli L; Geelen S; Gibb D; Guiguet M; Judd A; Leport C; Dabis F; Pantazis N; Porter K; Raffi F; Thorne C; Torti C; Walker S; Warszawski J; Wintergerst U; Chene G; Lundgren J\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e3282f88d02\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group, et al. Response to combination antiretroviral therapy: variation by age. Response to combination antiretroviral therapy: variation by age. 2008; 22:1463-73. doi: 10.1097/QAD.0b013e3282f88d02\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24945880\",\n",
      "        \"title\": \"Interruption of cART in clinical practice is associated with an increase in the long-term risk of subsequent immunosuppression in HIV-1-infected children.\",\n",
      "        \"authors\": \"Aupiais C; Faye A; Le Chenadec J; Rouzioux C; Bouallag N; Laurent C; Blanche S; Dollfus C; Warszawski J; ANRS EPF-CO10 French Pediatric Cohort\",\n",
      "        \"doi\": \"10.1097/INF.0000000000000450\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Aupiais C, et al. Interruption of cART in clinical practice is associated with an increase in the long-term risk of subsequent immunosuppression in HIV-1-infected children. Interruption of cART in clinical practice is associated with an increase in the long-term risk of subsequent immunosuppression in HIV-1-infected children. 2014; 33:1237-45. doi: 10.1097/INF.0000000000000450\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19194272\",\n",
      "        \"title\": \"Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants.\",\n",
      "        \"authors\": \"Goetghebuer T; Haelterman E; Le Chenadec J; Dollfus C; Gibb D; Judd A; Green H; Galli L; Ramos JT; Giaquinto C; Warszawski J; Levy J; European Infant Collaboration group\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e328326ca37\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Goetghebuer T, et al. Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. 2009; 23:597-604. doi: 10.1097/QAD.0b013e328326ca37\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24253249\",\n",
      "        \"title\": \"Naive T lymphocytes and recent thymic emigrants are associated with HIV-1 disease history in french adolescents and young adults infected in the perinatal period: the ANRS-EP38-IMMIP study.\",\n",
      "        \"authors\": \"Blanche S; Scott-Algara D; Le Chenadec J; Didier C; Montange T; Avettand-Fenoel V; Rouzioux C; M\\u00e9lard A; Viard JP; Dollfus C; Bouallag N; Warszawski J; Buseyne F\",\n",
      "        \"doi\": \"10.1093/cid/cit729\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Blanche S, et al. Naive T lymphocytes and recent thymic emigrants are associated with HIV-1 disease history in french adolescents and young adults infected in the perinatal period: the ANRS-EP38-IMMIP study. Naive T lymphocytes and recent thymic emigrants are associated with HIV-1 disease history in french adolescents and young adults infected in the perinatal period: the ANRS-EP38-IMMIP study. 2014; 58:573-87. doi: 10.1093/cid/cit729\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00383734\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"23432777\",\n",
      "        \"title\": \"Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [Agence Nationale de Recherches sur le SIDA et les H\\u00e9patites Virales (ANRS) 132 SMILE].\",\n",
      "        \"authors\": \"Lafaurie M; Dolivo M; Girard PM; May T; Bouchaud O; Carbonnel E; Madelaine I; Loze B; Porcher R; Molina JM; ANRS 132 SMILE study group\",\n",
      "        \"doi\": \"10.1111/hiv.12021\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Lafaurie M, et al. Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [Agence Nationale de Recherches sur le SIDA et les H\\u00e9patites Virales (ANRS) 132 SMILE]. Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [Agence Nationale de Recherches sur le SIDA et les H\\u00e9patites Virales (ANRS) 132 SMILE]. 2013; 14:410-20. doi: 10.1111/hiv.12021\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00901524\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"24905490\",\n",
      "        \"title\": \"Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection.\",\n",
      "        \"authors\": \"Laird ME; Mohsen A; Duffy D; Mamdouh R; LeFouler L; Casrouge A; El-Daly M; Rafik M; Abdel-Hamid M; Soulier A; Pawlotsky JM; H\\u00e9zode C; Rosa I; Renard P; Mohamed MK; Bonnard P; Izopet J; Mallet V; Pol S; Albert ML; Fontanet A\",\n",
      "        \"doi\": \"10.1016/j.jhep.2014.05.040\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Laird ME, et al. Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection. Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection. 2014; 61:770-6. doi: 10.1016/j.jhep.2014.05.040\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01493934\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03078439\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"38408861\",\n",
      "        \"title\": \"Birth weight and head circumference discordance and outcome in preterms: results from the EPIPAGE-2 cohort.\",\n",
      "        \"authors\": \"Guellec I; Brunet A; Lapillonne A; Taine M; Torchin H; Favrais G; Gascoin G; Simon L; Heude B; Scherdel P; Kayem G; Delorme P; Jarreau PH; Ancel PY\",\n",
      "        \"doi\": \"10.1136/archdischild-2023-326336\",\n",
      "        \"year\": \"2024\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Guellec I, et al. Birth weight and head circumference discordance and outcome in preterms: results from the EPIPAGE-2 cohort. Birth weight and head circumference discordance and outcome in preterms: results from the EPIPAGE-2 cohort. 2024; (unknown volume):(unknown pages). doi: 10.1136/archdischild-2023-326336\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04808986\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01207986\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02626286\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"33753460\",\n",
      "        \"title\": \"Decrease in incidence of sexually transmitted infections symptoms in men who have sex with men enrolled in a quarterly HIV prevention and care programme in West Africa (CohMSM ANRS 12324-Expertise France).\",\n",
      "        \"authors\": \"Yaya I; Diallo F; Kouam\\u00e9 MJ; Agboyibor MK; Traor\\u00e9 I; Coulibaly A; Maiga K; Mora M; Palvadeau P; Dah ETT; Mensah E; Anoma C; Demb\\u00e9l\\u00e9 Keita B; Spire B; Laurent C; CohMSM Study Group\",\n",
      "        \"doi\": \"10.1136/sextrans-2020-054755\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Yaya I, et al. Decrease in incidence of sexually transmitted infections symptoms in men who have sex with men enrolled in a quarterly HIV prevention and care programme in West Africa (CohMSM ANRS 12324-Expertise France). Decrease in incidence of sexually transmitted infections symptoms in men who have sex with men enrolled in a quarterly HIV prevention and care programme in West Africa (CohMSM ANRS 12324-Expertise France). 2022; 98:85-94. doi: 10.1136/sextrans-2020-054755\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34022820\",\n",
      "        \"title\": \"Adherence to quarterly HIV prevention services and its impact on HIV incidence in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France).\",\n",
      "        \"authors\": \"Dah TTE; Yaya I; Sagaon-Teyssier L; Coulibaly A; Kouam\\u00e9 MJ; Agboyibor MK; Maiga K; Traor\\u00e9 I; Mora M; Palvadeau P; Rojas-Castro D; Diallo F; Mensah E; Anoma C; Keita BD; Spire B; Laurent C; CohMSM Study Group\",\n",
      "        \"doi\": \"10.1186/s12889-021-10994-4\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Dah TTE, et al. Adherence to quarterly HIV prevention services and its impact on HIV incidence in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France). Adherence to quarterly HIV prevention services and its impact on HIV incidence in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France). 2021; 21:972. doi: 10.1186/s12889-021-10994-4\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34352834\",\n",
      "        \"title\": \"Rapid antiretroviral therapy initiation and its effect on treatment response in MSM in West Africa.\",\n",
      "        \"authors\": \"Dah TTE; Yaya I; Mensah E; Coulibaly A; Kouam\\u00e9 JM; Traor\\u00e9 I; Mora M; Palvadeau P; Anoma C; Keita BD; Spire B; Laurent C; CohMSM Study Group\",\n",
      "        \"doi\": \"10.1097/QAD.0000000000003046\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Dah TTE, et al. Rapid antiretroviral therapy initiation and its effect on treatment response in MSM in West Africa. Rapid antiretroviral therapy initiation and its effect on treatment response in MSM in West Africa. 2021; 35:2201-2210. doi: 10.1097/QAD.0000000000003046\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02527096\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00121758\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"23759749\",\n",
      "        \"title\": \"Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers.\",\n",
      "        \"authors\": \"Richert L; Hue S; Hocini H; Raimbault M; Lacabaratz C; Surenaud M; Wiedemann A; Tisserand P; Durier C; Salmon D; Leli\\u00e8vre JD; Ch\\u00eane G; Thi\\u00e9baut R; L\\u00e9vy Y; ANRS Vaccine Network/Vaccine Research Institute\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32835f5b60\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Richert L, et al. Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers. Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers. 2013; 27:1421-31. doi: 10.1097/QAD.0b013e32835f5b60\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20625264\",\n",
      "        \"title\": \"Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial.\",\n",
      "        \"authors\": \"Salmon-C\\u00e9ron D; Durier C; Desaint C; Cuzin L; Surenaud M; Hamouda NB; Leli\\u00e8vre JD; Bonnet B; Pialoux G; Poizot-Martin I; Aboulker JP; L\\u00e9vy Y; Launay O; ANRS VAC18 trial group\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32833ce566\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Salmon-C\\u00e9ron D, et al. Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial. Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial. 2010; 24:2211-23. doi: 10.1097/QAD.0b013e32833ce566\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04684758\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02057796\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"32558469\",\n",
      "        \"title\": \"Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults.\",\n",
      "        \"authors\": \"Blanc FX; Badje AD; Bonnet M; Gabillard D; Messou E; Muzoora C; Samreth S; Nguyen BD; Borand L; Domergue A; Rapoud D; Natukunda N; Thai S; Juchet S; Eholi\\u00e9 SP; Lawn SD; Domoua SK; Anglaret X; Laureillard D; STATIS ANRS 12290 Trial Team\",\n",
      "        \"doi\": \"10.1056/NEJMoa1910708\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Blanc FX, et al. Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults. Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults. 2020; 382:2397-2410. doi: 10.1056/NEJMoa1910708\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"36883573\",\n",
      "        \"title\": \"High performance of systematic combined urine LAM test and sputum Xpert MTB/RIF\\u00ae for tuberculosis screening in severely immunosuppressed ambulatory adults with HIV.\",\n",
      "        \"authors\": \"Bonnet M; Gabillard D; Domoua S; Muzoora C; Messou E; Sovannarith S; Nguyen DB; Badje A; Juchet S; Bunnet D; Borand L; Natukunda N; Tran TH; Anglaret X; Laureillard D; Blanc FX; STATIS ANRS 12290 Trial Team\",\n",
      "        \"doi\": \"10.1093/cid/ciad125\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Bonnet M, et al. High performance of systematic combined urine LAM test and sputum Xpert MTB/RIF\\u00ae for tuberculosis screening in severely immunosuppressed ambulatory adults with HIV. High performance of systematic combined urine LAM test and sputum Xpert MTB/RIF\\u00ae for tuberculosis screening in severely immunosuppressed ambulatory adults with HIV. 2023; (unknown volume):(unknown pages). doi: 10.1093/cid/ciad125\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03071458\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02192658\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26846895\",\n",
      "        \"title\": \"HandiVIH--A population-based survey to understand the vulnerability of people with disabilities to HIV and other sexual and reproductive health problems in Cameroon: protocol and methodological considerations.\",\n",
      "        \"authors\": \"De Beaudrap P; Pasquier E; Tchoumkeu A; Touko A; Essomba F; Brus A; Desgr\\u00e9es du Lo\\u00fb A; Aderemi TJ; Hanass-Hancock J; Eide AH; Mont D; Mac-Seing M; Beninguisse G\",\n",
      "        \"doi\": \"10.1136/bmjopen-2015-008934\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"De Beaudrap P, et al. HandiVIH--A population-based survey to understand the vulnerability of people with disabilities to HIV and other sexual and reproductive health problems in Cameroon: protocol and methodological considerations. HandiVIH--A population-based survey to understand the vulnerability of people with disabilities to HIV and other sexual and reproductive health problems in Cameroon: protocol and methodological considerations. 2016; 6:e008934. doi: 10.1136/bmjopen-2015-008934\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01713335\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158522\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"16434426\",\n",
      "        \"title\": \"Higher clearance of hepatitis C virus infection in females compared with males.\",\n",
      "        \"authors\": \"Bakr I; Rekacewicz C; El Hosseiny M; Ismail S; El Daly M; El-Kafrawy S; Esmat G; Hamid MA; Mohamed MK; Fontanet A\",\n",
      "        \"doi\": \"10.1136/gut.2005.078147\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bakr I, et al. Higher clearance of hepatitis C virus infection in females compared with males. Higher clearance of hepatitis C virus infection in females compared with males. 2006; 55:1183-7. doi: 10.1136/gut.2005.078147\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15977225\",\n",
      "        \"title\": \"Surveillance of acute hepatitis C in Cairo, Egypt.\",\n",
      "        \"authors\": \"El Gaafary MM; Rekacewicz C; Abdel-Rahman AG; Allam MF; El Hosseiny M; Hamid MA; Colombani F; Sultan Y; El-Aidy S; Fontanet A; Mohamed MK\",\n",
      "        \"doi\": \"10.1002/jmv.20392\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"El Gaafary MM, et al. Surveillance of acute hepatitis C in Cairo, Egypt. Surveillance of acute hepatitis C in Cairo, Egypt. 2005; 76:520-5. doi: 10.1002/jmv.20392\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00640263\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26603917\",\n",
      "        \"title\": \"Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.\",\n",
      "        \"authors\": \"Nagot N; Kankasa C; Tumwine JK; Meda N; Hofmeyr GJ; Vallo R; Mwiya M; Kwagala M; Traore H; Sunday A; Singata M; Siuluta C; Some E; Rutagwera D; Neboua D; Ndeezi G; Jackson D; Mar\\u00e9chal V; Neveu D; Engebretsen IMS; Lombard C; Blanche S; Sommerfelt H; Rekacewicz C; Tyllesk\\u00e4r T; Van de Perre P; ANRS 12174 Trial Group\",\n",
      "        \"doi\": \"10.1016/S0140-6736(15)00984-8\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nagot N, et al. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. 2016; 387:566-573. doi: 10.1016/S0140-6736(15)00984-8\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30814028\",\n",
      "        \"title\": \"Growth in HIV-1-exposed but uninfected infants treated with lopinavir-ritonavir versus lamivudine: a secondary analysis of the ANRS 12174 trial.\",\n",
      "        \"authors\": \"Blanche S; Tyllesk\\u00e4r T; Peries M; Kankasa C; Engebretsen I; Meda N; Tumwine JK; Singata-Madliki M; Mwiya M; Van de Perre P; Nagot N; ANRS 12174 Trial Group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(18)30361-8\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Blanche S, et al. Growth in HIV-1-exposed but uninfected infants treated with lopinavir-ritonavir versus lamivudine: a secondary analysis of the ANRS 12174 trial. Growth in HIV-1-exposed but uninfected infants treated with lopinavir-ritonavir versus lamivudine: a secondary analysis of the ANRS 12174 trial. 2019; 6:e307-e314. doi: 10.1016/S2352-3018(18)30361-8\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31633158\",\n",
      "        \"title\": \"Lopinavir-Ritonavir Impairs Adrenal Function in Infants.\",\n",
      "        \"authors\": \"Kariyawasam D; Peries M; Foissac F; Eymard-Duvernay S; Tyllesk\\u00e4r T; Singata-Madliki M; Kankasa C; Meda N; Tumwine J; Mwiya M; Engebretsen I; Fl\\u00fcck CE; Hartmann MF; Wudy SA; Hirt D; Treluyer JM; Mol\\u00e8s JP; Blanche S; Van De Perre P; Polak M; Nagot N; ANRS 12174 Trial Group\",\n",
      "        \"doi\": \"10.1093/cid/ciz888\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kariyawasam D, et al. Lopinavir-Ritonavir Impairs Adrenal Function in Infants. Lopinavir-Ritonavir Impairs Adrenal Function in Infants. 2020; 71:1030-1039. doi: 10.1093/cid/ciz888\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28469697\",\n",
      "        \"title\": \"Breastfeeding patterns and its determinants among mothers living with Human Immuno-deficiency Virus -1 in four African countries participating in the ANRS 12174 trial.\",\n",
      "        \"authors\": \"Som\\u00e9 EN; Engebretsen IMS; Nagot N; Meda N; Lombard C; Vallo R; Peries M; Kankasa C; Tumwine JK; Hofmeyr GJ; Singata M; Harper K; Van De Perre P; Tylleskar T; ANRS 12174 Trial Group\",\n",
      "        \"doi\": \"10.1186/s13006-017-0112-2\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Som\\u00e9 EN, et al. Breastfeeding patterns and its determinants among mothers living with Human Immuno-deficiency Virus -1 in four African countries participating in the ANRS 12174 trial. Breastfeeding patterns and its determinants among mothers living with Human Immuno-deficiency Virus -1 in four African countries participating in the ANRS 12174 trial. 2016; 12:22. doi: 10.1186/s13006-017-0112-2\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27895016\",\n",
      "        \"title\": \"Are Prophylactic and Therapeutic Target Concentrations Different?: the Case of Lopinavir-Ritonavir or Lamivudine Administered to Infants for Prevention of Mother-to-Child HIV-1 Transmission during Breastfeeding.\",\n",
      "        \"authors\": \"Foissac F; Blume J; Tr\\u00e9luyer JM; Tyllesk\\u00e4r T; Kankasa C; Meda N; Tumwine JK; Singata-Madliki M; Harper K; Illamola SM; Bouazza N; Nagot N; Van de Perre P; Blanche S; Hirt D\",\n",
      "        \"doi\": \"10.1128/AAC.01869-16\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Foissac F, et al. Are Prophylactic and Therapeutic Target Concentrations Different?: the Case of Lopinavir-Ritonavir or Lamivudine Administered to Infants for Prevention of Mother-to-Child HIV-1 Transmission during Breastfeeding. Are Prophylactic and Therapeutic Target Concentrations Different?: the Case of Lopinavir-Ritonavir or Lamivudine Administered to Infants for Prevention of Mother-to-Child HIV-1 Transmission during Breastfeeding. 2017; 61:(unknown pages). doi: 10.1128/AAC.01869-16\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23039034\",\n",
      "        \"title\": \"Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174.\",\n",
      "        \"authors\": \"Nagot N; Kankasa C; Meda N; Hofmeyr J; Nikodem C; Tumwine JK; Karamagi C; Sommerfelt H; Neveu D; Tyllesk\\u00e4r T; Van de Perre P; PROMISE-PEP group\",\n",
      "        \"doi\": \"10.1186/1471-2334-12-246\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nagot N, et al. Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174. Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174. 2012; 12:246. doi: 10.1186/1471-2334-12-246\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32228542\",\n",
      "        \"title\": \"Caries experience and oral health related quality of life in a cohort of Ugandan HIV-1 exposed uninfected children compared with a matched cohort of HIV unexposed uninfected children.\",\n",
      "        \"authors\": \"Birungi N; Fadnes LT; Engebretsen IMS; Lie SA; Tumwine JK; \\u00c5str\\u00f8m AN; ANRS 12174 and 12341 study groups\",\n",
      "        \"doi\": \"10.1186/s12889-020-08564-1\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Birungi N, et al. Caries experience and oral health related quality of life in a cohort of Ugandan HIV-1 exposed uninfected children compared with a matched cohort of HIV unexposed uninfected children. Caries experience and oral health related quality of life in a cohort of Ugandan HIV-1 exposed uninfected children compared with a matched cohort of HIV unexposed uninfected children. 2020; 20:423. doi: 10.1186/s12889-020-08564-1\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32067040\",\n",
      "        \"title\": \"Clinical and Biological Factors Associated With Early Epstein-Barr Virus Infection in Human Immunodeficiency Virus-Exposed Uninfected Infants in Eastern Uganda.\",\n",
      "        \"authors\": \"Montoya-Ferrer A; Sanosyan A; Fayd'herbe de Maudave A; Pisoni A; Bollore K; Mol\\u00e8s JP; Peries M; Tylleskar T; Tumwine JK; Ndeezi G; Gorgolas M; Nagot N; van de Perre P; Tuaillon E\",\n",
      "        \"doi\": \"10.1093/cid/ciaa161\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Montoya-Ferrer A, et al. Clinical and Biological Factors Associated With Early Epstein-Barr Virus Infection in Human Immunodeficiency Virus-Exposed Uninfected Infants in Eastern Uganda. Clinical and Biological Factors Associated With Early Epstein-Barr Virus Infection in Human Immunodeficiency Virus-Exposed Uninfected Infants in Eastern Uganda. 2021; 72:1026-1032. doi: 10.1093/cid/ciaa161\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31994250\",\n",
      "        \"title\": \"Association of maternal HIV-1 severity with dental caries: an observational study of uninfected 5- to 7-yr-old children of HIV-1-infected mothers without severe immune suppression.\",\n",
      "        \"authors\": \"Birungi N; Fadnes LT; Engebretsen IMS; Lie SA; Tumwine JK; \\u00c5str\\u00f8m AN; ANRS 12174 and 12341 study groups\",\n",
      "        \"doi\": \"10.1111/eos.12669\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Birungi N, et al. Association of maternal HIV-1 severity with dental caries: an observational study of uninfected 5- to 7-yr-old children of HIV-1-infected mothers without severe immune suppression. Association of maternal HIV-1 severity with dental caries: an observational study of uninfected 5- to 7-yr-old children of HIV-1-infected mothers without severe immune suppression. 2020; 128:46-54. doi: 10.1111/eos.12669\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17825642\",\n",
      "        \"title\": \"Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments.\",\n",
      "        \"authors\": \"Kourtis AP; Jamieson DJ; de Vincenzi I; Taylor A; Thigpen MC; Dao H; Farley T; Fowler MG\",\n",
      "        \"doi\": \"10.1016/j.ajog.2007.03.003\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Kourtis AP, et al. Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments. Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments. 2007; 197:S113-22. doi: 10.1016/j.ajog.2007.03.003\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34425825\",\n",
      "        \"title\": \"The prevalence and socio-behavioural and clinical covariates of oral health related quality of life in Ugandan mothers with and without HIV-1.\",\n",
      "        \"authors\": \"Birungi N; Fadnes LT; Engebretsen IMS; Tumwine JK; \\u00c5str\\u00f8m AN; ANRS 12174 and 12341 study groups\",\n",
      "        \"doi\": \"10.1186/s12955-021-01844-3\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Birungi N, et al. The prevalence and socio-behavioural and clinical covariates of oral health related quality of life in Ugandan mothers with and without HIV-1. The prevalence and socio-behavioural and clinical covariates of oral health related quality of life in Ugandan mothers with and without HIV-1. 2021; 19:201. doi: 10.1186/s12955-021-01844-3\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32991450\",\n",
      "        \"title\": \"Antiretroviral treatment and its impact on oral health outcomes in 5 to 7 year old Ugandan children: A 6 year follow-up visit from the ANRS 12174 randomized trial.\",\n",
      "        \"authors\": \"Birungi N; Fadnes LT; Engebretsen IMS; Tumwine JK; \\u00c5str\\u00f8m AN; for ANRS 12174 AND 12341 study groups\",\n",
      "        \"doi\": \"10.1097/MD.0000000000022352\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Birungi N, et al. Antiretroviral treatment and its impact on oral health outcomes in 5 to 7 year old Ugandan children: A 6 year follow-up visit from the ANRS 12174 randomized trial. Antiretroviral treatment and its impact on oral health outcomes in 5 to 7 year old Ugandan children: A 6 year follow-up visit from the ANRS 12174 randomized trial. 2020; 99:e22352. doi: 10.1097/MD.0000000000022352\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02428816\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00122616\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"23800784\",\n",
      "        \"title\": \"The effects of a maintenance therapy with peg-interferon alpha-2a on liver fibrosis in HIV/HCV co-infected patients: a randomized controlled trial.\",\n",
      "        \"authors\": \"Chapplain JM; Bellissant E; Guyader D; Molina JM; Poizot-Martin I; Perr\\u00e9 P; Pialoux G; Turlin B; Mouchel C; Renault A; Michelet C; ANRS HC-12 Study Group\",\n",
      "        \"doi\": \"10.1016/j.jinf.2013.05.007\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Chapplain JM, et al. The effects of a maintenance therapy with peg-interferon alpha-2a on liver fibrosis in HIV/HCV co-infected patients: a randomized controlled trial. The effects of a maintenance therapy with peg-interferon alpha-2a on liver fibrosis in HIV/HCV co-infected patients: a randomized controlled trial. 2013; 67:313-21. doi: 10.1016/j.jinf.2013.05.007\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00196586\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00148863\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"23190183\",\n",
      "        \"title\": \"Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI).\",\n",
      "        \"authors\": \"Couzigou P; P\\u00e9rusat S; Bourli\\u00e8re M; Trimoulet P; Poynard T; Leroy V; Marcellin P; Foucher J; Bronowicki JP; Ch\\u00eane G; ANRS HC16 GAMMATRI Trial Group\",\n",
      "        \"doi\": \"10.1111/jgh.12060\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Couzigou P, et al. Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI). Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI). 2013; 28:329-34. doi: 10.1111/jgh.12060\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03150290\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01514890\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"25556540\",\n",
      "        \"title\": \"Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy.\",\n",
      "        \"authors\": \"Sultanik P; Mallet V; Lagaye S; Casrouge A; Dorival C; Barthe Y; Fontaine H; H\\u00e9zode C; Mottez E; Bronowicki JP; Carrat F; Theodorou I; Abel L; Gayat E; Fontanet A; Pol S; Albert ML; ANRS CO20-CUPIC\",\n",
      "        \"doi\": \"10.1111/liv.12759\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sultanik P, et al. Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy. Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy. 2015; 35:1833-44. doi: 10.1111/liv.12759\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24704719\",\n",
      "        \"title\": \"Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.\",\n",
      "        \"authors\": \"H\\u00e9zode C; Fontaine H; Dorival C; Zoulim F; Larrey D; Canva V; De Ledinghen V; Poynard T; Samuel D; Bourliere M; Alric L; Raabe JJ; Zarski JP; Marcellin P; Riachi G; Bernard PH; Loustaud-Ratti V; Chazouilleres O; Abergel A; Guyader D; Metivier S; Tran A; Di Martino V; Causse X; Dao T; Lucidarme D; Portal I; Cacoub P; Gournay J; Grando-Lemaire V; Hillon P; Attali P; Fontanges T; Rosa I; Petrov-Sanchez V; Barthe Y; Pawlotsky JM; Pol S; Carrat F; Bronowicki JP; CUPIC Study Group\",\n",
      "        \"doi\": \"10.1053/j.gastro.2014.03.051\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\"\n",
      "        ],\n",
      "        \"citation\": \"H\\u00e9zode C, et al. Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis. Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis. 2014; 147:132-142.e4. doi: 10.1053/j.gastro.2014.03.051\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23669289\",\n",
      "        \"title\": \"Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.\",\n",
      "        \"authors\": \"H\\u00e9zode C; Fontaine H; Dorival C; Larrey D; Zoulim F; Canva V; de Ledinghen V; Poynard T; Samuel D; Bourli\\u00e8re M; Zarski JP; Raabe JJ; Alric L; Marcellin P; Riachi G; Bernard PH; Loustaud-Ratti V; M\\u00e9tivier S; Tran A; Serfaty L; Abergel A; Causse X; Di Martino V; Guyader D; Lucidarme D; Grando-Lemaire V; Hillon P; Feray C; Dao T; Cacoub P; Rosa I; Attali P; Petrov-Sanchez V; Barthe Y; Pawlotsky JM; Pol S; Carrat F; Bronowicki JP; CUPIC Study Group\",\n",
      "        \"doi\": \"10.1016/j.jhep.2013.04.035\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"H\\u00e9zode C, et al. Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890. Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890. 2013; 59:434-41. doi: 10.1016/j.jhep.2013.04.035\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03652090\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02738502\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26854809\",\n",
      "        \"title\": \"Risk of cancer in children exposed to didanosine in utero.\",\n",
      "        \"authors\": \"Hleyhel M; Goujon S; Delteil C; Vasiljevic A; Luzi S; Stephan JL; Reliquet V; Jannier S; Tubiana R; Dollfus C; Faye A; Mandelbrot L; Clavel J; Warszawski J; Blanche S; ANRS French Perinatal Cohort Study Group\",\n",
      "        \"doi\": \"10.1097/QAD.0000000000001051\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hleyhel M, et al. Risk of cancer in children exposed to didanosine in utero. Risk of cancer in children exposed to didanosine in utero. 2016; 30:1245-56. doi: 10.1097/QAD.0000000000001051\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22848481\",\n",
      "        \"title\": \"Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks.\",\n",
      "        \"authors\": \"Lambert-Niclot S; Flandre P; Valantin MA; Soulie C; Fourati S; Wirden M; Sayon S; Pakianather S; Bocket L; Masquelier B; Dos Santos G; Katlama C; Calvez V; Marcelin AG\",\n",
      "        \"doi\": \"10.1371/journal.pone.0041390\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Lambert-Niclot S, et al. Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks. Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks. 2012; 7:e41390. doi: 10.1371/journal.pone.0041390\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26197844\",\n",
      "        \"title\": \"No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.\",\n",
      "        \"authors\": \"Mandelbrot L; Tubiana R; Le Chenadec J; Dollfus C; Faye A; Pannier E; Matheron S; Khuong MA; Garrait V; Reliquet V; Devidas A; Berrebi A; Allisy C; Elleau C; Arvieux C; Rouzioux C; Warszawski J; Blanche S; ANRS-EPF Study Group\",\n",
      "        \"doi\": \"10.1093/cid/civ578\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mandelbrot L, et al. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception. 2015; 61:1715-25. doi: 10.1093/cid/civ578\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23559464\",\n",
      "        \"title\": \"Genotoxic signature in cord blood cells of newborns exposed in utero to a Zidovudine-based antiretroviral combination.\",\n",
      "        \"authors\": \"Andr\\u00e9-Schmutz I; Dal-Cortivo L; Six E; Kaltenbach S; Cocchiarella F; Le Chenadec J; Cagnard N; Cordier AG; Benachi A; Mandelbrot L; Azria E; Bouallag N; Luce S; Ternaux B; Reimann C; Revy P; Radford-Weiss I; Leschi C; Recchia A; Mavilio F; Cavazzana M; Blanche S\",\n",
      "        \"doi\": \"10.1093/infdis/jit149\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Andr\\u00e9-Schmutz I, et al. Genotoxic signature in cord blood cells of newborns exposed in utero to a Zidovudine-based antiretroviral combination. Genotoxic signature in cord blood cells of newborns exposed in utero to a Zidovudine-based antiretroviral combination. 2013; 208:235-43. doi: 10.1093/infdis/jit149\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26709605\",\n",
      "        \"title\": \"Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials.\",\n",
      "        \"authors\": \"Arribas JR; Girard PM; Paton N; Winston A; Marcelin AG; Elbirt D; Hill A; Hadacek MB\",\n",
      "        \"doi\": \"10.1111/hiv.12348\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Meta-Analysis\"\n",
      "        ],\n",
      "        \"citation\": \"Arribas JR, et al. Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials. Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials. 2016; 17:358-67. doi: 10.1111/hiv.12348\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23766338\",\n",
      "        \"title\": \"Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial.\",\n",
      "        \"authors\": \"Tubiana R; Mandelbrot L; Le Chenadec J; Delmas S; Rouzioux C; Hirt D; Treluyer JM; Ekoukou D; Bui E; Chaix ML; Blanche S; Warszawski J; ANRS 135 PRIMEVA (Protease Inhibitor Monotherapy Evaluation) Study Group\",\n",
      "        \"doi\": \"10.1093/cid/cit390\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Tubiana R, et al. Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial. Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial. 2013; 57:891-902. doi: 10.1093/cid/cit390\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22160145\",\n",
      "        \"title\": \"Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study.\",\n",
      "        \"authors\": \"Valantin MA; Lambert-Niclot S; Flandre P; Morand-Joubert L; Cabi\\u00e8 A; Meynard JL; Ponscarme D; Ajana F; Slama L; Curjol A; Cuzin L; Schneider L; Taburet AM; Marcelin AG; Katlama C; MONOI ANRS 136 Study Group\",\n",
      "        \"doi\": \"10.1093/jac/dkr504\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Valantin MA, et al. Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study. Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study. 2012; 67:691-5. doi: 10.1093/jac/dkr504\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02212379\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"31269208\",\n",
      "        \"title\": \"Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study.\",\n",
      "        \"authors\": \"Katlama C; Assoumou L; Valantin MA; Souli\\u00e9 C; Martinez E; B\\u00e9niguel L; Bouchaud O; Raffi F; Molina JM; Fellahi S; Peytavin G; Marcelin AG; Kolta S; Capeau J; Gibowski S; Cardon F; Reynes J; Costagliola D; members of the ANRS 163 ETRAL study\",\n",
      "        \"doi\": \"10.1093/jac/dkz224\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Katlama C, et al. Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study. Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study. 2019; 74:2742-2751. doi: 10.1093/jac/dkz224\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00465790\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01605890\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29590335\",\n",
      "        \"title\": \"First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2).\",\n",
      "        \"authors\": \"Matheron S; Descamps D; Gallien S; Besseghir A; Sellier P; Blum L; Mortier E; Charpentier C; Tubiana R; Damond F; Peytavin G; Ponscarme D; Collin F; Brun-Vezinet F; Chene G; France REcherche Nord&Sud Sida-Hiv H\\u00e9patites (ANRS) 159 HIV-2 Trial Study Group\",\n",
      "        \"doi\": \"10.1093/cid/ciy245\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Matheron S, et al. First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2). First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2). 2018; 67:1161-1167. doi: 10.1093/cid/ciy245\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00196664\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00122603\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"19420019\",\n",
      "        \"title\": \"Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.\",\n",
      "        \"authors\": \"Landman R; Capitant C; Descamps D; Chazallon C; Peytavin G; Katlama C; Pialoux G; Bentata M; Brun-V\\u00e9zinet F; Aboulker JP; Y\\u00e9ni P; ANRS 127 Study Group\",\n",
      "        \"doi\": \"10.1093/jac/dkp146\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Landman R, et al. Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study. Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study. 2009; 64:118-25. doi: 10.1093/jac/dkp146\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02992184\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29615488\",\n",
      "        \"title\": \"Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus.\",\n",
      "        \"authors\": \"Llibre A; Shimakawa Y; Mottez E; Ainsworth S; Buivan TP; Firth R; Harrison E; Rosenberg AR; Meritet JF; Fontanet A; Castan P; Madej\\u00f3n A; Laverick M; Glass A; Viana R; Pol S; McClure CP; Irving WL; Miele G; Albert ML; Duffy D\",\n",
      "        \"doi\": \"10.1136/gutjnl-2017-315783\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Validation Study\"\n",
      "        ],\n",
      "        \"citation\": \"Llibre A, et al. Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus. Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus. 2018; 67:2017-2024. doi: 10.1136/gutjnl-2017-315783\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02071784\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01432821\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"15037514\",\n",
      "        \"title\": \"Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat.\",\n",
      "        \"authors\": \"Ahmad S; Fowler LJ; Whitton PS\",\n",
      "        \"doi\": \"10.1038/sj.bjp.0705737\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Ahmad S, et al. Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat. Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat. 2004; 142:136-42. doi: 10.1038/sj.bjp.0705737\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15777732\",\n",
      "        \"title\": \"Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids.\",\n",
      "        \"authors\": \"Ahmad S; Fowler LJ; Whitton PS\",\n",
      "        \"doi\": \"10.1016/j.eplepsyres.2005.02.002\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Ahmad S, et al. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids. 2005; 63:141-9. doi: 10.1016/j.eplepsyres.2005.02.002\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"12914551\",\n",
      "        \"title\": \"Pharmacokinetic-pharmacodynamic study of apomorphine's effect on growth hormone secretion in healthy subjects.\",\n",
      "        \"authors\": \"Aymard G; Berlin I; de Brettes B; Diquet B\",\n",
      "        \"doi\": \"10.1046/j.1472-8206.2003.00152.x\",\n",
      "        \"year\": \"2003\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Aymard G, et al. Pharmacokinetic-pharmacodynamic study of apomorphine's effect on growth hormone secretion in healthy subjects. Pharmacokinetic-pharmacodynamic study of apomorphine's effect on growth hormone secretion in healthy subjects. 2003; 17:473-81. doi: 10.1046/j.1472-8206.2003.00152.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15249613\",\n",
      "        \"title\": \"PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy.\",\n",
      "        \"authors\": \"Biraben A; Semah F; Ribeiro MJ; Douaud G; Remy P; Depaulis A\",\n",
      "        \"doi\": \"10.1212/01.wnl.0000132840.40838.13\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Biraben A, et al. PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy. PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy. 2004; 63:73-7. doi: 10.1212/01.wnl.0000132840.40838.13\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"2271377\",\n",
      "        \"title\": \"Apomorphine-induced blinking and yawning in healthy volunteers.\",\n",
      "        \"authors\": \"Blin O; Masson G; Azulay JP; Fondarai J; Serratrice G\",\n",
      "        \"doi\": \"10.1111/j.1365-2125.1990.tb03848.x\",\n",
      "        \"year\": \"1990\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Blin O, et al. Apomorphine-induced blinking and yawning in healthy volunteers. Apomorphine-induced blinking and yawning in healthy volunteers. 1990; 30:769-73. doi: 10.1111/j.1365-2125.1990.tb03848.x\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00121121\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"17712402\",\n",
      "        \"title\": \"Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial.\",\n",
      "        \"authors\": \"Launay O; Durier C; Desaint C; Silbermann B; Jackson A; Pialoux G; Bonnet B; Poizot-Martin I; Gonzalez-Canali G; Cuzin L; Figuereido S; Surenaud M; Ben Hamouda N; Gahery H; Choppin J; Salmon D; Gu\\u00e9rin C; Bourgault Villada I; Guillet JG; ANRS VAC16 Study Group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0000725\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Launay O, et al. Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial. Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial. 2007; 2:e725. doi: 10.1371/journal.pone.0000725\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02126384\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02323308\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02314208\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01348308\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"32040959\",\n",
      "        \"title\": \"Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial.\",\n",
      "        \"authors\": \"L\\u00e9vy Y; Leli\\u00e8vre JD; Assoumou L; Aznar E; Pulido F; Tambussi G; Crespo M; Meybeck A; Molina JM; Delaugerre C; Izopet J; Peytavin G; Cardon F; Diallo A; Lancar R; B\\u00e9niguel L; Costagliola D\",\n",
      "        \"doi\": \"10.7326/M19-2133\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"L\\u00e9vy Y, et al. Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial. Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial. 2020; 172:297-305. doi: 10.7326/M19-2133\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02113943\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00299143\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04824638\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00120367\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"21738597\",\n",
      "        \"title\": \"Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy.\",\n",
      "        \"authors\": \"Gasnault J; Costagliola D; Hendel-Chavez H; Dulioust A; Pakianather S; Mazet AA; de Goer de Herve MG; Lancar R; Lascaux AS; Porte L; Delfraissy JF; Taoufik Y; ANRS 125 Trial Team\",\n",
      "        \"doi\": \"10.1371/journal.pone.0020967\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Gasnault J, et al. Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy. Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy. 2011; 6:e20967. doi: 10.1371/journal.pone.0020967\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00323804\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03642704\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04849767\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"34916316\",\n",
      "        \"title\": \"Living conditions, HIV and gender affirmation care pathways of transgender people living with HIV in France: a nationwide, comprehensive, cross-sectional, community-based research protocol (ANRS Trans&HIV).\",\n",
      "        \"authors\": \"Mora M; Rincon G; Bourrelly M; Maradan G; Freire Maresca A; Michard F; Rouveix E; Pannetier J; Leriche D; Alain T; Yazdanpanah Y; Michels D; Spire B\",\n",
      "        \"doi\": \"10.1136/bmjopen-2021-052691\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mora M, et al. Living conditions, HIV and gender affirmation care pathways of transgender people living with HIV in France: a nationwide, comprehensive, cross-sectional, community-based research protocol (ANRS Trans&HIV). Living conditions, HIV and gender affirmation care pathways of transgender people living with HIV in France: a nationwide, comprehensive, cross-sectional, community-based research protocol (ANRS Trans&HIV). 2021; 11:e052691. doi: 10.1136/bmjopen-2021-052691\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00573001\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02267304\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01525472\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02073604\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01127204\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"28483965\",\n",
      "        \"title\": \"Pharmacokinetics of Efavirenz at a High Dose of 25 Milligrams per Kilogram per Day in Children 2 to 3 Years Old.\",\n",
      "        \"authors\": \"Pressiat C; Amorissani-Folquet M; Yonaba C; Treluyer JM; Dahourou DL; Eboua F; Blanche S; Mea-Assande V; Bouazza N; Foissac F; Malateste K; Ouedraogo S; Lui G; Leroy V; Hirt D\",\n",
      "        \"doi\": \"10.1128/AAC.00297-17\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Pressiat C, et al. Pharmacokinetics of Efavirenz at a High Dose of 25 Milligrams per Kilogram per Day in Children 2 to 3 Years Old. Pharmacokinetics of Efavirenz at a High Dose of 25 Milligrams per Kilogram per Day in Children 2 to 3 Years Old. 2017; 61:(unknown pages). doi: 10.1128/AAC.00297-17\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28434406\",\n",
      "        \"title\": \"Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and C\\u00f4te d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.\",\n",
      "        \"authors\": \"Dahourou DL; Amorissani-Folquet M; Malateste K; Amani-Bosse C; Coulibaly M; Seguin-Devaux C; Toni T; Ou\\u00e9draogo R; Blanche S; Yonaba C; Eboua F; Lepage P; Avit D; Ou\\u00e9draogo S; Van de Perre P; N'Gbeche S; Kalmogho A; Salamon R; Meda N; Timit\\u00e9-Konan M; Leroy V; MONOD Study Group\",\n",
      "        \"doi\": \"10.1186/s12916-017-0842-4\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Dahourou DL, et al. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and C\\u00f4te d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and C\\u00f4te d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial. 2017; 15:85. doi: 10.1186/s12916-017-0842-4\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27015798\",\n",
      "        \"title\": \"Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013.\",\n",
      "        \"authors\": \"Dahourou DL; Amorissani-Folquet M; Coulibaly M; Avit-Edi D; Meda N; Timite-Konan M; Arendt V; Ye D; Amani-Bosse C; Salamon R; Lepage P; Leroy V; Monod Anrs 12206 Study Group\",\n",
      "        \"doi\": \"10.7448/IAS.19.1.20601\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Dahourou DL, et al. Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013. Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013. 2016; 19:20601. doi: 10.7448/IAS.19.1.20601\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31334298\",\n",
      "        \"title\": \"Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus.\",\n",
      "        \"authors\": \"Desmonde S; Frank SC; Coovadia A; Dahourou DL; Hou T; Abrams EJ; Amorissani-Folquet M; Walensky RP; Strehlau R; Penazzato M; Freedberg KA; Kuhn L; Leroy V; Ciaranello AL\",\n",
      "        \"doi\": \"10.1093/ofid/ofz276\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Desmonde S, et al. Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus. Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus. 2019; 6:ofz276. doi: 10.1093/ofid/ofz276\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28800382\",\n",
      "        \"title\": \"Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines.\",\n",
      "        \"authors\": \"Pressiat C; Mea-Assande V; Yonaba C; Treluyer JM; Dahourou DL; Amorissani-Folquet M; Blanche S; Eboua F; Ye D; Lui G; Malateste K; Zheng Y; Leroy V; Hirt D; MONOD Study Group\",\n",
      "        \"doi\": \"10.1111/bcp.13397\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Pressiat C, et al. Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines. Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines. 2017; 83:2729-2740. doi: 10.1111/bcp.13397\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34723858\",\n",
      "        \"title\": \"High nevirapine levels in breast milk and consequences in HIV-infected child when initiated on antiretroviral therapy.\",\n",
      "        \"authors\": \"Pressiat C; Toni TD; Treluyer JM; Yonaba C; Dahourou DL; Malateste K; Seguin-Devaux C; Leroy V; Hirt D; MONOD ANRS Study Group\",\n",
      "        \"doi\": \"10.1097/QAD.0000000000003043\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Letter\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Pressiat C, et al. High nevirapine levels in breast milk and consequences in HIV-infected child when initiated on antiretroviral therapy. High nevirapine levels in breast milk and consequences in HIV-infected child when initiated on antiretroviral therapy. 2021; 35:2409-2410. doi: 10.1097/QAD.0000000000003043\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28453240\",\n",
      "        \"title\": \"Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort.\",\n",
      "        \"authors\": \"Amani-Bosse C; Dahourou DL; Malateste K; Amorissani-Folquet M; Coulibaly M; Dattez S; Emieme A; Barry M; Rouzioux C; N'gbeche S; Yonaba C; Timit\\u00e9-Konan M; Mea V; Ou\\u00e9draogo S; Blanche S; Meda N; Seguin-Devaux C; Leroy V\",\n",
      "        \"doi\": \"10.7448/IAS.20.01.21362\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Amani-Bosse C, et al. Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort. Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort. 2017; 20:21362. doi: 10.7448/IAS.20.01.21362\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01473472\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26624850\",\n",
      "        \"title\": \"On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.\",\n",
      "        \"authors\": \"Molina JM; Capitant C; Spire B; Pialoux G; Cotte L; Charreau I; Tremblay C; Le Gall JM; Cua E; Pasquet A; Raffi F; Pintado C; Chidiac C; Chas J; Charbonneau P; Delaugerre C; Suzan-Monti M; Loze B; Fonsart J; Peytavin G; Cheret A; Timsit J; Girard G; Lorente N; Pr\\u00e9au M; Rooney JF; Wainberg MA; Thompson D; Rozenbaum W; Dor\\u00e9 V; Marchand L; Simon MC; Etien N; Aboulker JP; Meyer L; Delfraissy JF; ANRS IPERGAY Study Group\",\n",
      "        \"doi\": \"10.1056/NEJMoa1506273\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Molina JM, et al. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. 2015; 373:2237-46. doi: 10.1056/NEJMoa1506273\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"36601747\",\n",
      "        \"title\": \"Hepatitis A and B vaccine uptake and immunisation among men who have sex with men seeking PrEP: a substudy of the ANRS IPERGAY trial.\",\n",
      "        \"authors\": \"Le Turnier P; Charreau I; Gabassi A; Carette D; Cotte L; Pialoux G; Tremblay C; Spire B; Chaix ML; Meyer L; Capitant C; Delaugerre C; Raffi F; Molina JM; ANRS IPERGAY study group\",\n",
      "        \"doi\": \"10.1136/sextrans-2022-055634\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Letter\"\n",
      "        ],\n",
      "        \"citation\": \"Le Turnier P, et al. Hepatitis A and B vaccine uptake and immunisation among men who have sex with men seeking PrEP: a substudy of the ANRS IPERGAY trial. Hepatitis A and B vaccine uptake and immunisation among men who have sex with men seeking PrEP: a substudy of the ANRS IPERGAY trial. 2023; 99:140-142. doi: 10.1136/sextrans-2022-055634\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31784343\",\n",
      "        \"title\": \"On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.\",\n",
      "        \"authors\": \"Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM; ANRS IPERGAY study group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(19)30341-8\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Antoni G, et al. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. 2020; 7:e113-e120. doi: 10.1016/S2352-3018(19)30341-8\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28747274\",\n",
      "        \"title\": \"Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.\",\n",
      "        \"authors\": \"Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Dor\\u00e9 V; Meyer L; ANRS IPERGAY Study Group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(17)30089-9\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Molina JM, et al. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. 2017; 4:e402-e410. doi: 10.1016/S2352-3018(17)30089-9\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29229440\",\n",
      "        \"title\": \"Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.\",\n",
      "        \"authors\": \"Molina JM; Charreau I; Chidiac C; Pialoux G; Cua E; Delaugerre C; Capitant C; Rojas-Castro D; Fonsart J; Bercot B; B\\u00e9b\\u00e9ar C; Cotte L; Robineau O; Raffi F; Charbonneau P; Aslan A; Chas J; Niedbalski L; Spire B; Sagaon-Teyssier L; Carette D; Mestre SL; Dor\\u00e9 V; Meyer L; ANRS IPERGAY Study Group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(17)30725-9\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Molina JM, et al. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. 2018; 18:308-317. doi: 10.1016/S1473-3099(17)30725-9\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00122538\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"20516271\",\n",
      "        \"title\": \"Is the recommended once-daily dose of lamivudine optimal in West African HIV-infected children?\",\n",
      "        \"authors\": \"Bouazza N; Hirt D; Bardin C; Diagbouga S; Nacro B; Hien H; Zoure E; Rouet F; Ouiminga A; Blanche S; Van De Perre P; Tr\\u00e9luyer JM; Msellati P; Urien S\",\n",
      "        \"doi\": \"10.1128/AAC.00306-10\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Bouazza N, et al. Is the recommended once-daily dose of lamivudine optimal in West African HIV-infected children?. Is the recommended once-daily dose of lamivudine optimal in West African HIV-infected children?. 2010; 54:3280-6. doi: 10.1128/AAC.00306-10\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21857286\",\n",
      "        \"title\": \"Short-term virological efficacy, immune reconstitution, tolerance, and adherence of once-daily dosing of didanosine, lamivudine, and efavirenz in HIV-1-infected African children: ANRS 12103 Burkiname.\",\n",
      "        \"authors\": \"Barro M; Some J; Foulongne V; Diasso Y; Zour\\u00e9 E; Hien H; Fran\\u00e7ois R; Michel S; Drabo A; Tamboura H; Ouiminga A; Diagbouga S; Hien A; Yam\\u00e9ogo S; Van De Perre P; Nacro B; Msellati P\",\n",
      "        \"doi\": \"10.1097/QAI.0b013e31821fd64f\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Barro M, et al. Short-term virological efficacy, immune reconstitution, tolerance, and adherence of once-daily dosing of didanosine, lamivudine, and efavirenz in HIV-1-infected African children: ANRS 12103 Burkiname. Short-term virological efficacy, immune reconstitution, tolerance, and adherence of once-daily dosing of didanosine, lamivudine, and efavirenz in HIV-1-infected African children: ANRS 12103 Burkiname. 2011; 57 Suppl 1:S44-9. doi: 10.1097/QAI.0b013e31821fd64f\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23719348\",\n",
      "        \"title\": \"A novel pharmacokinetic approach to predict virologic failure in HIV-1-infected paediatric patients.\",\n",
      "        \"authors\": \"Bouazza N; Tr\\u00e9luyer JM; Msellati P; Van de Perre P; Diagbouga S; Nacro B; Hien H; Zoure E; Rouet F; Ouiminga A; Blanche S; Hirt D; Urien S\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32835caad1\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bouazza N, et al. A novel pharmacokinetic approach to predict virologic failure in HIV-1-infected paediatric patients. A novel pharmacokinetic approach to predict virologic failure in HIV-1-infected paediatric patients. 2013; 27:761-8. doi: 10.1097/QAD.0b013e32835caad1\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01555450\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"28823681\",\n",
      "        \"title\": \"Patient navigation to reduce social inequalities in colorectal cancer screening participation: A cluster randomized controlled trial.\",\n",
      "        \"authors\": \"Guillaume E; Dejardin O; Bouvier V; De Mil R; Berchi C; Pornet C; Christophe V; Notari A; Delattre Massy H; De Seze C; Peng J; Guittet L; Launoy G\",\n",
      "        \"doi\": \"10.1016/j.ypmed.2017.08.012\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Guillaume E, et al. Patient navigation to reduce social inequalities in colorectal cancer screening participation: A cluster randomized controlled trial. Patient navigation to reduce social inequalities in colorectal cancer screening participation: A cluster randomized controlled trial. 2017; 103:76-83. doi: 10.1016/j.ypmed.2017.08.012\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29909873\",\n",
      "        \"title\": \"Cost-Effectiveness Analysis of a Navigation Program for Colorectal Cancer Screening to Reduce Social Health Inequalities: A French Cluster Randomized Controlled Trial.\",\n",
      "        \"authors\": \"De Mil R; Guillaume E; Guittet L; Dejardin O; Bouvier V; Pornet C; Christophe V; Notari A; Delattre-Massy H; De Seze C; Peng J; Launoy G; Berchi C\",\n",
      "        \"doi\": \"10.1016/j.jval.2017.09.020\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"De Mil R, et al. Cost-Effectiveness Analysis of a Navigation Program for Colorectal Cancer Screening to Reduce Social Health Inequalities: A French Cluster Randomized Controlled Trial. Cost-Effectiveness Analysis of a Navigation Program for Colorectal Cancer Screening to Reduce Social Health Inequalities: A French Cluster Randomized Controlled Trial. 2018; 21:685-691. doi: 10.1016/j.jval.2017.09.020\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21256688\",\n",
      "        \"title\": \"[Social inequalities in health from observational studies to intervention: can the patient navigator reduce social inequalities in cancer patients?].\",\n",
      "        \"authors\": \"Dejardin O; Berchi C; Mignon A; Pornet C; Guillaume E; Guittet L; Bouvier V; Sailly M; Salinas A; Christophe V; Launoy G\",\n",
      "        \"doi\": \"10.1016/j.respe.2010.10.008\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"English Abstract\",\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Dejardin O, et al. [Social inequalities in health from observational studies to intervention: can the patient navigator reduce social inequalities in cancer patients?]. [Social inequalities in health from observational studies to intervention: can the patient navigator reduce social inequalities in cancer patients?]. 2011; 59:45-51. doi: 10.1016/j.respe.2010.10.008\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01696708\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"25568297\",\n",
      "        \"title\": \"Triheptanoin improves brain energy metabolism in patients with Huntington disease.\",\n",
      "        \"authors\": \"Adanyeguh IM; Rinaldi D; Henry PG; Caillet S; Valabregue R; Durr A; Mochel F\",\n",
      "        \"doi\": \"10.1212/WNL.0000000000001214\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Adanyeguh IM, et al. Triheptanoin improves brain energy metabolism in patients with Huntington disease. Triheptanoin improves brain energy metabolism in patients with Huntington disease. 2015; 84:490-5. doi: 10.1212/WNL.0000000000001214\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01100281\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00424814\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"23766338\",\n",
      "        \"title\": \"Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial.\",\n",
      "        \"authors\": \"Tubiana R; Mandelbrot L; Le Chenadec J; Delmas S; Rouzioux C; Hirt D; Treluyer JM; Ekoukou D; Bui E; Chaix ML; Blanche S; Warszawski J; ANRS 135 PRIMEVA (Protease Inhibitor Monotherapy Evaluation) Study Group\",\n",
      "        \"doi\": \"10.1093/cid/cit390\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Tubiana R, et al. Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial. Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial. 2013; 57:891-902. doi: 10.1093/cid/cit390\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25838291\",\n",
      "        \"title\": \"In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.\",\n",
      "        \"authors\": \"Sibiude J; Le Chenadec J; Bonnet D; Tubiana R; Faye A; Dollfus C; Mandelbrot L; Delmas S; Lelong N; Khoshnood B; Warszawski J; Blanche S; French National Agency for Research on AIDS and Viral Hepatitis French Perinatal Cohort/Protease Inhibitor Monotherapy Evaluation Trial\",\n",
      "        \"doi\": \"10.1093/cid/civ260\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Observational Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sibiude J, et al. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial. 2015; 61:270-80. doi: 10.1093/cid/civ260\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00946595\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29767684\",\n",
      "        \"title\": \"Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies.\",\n",
      "        \"authors\": \"Lambert-Niclot S; Grude M; Meynard JL; Marcelin AG; Valantin MA; Flandre P; Izopet J; Moinot L; Bouteloup V; Calvez V; Katlama C; Girard PM; Morand-Joubert L\",\n",
      "        \"doi\": \"10.1093/cid/ciy382\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Lambert-Niclot S, et al. Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. 2018; 67:1883-1889. doi: 10.1093/cid/ciy382\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30968368\",\n",
      "        \"title\": \"Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM).\",\n",
      "        \"authors\": \"Garay OU; Nishimwe ML; Bousmah MA; Janah A; Girard PM; Ch\\u00eane G; Moinot L; Sagaon-Teyssier L; Meynard JL; Spire B; Boyer S\",\n",
      "        \"doi\": \"10.1007/s41669-019-0130-7\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Garay OU, et al. Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM). Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM). 2019; 3:505-515. doi: 10.1007/s41669-019-0130-7\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02488395\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"6774653\",\n",
      "        \"title\": \"Visual-motor function of the primate superior colliculus.\",\n",
      "        \"authors\": \"Wurtz RH; Albano JE\",\n",
      "        \"doi\": \"10.1146/annurev.ne.03.030180.001201\",\n",
      "        \"year\": \"1980\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Wurtz RH and Albano JE. Visual-motor function of the primate superior colliculus. Visual-motor function of the primate superior colliculus. 1980; 3:189-226. doi: 10.1146/annurev.ne.03.030180.001201\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22639796\",\n",
      "        \"title\": \"Linking visual response properties in the superior colliculus to saccade behavior.\",\n",
      "        \"authors\": \"Marino RA; Levy R; Boehnke S; White BJ; Itti L; Munoz DP\",\n",
      "        \"doi\": \"10.1111/j.1460-9568.2012.08079.x\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Marino RA, et al. Linking visual response properties in the superior colliculus to saccade behavior. Linking visual response properties in the superior colliculus to saccade behavior. 2012; 35:1738-52. doi: 10.1111/j.1460-9568.2012.08079.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23916713\",\n",
      "        \"title\": \"Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease.\",\n",
      "        \"authors\": \"Rolland M; Carcenac C; Overton PG; Savasta M; Coizet V\",\n",
      "        \"doi\": \"10.1016/j.neuroscience.2013.07.047\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Rolland M, et al. Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease. Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease. 2013; 252:277-88. doi: 10.1016/j.neuroscience.2013.07.047\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03335995\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"37497675\",\n",
      "        \"title\": \"One-Year Outcomes in Patients With Acute Stroke Requiring Mechanical Ventilation.\",\n",
      "        \"authors\": \"Sonneville R; Mazighi M; Collet M; Gayat E; Degos V; Duranteau J; Gr\\u00e9goire C; Sharshar T; Naim G; Cortier D; Jost PH; Foucrier A; Bagate F; de Montmollin E; Papin G; Magalhaes E; Guidet B; Ben Hadj Salem O; Benghanem S; le Guennec L; Delpierre E; Legriel S; Megarbane B; Toumert K; Tran M; Geri G; Monchi M; Bodiguel E; Mariotte E; Demoule A; Zarka J; Diehl JL; Roux D; Barr\\u00e9 E; Tanaka S; Osman D; Pasquier P; Lamara F; Crassard I; Boursin P; Ruckly S; Staiquly Q; Timsit JF; Woimant F; SPICE Investigators\",\n",
      "        \"doi\": \"10.1161/STROKEAHA.123.042910\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Multicenter Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sonneville R, et al. One-Year Outcomes in Patients With Acute Stroke Requiring Mechanical Ventilation. One-Year Outcomes in Patients With Acute Stroke Requiring Mechanical Ventilation. 2023; 54:2328-2337. doi: 10.1161/STROKEAHA.123.042910\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32026446\",\n",
      "        \"title\": \"Outcomes of Acute Stroke Patients Requiring Mechanical Ventilation: Study Protocol for the SPICE Multicenter Prospective Observational Study.\",\n",
      "        \"authors\": \"Sonneville R; Mazighi M; Bresson D; Crassard I; Crozier S; de Montmollin E; Degos V; Faugeras F; Gayat E; Josse L; Lamy C; Magalhaes E; Maldjian A; Ruckly S; Servan J; Vassel P; Vigu\\u00e9 B; Timsit JF; Woimant F; SPICE investigators\",\n",
      "        \"doi\": \"10.1007/s12028-019-00907-0\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sonneville R, et al. Outcomes of Acute Stroke Patients Requiring Mechanical Ventilation: Study Protocol for the SPICE Multicenter Prospective Observational Study. Outcomes of Acute Stroke Patients Requiring Mechanical Ventilation: Study Protocol for the SPICE Multicenter Prospective Observational Study. 2020; 32:624-629. doi: 10.1007/s12028-019-00907-0\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01647295\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01226446\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"25987791\",\n",
      "        \"title\": \"Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study.\",\n",
      "        \"authors\": \"Terrier B; Lapidus N; Pol S; Serfaty L; Ratziu V; Asselah T; Thibault V; Souberbielle JC; Carrat F; Cacoub P\",\n",
      "        \"doi\": \"10.3748/wjg.v21.i18.5647\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\"\n",
      "        ],\n",
      "        \"citation\": \"Terrier B, et al. Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study. Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study. 2015; 21:5647-53. doi: 10.3748/wjg.v21.i18.5647\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00658346\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"31063537\",\n",
      "        \"title\": \"Comparative Immunovirological and Clinical Responses to Antiretroviral Therapy Between HIV-1 Group O and HIV-1 Group M Infected Patients.\",\n",
      "        \"authors\": \"Kouanfack C; Unal G; Schaeffer L; Kfutwah A; Aghokeng A; Mougnutou R; Tchemgui-Noumsi N; Alessandri-Gradt E; Delaporte E; Simon F; Vray M; Plantier JC; ANRS 12168 DynaMO Study\",\n",
      "        \"doi\": \"10.1093/cid/ciz371\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kouanfack C, et al. Comparative Immunovirological and Clinical Responses to Antiretroviral Therapy Between HIV-1 Group O and HIV-1 Group M Infected Patients. Comparative Immunovirological and Clinical Responses to Antiretroviral Therapy Between HIV-1 Group O and HIV-1 Group M Infected Patients. 2020; 70:1471-1477. doi: 10.1093/cid/ciz371\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01874808\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01509508\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"27504637\",\n",
      "        \"title\": \"Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial.\",\n",
      "        \"authors\": \"Iwuji CC; Orne-Gliemann J; Larmarange J; Okesola N; Tanser F; Thiebaut R; Rekacewicz C; Newell ML; Dabis F; ANRS 12249 TasP trial group\",\n",
      "        \"doi\": \"10.1371/journal.pmed.1002107\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Iwuji CC, et al. Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial. Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial. 2016; 13:e1002107. doi: 10.1371/journal.pmed.1002107\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29199100\",\n",
      "        \"title\": \"Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial.\",\n",
      "        \"authors\": \"Iwuji CC; Orne-Gliemann J; Larmarange J; Balestre E; Thiebaut R; Tanser F; Okesola N; Makowa T; Dreyer J; Herbst K; McGrath N; B\\u00e4rnighausen T; Boyer S; De Oliveira T; Rekacewicz C; Bazin B; Newell ML; Pillay D; Dabis F; ANRS 12249 TasP Study Group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(17)30205-9\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase IV\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Iwuji CC, et al. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. 2018; 5:e116-e125. doi: 10.1016/S2352-3018(17)30205-9\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30321314\",\n",
      "        \"title\": \"Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial.\",\n",
      "        \"authors\": \"Derache A; Iwuji CC; Baisley K; Danaviah S; Marcelin AG; Calvez V; de Oliveira T; Dabis F; Porter K; Pillay D\",\n",
      "        \"doi\": \"10.1093/cid/ciy881\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Derache A, et al. Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial. Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial. 2019; 69:207-214. doi: 10.1093/cid/ciy881\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30412926\",\n",
      "        \"title\": \"\\\"If you are here at the clinic, you do not know how many people need help in the community\\\": Perspectives of home-based HIV services from health care workers in rural KwaZulu-Natal, South Africa in the era of universal test-and-treat.\",\n",
      "        \"authors\": \"Perriat D; Plazy M; Gumede D; Boyer S; Pillay D; Dabis F; Seeley J; Orne-Gliemann J; ANRS 12249 TasP Study Group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0202473\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Perriat D, et al. \\\"If you are here at the clinic, you do not know how many people need help in the community\\\": Perspectives of home-based HIV services from health care workers in rural KwaZulu-Natal, South Africa in the era of universal test-and-treat. \\\"If you are here at the clinic, you do not know how many people need help in the community\\\": Perspectives of home-based HIV services from health care workers in rural KwaZulu-Natal, South Africa in the era of universal test-and-treat. 2018; 13:e0202473. doi: 10.1371/journal.pone.0202473\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25880823\",\n",
      "        \"title\": \"Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal.\",\n",
      "        \"authors\": \"Orne-Gliemann J; Larmarange J; Boyer S; Iwuji C; McGrath N; B\\u00e4rnighausen T; Zuma T; Dray-Spira R; Spire B; Rochat T; Lert F; Imrie J; ANRS 12249 TasP Group\",\n",
      "        \"doi\": \"10.1186/s12889-015-1344-y\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Orne-Gliemann J, et al. Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal. Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal. 2015; 15:209. doi: 10.1186/s12889-015-1344-y\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30027600\",\n",
      "        \"title\": \"The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa).\",\n",
      "        \"authors\": \"Larmarange J; Diallo MH; McGrath N; Iwuji C; Plazy M; Thi\\u00e9baut R; Tanser F; B\\u00e4rnighausen T; Pillay D; Dabis F; Orne-Gliemann J; ANRS 12249 TasP Study Group\",\n",
      "        \"doi\": \"10.1002/jia2.25128\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Larmarange J, et al. The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa). The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa). 2018; 21 Suppl 4:e25128. doi: 10.1002/jia2.25128\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31637821\",\n",
      "        \"title\": \"Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa.\",\n",
      "        \"authors\": \"Larmarange J; Diallo MH; McGrath N; Iwuji C; Plazy M; Thi\\u00e9baut R; Tanser F; B\\u00e4rnighausen T; Orne-Gliemann J; Pillay D; Dabis F; ANRS 12249 TasP Study Group\",\n",
      "        \"doi\": \"10.1002/jia2.25402\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Larmarange J, et al. Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa. Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa. 2019; 22:e25402. doi: 10.1002/jia2.25402\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29890048\",\n",
      "        \"title\": \"Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial.\",\n",
      "        \"authors\": \"Iwuji C; McGrath N; Calmy A; Dabis F; Pillay D; Newell ML; Baisley K; Porter K\",\n",
      "        \"doi\": \"10.1002/jia2.25112\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Iwuji C, et al. Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial. Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial. 2018; 21:e25112. doi: 10.1002/jia2.25112\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28329393\",\n",
      "        \"title\": \"Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.\",\n",
      "        \"authors\": \"Collier D; Iwuji C; Derache A; de Oliveira T; Okesola N; Calmy A; Dabis F; Pillay D; Gupta RK; French National Agency for AIDS and Viral Hepatitis Research (ANRS) 12249 Treatment as Prevention (TasP) Study Group\",\n",
      "        \"doi\": \"10.1093/cid/cix015\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Collier D, et al. Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis. Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis. 2017; 64:1006-1016. doi: 10.1093/cid/cix015\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32970730\",\n",
      "        \"title\": \"Test but not treat: Community members' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa.\",\n",
      "        \"authors\": \"Iwuji C; Chimukuche RS; Zuma T; Plazy M; Larmarange J; Orne-Gliemann J; Siedner M; Shahmanesh M; Seeley J\",\n",
      "        \"doi\": \"10.1371/journal.pone.0239513\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Iwuji C, et al. Test but not treat: Community members' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa. Test but not treat: Community members' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa. 2020; 15:e0239513. doi: 10.1371/journal.pone.0239513\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23880306\",\n",
      "        \"title\": \"Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial.\",\n",
      "        \"authors\": \"Iwuji CC; Orne-Gliemann J; Tanser F; Boyer S; Lessells RJ; Lert F; Imrie J; B\\u00e4rnighausen T; Rekacewicz C; Bazin B; Newell ML; Dabis F; ANRS 12249 TasP Study Group\",\n",
      "        \"doi\": \"10.1186/1745-6215-14-230\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Iwuji CC, et al. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial. 2013; 14:230. doi: 10.1186/1745-6215-14-230\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00391638\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01426243\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26314624\",\n",
      "        \"title\": \"Molecular characterization of the 17D-204 yellow fever vaccine.\",\n",
      "        \"authors\": \"Salmona M; Gazaignes S; Mercier-Delarue S; Garnier F; Korimbocus J; Colin de Verdi\\u00e8re N; LeGoff J; Roques P; Simon F\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2015.08.055\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Salmona M, et al. Molecular characterization of the 17D-204 yellow fever vaccine. Molecular characterization of the 17D-204 yellow fever vaccine. 2015; 33:5432-5436. doi: 10.1016/j.vaccine.2015.08.055\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30096071\",\n",
      "        \"title\": \"Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients.\",\n",
      "        \"authors\": \"Colin de Verdiere N; Durier C; Samri A; Meiffredy V; Launay O; Matheron S; Mercier-Delarue S; Even S; Aboulker JP; Molina JM; Autran B; Simon F; ANRS EP46 NOVAA Group\",\n",
      "        \"doi\": \"10.1097/QAD.0000000000001963\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Colin de Verdiere N, et al. Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients. Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients. 2018; 32:2291-2299. doi: 10.1097/QAD.0000000000001963\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02496312\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"15897497\",\n",
      "        \"title\": \"Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?\",\n",
      "        \"authors\": \"Czernecki V; Pillon B; Houeto JL; Welter ML; Mesnage V; Agid Y; Dubois B\",\n",
      "        \"doi\": \"10.1136/jnnp.2003.033258\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Czernecki V, et al. Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?. Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?. 2005; 76:775-9. doi: 10.1136/jnnp.2003.033258\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"12461757\",\n",
      "        \"title\": \"The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment.\",\n",
      "        \"authors\": \"Robert PH; Clairet S; Benoit M; Koutaich J; Bertogliati C; Tible O; Caci H; Borg M; Brocker P; Bedoucha P\",\n",
      "        \"doi\": \"10.1002/gps.755\",\n",
      "        \"year\": \"2002\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Validation Study\"\n",
      "        ],\n",
      "        \"citation\": \"Robert PH, et al. The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. 2002; 17:1099-105. doi: 10.1002/gps.755\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16207933\",\n",
      "        \"title\": \"Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits.\",\n",
      "        \"authors\": \"Levy R; Dubois B\",\n",
      "        \"doi\": \"10.1093/cercor/bhj043\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Levy R and Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. 2006; 16:916-28. doi: 10.1093/cercor/bhj043\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"1821241\",\n",
      "        \"title\": \"Apathy: a neuropsychiatric syndrome.\",\n",
      "        \"authors\": \"Marin RS\",\n",
      "        \"doi\": \"10.1176/jnp.3.3.243\",\n",
      "        \"year\": \"1991\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, U.S. Gov't, P.H.S.\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Marin RS. Apathy: a neuropsychiatric syndrome. Apathy: a neuropsychiatric syndrome. 1991; 3:243-54. doi: 10.1176/jnp.3.3.243\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21895376\",\n",
      "        \"title\": \"The SEA (Social cognition and Emotional Assessment): a clinical neuropsychological tool for early diagnosis of frontal variant of frontotemporal lobar degeneration.\",\n",
      "        \"authors\": \"Funkiewiez A; Bertoux M; de Souza LC; L\\u00e9vy R; Dubois B\",\n",
      "        \"doi\": \"10.1037/a0025318\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Funkiewiez A, et al. The SEA (Social cognition and Emotional Assessment): a clinical neuropsychological tool for early diagnosis of frontal variant of frontotemporal lobar degeneration. The SEA (Social cognition and Emotional Assessment): a clinical neuropsychological tool for early diagnosis of frontal variant of frontotemporal lobar degeneration. 2012; 26:81-90. doi: 10.1037/a0025318\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18307266\",\n",
      "        \"title\": \"The Lille Apathy Rating Scale: validation of a caregiver-based version.\",\n",
      "        \"authors\": \"Dujardin K; Sockeel P; Delliaux M; Dest\\u00e9e A; Defebvre L\",\n",
      "        \"doi\": \"10.1002/mds.21968\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Dujardin K, et al. The Lille Apathy Rating Scale: validation of a caregiver-based version. The Lille Apathy Rating Scale: validation of a caregiver-based version. 2008; 23:845-9. doi: 10.1002/mds.21968\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19933975\",\n",
      "        \"title\": \"Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study.\",\n",
      "        \"authors\": \"Le Jeune F; Drapier D; Bourguignon A; P\\u00e9ron J; Mesbah H; Drapier S; Sauleau P; Haegelen C; Travers D; Garin E; Malbert CH; Millet B; V\\u00e9rin M\",\n",
      "        \"doi\": \"10.1212/WNL.0b013e3181c34b34\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Le Jeune F, et al. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. 2009; 73:1746-51. doi: 10.1212/WNL.0b013e3181c34b34\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17131230\",\n",
      "        \"title\": \"Apathy and the basal ganglia.\",\n",
      "        \"authors\": \"Levy R; Czernecki V\",\n",
      "        \"doi\": \"10.1007/s00415-006-7012-5\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Levy R and Czernecki V. Apathy and the basal ganglia. Apathy and the basal ganglia. 2006; 253 Suppl 7:VII54-61. doi: 10.1007/s00415-006-7012-5\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"10941190\",\n",
      "        \"title\": \"Negative symptoms: the 'pathology' of motivation and goal-directed behaviour.\",\n",
      "        \"authors\": \"Brown RG; Pluck G\",\n",
      "        \"doi\": \"10.1016/s0166-2236(00)01626-x\",\n",
      "        \"year\": \"2000\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Brown RG and Pluck G. Negative symptoms: the 'pathology' of motivation and goal-directed behaviour. Negative symptoms: the 'pathology' of motivation and goal-directed behaviour. 2000; 23:412-7. doi: 10.1016/s0166-2236(00)01626-x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19713543\",\n",
      "        \"title\": \"A longitudinal view of apathy and its impact after stroke.\",\n",
      "        \"authors\": \"Mayo NE; Fellows LK; Scott SC; Cameron J; Wood-Dauphinee S\",\n",
      "        \"doi\": \"10.1161/STROKEAHA.109.554410\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mayo NE, et al. A longitudinal view of apathy and its impact after stroke. A longitudinal view of apathy and its impact after stroke. 2009; 40:3299-307. doi: 10.1161/STROKEAHA.109.554410\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17027767\",\n",
      "        \"title\": \"Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease.\",\n",
      "        \"authors\": \"Winograd-Gurvich C; Fitzgerald PB; Georgiou-Karistianis N; Bradshaw JL; White OB\",\n",
      "        \"doi\": \"10.1016/j.brainresbull.2006.06.007\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Winograd-Gurvich C, et al. Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease. Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease. 2006; 70:312-21. doi: 10.1016/j.brainresbull.2006.06.007\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"10436334\",\n",
      "        \"title\": \"The clinical picture of frontotemporal dementia: diagnosis and follow-up.\",\n",
      "        \"authors\": \"Pasquier F; Lebert F; Lavenu I; Guillaume B\",\n",
      "        \"doi\": \"10.1159/000051206\",\n",
      "        \"year\": \"1999\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Pasquier F, et al. The clinical picture of frontotemporal dementia: diagnosis and follow-up. The clinical picture of frontotemporal dementia: diagnosis and follow-up. 1999; 10 Suppl 1:10-4. doi: 10.1159/000051206\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"10678322\",\n",
      "        \"title\": \"Group differences in the relationship between apathy and depression.\",\n",
      "        \"authors\": \"Marin RS; Firinciogullari S; Biedrzycki RC\",\n",
      "        \"doi\": \"10.1097/00005053-199404000-00008\",\n",
      "        \"year\": \"1994\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, U.S. Gov't, P.H.S.\"\n",
      "        ],\n",
      "        \"citation\": \"Marin RS, et al. Group differences in the relationship between apathy and depression. Group differences in the relationship between apathy and depression. 1994; 182:235-9. doi: 10.1097/00005053-199404000-00008\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16421064\",\n",
      "        \"title\": \"Reduced daytime activity in patients with acquired brain damage and apathy: a study with ambulatory actigraphy.\",\n",
      "        \"authors\": \"M\\u00fcller U; Czymmek J; Th\\u00f6ne-Otto A; Von Cramon DY\",\n",
      "        \"doi\": \"10.1080/02699050500443467\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"M\\u00fcller U, et al. Reduced daytime activity in patients with acquired brain damage and apathy: a study with ambulatory actigraphy. Reduced daytime activity in patients with acquired brain damage and apathy: a study with ambulatory actigraphy. 2006; 20:157-60. doi: 10.1080/02699050500443467\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19533496\",\n",
      "        \"title\": \"Apathy after acquired brain impairment: a systematic review of non-pharmacological interventions.\",\n",
      "        \"authors\": \"Lane-Brown AT; Tate RL\",\n",
      "        \"doi\": \"10.1080/09602010902949207\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\",\n",
      "          \"Systematic Review\"\n",
      "        ],\n",
      "        \"citation\": \"Lane-Brown AT and Tate RL. Apathy after acquired brain impairment: a systematic review of non-pharmacological interventions. Apathy after acquired brain impairment: a systematic review of non-pharmacological interventions. 2009; 19:481-516. doi: 10.1080/09602010902949207\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03519503\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26603917\",\n",
      "        \"title\": \"Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.\",\n",
      "        \"authors\": \"Nagot N; Kankasa C; Tumwine JK; Meda N; Hofmeyr GJ; Vallo R; Mwiya M; Kwagala M; Traore H; Sunday A; Singata M; Siuluta C; Some E; Rutagwera D; Neboua D; Ndeezi G; Jackson D; Mar\\u00e9chal V; Neveu D; Engebretsen IMS; Lombard C; Blanche S; Sommerfelt H; Rekacewicz C; Tyllesk\\u00e4r T; Van de Perre P; ANRS 12174 Trial Group\",\n",
      "        \"doi\": \"10.1016/S0140-6736(15)00984-8\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nagot N, et al. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. 2016; 387:566-573. doi: 10.1016/S0140-6736(15)00984-8\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22814853\",\n",
      "        \"title\": \"HIV-1 reservoirs in breast milk and challenges to elimination of breast-feeding transmission of HIV-1.\",\n",
      "        \"authors\": \"Van de Perre P; Rubbo PA; Viljoen J; Nagot N; Tyllesk\\u00e4r T; Lepage P; Vendrell JP; Tuaillon E\",\n",
      "        \"doi\": \"10.1126/scitranslmed.3003327\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Van de Perre P, et al. HIV-1 reservoirs in breast milk and challenges to elimination of breast-feeding transmission of HIV-1. HIV-1 reservoirs in breast milk and challenges to elimination of breast-feeding transmission of HIV-1. 2012; 4:143sr3. doi: 10.1126/scitranslmed.3003327\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21602695\",\n",
      "        \"title\": \"Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children.\",\n",
      "        \"authors\": \"Heidari S; Mofenson L; Cotton MF; Marlink R; Cahn P; Katabira E\",\n",
      "        \"doi\": \"10.1097/QAI.0b013e318221c56a\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Heidari S, et al. Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children. Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children. 2011; 57:290-6. doi: 10.1097/QAI.0b013e318221c56a\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00196612\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"15717256\",\n",
      "        \"title\": \"Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen: a randomized trial.\",\n",
      "        \"authors\": \"Molina JM; Journot V; Morand-Joubert L; Y\\u00e9ni P; Rozenbaum W; Rancinan C; Fournier S; Morlat P; Palmer P; Dupont B; Goujard C; Dellamonica P; Collin F; Poizot-Martin I; Chene G; ALIZE (Agence Nationale de Recherches sur le SIDA 099) Study Team\",\n",
      "        \"doi\": \"10.1086/428091\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Molina JM, et al. Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen: a randomized trial. Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen: a randomized trial. 2005; 191:830-9. doi: 10.1086/428091\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04133012\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03298360\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01490489\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"19602057\",\n",
      "        \"title\": \"Role of EG-VEGF in human placentation: Physiological and pathological implications.\",\n",
      "        \"authors\": \"Hoffmann P; Saoudi Y; Benharouga M; Graham CH; Schaal JP; Mazouni C; Feige JJ; Alfaidy N\",\n",
      "        \"doi\": \"10.1111/j.1582-4934.2008.00554.x\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hoffmann P, et al. Role of EG-VEGF in human placentation: Physiological and pathological implications. Role of EG-VEGF in human placentation: Physiological and pathological implications. 2009; 13:2224-2235. doi: 10.1111/j.1582-4934.2008.00554.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16384869\",\n",
      "        \"title\": \"Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy.\",\n",
      "        \"authors\": \"Hoffmann P; Feige JJ; Alfaidy N\",\n",
      "        \"doi\": \"10.1210/en.2005-0912\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hoffmann P, et al. Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy. Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy. 2006; 147:1675-84. doi: 10.1210/en.2005-0912\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17531315\",\n",
      "        \"title\": \"Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation.\",\n",
      "        \"authors\": \"Hoffmann P; Feige JJ; Alfaidy N\",\n",
      "        \"doi\": \"10.1016/j.placenta.2007.03.008\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hoffmann P, et al. Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation. Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation. 2007; 28:1049-58. doi: 10.1016/j.placenta.2007.03.008\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04780191\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"32232101\",\n",
      "        \"title\": \"Non-invasive treatment of patients with upper extremity spasticity following stroke using paired trans-spinal and peripheral direct current stimulation.\",\n",
      "        \"authors\": \"Paget-Blanc A; Chang JL; Saul M; Lin R; Ahmed Z; Volpe BT\",\n",
      "        \"doi\": \"10.1186/s42234-019-0028-9\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Paget-Blanc A, et al. Non-invasive treatment of patients with upper extremity spasticity following stroke using paired trans-spinal and peripheral direct current stimulation. Non-invasive treatment of patients with upper extremity spasticity following stroke using paired trans-spinal and peripheral direct current stimulation. 2019; 5:11. doi: 10.1186/s42234-019-0028-9\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01164462\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02051413\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01531036\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"20505064\",\n",
      "        \"title\": \"Breast lesions: quantitative elastography with supersonic shear imaging--preliminary results.\",\n",
      "        \"authors\": \"Athanasiou A; Tardivon A; Tanter M; Sigal-Zafrani B; Bercoff J; Deffieux T; Gennisson JL; Fink M; Neuenschwander S\",\n",
      "        \"doi\": \"10.1148/radiol.10090385\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Athanasiou A, et al. Breast lesions: quantitative elastography with supersonic shear imaging--preliminary results. Breast lesions: quantitative elastography with supersonic shear imaging--preliminary results. 2010; 256:297-303. doi: 10.1148/radiol.10090385\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01164436\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00870649\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"30532268\",\n",
      "        \"title\": \"Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: A phase 3 randomized, controlled trial in Senegalese children.\",\n",
      "        \"authors\": \"Riveau G; Schacht AM; Dompnier JP; Deplanque D; Seck M; Waucquier N; Senghor S; Delcroix-Genete D; Hermann E; Idris-Khodja N; Levy-Marchal C; Capron M; Capron A\",\n",
      "        \"doi\": \"10.1371/journal.pntd.0006968\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Riveau G, et al. Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: A phase 3 randomized, controlled trial in Senegalese children. Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: A phase 3 randomized, controlled trial in Senegalese children. 2018; 12:e0006968. doi: 10.1371/journal.pntd.0006968\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01842919\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT06260319\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01569399\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03193099\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01094899\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01038999\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22829920\",\n",
      "        \"title\": \"HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 \\\"Aging\\\" study.\",\n",
      "        \"authors\": \"Perrin S; Cremer J; Roll P; Faucher O; M\\u00e9nard A; Reynes J; Dellamonica P; Naqvi A; Micallef J; Jouve E; Tamalet C; Solas C; Pissier C; Arnoux I; Nicolino-Brunet C; Espinosa L; L\\u00e9vy N; Kaspi E; Robaglia-Schlupp A; Poizot-Martin I; Cau P\",\n",
      "        \"doi\": \"10.1371/journal.pone.0041129\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Perrin S, et al. HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 \\\"Aging\\\" study. HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 \\\"Aging\\\" study. 2012; 7:e41129. doi: 10.1371/journal.pone.0041129\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23285253\",\n",
      "        \"title\": \"HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 \\\"aging\\\" study.\",\n",
      "        \"authors\": \"Perrin S; Cremer J; Faucher O; Reynes J; Dellamonica P; Micallef J; Solas C; Lacarelle B; Stretti C; Kaspi E; Robaglia-Schlupp A; Nicolino-Brunet C; Tamalet C; L\\u00e9vy N; Poizot-Martin I; Cau P; Roll P\",\n",
      "        \"doi\": \"10.1371/journal.pone.0053035\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Controlled Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Perrin S, et al. HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 \\\"aging\\\" study. HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 \\\"aging\\\" study. 2012; 7:e53035. doi: 10.1371/journal.pone.0053035\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03831906\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"33743621\",\n",
      "        \"title\": \"Impact of systematic early tuberculosis detection using Xpert MTB/RIF Ultra in children with severe pneumonia in high tuberculosis burden countries (TB-Speed pneumonia): a stepped wedge cluster randomized trial.\",\n",
      "        \"authors\": \"Vessi\\u00e8re A; Font H; Gabillard D; Adonis-Koffi L; Borand L; Chabala C; Khosa C; Mavale S; Moh R; Mulenga V; Mwanga-Amumpere J; Taguebue JV; Eang MT; Delacourt C; Seddon JA; Lounnas M; Godreuil S; Wobudeya E; Bonnet M; Marcy O\",\n",
      "        \"doi\": \"10.1186/s12887-021-02576-5\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Vessi\\u00e8re A, et al. Impact of systematic early tuberculosis detection using Xpert MTB/RIF Ultra in children with severe pneumonia in high tuberculosis burden countries (TB-Speed pneumonia): a stepped wedge cluster randomized trial. Impact of systematic early tuberculosis detection using Xpert MTB/RIF Ultra in children with severe pneumonia in high tuberculosis burden countries (TB-Speed pneumonia): a stepped wedge cluster randomized trial. 2021; 21:136. doi: 10.1186/s12887-021-02576-5\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32853411\",\n",
      "        \"title\": \"Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.\",\n",
      "        \"authors\": \"Kay AW; Gonz\\u00e1lez Fern\\u00e1ndez L; Takwoingi Y; Eisenhut M; Detjen AK; Steingart KR; Mandalakas AM\",\n",
      "        \"doi\": \"10.1002/14651858.CD013359.pub2\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Meta-Analysis\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Systematic Review\"\n",
      "        ],\n",
      "        \"citation\": \"Kay AW, et al. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children. 2020; 8:CD013359. doi: 10.1002/14651858.CD013359.pub2\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"36395782\",\n",
      "        \"title\": \"Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trial.\",\n",
      "        \"authors\": \"Marcy O; Wobudeya E; Font H; Vessi\\u00e8re A; Chabala C; Khosa C; Taguebue JV; Moh R; Mwanga-Amumpaire J; Lounnas M; Mulenga V; Mavale S; Chilundo J; Rego D; Nduna B; Shankalala P; Chirwa U; De Lauzanne A; Dim B; Tiogouo Ngouana E; Folquet Amorrissani M; Cisse L; Amon Tanoh Dick F; Komena EA; Kwedi Nolna S; Businge G; Natukunda N; Cumbe S; Mbekeka P; Kim A; Kheang C; Pol S; Maleche-Obimbo E; Seddon JA; Mao TE; Graham SM; Delacourt C; Borand L; Bonnet M; TB-Speed Pneumonia Study Group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(22)00668-5\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Marcy O, et al. Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trial. Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trial. 2023; 23:341-351. doi: 10.1016/S1473-3099(22)00668-5\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01008813\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00604149\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01779713\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"30354977\",\n",
      "        \"title\": \"Whole-Blood miRNA Sequencing Profiling for Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage.\",\n",
      "        \"authors\": \"Pulcrano-Nicolas AS; Proust C; Claren\\u00e7on F; Jacquens A; Perret C; Roux M; Shotar E; Thibord F; Puybasset L; Garnier S; Degos V; Tr\\u00e9gou\\u00ebt DA\",\n",
      "        \"doi\": \"10.1161/STROKEAHA.118.021101\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Pulcrano-Nicolas AS, et al. Whole-Blood miRNA Sequencing Profiling for Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage. Whole-Blood miRNA Sequencing Profiling for Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage. 2018; 49:2220-2223. doi: 10.1161/STROKEAHA.118.021101\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02160119\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01207349\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22030240\",\n",
      "        \"title\": \"Quarterly individual outpatients lifestyle counseling after initial inpatients education on type 2 diabetes: the REDIA Prev-2 randomized controlled trial in Reunion Island.\",\n",
      "        \"authors\": \"Debussche X; Rollot O; Le Pommelet C; Fianu A; Le Moullec N; R\\u00e9gnier C; Boyer MC; Cogne M; Bakiri F; Schwager JC; Favier F\",\n",
      "        \"doi\": \"10.1016/j.diabet.2011.07.002\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Debussche X, et al. Quarterly individual outpatients lifestyle counseling after initial inpatients education on type 2 diabetes: the REDIA Prev-2 randomized controlled trial in Reunion Island. Quarterly individual outpatients lifestyle counseling after initial inpatients education on type 2 diabetes: the REDIA Prev-2 randomized controlled trial in Reunion Island. 2012; 38:46-53. doi: 10.1016/j.diabet.2011.07.002\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00944541\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02102737\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01942655\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03870438\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26603917\",\n",
      "        \"title\": \"Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.\",\n",
      "        \"authors\": \"Nagot N; Kankasa C; Tumwine JK; Meda N; Hofmeyr GJ; Vallo R; Mwiya M; Kwagala M; Traore H; Sunday A; Singata M; Siuluta C; Some E; Rutagwera D; Neboua D; Ndeezi G; Jackson D; Mar\\u00e9chal V; Neveu D; Engebretsen IMS; Lombard C; Blanche S; Sommerfelt H; Rekacewicz C; Tyllesk\\u00e4r T; Van de Perre P; ANRS 12174 Trial Group\",\n",
      "        \"doi\": \"10.1016/S0140-6736(15)00984-8\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nagot N, et al. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. 2016; 387:566-573. doi: 10.1016/S0140-6736(15)00984-8\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33872801\",\n",
      "        \"title\": \"Design and challenges of a large HIV prevention clinical study on mother-to-child transmission: ANRS 12397 PROMISE-EPI study in Zambia and Burkina Faso.\",\n",
      "        \"authors\": \"Mennecier A; Kankasa C; Fao P; Moles JP; Eymard-Duvernay S; Mwiya M; Kania D; Chunda-Liyoka C; Sakana L; Rutagwera D; Tassembedo S; Wilfred-Tonga MM; Mosqueira B; Tyllesk\\u00e4r T; Nagot N; Van de Perre P; ANRS 12397 Study group\",\n",
      "        \"doi\": \"10.1016/j.cct.2021.106402\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial Protocol\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mennecier A, et al. Design and challenges of a large HIV prevention clinical study on mother-to-child transmission: ANRS 12397 PROMISE-EPI study in Zambia and Burkina Faso. Design and challenges of a large HIV prevention clinical study on mother-to-child transmission: ANRS 12397 PROMISE-EPI study in Zambia and Burkina Faso. 2021; 105:106402. doi: 10.1016/j.cct.2021.106402\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04945655\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"35332045\",\n",
      "        \"title\": \"Impact of a school-based and primary care-based multicomponent intervention on HPV vaccination coverage among French adolescents: a cluster randomised controlled trial protocol (the PrevHPV study).\",\n",
      "        \"authors\": \"Bocquier A; Michel M; Giraudeau B; Bonnay S; Gagneux-Brunon A; Gauchet A; Gilberg S; Le Duc-Banaszuk AS; Mueller JE; Chevreul K; Thilly N; PrevHPV Study group\",\n",
      "        \"doi\": \"10.1136/bmjopen-2021-057943\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial Protocol\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bocquier A, et al. Impact of a school-based and primary care-based multicomponent intervention on HPV vaccination coverage among French adolescents: a cluster randomised controlled trial protocol (the PrevHPV study). Impact of a school-based and primary care-based multicomponent intervention on HPV vaccination coverage among French adolescents: a cluster randomised controlled trial protocol (the PrevHPV study). 2022; 12:e057943. doi: 10.1136/bmjopen-2021-057943\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01188512\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"19625486\",\n",
      "        \"title\": \"A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice.\",\n",
      "        \"authors\": \"Skerry CM; Cassidy JP; English K; Feunou-Feunou P; Locht C; Mahon BP\",\n",
      "        \"doi\": \"10.1128/CVI.00082-09\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Skerry CM, et al. A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. 2009; 16:1344-51. doi: 10.1128/CVI.00082-09\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24793938\",\n",
      "        \"title\": \"B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial.\",\n",
      "        \"authors\": \"Jahnmatz M; Amu S; Ljungman M; Wehlin L; Chiodi F; Mielcarek N; Locht C; Thorstensson R\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2014.04.048\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Jahnmatz M, et al. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial. 2014; 32:3350-6. doi: 10.1016/j.vaccine.2014.04.048\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24261996\",\n",
      "        \"title\": \"Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism.\",\n",
      "        \"authors\": \"Schnoeller C; Roux X; Sawant D; Raze D; Olszewska W; Locht C; Openshaw PJ\",\n",
      "        \"doi\": \"10.1164/rccm.201307-1227OC\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Evaluation Study\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Schnoeller C, et al. Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism. Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism. 2014; 189:194-202. doi: 10.1164/rccm.201307-1227OC\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24421886\",\n",
      "        \"title\": \"A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers.\",\n",
      "        \"authors\": \"Thorstensson R; Trollfors B; Al-Tawil N; Jahnmatz M; Bergstr\\u00f6m J; Ljungman M; T\\u00f6rner A; Wehlin L; Van Broekhoven A; Bosman F; Debrie AS; Mielcarek N; Locht C\",\n",
      "        \"doi\": \"10.1371/journal.pone.0083449\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Thorstensson R, et al. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. 2014; 9:e83449. doi: 10.1371/journal.pone.0083449\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16839199\",\n",
      "        \"title\": \"Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough.\",\n",
      "        \"authors\": \"Mielcarek N; Debrie AS; Raze D; Bertout J; Rouanet C; Younes AB; Creusy C; Engle J; Goldman WE; Locht C\",\n",
      "        \"doi\": \"10.1371/journal.ppat.0020065\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mielcarek N, et al. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. 2006; 2:e65. doi: 10.1371/journal.ppat.0020065\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18762220\",\n",
      "        \"title\": \"Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1.\",\n",
      "        \"authors\": \"Feunou PF; Ismaili J; Debrie AS; Huot L; Hot D; Raze D; Lemoine Y; Locht C\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2008.08.018\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Feunou PF, et al. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1. 2008; 26:5722-7. doi: 10.1016/j.vaccine.2008.08.018\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20184606\",\n",
      "        \"title\": \"Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model.\",\n",
      "        \"authors\": \"Kavanagh H; Noone C; Cahill E; English K; Locht C; Mahon BP\",\n",
      "        \"doi\": \"10.1111/j.1365-2222.2010.03459.x\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kavanagh H, et al. Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model. Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model. 2010; 40:933-41. doi: 10.1111/j.1365-2222.2010.03459.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20107007\",\n",
      "        \"title\": \"Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice.\",\n",
      "        \"authors\": \"Mielcarek N; Debrie AS; Mahieux S; Locht C\",\n",
      "        \"doi\": \"10.1128/CVI.00322-09\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mielcarek N, et al. Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice. Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice. 2010; 17:317-24. doi: 10.1128/CVI.00322-09\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01038401\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01086904\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01332955\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"25139963\",\n",
      "        \"title\": \"Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial.\",\n",
      "        \"authors\": \"Cotte L; Braun J; Lascoux-Combe C; Vincent C; Valantin MA; Sogni P; Lacombe K; Neau D; Aumaitre H; Batisse D; de Truchis P; Gervais A; Michelet C; Morlat P; Vittecoq D; Rosa I; Bertucci I; Chevaliez S; Aboulker JP; Molina JM; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) HC26 Study Group\",\n",
      "        \"doi\": \"10.1093/cid/ciu659\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Cotte L, et al. Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial. Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial. 2014; 59:1768-76. doi: 10.1093/cid/ciu659\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02469350\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29636105\",\n",
      "        \"title\": \"The feasibility and positive effects of a customised videogame rehabilitation programme for freezing of gait and falls in Parkinson's disease patients: a pilot study.\",\n",
      "        \"authors\": \"Nuic D; Vinti M; Karachi C; Foulon P; Van Hamme A; Welter ML\",\n",
      "        \"doi\": \"10.1186/s12984-018-0375-x\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nuic D, et al. The feasibility and positive effects of a customised videogame rehabilitation programme for freezing of gait and falls in Parkinson's disease patients: a pilot study. The feasibility and positive effects of a customised videogame rehabilitation programme for freezing of gait and falls in Parkinson's disease patients: a pilot study. 2018; 15:31. doi: 10.1186/s12984-018-0375-x\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00480792\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"27064975\",\n",
      "        \"title\": \"Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial.\",\n",
      "        \"authors\": \"Launay O; Rosenberg AR; Rey D; Pouget N; Michel ML; Reynes J; Neau D; Raffi F; Piroth L; Carrat F; ANRS HB03 VIHVAC-B (Trial Comparing 3 Strategies of Vaccination Against the Virus of Hepatitis B in HIV-Infected Patients) Group\",\n",
      "        \"doi\": \"10.1001/jamainternmed.2016.0741\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Launay O, et al. Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial. Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial. 2016; 176:603-10. doi: 10.1001/jamainternmed.2016.0741\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21486976\",\n",
      "        \"title\": \"Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.\",\n",
      "        \"authors\": \"Launay O; van der Vliet D; Rosenberg AR; Michel ML; Piroth L; Rey D; Colin de Verdi\\u00e8re N; Slama L; Martin K; Lortholary O; Carrat F; ANRS HB03 VIHVAC-B Trial\",\n",
      "        \"doi\": \"10.1001/jama.2011.351\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Launay O, et al. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial. 2011; 305:1432-40. doi: 10.1001/jama.2011.351\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04484740\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01095744\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00236340\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"11438952\",\n",
      "        \"title\": \"Rapid and radical amniodrainage in the treatment of severe twin-twin transfusion syndrome.\",\n",
      "        \"authors\": \"Jauniaux E; Holmes A; Hyett J; Yates R; Rodeck C\",\n",
      "        \"doi\": \"10.1002/pd.96\",\n",
      "        \"year\": \"2001\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Jauniaux E, et al. Rapid and radical amniodrainage in the treatment of severe twin-twin transfusion syndrome. Rapid and radical amniodrainage in the treatment of severe twin-twin transfusion syndrome. 2001; 21:471-6. doi: 10.1002/pd.96\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"7970458\",\n",
      "        \"title\": \"Large-volume therapeutic amniocentesis in the treatment of hydramnios.\",\n",
      "        \"authors\": \"Elliott JP; Sawyer AT; Radin TG; Strong RE\",\n",
      "        \"doi\": null,\n",
      "        \"year\": \"1994\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Elliott JP, et al. Large-volume therapeutic amniocentesis in the treatment of hydramnios. Large-volume therapeutic amniocentesis in the treatment of hydramnios. 1994; 84:1025-7.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"9464739\",\n",
      "        \"title\": \"Therapeutic amniocentesis using a vacuum bottle aspiration system.\",\n",
      "        \"authors\": \"Dolinger MB; Donnenfeld AE\",\n",
      "        \"doi\": \"10.1016/s0029-7844(97)00584-x\",\n",
      "        \"year\": \"1998\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Dolinger MB and Donnenfeld AE. Therapeutic amniocentesis using a vacuum bottle aspiration system. Therapeutic amniocentesis using a vacuum bottle aspiration system. 1998; 91:143-4. doi: 10.1016/s0029-7844(97)00584-x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"14770396\",\n",
      "        \"title\": \"Procedure-related complications of rapid amniodrainage in the treatment of polyhydramnios.\",\n",
      "        \"authors\": \"Leung WC; Jouannic JM; Hyett J; Rodeck C; Jauniaux E\",\n",
      "        \"doi\": \"10.1002/uog.972\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Leung WC, et al. Procedure-related complications of rapid amniodrainage in the treatment of polyhydramnios. Procedure-related complications of rapid amniodrainage in the treatment of polyhydramnios. 2004; 23:154-8. doi: 10.1002/uog.972\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02384967\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29905808\",\n",
      "        \"title\": \"Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100\\u2009mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study.\",\n",
      "        \"authors\": \"L\\u00ea MP; Chaix ML; Chevret S; Bertrand J; Raffi F; Gallien S; El Abbassi EMB; Katlama C; Delobel P; Yazdanpanah Y; Saillard J; Molina JM; Peytavin G; ANRS 165 DARULIGHT Study Group\",\n",
      "        \"doi\": \"10.1093/jac/dky193\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"L\\u00ea MP, et al. Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100\\u2009mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study. Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100\\u2009mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study. 2018; 73:2120-2128. doi: 10.1093/jac/dky193\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03109067\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00988767\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"20090916\",\n",
      "        \"title\": \"Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination.\",\n",
      "        \"authors\": \"Scott-Algara D; Mancini-Bourgine M; Fontaine H; Pol S; Michel ML\",\n",
      "        \"doi\": \"10.1371/journal.pone.0008761\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Scott-Algara D, et al. Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination. Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination. 2010; 5:e8761. doi: 10.1371/journal.pone.0008761\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15382173\",\n",
      "        \"title\": \"Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers.\",\n",
      "        \"authors\": \"Mancini-Bourgine M; Fontaine H; Scott-Algara D; Pol S; Br\\u00e9chot C; Michel ML\",\n",
      "        \"doi\": \"10.1002/hep.20408\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mancini-Bourgine M, et al. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. 2004; 40:874-82. doi: 10.1002/hep.20408\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16310901\",\n",
      "        \"title\": \"Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers.\",\n",
      "        \"authors\": \"Mancini-Bourgine M; Fontaine H; Br\\u00e9chot C; Pol S; Michel ML\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2005.08.013\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mancini-Bourgine M, et al. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. 2006; 24:4482-9. doi: 10.1016/j.vaccine.2005.08.013\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01552044\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03047967\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT05199831\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00113282\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01039220\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04265742\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01089400\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"24646009\",\n",
      "        \"title\": \"Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.\",\n",
      "        \"authors\": \"Guihot A; Luyt CE; Parrot A; Rousset D; Cavaillon JM; Boutolleau D; Fitting C; Pajanirassa P; Mallet A; Fartoukh M; Agut H; Musset L; Zoorob R; Kirilovksy A; Combadi\\u00e8re B; van der Werf S; Autran B; Carcelain G; FluBAL Study Group\",\n",
      "        \"doi\": \"10.1164/rccm.201311-2071OC\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Guihot A, et al. Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection. Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection. 2014; 189:1240-9. doi: 10.1164/rccm.201311-2071OC\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00445575\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158496\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"16019104\",\n",
      "        \"title\": \"Changing pattern of hepatitis C virus spread in rural areas of Egypt.\",\n",
      "        \"authors\": \"Arafa N; El Hoseiny M; Rekacewicz C; Bakr I; El-Kafrawy S; El Daly M; Aoun S; Marzouk D; Mohamed MK; Fontanet A\",\n",
      "        \"doi\": \"10.1016/j.jhep.2005.03.021\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Arafa N, et al. Changing pattern of hepatitis C virus spread in rural areas of Egypt. Changing pattern of hepatitis C virus spread in rural areas of Egypt. 2005; 43:418-24. doi: 10.1016/j.jhep.2005.03.021\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16434426\",\n",
      "        \"title\": \"Higher clearance of hepatitis C virus infection in females compared with males.\",\n",
      "        \"authors\": \"Bakr I; Rekacewicz C; El Hosseiny M; Ismail S; El Daly M; El-Kafrawy S; Esmat G; Hamid MA; Mohamed MK; Fontanet A\",\n",
      "        \"doi\": \"10.1136/gut.2005.078147\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bakr I, et al. Higher clearance of hepatitis C virus infection in females compared with males. Higher clearance of hepatitis C virus infection in females compared with males. 2006; 55:1183-7. doi: 10.1136/gut.2005.078147\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16956918\",\n",
      "        \"title\": \"Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt.\",\n",
      "        \"authors\": \"Marzouk D; Sass J; Bakr I; El Hosseiny M; Abdel-Hamid M; Rekacewicz C; Chaturvedi N; Mohamed MK; Fontanet A\",\n",
      "        \"doi\": \"10.1136/gut.2006.091983\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Marzouk D, et al. Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. 2007; 56:1105-10. doi: 10.1136/gut.2006.091983\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16847958\",\n",
      "        \"title\": \"HCV-related morbidity in a rural community of Egypt.\",\n",
      "        \"authors\": \"Mohamed MK; Bakr I; El-Hoseiny M; Arafa N; Hassan A; Ismail S; Anwar M; Attala M; Rekacewicz C; Zalata K; Abdel-Hamid M; Esmat G; Fontanet A\",\n",
      "        \"doi\": \"10.1002/jmv.20679\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mohamed MK, et al. HCV-related morbidity in a rural community of Egypt. HCV-related morbidity in a rural community of Egypt. 2006; 78:1185-9. doi: 10.1002/jmv.20679\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01271842\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22948576\",\n",
      "        \"title\": \"Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS.\",\n",
      "        \"authors\": \"Luyt CE; Combes A; Becquemin MH; Beigelman-Aubry C; Hatem S; Brun AL; Zraik N; Carrat F; Grenier PA; Richard JM; Mercat A; Brochard L; Brun-Buisson C; Chastre J; REVA Study Group\",\n",
      "        \"doi\": \"10.1378/chest.11-2196\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Luyt CE, et al. Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS. Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS. 2012; 142:583-592. doi: 10.1378/chest.11-2196\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01917175\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01905059\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"28566227\",\n",
      "        \"title\": \"Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.\",\n",
      "        \"authors\": \"Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E; MOBIDIP study group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(17)30069-3\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Equivalence Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Ciaffi L, et al. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial. 2017; 4:e384-e392. doi: 10.1016/S2352-3018(17)30069-3\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21811554\",\n",
      "        \"title\": \"Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis.\",\n",
      "        \"authors\": \"Mathis S; Khanlari B; Pulido F; Schechter M; Negredo E; Nelson M; Vernazza P; Cahn P; Meynard JL; Arribas J; Bucher HC\",\n",
      "        \"doi\": \"10.1371/journal.pone.0022003\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Meta-Analysis\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Mathis S, et al. Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis. Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis. 2011; 6:e22003. doi: 10.1371/journal.pone.0022003\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20010070\",\n",
      "        \"title\": \"The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml.\",\n",
      "        \"authors\": \"Arribas JR; Horban A; Gerstoft J; F\\u00e4tkenheuer G; Nelson M; Clumeck N; Pulido F; Hill A; van Delft Y; Stark T; Moecklinghoff C\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e3283348944\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Arribas JR, et al. The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml. The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml. 2010; 24:223-30. doi: 10.1097/QAD.0b013e3283348944\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17545707\",\n",
      "        \"title\": \"The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial.\",\n",
      "        \"authors\": \"Vernazza P; Daneel S; Schiffer V; Decosterd L; Fierz W; Klimkait T; Hoffmann M; Hirschel B\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32814e6b1c\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Vernazza P, et al. The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial. The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial. 2007; 21:1309-15. doi: 10.1097/QAD.0b013e32814e6b1c\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21886816\",\n",
      "        \"title\": \"Pilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimen.\",\n",
      "        \"authors\": \"Cahn P; Montaner J; Junod P; Patterson P; Krolewiecki A; Andrade-Villanueva J; Cassetti I; Sierra-Madero J; Casir\\u00f3 AD; Bortolozzi R; Lupo SH; Longo N; Rampakakis E; Ackad N; Sampalis JS\",\n",
      "        \"doi\": \"10.1371/journal.pone.0023726\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Cahn P, et al. Pilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimen. Pilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimen. 2011; 6:e23726. doi: 10.1371/journal.pone.0023726\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16549962\",\n",
      "        \"title\": \"Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study).\",\n",
      "        \"authors\": \"Castagna A; Danise A; Menzo S; Galli L; Gianotti N; Carini E; Boeri E; Galli A; Cernuschi M; Hasson H; Clementi M; Lazzarin A\",\n",
      "        \"doi\": \"10.1097/01.aids.0000218542.08845.b2\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Castagna A, et al. Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study). Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study). 2006; 20:795-803. doi: 10.1097/01.aids.0000218542.08845.b2\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16249701\",\n",
      "        \"title\": \"Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study).\",\n",
      "        \"authors\": \"Arribas JR; Pulido F; Delgado R; Lorenzo A; Miralles P; Arranz A; Gonz\\u00e1lez-Garc\\u00eda JJ; Cepeda C; Herv\\u00e1s R; Pa\\u00f1o JR; Gaya F; Carcas A; Montes ML; Costa JR; Pe\\u00f1a JM\",\n",
      "        \"doi\": \"10.1097/01.qai.0000180077.59159.f4\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Arribas JR, et al. Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study). Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study). 2005; 40:280-7. doi: 10.1097/01.qai.0000180077.59159.f4\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23075703\",\n",
      "        \"title\": \"A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study.\",\n",
      "        \"authors\": \"Bunupuradah T; Chetchotisakd P; Ananworanich J; Munsakul W; Jirajariyavej S; Kantipong P; Prasithsirikul W; Sungkanuparph S; Bowonwatanuwong C; Klinbuayaem V; Kerr SJ; Sophonphan J; Bhakeecheep S; Hirschel B; Ruxrungtham K; HIV STAR Study Group\",\n",
      "        \"doi\": \"10.3851/IMP2443\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bunupuradah T, et al. A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study. A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study. 2012; 17:1351-61. doi: 10.3851/IMP2443\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22441252\",\n",
      "        \"title\": \"Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings.\",\n",
      "        \"authors\": \"Bartlett JA; Ribaudo HJ; Wallis CL; Aga E; Katzenstein DA; Stevens WS; Norton MR; Klingman KL; Hosseinipour MC; Crump JA; Supparatpinyo K; Badal-Faesen S; Kallungal BA; Kumarasamy N\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e328353b066\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Research Support, U.S. Gov't, P.H.S.\"\n",
      "        ],\n",
      "        \"citation\": \"Bartlett JA, et al. Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings. Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings. 2012; 26:1345-54. doi: 10.1097/QAD.0b013e328353b066\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20802298\",\n",
      "        \"title\": \"Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir.\",\n",
      "        \"authors\": \"Gutmann C; Cusini A; G\\u00fcnthard HF; Fux C; Hirschel B; Decosterd LA; Cavassini M; Yerly S; Vernazza PL; Swiss HIV Cohort Study (SHCS)\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32833db9a1\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Gutmann C, et al. Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir. Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir. 2010; 24:2347-54. doi: 10.1097/QAD.0b013e32833db9a1\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20802297\",\n",
      "        \"title\": \"Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136.\",\n",
      "        \"authors\": \"Katlama C; Valantin MA; Algarte-Genin M; Duvivier C; Lambert-Niclot S; Girard PM; Molina JM; Hoen B; Pakianather S; Peytavin G; Marcelin AG; Flandre P\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32833dec20\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Katlama C, et al. Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136. Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136. 2010; 24:2365-74. doi: 10.1097/QAD.0b013e32833dec20\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18540803\",\n",
      "        \"title\": \"A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy.\",\n",
      "        \"authors\": \"Cameron DW; da Silva BA; Arribas JR; Myers RA; Bellos NC; Gilmore N; King MS; Bernstein BM; Brun SC; Hanna GJ\",\n",
      "        \"doi\": \"10.1086/589622\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Controlled Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Cameron DW, et al. A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy. A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy. 2008; 198:234-40. doi: 10.1086/589622\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18097218\",\n",
      "        \"title\": \"Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV.\",\n",
      "        \"authors\": \"Pulido F; Arribas JR; Delgado R; Cabrero E; Gonz\\u00e1lez-Garc\\u00eda J; P\\u00e9rez-Elias MJ; Arranz A; Portilla J; Pasquau J; Iribarren JA; Rubio R; Norton M; OK04 Study Group\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e3282f4243b\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Classical Article\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Pulido F, et al. Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV. Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV. 2008; 22:F1-9. doi: 10.1097/QAD.0b013e3282f4243b\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22814125\",\n",
      "        \"title\": \"Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA).\",\n",
      "        \"authors\": \"Gilks CF; Walker AS; Dunn DT; Gibb DM; Kikaire B; Reid A; Musana H; Mambule I; Kasirye R; Robertson V; Ssali F; Spyer M; Pillay D; Yirrell D; Kaleebu P; DART Virology Group and Trial Team\",\n",
      "        \"doi\": \"10.3851/IMP2253\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Gilks CF, et al. Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA). Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA). 2012; 17:1363-73. doi: 10.3851/IMP2253\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01592175\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00574652\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22129253\",\n",
      "        \"title\": \"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.\",\n",
      "        \"authors\": \"Saadoun D; Rosenzwajg M; Joly F; Six A; Carrat F; Thibault V; Sene D; Cacoub P; Klatzmann D\",\n",
      "        \"doi\": \"10.1056/NEJMoa1105143\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Saadoun D, et al. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. 2011; 365:2067-77. doi: 10.1056/NEJMoa1105143\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02236832\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01269632\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01024400\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22147712\",\n",
      "        \"title\": \"Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial.\",\n",
      "        \"authors\": \"Tsatsaris V; Capitant C; Schmitz T; Chazallon C; Bulifon S; Riethmuller D; Picone O; Poulain P; Lewin F; Lain\\u00e9 F; Jacqz-Aigrain E; Aboulker JP; Launay O; Inserm C09-33 PREFLUVAC (Immunogenicity and Safety of an Inactivated Nonadjuvanted A[H1N1v] Influenza Vaccine in Pregnant Women) Study Group\",\n",
      "        \"doi\": \"10.7326/0003-4819-155-11-201112060-00005\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Tsatsaris V, et al. Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial. Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial. 2011; 155:733-41. doi: 10.7326/0003-4819-155-11-201112060-00005\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02542800\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158470\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01779752\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03005652\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"36068621\",\n",
      "        \"title\": \"Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial.\",\n",
      "        \"authors\": \"Whitfield T; Demnitz-King H; Schlosser M; Barnhofer T; Frison E; Coll-Padros N; Dautricourt S; Requier F; Delarue M; Gonneaud J; Klimecki OM; Lutz A; Paly L; Salmon E; Schild AK; Walker Z; Jessen F; Ch\\u00e9telat G; Collette F; Wirth M; Marchant NL; Medit-Ageing Research Group\",\n",
      "        \"doi\": \"10.1186/s13195-022-01057-w\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Whitfield T, et al. Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial. Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial. 2022; 14:125. doi: 10.1186/s13195-022-01057-w\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35853750\",\n",
      "        \"title\": \"Association of Self-reflection With Cognition and Brain Health in Cognitively Unimpaired Older Adults.\",\n",
      "        \"authors\": \"Demnitz-King H; Gonneaud J; Klimecki OM; Chocat A; Collette F; Dautricourt S; Jessen F; Krolak-Salmon P; Lutz A; Morse RM; Molinuevo JL; Poisnel G; Touron E; Wirth M; Walker Z; Ch\\u00e9telat G; Marchant NL; Medit-Ageing Research Group\",\n",
      "        \"doi\": \"10.1212/WNL.0000000000200951\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Demnitz-King H, et al. Association of Self-reflection With Cognition and Brain Health in Cognitively Unimpaired Older Adults. Association of Self-reflection With Cognition and Brain Health in Cognitively Unimpaired Older Adults. 2022; 99:e1422-e1431. doi: 10.1212/WNL.0000000000200951\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"38100477\",\n",
      "        \"title\": \"Effects of a mindfulness-based intervention and a health self-management programme on psychological well-being in older adults with subjective cognitive decline: Secondary analyses from the SCD-Well randomised clinical trial.\",\n",
      "        \"authors\": \"Schlosser M; Demnitz-King H; Barnhofer T; Collette F; Gonneaud J; Ch\\u00e9telat G; Jessen F; Kliegel M; Klimecki OM; Lutz A; Marchant NL; Medit-Ageing Research Group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0295175\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Schlosser M, et al. Effects of a mindfulness-based intervention and a health self-management programme on psychological well-being in older adults with subjective cognitive decline: Secondary analyses from the SCD-Well randomised clinical trial. Effects of a mindfulness-based intervention and a health self-management programme on psychological well-being in older adults with subjective cognitive decline: Secondary analyses from the SCD-Well randomised clinical trial. 2023; 18:e0295175. doi: 10.1371/journal.pone.0295175\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33873195\",\n",
      "        \"title\": \"Effects of a Mindfulness-Based Intervention versus Health Self-Management on Subclinical Anxiety in Older Adults with Subjective Cognitive Decline: The SCD-Well Randomized Superiority Trial.\",\n",
      "        \"authors\": \"Marchant NL; Barnhofer T; Coueron R; Wirth M; Lutz A; Arenaza-Urquijo EM; Collette F; Poisnel G; Demnitz-King H; Schild AK; Coll-Padros N; Delphin-Combe F; Whitfield T; Schlosser M; Gonneaud J; Asselineau J; Walker Z; Krolak-Salmon P; Molinuevo JL; Frison E; Ch\\u00e9telat G; Jessen F; Klimecki OM; The\\u00a0Medit-Ageing\\u00a0Research\\u00a0Group\",\n",
      "        \"doi\": \"10.1159/000515669\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Marchant NL, et al. Effects of a Mindfulness-Based Intervention versus Health Self-Management on Subclinical Anxiety in Older Adults with Subjective Cognitive Decline: The SCD-Well Randomized Superiority Trial. Effects of a Mindfulness-Based Intervention versus Health Self-Management on Subclinical Anxiety in Older Adults with Subjective Cognitive Decline: The SCD-Well Randomized Superiority Trial. 2021; 90:341-350. doi: 10.1159/000515669\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01311752\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02916732\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"33657112\",\n",
      "        \"title\": \"Reassessment of the risk of birth defects due to Zika virus in Guadeloupe, 2016.\",\n",
      "        \"authors\": \"Funk AL; Hoen B; Vingdassalom I; Ryan C; Kadhel P; Schepers K; Gaete S; Tressi\\u00e8res B; Fontanet A\",\n",
      "        \"doi\": \"10.1371/journal.pntd.0009048\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Funk AL, et al. Reassessment of the risk of birth defects due to Zika virus in Guadeloupe, 2016. Reassessment of the risk of birth defects due to Zika virus in Guadeloupe, 2016. 2021; 15:e0009048. doi: 10.1371/journal.pntd.0009048\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29539287\",\n",
      "        \"title\": \"Pregnancy Outcomes after ZIKV Infection in French Territories in the Americas.\",\n",
      "        \"authors\": \"Hoen B; Schaub B; Funk AL; Ardillon V; Boullard M; Cabi\\u00e9 A; Callier C; Carles G; Cassadou S; C\\u00e9saire R; Douine M; Herrmann-Storck C; Kadhel P; Laou\\u00e9nan C; Madec Y; Monthieux A; Nacher M; Najioullah F; Rousset D; Ryan C; Schepers K; Stegmann-Planchard S; Tressi\\u00e8res B; Volum\\u00e9nie JL; Yassinguezo S; Janky E; Fontanet A\",\n",
      "        \"doi\": \"10.1056/NEJMoa1709481\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hoen B, et al. Pregnancy Outcomes after ZIKV Infection in French Territories in the Americas. Pregnancy Outcomes after ZIKV Infection in French Territories in the Americas. 2018; 378:985-994. doi: 10.1056/NEJMoa1709481\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03215732\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"31320358\",\n",
      "        \"title\": \"Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356).\",\n",
      "        \"authors\": \"Coste M; De S\\u00e8ze M; Diallo A; Carrieri MP; Marcellin F; Boyer S; ANRS 12356 AmBASS Study Group\",\n",
      "        \"doi\": \"10.1136/bmjopen-2019-030211\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Coste M, et al. Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356). Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356). 2019; 9:e030211. doi: 10.1136/bmjopen-2019-030211\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"37143029\",\n",
      "        \"title\": \"Hepatitis B prevention and treatment needs in women in Senegal (ANRS 12356 AmBASS survey).\",\n",
      "        \"authors\": \"Djaogol T; P\\u00e9ri\\u00e8res L; Marcellin F; Diouf A; Carrieri MP; Diallo A; Boyer S; ANRS 12356 AmBASS Study Group\",\n",
      "        \"doi\": \"10.1186/s12889-023-15710-y\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Djaogol T, et al. Hepatitis B prevention and treatment needs in women in Senegal (ANRS 12356 AmBASS survey). Hepatitis B prevention and treatment needs in women in Senegal (ANRS 12356 AmBASS survey). 2023; 23:825. doi: 10.1186/s12889-023-15710-y\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02405013\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"36686592\",\n",
      "        \"title\": \"Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial).\",\n",
      "        \"authors\": \"Marcellin F; Mourad A; Lemoine M; Kouanfack C; Seydi M; Carrieri P; Attia A; Protopopescu C; Lacombe K; Boyer S\",\n",
      "        \"doi\": \"10.1016/j.jhepr.2022.100665\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Marcellin F, et al. Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial). Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial). 2023; 5:100665. doi: 10.1016/j.jhepr.2022.100665\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00820118\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26568566\",\n",
      "        \"title\": \"Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial).\",\n",
      "        \"authors\": \"Piroth L; Moinot L; Yeni P; Avettand-F\\u00e9noel V; Reynes J; Girard PM; Marchou B; Georget A; Rouzioux C; Autran B; Duvillard L; Ch\\u00eane G; Fagard C; ANRS 141 TIPI Trial Study Group\",\n",
      "        \"doi\": \"10.1093/jac/dkv369\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Piroth L, et al. Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial). Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial). 2016; 71:490-6. doi: 10.1093/jac/dkv369\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01952587\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00640887\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"25406657\",\n",
      "        \"title\": \"Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy.\",\n",
      "        \"authors\": \"Naiker S; Connolly C; Wiesner L; Kellerman T; Reddy T; Harries A; McIlleron H; Lienhardt C; Pym A\",\n",
      "        \"doi\": \"10.1186/2050-6511-15-61\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Naiker S, et al. Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy. Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy. 2014; 15:61. doi: 10.1186/2050-6511-15-61\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26482301\",\n",
      "        \"title\": \"Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis.\",\n",
      "        \"authors\": \"Hennig S; Naiker S; Reddy T; Egan D; Kellerman T; Wiesner L; Owen A; McIlleron H; Pym A\",\n",
      "        \"doi\": \"10.1128/AAC.01195-15\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hennig S, et al. Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis. Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis. 2016; 60:617-20. doi: 10.1128/AAC.01195-15\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01725542\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"25977266\",\n",
      "        \"title\": \"High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH Study.\",\n",
      "        \"authors\": \"Piroth L; Paniez H; Taburet AM; Vincent C; Rosenthal E; Lacombe K; Billaud E; Rey D; Zucman D; Bailly F; Bronowicki JP; Simony M; Diallo A; Izopet J; Aboulker JP; Meyer L; Molina JM; ANRS HC30 QUADRIH Study Group\",\n",
      "        \"doi\": \"10.1093/cid/civ381\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Piroth L, et al. High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH Study. High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH Study. 2015; 61:817-25. doi: 10.1093/cid/civ381\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02038842\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00115609\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04120415\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01192737\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00265642\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00918307\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"34611902\",\n",
      "        \"title\": \"Interventions for preventing weight gain after smoking cessation.\",\n",
      "        \"authors\": \"Hartmann-Boyce J; Theodoulou A; Farley A; Hajek P; Lycett D; Jones LL; Kudlek L; Heath L; Hajizadeh A; Schenkels M; Aveyard P\",\n",
      "        \"doi\": \"10.1002/14651858.CD006219.pub4\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Meta-Analysis\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\",\n",
      "          \"Systematic Review\"\n",
      "        ],\n",
      "        \"citation\": \"Hartmann-Boyce J, et al. Interventions for preventing weight gain after smoking cessation. Interventions for preventing weight gain after smoking cessation. 2021; 10:CD006219. doi: 10.1002/14651858.CD006219.pub4\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29329763\",\n",
      "        \"title\": \"Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial.\",\n",
      "        \"authors\": \"Merci\\u00e9 P; Arsandaux J; Katlama C; Ferret S; Beuscart A; Spadone C; Duvivier C; Reynes J; Wirth N; Moinot L; B\\u00e9nard A; Zucman D; Duval X; Molina JM; Spire B; Fagard C; Ch\\u00eane G; ANRS 144 Inter-ACTIV study group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(18)30002-X\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Merci\\u00e9 P, et al. Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial. Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial. 2018; 5:e126-e135. doi: 10.1016/S2352-3018(18)30002-X\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01089387\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"28753830\",\n",
      "        \"title\": \"Intracavernous Injections of Bone Marrow Mononucleated Cells for Postradical Prostatectomy Erectile Dysfunction: Final Results of the INSTIN Clinical Trial.\",\n",
      "        \"authors\": \"Yiou R; Hamidou L; Birebent B; Bitari D; Le Corvoisier P; Contremoulins I; Rodriguez AM; Augustin D; Roudot-Thoraval F; de la Taille A; Rouard H\",\n",
      "        \"doi\": \"10.1016/j.euf.2017.06.009\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Letter\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Yiou R, et al. Intracavernous Injections of Bone Marrow Mononucleated Cells for Postradical Prostatectomy Erectile Dysfunction: Final Results of the INSTIN Clinical Trial. Intracavernous Injections of Bone Marrow Mononucleated Cells for Postradical Prostatectomy Erectile Dysfunction: Final Results of the INSTIN Clinical Trial. 2017; 3:643-645. doi: 10.1016/j.euf.2017.06.009\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26439886\",\n",
      "        \"title\": \"Safety of Intracavernous Bone Marrow-Mononuclear Cells for Postradical Prostatectomy Erectile Dysfunction: An Open Dose-Escalation Pilot Study.\",\n",
      "        \"authors\": \"Yiou R; Hamidou L; Birebent B; Bitari D; Lecorvoisier P; Contremoulins I; Khodari M; Rodriguez AM; Augustin D; Roudot-Thoraval F; de la Taille A; Rouard H\",\n",
      "        \"doi\": \"10.1016/j.eururo.2015.09.026\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Yiou R, et al. Safety of Intracavernous Bone Marrow-Mononuclear Cells for Postradical Prostatectomy Erectile Dysfunction: An Open Dose-Escalation Pilot Study. Safety of Intracavernous Bone Marrow-Mononuclear Cells for Postradical Prostatectomy Erectile Dysfunction: An Open Dose-Escalation Pilot Study. 2016; 69:988-91. doi: 10.1016/j.eururo.2015.09.026\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25974235\",\n",
      "        \"title\": \"Mesenchymal stem cell therapy for the treatment of erectile dysfunction.\",\n",
      "        \"authors\": \"Khera M; Albersen M; Mulhall JP\",\n",
      "        \"doi\": \"10.1111/jsm.12871\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Khera M, et al. Mesenchymal stem cell therapy for the treatment of erectile dysfunction. Mesenchymal stem cell therapy for the treatment of erectile dysfunction. 2015; 12:1105-6. doi: 10.1111/jsm.12871\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00928187\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"31273686\",\n",
      "        \"title\": \"Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa.\",\n",
      "        \"authors\": \"Boyer S; Nishimwe ML; Sagaon-Teyssier L; March L; Koulla-Shiro S; Bousmah MQ; Toby R; Mpoudi-Etame MP; Ngom Gueye NF; Sawadogo A; Kouanfack C; Ciaffi L; Spire B; Delaporte E; 2-Lady Group\",\n",
      "        \"doi\": \"10.1007/s41669-019-0157-9\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Boyer S, et al. Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa. Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa. 2020; 4:45-60. doi: 10.1007/s41669-019-0157-9\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03324633\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"23461846\",\n",
      "        \"title\": \"Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions.\",\n",
      "        \"authors\": \"Winnock M; Bani-Sadr F; Pambrun E; Loko MA; Carrieri P; Neau D; Morlat P; Marchou B; Dabis F; Salmon D; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) CO13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1111/hiv.12023\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Winnock M, et al. Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions. Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions. 2013; 14:430-6. doi: 10.1111/hiv.12023\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20969743\",\n",
      "        \"title\": \"The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010.\",\n",
      "        \"authors\": \"Loko MA; Salmon D; Carrieri P; Winnock M; Mora M; Merchadou L; Gillet S; Pambrun E; Delaune J; Valantin MA; Poizot-Martin I; Neau D; Bonnard P; Rosenthal E; Barange K; Morlat P; Lacombe K; Gervais A; Rouges F; See AB; Lascoux-Combe C; Vittecoq D; Goujard C; Duvivier C; Spire B; Izopet J; Sogni P; Serfaty L; Benhamou Y; Bani-Sadr F; Dabis F; ANRS CO 13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1186/1471-2334-10-303\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Loko MA, et al. The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010. The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010. 2010; 10:303. doi: 10.1186/1471-2334-10-303\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34212476\",\n",
      "        \"title\": \"Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participants.\",\n",
      "        \"authors\": \"Chalouni M; Wittkop L; Bani-Sadr F; Lacombe K; Esterle L; Gilbert C; Miailhes P; Zucman D; Valantin MA; Br\\u00e9gigeon-Ronot S; Morlat P; Billaud E; Piroth L; Naqvi A; Sogni P; Salmon D; ANRS CO13 HEPAVIH Cohort Study Group\",\n",
      "        \"doi\": \"10.1111/hiv.13127\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Chalouni M, et al. Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participants. Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participants. 2021; 22:791-804. doi: 10.1111/hiv.13127\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23226258\",\n",
      "        \"title\": \"HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients.\",\n",
      "        \"authors\": \"Abravanel F; Raymond S; Pambrun E; Winnock M; Bonnard P; Sogni P; Trimoulet P; Dabis F; Salmon-Ceron D; Izopet J; ANRS CO13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0050289\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Abravanel F, et al. HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients. HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients. 2012; 7:e50289. doi: 10.1371/journal.pone.0050289\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22781224\",\n",
      "        \"title\": \"Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction?\",\n",
      "        \"authors\": \"Solas C; Pambrun E; Winnock M; Salmon D; Poizot-Martin I; Dominguez S; Bani-Sadr F; Izopet J; Garraffo R; Peytavin G; ANRS CO-13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32835763a4\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Solas C, et al. Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction?. Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction?. 2012; 26:2193-9. doi: 10.1097/QAD.0b013e32835763a4\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27177169\",\n",
      "        \"title\": \"Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort).\",\n",
      "        \"authors\": \"Marcellin F; Protopopescu C; Poizot-Martin I; Miailhes P; Esterle L; Wittkop L; Spire B; Bocquier A; Salmon-Ceron D; Dabis F; Carrieri MP; HEPAVIH ANRS CO13 Study Group\",\n",
      "        \"doi\": \"10.1097/MEG.0000000000000664\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Observational Study\"\n",
      "        ],\n",
      "        \"citation\": \"Marcellin F, et al. Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort). Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort). 2016; 28:1003-7. doi: 10.1097/MEG.0000000000000664\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23052829\",\n",
      "        \"title\": \"Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort.\",\n",
      "        \"authors\": \"Loko MA; Bani-Sadr F; Valantin MA; Lascoux-Combe C; Fontaine H; Bonnard P; Gervais A; Bouchaud O; Garipuy D; Quertainmont Y; Vittecoq D; Tehrani MS; Winnock M; Dabis F; Salmon D; ANRS CO 13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.3851/IMP2419\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Loko MA, et al. Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort. Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort. 2012; 17:1335-43. doi: 10.3851/IMP2419\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26372388\",\n",
      "        \"title\": \"Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients.\",\n",
      "        \"authors\": \"ANRS CO13 HEPAVIH Cohort\",\n",
      "        \"doi\": \"10.1097/QAD.0000000000000787\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"ANRS CO13 HEPAVIH Cohort. Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients. Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients. 2015; 29:1821-30. doi: 10.1097/QAD.0000000000000787\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23421419\",\n",
      "        \"title\": \"Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort).\",\n",
      "        \"authors\": \"Marcellin F; Lions C; Winnock M; Salmon D; Durant J; Spire B; Mora M; Loko MA; Dabis F; Dominguez S; Roux P; Carrieri MP; ANRS CO13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1111/add.12149\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Marcellin F, et al. Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort). Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort). 2013; 108:1250-8. doi: 10.1111/add.12149\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21888878\",\n",
      "        \"title\": \"Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: results from ANRS CO13 HEPAVIH.\",\n",
      "        \"authors\": \"Carrieri MP; Cohen J; Salmon-Ceron D; Winnock M\",\n",
      "        \"doi\": \"10.1016/j.jhep.2011.08.005\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Letter\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Carrieri MP, et al. Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: results from ANRS CO13 HEPAVIH. Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: results from ANRS CO13 HEPAVIH. 2012; 56:745-7. doi: 10.1016/j.jhep.2011.08.005\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28235612\",\n",
      "        \"title\": \"Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort.\",\n",
      "        \"authors\": \"Piroth L; Wittkop L; Lacombe K; Rosenthal E; Gilbert C; Miailhes P; Carrieri P; Chas J; Poizot-Martin I; Gervais A; Dominguez S; Neau D; Zucman D; Billaud E; Morlat P; Aumaitre H; Lascoux-Combe C; Simon A; Bouchaud O; Teicher E; Bani-Sadr F; Alric L; Vittecoq D; Bou\\u00e9 F; Duvivier C; Valantin MA; Esterle L; Dabis F; Sogni P; Salmon D; ANRS CO13 HEPAVIH study group\",\n",
      "        \"doi\": \"10.1016/j.jhep.2017.02.012\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Piroth L, et al. Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort. Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort. 2017; 67:23-31. doi: 10.1016/j.jhep.2017.02.012\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24580042\",\n",
      "        \"title\": \"Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort.\",\n",
      "        \"authors\": \"Marcellin F; Roux P; Winnock M; Lions C; Dabis F; Salmon-Ceron D; Loko MA; Spire B; Carrieri MP\",\n",
      "        \"doi\": \"10.1586/17474124.2014.888949\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Marcellin F, et al. Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort. Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort. 2014; 8:351-8. doi: 10.1586/17474124.2014.888949\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22535683\",\n",
      "        \"title\": \"Elevated coffee consumption and reduced risk of insulin resistance in HIV-HCV coinfected patients (HEPAVIH ANRS CO-13).\",\n",
      "        \"authors\": \"Carrieri MP; Sogni P; Cohen J; Loko MA; Winnock M; Spire B; HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1002/hep.25813\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Letter\",\n",
      "          \"Comment\"\n",
      "        ],\n",
      "        \"citation\": \"Carrieri MP, et al. Elevated coffee consumption and reduced risk of insulin resistance in HIV-HCV coinfected patients (HEPAVIH ANRS CO-13). Elevated coffee consumption and reduced risk of insulin resistance in HIV-HCV coinfected patients (HEPAVIH ANRS CO-13). 2012; 56:2010. doi: 10.1002/hep.25813\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28430385\",\n",
      "        \"title\": \"Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort.\",\n",
      "        \"authors\": \"Knight R; Roux P; Vilotitch A; Marcellin F; Rosenthal E; Esterle L; Bou\\u00e9 F; Rey D; Piroth L; Dominguez S; Sogni P; Salmon-Ceron D; Spire B; Carrieri MP; ANRS CO13-HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1111/add.13851\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Knight R, et al. Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort. Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort. 2017; 112:1669-1679. doi: 10.1111/add.13851\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20876416\",\n",
      "        \"title\": \"Chocolate intake, depression, and clinical progression in HIV-HCV coinfected patients: still more questions than answers.\",\n",
      "        \"authors\": \"Carrieri MP; Cohen J; Winnock M; Salmon D\",\n",
      "        \"doi\": \"10.1001/archinternmed.2010.330\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Comment\",\n",
      "          \"Letter\"\n",
      "        ],\n",
      "        \"citation\": \"Carrieri MP, et al. Chocolate intake, depression, and clinical progression in HIV-HCV coinfected patients: still more questions than answers. Chocolate intake, depression, and clinical progression in HIV-HCV coinfected patients: still more questions than answers. 2010; 170:1607; author reply 1608-9. doi: 10.1001/archinternmed.2010.330\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24499953\",\n",
      "        \"title\": \"Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response.\",\n",
      "        \"authors\": \"Bani-Sadr F; Loko MA; Pambrun E; Winnock M; Carrieri P; Gilbert C; Duvivier C; Bouchaud O; Gervais A; Dabis F; Salmon D; ANRS CO 13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1097/QAD.0000000000000218\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bani-Sadr F, et al. Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response. Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response. 2014; 28:1155-60. doi: 10.1097/QAD.0000000000000218\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30570526\",\n",
      "        \"title\": \"Nadir CD4 Is Negatively Associated With Antinuclear Antibody Detection in HCV/HIV-Coinfected Patients.\",\n",
      "        \"authors\": \"Poizot-Martin I; Rosenthal E; Gilbert C; Cano CE; Simon A; Lascoux-Combe C; Alric L; Gervais A; Neau D; Esterle L; Salmon D; Sogni P; Wittkop L; ANRS CO13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1097/QAI.0000000000001940\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Poizot-Martin I, et al. Nadir CD4 Is Negatively Associated With Antinuclear Antibody Detection in HCV/HIV-Coinfected Patients. Nadir CD4 Is Negatively Associated With Antinuclear Antibody Detection in HCV/HIV-Coinfected Patients. 2019; 80:461-466. doi: 10.1097/QAI.0000000000001940\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28942916\",\n",
      "        \"title\": \"Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients.\",\n",
      "        \"authors\": \"Carrieri MP; Protopopescu C; Marcellin F; Rosellini S; Wittkop L; Esterle L; Zucman D; Raffi F; Rosenthal E; Poizot-Martin I; Salmon-Ceron D; Dabis F; Spire B; ANRS CO13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1016/j.jhep.2017.08.005\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Carrieri MP, et al. Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients. Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients. 2017; 67:1157-1167. doi: 10.1016/j.jhep.2017.08.005\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27073179\",\n",
      "        \"title\": \"No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort).\",\n",
      "        \"authors\": \"Marcellin F; Lions C; Rosenthal E; Roux P; Sogni P; Wittkop L; Protopopescu C; Spire B; Salmon-Ceron D; Dabis F; Carrieri MP; HEPAVIH ANRS CO13 Study Group*\",\n",
      "        \"doi\": \"10.1111/dar.12398\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Marcellin F, et al. No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort). No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort). 2017; 36:227-238. doi: 10.1111/dar.12398\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28418984\",\n",
      "        \"title\": \"Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH).\",\n",
      "        \"authors\": \"Marcellin F; Protopopescu C; Esterle L; Wittkop L; Piroth L; Aumaitre H; Bouchaud O; Goujard C; Vittecoq D; Dabis F; Salmon-Ceron D; Spire B; Roux P; Carrieri MP; ANRS CO13-HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1097/MEG.0000000000000883\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Marcellin F, et al. Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH). Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH). 2017; 29:786-791. doi: 10.1097/MEG.0000000000000883\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27339598\",\n",
      "        \"title\": \"A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients.\",\n",
      "        \"authors\": \"Ulveling D; Le Clerc S; Cobat A; Labib T; Noirel J; Laville V; Coulonges C; Carpentier W; Nalpas B; Heim MH; Poynard T; Cerny A; Pol S; Bochud PY; Dabis F; Theodorou I; L\\u00e9vy Y; Salmon D; Abel L; Dominguez S; Zagury JF; HEPAVIH ANRS CO13 Cohort Study Group; Swiss Hepatitis C Cohort Study Group; French ANRS HC EP 26 Genoscan Study Group\",\n",
      "        \"doi\": \"10.1002/hep.28695\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Ulveling D, et al. A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients. A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients. 2016; 64:1462-1472. doi: 10.1002/hep.28695\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23978720\",\n",
      "        \"title\": \"Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.\",\n",
      "        \"authors\": \"Carrieri MP; Lions C; Sogni P; Winnock M; Roux P; Mora M; Bonnard P; Salmon D; Dabis F; Spire B; ANRS CO13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1016/j.jhep.2013.08.014\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Carrieri MP, et al. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study. 2014; 60:46-53. doi: 10.1016/j.jhep.2013.08.014\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22409788\",\n",
      "        \"title\": \"Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France).\",\n",
      "        \"authors\": \"Salmon-Ceron D; Cohen J; Winnock M; Roux P; Sadr FB; Rosenthal E; Martin IP; Loko MA; Mora M; Sogni P; Spire B; Dabis F; Carrieri MP; HEPAVIH group\",\n",
      "        \"doi\": \"10.1186/1472-6963-12-59\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Salmon-Ceron D, et al. Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France). Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France). 2012; 12:59. doi: 10.1186/1472-6963-12-59\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22173166\",\n",
      "        \"title\": \"Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH.\",\n",
      "        \"authors\": \"Salmon D; Bani-Sadr F; Loko MA; Stitou H; Gervais A; Durant J; Rosenthal E; Quertainmont Y; Barange K; Vittecoq D; Shoai-Tehrani M; Alvarez M; Winnock M; Trinchet JC; Dabis F; Sogni P\",\n",
      "        \"doi\": \"10.1016/j.jhep.2011.11.009\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Salmon D, et al. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH. 2012; 56:862-8. doi: 10.1016/j.jhep.2011.11.009\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28780609\",\n",
      "        \"title\": \"Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort).\",\n",
      "        \"authors\": \"Yaya I; Roux P; Marcellin F; Salmon-Ceron D; Carrieri MP\",\n",
      "        \"doi\": \"10.1007/s10620-017-4703-y\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Letter\",\n",
      "          \"Comment\"\n",
      "        ],\n",
      "        \"citation\": \"Yaya I, et al. Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort). Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort). 2017; 62:2943-2944. doi: 10.1007/s10620-017-4703-y\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21920402\",\n",
      "        \"title\": \"Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination.\",\n",
      "        \"authors\": \"Winnock M; Bani-Sadr F; Pambrun E; Loko MA; Lascoux-Combe C; Garipuy D; Rosenthal E; Carrieri P; Dabis F; Salmon D\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2011.08.125\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Winnock M, et al. Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination. Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination. 2011; 29:8656-60. doi: 10.1016/j.vaccine.2011.08.125\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25015913\",\n",
      "        \"title\": \"High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort.\",\n",
      "        \"authors\": \"Marcellin F; Roux P; Loko MA; Lions C; Caumont-Prim A; Dabis F; Salmon-Ceron D; Spire B; Carrieri MP; HEPAVIH (ANRS CO13) Study Group\",\n",
      "        \"doi\": \"10.1093/cid/ciu525\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Letter\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Comment\"\n",
      "        ],\n",
      "        \"citation\": \"Marcellin F, et al. High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort. High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort. 2014; 59:1190-2. doi: 10.1093/cid/ciu525\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32798585\",\n",
      "        \"title\": \"Increased mortality in HIV/HCV-coinfected compared to\\u00a0HCV-monoinfected patients in the DAA era due to non-liver-related death.\",\n",
      "        \"authors\": \"Chalouni M; Pol S; Sogni P; Fontaine H; Lacombe K; Marc-Lacombe J; Esterle L; Dorival C; Bourli\\u00e8re M; Bani-Sadr F; de Ledinghen V; Zucman D; Larrey D; Salmon D; Carrat F; Wittkop L; ANRS CO13 HEPAVIH and ANRS CO22 HEPATHER cohort study groups\",\n",
      "        \"doi\": \"10.1016/j.jhep.2020.08.008\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Chalouni M, et al. Increased mortality in HIV/HCV-coinfected compared to\\u00a0HCV-monoinfected patients in the DAA era due to non-liver-related death. Increased mortality in HIV/HCV-coinfected compared to\\u00a0HCV-monoinfected patients in the DAA era due to non-liver-related death. 2021; 74:37-47. doi: 10.1016/j.jhep.2020.08.008\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26528903\",\n",
      "        \"title\": \"HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients.\",\n",
      "        \"authors\": \"Salmon D; Bani-Sadr F; Gilbert C; Rosenthal E; Valantin MA; Simon A; Neau D; Morlat P; Loko MA; Wittkop L; Dabis F; ANRS CO13HEPAVIH study group\",\n",
      "        \"doi\": \"10.1016/j.jcv.2015.10.010\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Observational Study\"\n",
      "        ],\n",
      "        \"citation\": \"Salmon D, et al. HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients. HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients. 2015; 73:32-35. doi: 10.1016/j.jcv.2015.10.010\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21692942\",\n",
      "        \"title\": \"Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.\",\n",
      "        \"authors\": \"Loko MA; Bani-Sadr F; Winnock M; Lacombe K; Carrieri P; Neau D; Morlat P; Serfaty L; Dabis F; Salmon D; ANRS CO 13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1111/j.1365-2893.2010.01417.x\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Loko MA, et al. Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients. Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients. 2011; 18:e307-14. doi: 10.1111/j.1365-2893.2010.01417.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21819472\",\n",
      "        \"title\": \"Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.\",\n",
      "        \"authors\": \"Roux P; Fugon L; Winnock M; Salmon-C\\u00e9ron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP; ANRS-CO-13-HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1111/j.1360-0443.2011.03608.x\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Roux P, et al. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users. 2012; 107:152-9. doi: 10.1111/j.1360-0443.2011.03608.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27317796\",\n",
      "        \"title\": \"All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort.\",\n",
      "        \"authors\": \"Sogni P; Gilbert C; Lacombe K; Piroth L; Rosenthal E; Miailhes P; Gervais A; Esterle L; Chas J; Poizot-Martin I; Dominguez S; Simon A; Morlat P; Neau D; Zucman D; Bouchaud O; Lascoux-Combe C; Bani-Sadr F; Alric L; Goujard C; Vittecoq D; Billaud E; Auma\\u00eetre H; Bou\\u00e9 F; Valantin MA; Dabis F; Salmon D; Wittkop L\",\n",
      "        \"doi\": \"10.1093/cid/ciw379\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sogni P, et al. All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort. All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort. 2016; 63:763-770. doi: 10.1093/cid/ciw379\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25778750\",\n",
      "        \"title\": \"Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH).\",\n",
      "        \"authors\": \"Carrieri MP; Serfaty L; Vilotitch A; Winnock M; Poizot-Martin I; Loko MA; Lions C; Lascoux-Combe C; Roux P; Salmon-Ceron D; Spire B; Dabis F; ANRS CO13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1093/cid/civ217\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Carrieri MP, et al. Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH). Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH). 2015; 61:40-8. doi: 10.1093/cid/civ217\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24166726\",\n",
      "        \"title\": \"Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort.\",\n",
      "        \"authors\": \"Roux P; Lions C; Cohen J; Winnock M; Salmon-C\\u00e9ron D; Bani-Sadr F; Sogni P; Spire B; Dabis F; Carrieri MP; ANRS-CO13-HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.3851/IMP2699\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Roux P, et al. Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort. Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort. 2014; 19:171-8. doi: 10.3851/IMP2699\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20493576\",\n",
      "        \"title\": \"Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.\",\n",
      "        \"authors\": \"Cal\\u00e8s P; Halfon P; Batisse D; Carrat F; Perr\\u00e9 P; Penaranda G; Guyader D; d'Alteroche L; Fouchard-Hubert I; Michelet C; Veillon P; Lambert J; Weiss L; Salmon D; Cacoub P\",\n",
      "        \"doi\": \"10.1016/j.jhep.2010.03.007\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Cal\\u00e8s P, et al. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection. 2010; 53:238-44. doi: 10.1016/j.jhep.2010.03.007\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22285372\",\n",
      "        \"title\": \"Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: should the same test be applied to all samples?\",\n",
      "        \"authors\": \"Trimoulet P; Merchadou L; Winnock M; Loko MA; Fleury H; Salmon D; Dabis F; Neau D; ANRS CO 13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1016/j.jviromet.2012.01.006\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Trimoulet P, et al. Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: should the same test be applied to all samples?. Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: should the same test be applied to all samples?. 2012; 181:131-3. doi: 10.1016/j.jviromet.2012.01.006\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21239121\",\n",
      "        \"title\": \"Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician.\",\n",
      "        \"authors\": \"Roux P; Cohen J; Lascoux-Combe C; Sogni P; Winnock M; Salmon-Ceron D; Spire B; Dabis F; Carrieri MP; ANRS-CO13-HEPAVIH study group\",\n",
      "        \"doi\": \"10.1016/j.drugalcdep.2010.09.025\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Roux P, et al. Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician. Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician. 2011; 116:228-32. doi: 10.1016/j.drugalcdep.2010.09.025\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02027051\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02027233\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00136630\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22491195\",\n",
      "        \"title\": \"Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia.\",\n",
      "        \"authors\": \"Tezenas du Montcel S; Charles P; Goizet C; Marelli C; Ribai P; Vincitorio C; Anheim M; Guyant-Mar\\u00e9chal L; Le Bayon A; Vandenberghe N; Tchikviladz\\u00e9 M; Devos D; Le Ber I; N'Guyen K; Cazeneuve C; Tallaksen C; Brice A; Durr A\",\n",
      "        \"doi\": \"10.1001/archneurol.2011.2713\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Tezenas du Montcel S, et al. Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia. Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia. 2012; 69:500-8. doi: 10.1001/archneurol.2011.2713\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16501573\",\n",
      "        \"title\": \"Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes.\",\n",
      "        \"authors\": \"Waters MF; Minassian NA; Stevanin G; Figueroa KP; Bannister JP; Nolte D; Mock AF; Evidente VG; Fee DB; M\\u00fcller U; D\\u00fcrr A; Brice A; Papazian DM; Pulst SM\",\n",
      "        \"doi\": \"10.1038/ng1758\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Waters MF, et al. Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes. Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes. 2006; 38:447-51. doi: 10.1038/ng1758\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17605047\",\n",
      "        \"title\": \"A novel locus for autosomal dominant \\\"uncomplicated\\\" hereditary spastic paraplegia maps to chromosome 8p21.1-q13.3.\",\n",
      "        \"authors\": \"Hanein S; D\\u00fcrr A; Ribai P; Forlani S; Leutenegger AL; Nelson I; Babron MC; Elleuch N; Depienne C; Charon C; Brice A; Stevanin G\",\n",
      "        \"doi\": \"10.1007/s00439-007-0396-1\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hanein S, et al. A novel locus for autosomal dominant \\\"uncomplicated\\\" hereditary spastic paraplegia maps to chromosome 8p21.1-q13.3. A novel locus for autosomal dominant \\\"uncomplicated\\\" hereditary spastic paraplegia maps to chromosome 8p21.1-q13.3. 2007; 122:261-73. doi: 10.1007/s00439-007-0396-1\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17957230\",\n",
      "        \"title\": \"Mental deficiency in three families with SPG4 spastic paraplegia.\",\n",
      "        \"authors\": \"Riba\\u00ef P; Depienne C; Fedirko E; Jothy AC; Viveweger C; Hahn-Barma V; Brice A; Durr A\",\n",
      "        \"doi\": \"10.1038/sj.ejhg.5201922\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Riba\\u00ef P, et al. Mental deficiency in three families with SPG4 spastic paraplegia. Mental deficiency in three families with SPG4 spastic paraplegia. 2008; 16:97-104. doi: 10.1038/sj.ejhg.5201922\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17597328\",\n",
      "        \"title\": \"A de novo SPAST mutation leading to somatic mosaicism is associated with a later age at onset in HSP.\",\n",
      "        \"authors\": \"Depienne C; Fedirko E; Faucheux JM; Forlani S; Bricka B; Goizet C; Lesourd S; Stevanin G; Ruberg M; Durr A; Brice A\",\n",
      "        \"doi\": \"10.1007/s10048-007-0090-4\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Case Reports\",\n",
      "          \"Letter\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Depienne C, et al. A de novo SPAST mutation leading to somatic mosaicism is associated with a later age at onset in HSP. A de novo SPAST mutation leading to somatic mosaicism is associated with a later age at onset in HSP. 2007; 8:231-3. doi: 10.1007/s10048-007-0090-4\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18853458\",\n",
      "        \"title\": \"Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10.\",\n",
      "        \"authors\": \"Goizet C; Boukhris A; Mundwiller E; Tallaksen C; Forlani S; Toutain A; Carriere N; Paquis V; Depienne C; Durr A; Stevanin G; Brice A\",\n",
      "        \"doi\": \"10.1002/humu.20920\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Goizet C, et al. Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. 2009; 30:E376-85. doi: 10.1002/humu.20920\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24780882\",\n",
      "        \"title\": \"Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6.\",\n",
      "        \"authors\": \"Tezenas du Montcel S; Durr A; Rakowicz M; Nanetti L; Charles P; Sulek A; Mariotti C; Rola R; Schols L; Bauer P; Dufaure-Gar\\u00e9 I; Jacobi H; Forlani S; Schmitz-H\\u00fcbsch T; Filla A; Timmann D; van de Warrenburg BP; Marelli C; Kang JS; Giunti P; Cook A; Baliko L; Melegh B; Boesch S; Szymanski S; Berciano J; Infante J; Buerk K; Masciullo M; Di Fabio R; Depondt C; Ratka S; Stevanin G; Klockgether T; Brice A; Golmard JL\",\n",
      "        \"doi\": \"10.1136/jmedgenet-2013-102200\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Tezenas du Montcel S, et al. Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6. Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6. 2014; 51:479-86. doi: 10.1136/jmedgenet-2013-102200\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15313841\",\n",
      "        \"title\": \"Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14.\",\n",
      "        \"authors\": \"Stevanin G; Hahn V; Lohmann E; Bouslam N; Gouttard M; Soumphonphakdy C; Welter ML; Ollagnon-Roman E; Lemainque A; Ruberg M; Brice A; Durr A\",\n",
      "        \"doi\": \"10.1001/archneur.61.8.1242\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Stevanin G, et al. Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14. Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14. 2004; 61:1242-8. doi: 10.1001/archneur.61.8.1242\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15365159\",\n",
      "        \"title\": \"Mutations in the FGF14 gene are not a major cause of spinocerebellar ataxia in Caucasians.\",\n",
      "        \"authors\": \"Stevanin G; Durr A; Dussert C; Penet C; Brice A\",\n",
      "        \"doi\": \"10.1212/01.wnl.0000137020.30604.1e\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Stevanin G, et al. Mutations in the FGF14 gene are not a major cause of spinocerebellar ataxia in Caucasians. Mutations in the FGF14 gene are not a major cause of spinocerebellar ataxia in Caucasians. 2004; 63:936. doi: 10.1212/01.wnl.0000137020.30604.1e\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16193476\",\n",
      "        \"title\": \"New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14.\",\n",
      "        \"authors\": \"Klebe S; Durr A; Rentschler A; Hahn-Barma V; Abele M; Bouslam N; Sch\\u00f6ls L; Jedynak P; Forlani S; Denis E; Dussert C; Agid Y; Bauer P; Globas C; W\\u00fcllner U; Brice A; Riess O; Stevanin G\",\n",
      "        \"doi\": \"10.1002/ana.20628\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Klebe S, et al. New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14. New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14. 2005; 58:720-9. doi: 10.1002/ana.20628\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17098887\",\n",
      "        \"title\": \"Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia.\",\n",
      "        \"authors\": \"Depienne C; Fedirko E; Forlani S; Cazeneuve C; Riba\\u00ef P; Feki I; Tallaksen C; Nguyen K; Stankoff B; Ruberg M; Stevanin G; Durr A; Brice A\",\n",
      "        \"doi\": \"10.1136/jmg.2006.046425\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Letter\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Depienne C, et al. Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia. Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia. 2007; 44:281-4. doi: 10.1136/jmg.2006.046425\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18378516\",\n",
      "        \"title\": \"Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment.\",\n",
      "        \"authors\": \"du Montcel ST; Charles P; Ribai P; Goizet C; Le Bayon A; Labauge P; Guyant-Mar\\u00e9chal L; Forlani S; Jauffret C; Vandenberghe N; N'guyen K; Le Ber I; Devos D; Vincitorio CM; Manto MU; Tison F; Hannequin D; Ruberg M; Brice A; Durr A\",\n",
      "        \"doi\": \"10.1093/brain/awn059\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Validation Study\"\n",
      "        ],\n",
      "        \"citation\": \"du Montcel ST, et al. Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment. Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment. 2008; 131:1352-61. doi: 10.1093/brain/awn059\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16055926\",\n",
      "        \"title\": \"Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases.\",\n",
      "        \"authors\": \"Depienne C; Tallaksen C; Lephay JY; Bricka B; Poea-Guyon S; Fontaine B; Labauge P; Brice A; Durr A\",\n",
      "        \"doi\": \"10.1136/jmg.2005.035311\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Letter\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Depienne C, et al. Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. 2006; 43:259-65. doi: 10.1136/jmg.2005.035311\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03459157\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"34048794\",\n",
      "        \"title\": \"HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study.\",\n",
      "        \"authors\": \"Laurent C; Demb\\u00e9l\\u00e9 Keita B; Yaya I; Le Guicher G; Sagaon-Teyssier L; Agboyibor MK; Coulibaly A; Traor\\u00e9 I; Malan JB; De Baetselier I; Eubanks A; Riegel L; Rojas Castro D; Fay\\u00e9-Kett\\u00e9 H; Kon\\u00e9 A; Diand\\u00e9 S; Dagnra CA; Serrano L; Diallo F; Mensah E; Dah TTE; Anoma C; Vuylsteke B; Spire B; CohMSM-PrEP Study Group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(21)00005-9\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Laurent C, et al. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study. 2021; 8:e420-e428. doi: 10.1016/S2352-3018(21)00005-9\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT05040048\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04470648\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"32338732\",\n",
      "        \"title\": \"Prevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston.\",\n",
      "        \"authors\": \"Baggett TP; Keyes H; Sporn N; Gaeta JM\",\n",
      "        \"doi\": \"10.1001/jama.2020.6887\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Baggett TP, et al. Prevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston. Prevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston. 2020; 323:2191-2192. doi: 10.1001/jama.2020.6887\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31995857\",\n",
      "        \"title\": \"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.\",\n",
      "        \"authors\": \"Li Q; Guan X; Wu P; Wang X; Zhou L; Tong Y; Ren R; Leung KSM; Lau EHY; Wong JY; Xing X; Xiang N; Wu Y; Li C; Chen Q; Li D; Liu T; Zhao J; Liu M; Tu W; Chen C; Jin L; Yang R; Wang Q; Zhou S; Wang R; Liu H; Luo Y; Liu Y; Shao G; Li H; Tao Z; Yang Y; Deng Z; Liu B; Ma Z; Zhang Y; Shi G; Lam TTY; Wu JT; Gao GF; Cowling BJ; Yang B; Leung GM; Feng Z\",\n",
      "        \"doi\": \"10.1056/NEJMoa2001316\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Li Q, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. 2020; 382:1199-1207. doi: 10.1056/NEJMoa2001316\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32109013\",\n",
      "        \"title\": \"Clinical Characteristics of Coronavirus Disease 2019 in China.\",\n",
      "        \"authors\": \"Guan WJ; Ni ZY; Hu Y; Liang WH; Ou CQ; He JX; Liu L; Shan H; Lei CL; Hui DSC; Du B; Li LJ; Zeng G; Yuen KY; Chen RC; Tang CL; Wang T; Chen PY; Xiang J; Li SY; Wang JL; Liang ZJ; Peng YX; Wei L; Liu Y; Hu YH; Peng P; Wang JM; Liu JY; Chen Z; Li G; Zheng ZJ; Qiu SQ; Luo J; Ye CJ; Zhu SY; Zhong NS; China Medical Treatment Expert Group for Covid-19\",\n",
      "        \"doi\": \"10.1056/NEJMoa2002032\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Guan WJ, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. Clinical Characteristics of Coronavirus Disease 2019 in China. 2020; 382:1708-1720. doi: 10.1056/NEJMoa2002032\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31978945\",\n",
      "        \"title\": \"A Novel Coronavirus from Patients with Pneumonia in China, 2019.\",\n",
      "        \"authors\": \"Zhu N; Zhang D; Wang W; Li X; Yang B; Song J; Zhao X; Huang B; Shi W; Lu R; Niu P; Zhan F; Ma X; Wang D; Xu W; Wu G; Gao GF; Tan W; China Novel Coronavirus Investigating and Research Team\",\n",
      "        \"doi\": \"10.1056/NEJMoa2001017\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Zhu N, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. A Novel Coronavirus from Patients with Pneumonia in China, 2019. 2020; 382:727-733. doi: 10.1056/NEJMoa2001017\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32070465\",\n",
      "        \"title\": \"First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020.\",\n",
      "        \"authors\": \"Bernard Stoecklin S; Rolland P; Silue Y; Mailles A; Campese C; Simondon A; Mechain M; Meurice L; Nguyen M; Bassi C; Yamani E; Behillil S; Ismael S; Nguyen D; Malvy D; Lescure FX; Georges S; Lazarus C; Taba\\u00ef A; Stempfelet M; Enouf V; Coignard B; Levy-Bruhl D; Investigation team\",\n",
      "        \"doi\": \"10.2807/1560-7917.ES.2020.25.6.2000094\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Case Reports\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Bernard Stoecklin S, et al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. 2020; 25:(unknown pages). doi: 10.2807/1560-7917.ES.2020.25.6.2000094\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32046819\",\n",
      "        \"title\": \"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020.\",\n",
      "        \"authors\": \"Backer JA; Klinkenberg D; Wallinga J\",\n",
      "        \"doi\": \"10.2807/1560-7917.ES.2020.25.5.2000062\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Backer JA, et al. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. 2020; 25:(unknown pages). doi: 10.2807/1560-7917.ES.2020.25.5.2000062\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32371096\",\n",
      "        \"title\": \"SARS-CoV-2 was already spreading in France in late December 2019.\",\n",
      "        \"authors\": \"Deslandes A; Berti V; Tandjaoui-Lambotte Y; Alloui C; Carbonnelle E; Zahar JR; Brichler S; Cohen Y\",\n",
      "        \"doi\": \"10.1016/j.ijantimicag.2020.106006\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Deslandes A, et al. SARS-CoV-2 was already spreading in France in late December 2019. SARS-CoV-2 was already spreading in France in late December 2019. 2020; 55:106006. doi: 10.1016/j.ijantimicag.2020.106006\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32224310\",\n",
      "        \"title\": \"Clinical and virological data of the first cases of COVID-19 in Europe: a case series.\",\n",
      "        \"authors\": \"Lescure FX; Bouadma L; Nguyen D; Parisey M; Wicky PH; Behillil S; Gaymard A; Bouscambert-Duchamp M; Donati F; Le Hingrat Q; Enouf V; Houhou-Fidouh N; Valette M; Mailles A; Lucet JC; Mentre F; Duval X; Descamps D; Malvy D; Timsit JF; Lina B; van-der-Werf S; Yazdanpanah Y\",\n",
      "        \"doi\": \"10.1016/S1473-3099(20)30200-0\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Lescure FX, et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. 2020; 20:697-706. doi: 10.1016/S1473-3099(20)30200-0\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02497274\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT05311865\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"37795682\",\n",
      "        \"title\": \"A randomised controlled trial to study the transmission of SARS-CoV-2 and other respiratory viruses during indoor clubbing events (ANRS0066s ITOC study).\",\n",
      "        \"authors\": \"Luong Nguyen LB; Goupil de Bouill\\u00e9 J; Menant L; Noret M; Dumas A; Salmona M; Le Goff J; Delaugerre C; Cr\\u00e9pey P; Zeggagh J; ITOC Study Group\\n\",\n",
      "        \"doi\": \"10.1093/cid/ciad603\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Luong Nguyen LB, et al. A randomised controlled trial to study the transmission of SARS-CoV-2 and other respiratory viruses during indoor clubbing events (ANRS0066s ITOC study). A randomised controlled trial to study the transmission of SARS-CoV-2 and other respiratory viruses during indoor clubbing events (ANRS0066s ITOC study). 2023; 77:1648-55. doi: 10.1093/cid/ciad603\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"36438274\",\n",
      "        \"title\": \"Transmission of SARS-CoV-2 during indoor clubbing events: A clustered randomized, controlled, multicentre trial protocol.\",\n",
      "        \"authors\": \"Goupil de Bouill\\u00e9 J; Luong Nguyen LB; Cr\\u00e9pey P; Garlantezec R; Dor\\u00e9 V; Dumas A; Ben Mechlia M; Tattevin P; Gaudart J; Spire B; Lert F; Yazdanpanah Y; Delaugerre C; Noret M; Zeggagh J\",\n",
      "        \"doi\": \"10.3389/fpubh.2022.981213\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial Protocol\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Goupil de Bouill\\u00e9 J, et al. Transmission of SARS-CoV-2 during indoor clubbing events: A clustered randomized, controlled, multicentre trial protocol. Transmission of SARS-CoV-2 during indoor clubbing events: A clustered randomized, controlled, multicentre trial protocol. 2022; 10:981213. doi: 10.3389/fpubh.2022.981213\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158457\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04315948\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"35643099\",\n",
      "        \"title\": \"Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19.\",\n",
      "        \"authors\": \"Ader F; Bouscambert-Duchamp M; Hites M; Peiffer-Smadja N; Mentr\\u00e9 F; Burdet C; DisCoVeRy Study Group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(22)00295-X\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Letter\"\n",
      "        ],\n",
      "        \"citation\": \"Ader F, et al. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19. 2022; 22:764-765. doi: 10.1016/S1473-3099(22)00295-X\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35233617\",\n",
      "        \"title\": \"Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial.\",\n",
      "        \"authors\": \"Lingas G; N\\u00e9ant N; Gaymard A; Belhadi D; Peytavin G; Hites M; Staub T; Greil R; Paiva JA; Poissy J; Peiffer-Smadja N; Costagliola D; Yazdanpanah Y; Wallet F; Gagneux-Brunon A; Mentr\\u00e9 F; Ader F; Burdet C; Guedj J; Bouscambert-Duchamp M\",\n",
      "        \"doi\": \"10.1093/jac/dkac048\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Lingas G, et al. Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial. Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial. 2022; 77:1404-1412. doi: 10.1093/jac/dkac048\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34350582\",\n",
      "        \"title\": \"Remdesivir for the treatment of COVID-19.\",\n",
      "        \"authors\": \"Ansems K; Grundeis F; Dahms K; Mikolajewska A; Thieme V; Piechotta V; Metzendorf MI; Stegemann M; Benstoem C; Fichtner F\",\n",
      "        \"doi\": \"10.1002/14651858.CD014962\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Systematic Review\"\n",
      "        ],\n",
      "        \"citation\": \"Ansems K, et al. Remdesivir for the treatment of COVID-19. Remdesivir for the treatment of COVID-19. 2021; 8:CD014962. doi: 10.1002/14651858.CD014962\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33089306\",\n",
      "        \"title\": \"Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response.\",\n",
      "        \"authors\": \"L\\u00ea MP; Peiffer-Smadja N; Guedj J; Neant N; Mentr\\u00e9 F; Ader F; Yazdanpanah Y; Peytavin G; C-20-15 DisCoVeRy French Steering Committee\",\n",
      "        \"doi\": \"10.1093/jac/dkaa415\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Comment\"\n",
      "        ],\n",
      "        \"citation\": \"L\\u00ea MP, et al. Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response. Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response. 2021; 76:277-279. doi: 10.1093/jac/dkaa415\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35623577\",\n",
      "        \"title\": \"Immunocompromised patients have been neglected in COVID-19 trials: a call for action.\",\n",
      "        \"authors\": \"Tr\\u00f8seid M; Hentzien M; Ader F; Cardoso SW; Arribas JR; Molina JM; Mueller N; Hites M; Bonnet F; Manuel O; Costagliola D; Grinsztejn B; Olsen IC; Yazdapanah Y; Calmy A; EU RESPONSE; COMBINE\",\n",
      "        \"doi\": \"10.1016/j.cmi.2022.05.005\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Tr\\u00f8seid M, et al. Immunocompromised patients have been neglected in COVID-19 trials: a call for action. Immunocompromised patients have been neglected in COVID-19 trials: a call for action. 2022; 28:1182-1183. doi: 10.1016/j.cmi.2022.05.005\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"36828006\",\n",
      "        \"title\": \"Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials.\",\n",
      "        \"authors\": \"Amstutz A; Speich B; Mentr\\u00e9 F; Rueegg CS; Belhadi D; Assoumou L; Burdet C; Murthy S; Dodd LE; Wang Y; Tikkinen KAO; Ader F; Hites M; Bouscambert M; Trabaud MA; Fralick M; Lee TC; Pinto R; Barratt-Due A; Lund-Johansen F; M\\u00fcller F; Nevalainen OPO; Cao B; Bonnett T; Griessbach A; Taji Heravi A; Sch\\u00f6nenberger C; Janiaud P; Werlen L; Aghlmandi S; Schandelmaier S; Yazdanpanah Y; Costagliola D; Olsen IC; Briel M\",\n",
      "        \"doi\": \"10.1016/S2213-2600(22)00528-8\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Systematic Review\",\n",
      "          \"Meta-Analysis\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Amstutz A, et al. Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials. Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials. 2023; 11:453-464. doi: 10.1016/S2213-2600(22)00528-8\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34763056\",\n",
      "        \"title\": \"Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group.\",\n",
      "        \"authors\": \"EU-Response investigators group; Diallo A; Tr\\u00f8seid M; Simensen VC; Boston A; Demotes J; Olsen IC; Chung F; Paiva JA; Hites M; Ader F; Arribas JR; Baratt-Due A; Melien \\u00d8; Tacconelli E; Staub T; Greil R; Tsiodras S; Briel M; Esperou H; Mentr\\u00e9 F; Eustace J; Saillard J; Delmas C; LeMestre S; Dumousseaux M; Costagliola D; R\\u00f8ttingen JA; Yazdanpanah Y\",\n",
      "        \"doi\": \"10.1016/j.cmi.2021.10.011\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"EU-Response investigators group, et al. Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group. Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group. 2022; 28:1-5. doi: 10.1016/j.cmi.2021.10.011\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"37302469\",\n",
      "        \"title\": \"Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20-15 DisCoVeRy study.\",\n",
      "        \"authors\": \"Fougerou-Leurent C; Delmas C; Saillard J; Dumousseaux M; Ferrane A; Mercier N; Terzic V; Le Mestre S; Dechanet A; Belhadi D; Metois A; Burdet C; Mentr\\u00e9 F; Noret M; Diallo A; Petrov-Sanchez V; Couffin-Cadiergues S; Hites M; Ader F; Esperou H\",\n",
      "        \"doi\": \"10.1016/j.cct.2023.107267\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Fougerou-Leurent C, et al. Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20-15 DisCoVeRy study. Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20-15 DisCoVeRy study. 2023; 131:107267. doi: 10.1016/j.cct.2023.107267\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34534511\",\n",
      "        \"title\": \"Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.\",\n",
      "        \"authors\": \"Ader F; Bouscambert-Duchamp M; Hites M; Peiffer-Smadja N; Poissy J; Belhadi D; Diallo A; L\\u00ea MP; Peytavin G; Staub T; Greil R; Guedj J; Paiva JA; Costagliola D; Yazdanpanah Y; Burdet C; Mentr\\u00e9 F; DisCoVeRy Study Group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(21)00485-0\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Ader F, et al. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. 2022; 22:209-221. doi: 10.1016/S1473-3099(21)00485-0\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32958495\",\n",
      "        \"title\": \"Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults.\",\n",
      "        \"authors\": \"Ader F; Discovery French Trial Management Team\",\n",
      "        \"doi\": \"10.1136/bmjopen-2020-041437\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Adaptive Clinical Trial\",\n",
      "          \"Clinical Trial Protocol\",\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Ader F and Discovery French Trial Management Team. Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults. Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults. 2020; 10:e041437. doi: 10.1136/bmjopen-2020-041437\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32304640\",\n",
      "        \"title\": \"Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base.\",\n",
      "        \"authors\": \"Taccone FS; Gorham J; Vincent JL\",\n",
      "        \"doi\": \"10.1016/S2213-2600(20)30172-7\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Taccone FS, et al. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base. 2020; 8:539-541. doi: 10.1016/S2213-2600(20)30172-7\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"37269068\",\n",
      "        \"title\": \"Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial.\",\n",
      "        \"authors\": \"Mercier N; Belhadi D; DeChanet A; Delmas C; Saillard J; Dumousseaux M; Le Mestre S; Fougerou-Leurent C; Ferrane A; Burdet C; Esp\\u00e9rou H; Ader F; Hites M; Peiffer-Smadja N; Poissy J; Andrejak C; Paiva JA; Tacconelli E; Staub T; Greil R; Costagliola D; Mentre F; Yazdanpanah Y; Diallo A; DisCoVeRy Safety Working group\",\n",
      "        \"doi\": \"10.1002/prp2.1072\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mercier N, et al. Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial. Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial. 2023; 11:e01072. doi: 10.1002/prp2.1072\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34048876\",\n",
      "        \"title\": \"An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-\\u03b2-1a and hydroxychloroquine in hospitalized patients with COVID-19.\",\n",
      "        \"authors\": \"Ader F; Peiffer-Smadja N; Poissy J; Bouscambert-Duchamp M; Belhadi D; Diallo A; Delmas C; Saillard J; Dechanet A; Mercier N; Dupont A; Alfaiate T; Lescure FX; Raffi F; Goehringer F; Kimmoun A; Jaureguiberry S; Reignier J; Nseir S; Danion F; Clere-Jehl R; Bouiller K; Navellou JC; Tolsma V; Cabi\\u00e9 A; Dubost C; Courjon J; Leroy S; Mootien J; Gaci R; Mourvillier B; Faure E; Pourcher V; Gallien S; Launay O; Lacombe K; Lanoix JP; Makinson A; Martin-Blondel G; Bouadma L; Botelho-Nevers E; Gagneux-Brunon A; Epaulard O; Piroth L; Wallet F; Richard JC; Reuter J; Staub T; Lina B; Noret M; Andrejak C; L\\u00ea MP; Peytavin G; Hites M; Costagliola D; Yazdanpanah Y; Burdet C; Mentr\\u00e9 F; DisCoVeRy study group\",\n",
      "        \"doi\": \"10.1016/j.cmi.2021.05.020\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Ader F, et al. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-\\u03b2-1a and hydroxychloroquine in hospitalized patients with COVID-19. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-\\u03b2-1a and hydroxychloroquine in hospitalized patients with COVID-19. 2021; 27:1826-1837. doi: 10.1016/j.cmi.2021.05.020\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34473343\",\n",
      "        \"title\": \"SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.\",\n",
      "        \"authors\": \"Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N\",\n",
      "        \"doi\": \"10.1002/14651858.CD013825.pub2\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\",\n",
      "          \"Systematic Review\"\n",
      "        ],\n",
      "        \"citation\": \"Kreuzberger N, et al. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. 2021; 9:CD013825. doi: 10.1002/14651858.CD013825.pub2\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35512728\",\n",
      "        \"title\": \"Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.\",\n",
      "        \"authors\": \"WHO Solidarity Trial Consortium\",\n",
      "        \"doi\": \"10.1016/S0140-6736(22)00519-0\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Meta-Analysis\"\n",
      "        ],\n",
      "        \"citation\": \"WHO Solidarity Trial Consortium. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses. 2022; 399:1941-1953. doi: 10.1016/S0140-6736(22)00519-0\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35533972\",\n",
      "        \"title\": \"An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-\\u03b2-1a, and hydroxychloroquine in hospitalized patients with COVID-19: final results.\",\n",
      "        \"authors\": \"Ader F; DisCoVeRy Study Group\",\n",
      "        \"doi\": \"10.1016/j.cmi.2022.04.016\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Letter\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Ader F and DisCoVeRy Study Group. An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-\\u03b2-1a, and hydroxychloroquine in hospitalized patients with COVID-19: final results. An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-\\u03b2-1a, and hydroxychloroquine in hospitalized patients with COVID-19: final results. 2022; 28:1293-1296. doi: 10.1016/j.cmi.2022.04.016\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"37728045\",\n",
      "        \"title\": \"Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients.\",\n",
      "        \"authors\": \"N\\u00e9ant N; Lingas G; Gaymard A; Belhadi D; Hites M; Staub T; Greil R; Paiva JA; Poissy J; Peiffer-Smadja N; Costagliola D; Yazdanpanah Y; Bouscambert-Duchamp M; Gagneux-Brunon A; Ader F; Mentr\\u00e9 F; Wallet F; Burdet C; Guedj J; DisCoVeRy study group\",\n",
      "        \"doi\": \"10.1002/psp4.13051\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"N\\u00e9ant N, et al. Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients. Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients. 2023; 12:2027-2037. doi: 10.1002/psp4.13051\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"36695483\",\n",
      "        \"title\": \"Remdesivir for the treatment of COVID-19.\",\n",
      "        \"authors\": \"Grundeis F; Ansems K; Dahms K; Thieme V; Metzendorf MI; Skoetz N; Benstoem C; Mikolajewska A; Griesel M; Fichtner F; Stegemann M\",\n",
      "        \"doi\": \"10.1002/14651858.CD014962.pub2\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Systematic Review\"\n",
      "        ],\n",
      "        \"citation\": \"Grundeis F, et al. Remdesivir for the treatment of COVID-19. Remdesivir for the treatment of COVID-19. 2023; 1:CD014962. doi: 10.1002/14651858.CD014962.pub2\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"36680782\",\n",
      "        \"title\": \"Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia.\",\n",
      "        \"authors\": \"Terzi\\u0107 V; Levoyer L; Figarella M; Bigagli E; Mercier N; De Gastines L; Gibowski S; Tr\\u00f8seid M; Demotes J; Olsen IC; Hites M; Ader F; Lopez JRA; Mentr\\u00e9 F; Esp\\u00e9rou H; Costagliola D; R\\u00f8ttingen JA; Poissy J; Roz\\u00e9 JC; Warris A; O'Leary J; Fernandes RM; Assoumou L; Hankard R; Turner MA; Yazdanpanah Y; Diallo A; EU-Response safety group; c4c safety group\",\n",
      "        \"doi\": \"10.1111/bcp.15669\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Terzi\\u0107 V, et al. Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia. Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia. 2023; 89:1318-1328. doi: 10.1111/bcp.15669\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33264556\",\n",
      "        \"title\": \"Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.\",\n",
      "        \"authors\": \"WHO Solidarity Trial Consortium; Pan H; Peto R; Henao-Restrepo AM; Preziosi MP; Sathiyamoorthy V; Abdool Karim Q; Alejandria MM; Hern\\u00e1ndez Garc\\u00eda C; Kieny MP; Malekzadeh R; Murthy S; Reddy KS; Roses Periago M; Abi Hanna P; Ader F; Al-Bader AM; Alhasawi A; Allum E; Alotaibi A; Alvarez-Moreno CA; Appadoo S; Asiri A; Aukrust P; Barratt-Due A; Bellani S; Branca M; Cappel-Porter HBC; Cerrato N; Chow TS; Como N; Eustace J; Garc\\u00eda PJ; Godbole S; Gotuzzo E; Griskevicius L; Hamra R; Hassan M; Hassany M; Hutton D; Irmansyah I; Jancoriene L; Kirwan J; Kumar S; Lennon P; Lopardo G; Lydon P; Magrini N; Maguire T; Manevska S; Manuel O; McGinty S; Medina MT; Mesa Rubio ML; Miranda-Montoya MC; Nel J; Nunes EP; Perola M; Portol\\u00e9s A; Rasmin MR; Raza A; Rees H; Reges PPS; Rogers CA; Salami K; Salvadori MI; Sinani N; Sterne JAC; Stevanovikj M; Tacconelli E; Tikkinen KAO; Trelle S; Zaid H; R\\u00f8ttingen JA; Swaminathan S\",\n",
      "        \"doi\": \"10.1056/NEJMoa2023184\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"WHO Solidarity Trial Consortium, et al. Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. 2021; 384:497-511. doi: 10.1056/NEJMoa2023184\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32473020\",\n",
      "        \"title\": \"Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.\",\n",
      "        \"authors\": \"L\\u00ea MP; Peiffer-Smadja N; Guedj J; N\\u00e9ant N; Mentr\\u00e9 F; Ader F; Yazdanpanah Y; Peytavin G\",\n",
      "        \"doi\": \"10.1093/jac/dkaa191\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"L\\u00ea MP, et al. Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial. Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial. 2020; 75:2376-2380. doi: 10.1093/jac/dkaa191\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01620957\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01693848\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02107365\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00196625\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"15456093\",\n",
      "        \"title\": \"Salvage therapy with amprenavir, lopinavir and ritonavir 200 mg/d or 400 mg/d in HIV-infected patients in virological failure.\",\n",
      "        \"authors\": \"Raguin G; Ch\\u00eane G; Morand-Joubert L; Taburet AM; Droz C; Le Tiec C; Clavel F; Girard PM; Puzzle 1 Study Group\",\n",
      "        \"doi\": null,\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Raguin G, et al. Salvage therapy with amprenavir, lopinavir and ritonavir 200 mg/d or 400 mg/d in HIV-infected patients in virological failure. Salvage therapy with amprenavir, lopinavir and ritonavir 200 mg/d or 400 mg/d in HIV-infected patients in virological failure. 2004; 9:615-25.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15060509\",\n",
      "        \"title\": \"Interactions between amprenavir and the lopinavir-ritonavir combination in heavily pretreated patients infected with human immunodeficiency virus.\",\n",
      "        \"authors\": \"Taburet AM; Raguin G; Le Tiec C; Droz C; Barrail A; Vincent I; Morand-Joubert L; Ch\\u00eane G; Clavel F; Girard PM\",\n",
      "        \"doi\": \"10.1016/j.clpt.2003.12.013\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Taburet AM, et al. Interactions between amprenavir and the lopinavir-ritonavir combination in heavily pretreated patients infected with human immunodeficiency virus. Interactions between amprenavir and the lopinavir-ritonavir combination in heavily pretreated patients infected with human immunodeficiency virus. 2004; 75:310-23. doi: 10.1016/j.clpt.2003.12.013\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01359774\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"21320997\",\n",
      "        \"title\": \"Validation of plasma branched chain amino acids as biomarkers in Huntington disease.\",\n",
      "        \"authors\": \"Mochel F; Benaich S; Rabier D; Durr A\",\n",
      "        \"doi\": \"10.1001/archneurol.2010.358\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Letter\",\n",
      "          \"Validation Study\"\n",
      "        ],\n",
      "        \"citation\": \"Mochel F, et al. Validation of plasma branched chain amino acids as biomarkers in Huntington disease. Validation of plasma branched chain amino acids as biomarkers in Huntington disease. 2011; 68:265-7. doi: 10.1001/archneurol.2010.358\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17653274\",\n",
      "        \"title\": \"Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression.\",\n",
      "        \"authors\": \"Mochel F; Charles P; Seguin F; Barritault J; Coussieu C; Perin L; Le Bouc Y; Gervais C; Carcelain G; Vassault A; Feingold J; Rabier D; Durr A\",\n",
      "        \"doi\": \"10.1371/journal.pone.0000647\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mochel F, et al. Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. 2007; 2:e647. doi: 10.1371/journal.pone.0000647\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21285522\",\n",
      "        \"title\": \"Energy deficit in Huntington disease: why it matters.\",\n",
      "        \"authors\": \"Mochel F; Haller RG\",\n",
      "        \"doi\": \"10.1172/JCI45691\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Mochel F and Haller RG. Energy deficit in Huntington disease: why it matters. Energy deficit in Huntington disease: why it matters. 2011; 121:493-9. doi: 10.1172/JCI45691\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02273765\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"33667406\",\n",
      "        \"title\": \"Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12\\u2008300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial.\",\n",
      "        \"authors\": \"De Castro N; Marcy O; Chazallon C; Messou E; Eholi\\u00e9 S; N'takpe JB; Bhatt N; Khosa C; Timana Massango I; Laureillard D; Chau GD; Domergue A; Veloso V; Escada R; Wagner Cardoso S; Delaugerre C; Anglaret X; Molina JM; Grinsztejn B; ANRS 12300 Reflate TB2 study group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(20)30869-0\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"De Castro N, et al. Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12\\u2008300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial. Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12\\u2008300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial. 2021; 21:813-822. doi: 10.1016/S1473-3099(20)30869-0\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00490074\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02081066\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00651066\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"24465443\",\n",
      "        \"title\": \"Randomised pharmacokinetic trial of rifabutin with lopinavir/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in Vietnam.\",\n",
      "        \"authors\": \"Lan NT; Thu NT; Barrail-Tran A; Duc NH; Lan NN; Laureillard D; Lien TT; Borand L; Quillet C; Connolly C; Lagarde D; Pym A; Lienhardt C; Dung NH; Taburet AM; Harries AD\",\n",
      "        \"doi\": \"10.1371/journal.pone.0084866\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Lan NT, et al. Randomised pharmacokinetic trial of rifabutin with lopinavir/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in Vietnam. Randomised pharmacokinetic trial of rifabutin with lopinavir/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in Vietnam. 2014; 9:e84866. doi: 10.1371/journal.pone.0084866\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02566148\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29437866\",\n",
      "        \"title\": \"How to use sequence analysis for life course epidemiology? An example on HIV-positive Sub-Saharan migrants in France.\",\n",
      "        \"authors\": \"Gosselin A; Desgr\\u00e9es du Lo\\u00fb A; Leli\\u00e8vre E; PARCOURS Study Group\",\n",
      "        \"doi\": \"10.1136/jech-2017-209739\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Gosselin A, et al. How to use sequence analysis for life course epidemiology? An example on HIV-positive Sub-Saharan migrants in France. How to use sequence analysis for life course epidemiology? An example on HIV-positive Sub-Saharan migrants in France. 2018; 72:507-512. doi: 10.1136/jech-2017-209739\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29982518\",\n",
      "        \"title\": \"Refusal to provide healthcare to sub-Saharan migrants in France: a comparison according to their HIV and HBV status.\",\n",
      "        \"authors\": \"Vignier N; Dray Spira R; Pannetier J; Ravalihasy A; Gosselin A; Lert F; Lydie N; Bouchaud O; Desgrees Du Lou A; Chauvin P; PARCOURS Study Group\",\n",
      "        \"doi\": \"10.1093/eurpub/cky118\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Vignier N, et al. Refusal to provide healthcare to sub-Saharan migrants in France: a comparison according to their HIV and HBV status. Refusal to provide healthcare to sub-Saharan migrants in France: a comparison according to their HIV and HBV status. 2018; 28:904-910. doi: 10.1093/eurpub/cky118\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29307383\",\n",
      "        \"title\": \"Prevalence and circumstances of forced sex and post-migration HIV acquisition in sub-Saharan African migrant women in France: an analysis of the ANRS-PARCOURS retrospective population-based study.\",\n",
      "        \"authors\": \"Pannetier J; Ravalihasy A; Lydi\\u00e9 N; Lert F; Desgr\\u00e9es du Lo\\u00fb A; Parcours study group\",\n",
      "        \"doi\": \"10.1016/S2468-2667(17)30211-6\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Pannetier J, et al. Prevalence and circumstances of forced sex and post-migration HIV acquisition in sub-Saharan African migrant women in France: an analysis of the ANRS-PARCOURS retrospective population-based study. Prevalence and circumstances of forced sex and post-migration HIV acquisition in sub-Saharan African migrant women in France: an analysis of the ANRS-PARCOURS retrospective population-based study. 2018; 3:e16-e23. doi: 10.1016/S2468-2667(17)30211-6\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02073630\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02573948\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"27006257\",\n",
      "        \"title\": \"Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam.\",\n",
      "        \"authors\": \"Des Jarlais DC; Thi Huong D; Thi Hai Oanh K; Khu\\u00ea Pham M; Thi Giang H; Thi Tuyet Thanh N; Arasteh K; Feelemyer J; Hammett T; Peries M; Michel L; Vu Hai V; Roustide MJ; Moles JP; Laureillard D; Nagot N; DRIVE Study Team\",\n",
      "        \"doi\": \"10.1016/j.drugpo.2016.02.021\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Research Support, N.I.H., Extramural\"\n",
      "        ],\n",
      "        \"citation\": \"Des Jarlais DC, et al. Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam. Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam. 2016; 32:50-6. doi: 10.1016/j.drugpo.2016.02.021\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25540950\",\n",
      "        \"title\": \"AIDS, people who use drugs, and altruism: reflection on a personal image.\",\n",
      "        \"authors\": \"Des Jarlais DC\",\n",
      "        \"doi\": \"10.3109/10826084.2015.978185\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Des Jarlais DC. AIDS, people who use drugs, and altruism: reflection on a personal image. AIDS, people who use drugs, and altruism: reflection on a personal image. 2015; 50:532-3. doi: 10.3109/10826084.2015.978185\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28800503\",\n",
      "        \"title\": \"Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions.\",\n",
      "        \"authors\": \"Michel L; Des Jarlais DC; Duong Thi H; Khuat Thi Hai O; Pham Minh K; Peries M; Vallo R; Nham Thi Tuyet T; Hoang Thi G; Le Sao M; Feelemyer J; Vu Hai V; Moles JP; Laureillard D; Nagot N; DRIVE Study Team\",\n",
      "        \"doi\": \"10.1016/j.drugalcdep.2017.07.004\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Michel L, et al. Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions. Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions. 2017; 179:198-204. doi: 10.1016/j.drugalcdep.2017.07.004\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26050614\",\n",
      "        \"title\": \"An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.\",\n",
      "        \"authors\": \"Perlman DC; Jordan AE; Uuskula A; Huong DT; Masson CL; Schackman BR; Des Jarlais DC\",\n",
      "        \"doi\": \"10.1016/j.drugpo.2015.04.015\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\"\n",
      "        ],\n",
      "        \"citation\": \"Perlman DC, et al. An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential. An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential. 2015; 26:1056-63. doi: 10.1016/j.drugpo.2015.04.015\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26075647\",\n",
      "        \"title\": \"Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?\",\n",
      "        \"authors\": \"Perlman DC; Des Jarlais DC; Feelemyer J\",\n",
      "        \"doi\": \"10.1080/10550887.2015.1059111\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\"\n",
      "        ],\n",
      "        \"citation\": \"Perlman DC, et al. Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?. Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?. 2015; 34:198-205. doi: 10.1080/10550887.2015.1059111\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28612212\",\n",
      "        \"title\": \"Risk Behaviors for HIV and HCV Infection Among People Who Inject Drugs in Hai Phong, Viet Nam, 2014.\",\n",
      "        \"authors\": \"Duong HT; Jarlais DD; Khuat OHT; Arasteh K; Feelemyer J; Khue PM; Giang HT; Laureillard D; Hai VV; Vallo R; Michel L; Moles JP; Nagot N; Drive Study Group\",\n",
      "        \"doi\": \"10.1007/s10461-017-1814-6\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Duong HT, et al. Risk Behaviors for HIV and HCV Infection Among People Who Inject Drugs in Hai Phong, Viet Nam, 2014. Risk Behaviors for HIV and HCV Infection Among People Who Inject Drugs in Hai Phong, Viet Nam, 2014. 2018; 22:2161-2171. doi: 10.1007/s10461-017-1814-6\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26032121\",\n",
      "        \"title\": \"Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme.\",\n",
      "        \"authors\": \"Hatzakis A; Sypsa V; Paraskevis D; Nikolopoulos G; Tsiara C; Micha K; Panopoulos A; Malliori M; Psichogiou M; Pharris A; Wiessing L; van de Laar M; Donoghoe M; Heckathorn DD; Friedman SR; Des Jarlais DC\",\n",
      "        \"doi\": \"10.1111/add.12999\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hatzakis A, et al. Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme. Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme. 2015; 110:1453-67. doi: 10.1111/add.12999\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27178119\",\n",
      "        \"title\": \"Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.\",\n",
      "        \"authors\": \"Des Jarlais D; Duong HT; Pham Minh K; Khuat OH; Nham TT; Arasteh K; Feelemyer J; Heckathorn DD; Peries M; Moles JP; Laureillard D; Nagot N; (The Drive Study Team)\",\n",
      "        \"doi\": \"10.1080/09540121.2016.1178698\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Des Jarlais D, et al. Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. 2016; 28:1312-5. doi: 10.1080/09540121.2016.1178698\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26080690\",\n",
      "        \"title\": \"HIV, Hepatitis C, and Abstinence from Alcohol Among Injection and Non-injection Drug Users.\",\n",
      "        \"authors\": \"Elliott JC; Hasin DS; Stohl M; Des Jarlais DC\",\n",
      "        \"doi\": \"10.1007/s10461-015-1113-z\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Elliott JC, et al. HIV, Hepatitis C, and Abstinence from Alcohol Among Injection and Non-injection Drug Users. HIV, Hepatitis C, and Abstinence from Alcohol Among Injection and Non-injection Drug Users. 2016; 20:548-54. doi: 10.1007/s10461-015-1113-z\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00339157\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"21173013\",\n",
      "        \"title\": \"A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial).\",\n",
      "        \"authors\": \"Quartier P; Allantaz F; Cimaz R; Pillet P; Messiaen C; Bardin C; Bossuyt X; Boutten A; Bienvenu J; Duquesne A; Richer O; Chaussabel D; Mogenet A; Banchereau J; Treluyer JM; Landais P; Pascual V\",\n",
      "        \"doi\": \"10.1136/ard.2010.134254\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Quartier P, et al. A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). 2011; 70:747-54. doi: 10.1136/ard.2010.134254\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02453048\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"24950361\",\n",
      "        \"title\": \"Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice.\",\n",
      "        \"authors\": \"Feunou PF; Kammoun H; Debrie AS; Locht C\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2014.06.019\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Feunou PF, et al. Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice. Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice. 2014; 32:4281-8. doi: 10.1016/j.vaccine.2014.06.019\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19625486\",\n",
      "        \"title\": \"A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice.\",\n",
      "        \"authors\": \"Skerry CM; Cassidy JP; English K; Feunou-Feunou P; Locht C; Mahon BP\",\n",
      "        \"doi\": \"10.1128/CVI.00082-09\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Skerry CM, et al. A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. 2009; 16:1344-51. doi: 10.1128/CVI.00082-09\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31945015\",\n",
      "        \"title\": \"Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans.\",\n",
      "        \"authors\": \"Lin A; Apostolovic D; Jahnmatz M; Liang F; Ols S; Tecleab T; Wu C; van Hage M; Solovay K; Rubin K; Locht C; Thorstensson R; Thalen M; Lor\\u00e9 K\",\n",
      "        \"doi\": \"10.1172/JCI135020\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Lin A, et al. Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans. Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans. 2020; 130:2332-2346. doi: 10.1172/JCI135020\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22814407\",\n",
      "        \"title\": \"Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice.\",\n",
      "        \"authors\": \"Kammoun H; Feunou PF; Foligne B; Debrie AS; Raze D; Mielcarek N; Locht C\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2012.07.005\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kammoun H, et al. Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice. Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice. 2012; 30:5864-70. doi: 10.1016/j.vaccine.2012.07.005\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24793938\",\n",
      "        \"title\": \"B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial.\",\n",
      "        \"authors\": \"Jahnmatz M; Amu S; Ljungman M; Wehlin L; Chiodi F; Mielcarek N; Locht C; Thorstensson R\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2014.04.048\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Jahnmatz M, et al. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial. 2014; 32:3350-6. doi: 10.1016/j.vaccine.2014.04.048\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24421886\",\n",
      "        \"title\": \"A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers.\",\n",
      "        \"authors\": \"Thorstensson R; Trollfors B; Al-Tawil N; Jahnmatz M; Bergstr\\u00f6m J; Ljungman M; T\\u00f6rner A; Wehlin L; Van Broekhoven A; Bosman F; Debrie AS; Mielcarek N; Locht C\",\n",
      "        \"doi\": \"10.1371/journal.pone.0083449\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Thorstensson R, et al. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. 2014; 9:e83449. doi: 10.1371/journal.pone.0083449\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18762220\",\n",
      "        \"title\": \"Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1.\",\n",
      "        \"authors\": \"Feunou PF; Ismaili J; Debrie AS; Huot L; Hot D; Raze D; Lemoine Y; Locht C\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2008.08.018\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Feunou PF, et al. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1. 2008; 26:5722-7. doi: 10.1016/j.vaccine.2008.08.018\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32687804\",\n",
      "        \"title\": \"Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study.\",\n",
      "        \"authors\": \"Jahnmatz M; Richert L; Al-Tawil N; Storsaeter J; Colin C; Bauduin C; Thalen M; Solovay K; Rubin K; Mielcarek N; Thorstensson R; Locht C; BPZE1 study team\",\n",
      "        \"doi\": \"10.1016/S1473-3099(20)30274-7\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Jahnmatz M, et al. Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study. Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study. 2020; 20:1290-1301. doi: 10.1016/S1473-3099(20)30274-7\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20419113\",\n",
      "        \"title\": \"T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis.\",\n",
      "        \"authors\": \"Feunou PF; Bertout J; Locht C\",\n",
      "        \"doi\": \"10.1371/journal.pone.0010178\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Feunou PF, et al. T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis. T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis. 2010; 5:e10178. doi: 10.1371/journal.pone.0010178\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20708998\",\n",
      "        \"title\": \"Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.\",\n",
      "        \"authors\": \"Feunou PF; Kammoun H; Debrie AS; Mielcarek N; Locht C\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2010.08.017\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Feunou PF, et al. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1. 2010; 28:7047-53. doi: 10.1016/j.vaccine.2010.08.017\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21147936\",\n",
      "        \"title\": \"A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model.\",\n",
      "        \"authors\": \"Skerry CM; Mahon BP\",\n",
      "        \"doi\": \"10.1128/CVI.00371-10\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Skerry CM and Mahon BP. A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model. A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model. 2011; 18:187-93. doi: 10.1128/CVI.00371-10\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21430219\",\n",
      "        \"title\": \"Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response.\",\n",
      "        \"authors\": \"Fedele G; Bianco M; Debrie AS; Locht C; Ausiello CM\",\n",
      "        \"doi\": \"10.4049/jimmunol.1003765\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Fedele G, et al. Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response. Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response. 2011; 186:5388-96. doi: 10.4049/jimmunol.1003765\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20107007\",\n",
      "        \"title\": \"Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice.\",\n",
      "        \"authors\": \"Mielcarek N; Debrie AS; Mahieux S; Locht C\",\n",
      "        \"doi\": \"10.1128/CVI.00322-09\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mielcarek N, et al. Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice. Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice. 2010; 17:317-24. doi: 10.1128/CVI.00322-09\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03446430\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00120757\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22353022\",\n",
      "        \"title\": \"Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120).\",\n",
      "        \"authors\": \"Rozenberg S; Lanoy E; Bentata M; Viard JP; Valantin MA; Missy P; Darasteanu I; Roux C; Kolta S; Costagliola D; ANRS 120 Fosivir Study Group\",\n",
      "        \"doi\": \"10.1089/AID.2011.0224\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Rozenberg S, et al. Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120). Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120). 2012; 28:972-80. doi: 10.1089/AID.2011.0224\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02987530\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02100774\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26063065\",\n",
      "        \"title\": \"A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Dietary \\u03b2-Carotene Bioavailability in Healthy Men.\",\n",
      "        \"authors\": \"Borel P; Desmarchelier C; Nowicki M; Bott R\",\n",
      "        \"doi\": \"10.3945/jn.115.212837\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Borel P, et al. A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Dietary \\u03b2-Carotene Bioavailability in Healthy Men. A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Dietary \\u03b2-Carotene Bioavailability in Healthy Men. 2015; 145:1740-7. doi: 10.3945/jn.115.212837\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27798339\",\n",
      "        \"title\": \"A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Cholecalciferol Bioavailability in Healthy Men.\",\n",
      "        \"authors\": \"Desmarchelier C; Borel P; Goncalves A; Kopec R; Nowicki M; Morange S; Lesavre N; Portugal H; Reboul E\",\n",
      "        \"doi\": \"10.3945/jn.116.237115\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Desmarchelier C, et al. A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Cholecalciferol Bioavailability in Healthy Men. A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Cholecalciferol Bioavailability in Healthy Men. 2016; 146:2421-2428. doi: 10.3945/jn.116.237115\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24808487\",\n",
      "        \"title\": \"Interindividual variability of lutein bioavailability in healthy men: characterization, genetic variants involved, and relation with fasting plasma lutein concentration.\",\n",
      "        \"authors\": \"Borel P; Desmarchelier C; Nowicki M; Bott R; Morange S; Lesavre N\",\n",
      "        \"doi\": \"10.3945/ajcn.114.085720\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Borel P, et al. Interindividual variability of lutein bioavailability in healthy men: characterization, genetic variants involved, and relation with fasting plasma lutein concentration. Interindividual variability of lutein bioavailability in healthy men: characterization, genetic variants involved, and relation with fasting plasma lutein concentration. 2014; 100:168-75. doi: 10.3945/ajcn.114.085720\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21957063\",\n",
      "        \"title\": \"Genetic variations involved in interindividual variability in carotenoid status.\",\n",
      "        \"authors\": \"Borel P\",\n",
      "        \"doi\": \"10.1002/mnfr.201100322\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Borel P. Genetic variations involved in interindividual variability in carotenoid status. Genetic variations involved in interindividual variability in carotenoid status. 2012; 56:228-40. doi: 10.1002/mnfr.201100322\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00460382\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00820820\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01066962\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"33794182\",\n",
      "        \"title\": \"Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial.\",\n",
      "        \"authors\": \"Esteban-Cantos A; Rodr\\u00edguez-Centeno J; Barruz P; Alejos B; Saiz-Medrano G; Nevado J; Martin A; Gay\\u00e1 F; De Miguel R; Bernardino JI; Montejano R; Mena-Garay B; Cadi\\u00f1anos J; Florence E; Mulcahy F; Banhegyi D; Antinori A; Pozniak A; Wallet C; Raffi F; Rod\\u00e9s B; Arribas JR; NEAT001/ANRS143 Study Group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(21)00006-0\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Esteban-Cantos A, et al. Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial. Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial. 2021; 8:e197-e205. doi: 10.1016/S2352-3018(21)00006-0\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30365452\",\n",
      "        \"title\": \"Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial.\",\n",
      "        \"authors\": \"Ammassari A; St\\u00f6hr W; Antinori A; Molina JM; Schwimmer C; Domingo P; Thalme A; Di Pietro M; Wallet C; Pozniak A; Richert L; Raffi F; NEAT001/ANRS143 Trial Study Group\",\n",
      "        \"doi\": \"10.1097/QAI.0000000000001834\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Ammassari A, et al. Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial. Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial. 2018; 79:481-490. doi: 10.1097/QAI.0000000000001834\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26520926\",\n",
      "        \"title\": \"Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial.\",\n",
      "        \"authors\": \"Bernardino JI; Mocroft A; Mallon PW; Wallet C; Gerstoft J; Russell C; Reiss P; Katlama C; De Wit S; Richert L; Babiker A; Bu\\u00f1o A; Castagna A; Girard PM; Chene G; Raffi F; Arribas JR; NEAT001/ANRS143 Study Group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(15)00181-2\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bernardino JI, et al. Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial. Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial. 2015; 2:e464-73. doi: 10.1016/S2352-3018(15)00181-2\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25103176\",\n",
      "        \"title\": \"Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.\",\n",
      "        \"authors\": \"Raffi F; Babiker AG; Richert L; Molina JM; George EC; Antinori A; Arribas JR; Grarup J; Hudson F; Schwimmer C; Saillard J; Wallet C; Jansson PO; Allavena C; Van Leeuwen R; Delfraissy JF; Vella S; Ch\\u00eane G; Pozniak A; NEAT001/ANRS143 Study Group\",\n",
      "        \"doi\": \"10.1016/S0140-6736(14)61170-3\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Raffi F, et al. Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial. Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial. 2014; 384:1942-51. doi: 10.1016/S0140-6736(14)61170-3\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03671291\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00117494\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22318219\",\n",
      "        \"title\": \"Determinants of low-density lipoprotein particle diameter during antiretroviral therapy including protease inhibitors in HIV-1-infected patients.\",\n",
      "        \"authors\": \"Bittar R; Giral P; Aslangul E; Assoumou L; Valantin MA; Kalmykova O; Fesel-Fouquier V; Costagliola D; Bonnefont-Rousselot D; ANRS 126 study group\",\n",
      "        \"doi\": \"10.3851/IMP2065\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bittar R, et al. Determinants of low-density lipoprotein particle diameter during antiretroviral therapy including protease inhibitors in HIV-1-infected patients. Determinants of low-density lipoprotein particle diameter during antiretroviral therapy including protease inhibitors in HIV-1-infected patients. 2012; 17:855-60. doi: 10.3851/IMP2065\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22739396\",\n",
      "        \"title\": \"Effects of rosuvastatin versus pravastatin on low-density lipoprotein diameter in HIV-1-infected patients receiving ritonavir-boosted protease inhibitor.\",\n",
      "        \"authors\": \"Bittar R; Giral P; Aslangul E; Assoumou L; Valantin MA; Kalmykova O; Federspiel MC; Cherfils C; Costagliola D; Bonnefont-Rousselot D; French National Agency for AIDS and Viral Hepatitis Research (ANRS) 126 study group\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e328357063c\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bittar R, et al. Effects of rosuvastatin versus pravastatin on low-density lipoprotein diameter in HIV-1-infected patients receiving ritonavir-boosted protease inhibitor. Effects of rosuvastatin versus pravastatin on low-density lipoprotein diameter in HIV-1-infected patients receiving ritonavir-boosted protease inhibitor. 2012; 26:1801-5. doi: 10.1097/QAD.0b013e328357063c\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01771562\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"30081838\",\n",
      "        \"title\": \"Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study.\",\n",
      "        \"authors\": \"Cames C; Pascal L; Ba A; Mbodj H; Ouattara B; Diallo NF; Msellati P; Mbaye N; Sy Signate H; Blanche S; Diack A; MAGGSEN Cohort Study Group\",\n",
      "        \"doi\": \"10.1186/s12879-018-3282-7\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Cames C, et al. Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study. Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study. 2018; 18:374. doi: 10.1186/s12879-018-3282-7\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27881690\",\n",
      "        \"title\": \"Acceptability of Outpatient Ready-To-Use Food-Based Protocols in HIV-Infected Senegalese Children and Adolescents Within the MAGGSEN Cohort Study.\",\n",
      "        \"authors\": \"Cames C; Varloteaux M; Have NN; Diom AB; Msellati P; Mbaye N; Mbodj H; Sy Signate H; Diack A; ANRS 12279 MAGGSEN Cohort Study Group\",\n",
      "        \"doi\": \"10.1177/0379572116679053\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Cames C, et al. Acceptability of Outpatient Ready-To-Use Food-Based Protocols in HIV-Infected Senegalese Children and Adolescents Within the MAGGSEN Cohort Study. Acceptability of Outpatient Ready-To-Use Food-Based Protocols in HIV-Infected Senegalese Children and Adolescents Within the MAGGSEN Cohort Study. 2017; 38:27-36. doi: 10.1177/0379572116679053\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02542891\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"34874888\",\n",
      "        \"title\": \"Examining the Theoretical Framework of Behavioral Activation for Major Depressive Disorder: Smartphone-Based Ecological Momentary Assessment Study.\",\n",
      "        \"authors\": \"van Genugten CR; Schuurmans J; Hoogendoorn AW; Araya R; Andersson G; Ba\\u00f1os R; Botella C; Cerga Pashoja A; Cieslak R; Ebert DD; Garc\\u00eda-Palacios A; Hazo JB; Herrero R; Holtzmann J; Kemmeren L; Kleiboer A; Krieger T; Smoktunowicz E; Titzler I; Topooco N; Urech A; Smit JH; Riper H\",\n",
      "        \"doi\": \"10.2196/32007\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"van Genugten CR, et al. Examining the Theoretical Framework of Behavioral Activation for Major Depressive Disorder: Smartphone-Based Ecological Momentary Assessment Study. Examining the Theoretical Framework of Behavioral Activation for Major Depressive Disorder: Smartphone-Based Ecological Momentary Assessment Study. 2021; 8:e32007. doi: 10.2196/32007\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27488181\",\n",
      "        \"title\": \"European COMPARative Effectiveness research on blended Depression treatment versus treatment-as-usual (E-COMPARED): study protocol for a randomized controlled, non-inferiority trial in eight European countries.\",\n",
      "        \"authors\": \"Kleiboer A; Smit J; Bosmans J; Ruwaard J; Andersson G; Topooco N; Berger T; Krieger T; Botella C; Ba\\u00f1os R; Chevreul K; Araya R; Cerga-Pashoja A; Cie\\u015blak R; Rogala A; Vis C; Draisma S; van Schaik A; Kemmeren L; Ebert D; Berking M; Funk B; Cuijpers P; Riper H\",\n",
      "        \"doi\": \"10.1186/s13063-016-1511-1\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Equivalence Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Pragmatic Clinical Trial\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Kleiboer A, et al. European COMPARative Effectiveness research on blended Depression treatment versus treatment-as-usual (E-COMPARED): study protocol for a randomized controlled, non-inferiority trial in eight European countries. European COMPARative Effectiveness research on blended Depression treatment versus treatment-as-usual (E-COMPARED): study protocol for a randomized controlled, non-inferiority trial in eight European countries. 2016; 17:387. doi: 10.1186/s13063-016-1511-1\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01508494\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT05349162\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"36735263\",\n",
      "        \"title\": \"Epicardial vs. transvenous implantable cardioverter defibrillators in children.\",\n",
      "        \"authors\": \"Le Bos PA; Pontailler M; Maltret A; Kraiche D; Gaudin R; Barbanti C; Marijon E; Raisky O; Bonnet D; Waldmann V\",\n",
      "        \"doi\": \"10.1093/europace/euad015\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Le Bos PA, et al. Epicardial vs. transvenous implantable cardioverter defibrillators in children. Epicardial vs. transvenous implantable cardioverter defibrillators in children. 2023; 25:961-968. doi: 10.1093/europace/euad015\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01882062\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"25568297\",\n",
      "        \"title\": \"Triheptanoin improves brain energy metabolism in patients with Huntington disease.\",\n",
      "        \"authors\": \"Adanyeguh IM; Rinaldi D; Henry PG; Caillet S; Valabregue R; Durr A; Mochel F\",\n",
      "        \"doi\": \"10.1212/WNL.0000000000001214\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Adanyeguh IM, et al. Triheptanoin improves brain energy metabolism in patients with Huntington disease. Triheptanoin improves brain energy metabolism in patients with Huntington disease. 2015; 84:490-5. doi: 10.1212/WNL.0000000000001214\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01489592\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"16946298\",\n",
      "        \"title\": \"STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation.\",\n",
      "        \"authors\": \"Verga Falzacappa MV; Vujic Spasic M; Kessler R; Stolte J; Hentze MW; Muckenthaler MU\",\n",
      "        \"doi\": \"10.1182/blood-2006-07-033969\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Verga Falzacappa MV, et al. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. 2007; 109:353-8. doi: 10.1182/blood-2006-07-033969\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15974953\",\n",
      "        \"title\": \"Hepcidin in iron metabolism.\",\n",
      "        \"authors\": \"Lor\\u00e9al O; Haziza-Pigeon C; Troadec MB; Detivaud L; Turlin B; Courselaud B; Ilyin G; Brissot P\",\n",
      "        \"doi\": \"10.2174/1389203054065392\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Lor\\u00e9al O, et al. Hepcidin in iron metabolism. Hepcidin in iron metabolism. 2005; 6:279-91. doi: 10.2174/1389203054065392\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15501961\",\n",
      "        \"title\": \"Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance.\",\n",
      "        \"authors\": \"Sharma RA; Euden SA; Platton SL; Cooke DN; Shafayat A; Hewitt HR; Marczylo TH; Morgan B; Hemingway D; Plummer SM; Pirmohamed M; Gescher AJ; Steward WP\",\n",
      "        \"doi\": \"10.1158/1078-0432.CCR-04-0744\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sharma RA, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. 2004; 10:6847-54. doi: 10.1158/1078-0432.CCR-04-0744\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18559556\",\n",
      "        \"title\": \"Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects.\",\n",
      "        \"authors\": \"Vareed SK; Kakarala M; Ruffin MT; Crowell JA; Normolle DP; Djuric Z; Brenner DE\",\n",
      "        \"doi\": \"10.1158/1055-9965.EPI-07-2693\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Vareed SK, et al. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. 2008; 17:1411-7. doi: 10.1158/1055-9965.EPI-07-2693\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20169331\",\n",
      "        \"title\": \"Natural and synthetic STAT3 inhibitors reduce hepcidin expression in differentiated mouse hepatocytes expressing the active phosphorylated STAT3 form.\",\n",
      "        \"authors\": \"Fatih N; Camberlein E; Island ML; Corlu A; Abgueguen E; D\\u00e9tivaud L; Leroyer P; Brissot P; Lor\\u00e9al O\",\n",
      "        \"doi\": \"10.1007/s00109-009-0588-3\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Fatih N, et al. Natural and synthetic STAT3 inhibitors reduce hepcidin expression in differentiated mouse hepatocytes expressing the active phosphorylated STAT3 form. Natural and synthetic STAT3 inhibitors reduce hepcidin expression in differentiated mouse hepatocytes expressing the active phosphorylated STAT3 form. 2010; 88:477-86. doi: 10.1007/s00109-009-0588-3\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01453192\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"30688008\",\n",
      "        \"title\": \"Low incidence of acute rejection within 6 months of kidney transplantation in HIV-infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les H\\u00e9patites Virales (ANRS) 153 TREVE trial.\",\n",
      "        \"authors\": \"Matignon M; Leli\\u00e8vre JD; Lahiani A; Abbassi K; Desvaux D; Diallo A; Peraldi MN; Taburet AM; Saillard J; Delaugerre C; Costagliola D; Assoumou L; Grimbert P; ANRS 153 TREVE study group\",\n",
      "        \"doi\": \"10.1111/hiv.12700\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Matignon M, et al. Low incidence of acute rejection within 6 months of kidney transplantation in HIV-infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les H\\u00e9patites Virales (ANRS) 153 TREVE trial. Low incidence of acute rejection within 6 months of kidney transplantation in HIV-infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les H\\u00e9patites Virales (ANRS) 153 TREVE trial. 2019; 20:202-213. doi: 10.1111/hiv.12700\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01033760\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"25701561\",\n",
      "        \"title\": \"Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.\",\n",
      "        \"authors\": \"Ch\\u00e9ret A; Nembot G; M\\u00e9lard A; Lascoux C; Slama L; Miailhes P; Yeni P; Abel S; Avettand-Fenoel V; Venet A; Chaix ML; Molina JM; Katlama C; Goujard C; Tamalet C; Raffi F; Lafeuillade A; Reynes J; Ravaux I; Ho\\u00ebn B; Delfraissy JF; Meyer L; Rouzioux C; OPTIPRIM ANRS Study Group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(15)70021-6\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Ch\\u00e9ret A, et al. Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial. Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial. 2015; 15:387-96. doi: 10.1016/S1473-3099(15)70021-6\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28708873\",\n",
      "        \"title\": \"Impact of early cART on HIV blood and semen compartments at the time of primary infection.\",\n",
      "        \"authors\": \"Ch\\u00e9ret A; Durier C; M\\u00e9lard A; Ploquin M; Heitzmann J; L\\u00e9curoux C; Avettand-Feno\\u00ebl V; David L; Pialoux G; Chennebault JM; M\\u00fcller-Trutwin M; Goujard C; Rouzioux C; Meyer L; ANRS OPTIPRIM study group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0180191\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Ch\\u00e9ret A, et al. Impact of early cART on HIV blood and semen compartments at the time of primary infection. Impact of early cART on HIV blood and semen compartments at the time of primary infection. 2017; 12:e0180191. doi: 10.1371/journal.pone.0180191\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00545194\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"11236117\",\n",
      "        \"title\": \"In vivo controlled release of PGE2 from a vaginal insert (0.8 mm, 10 mg) during induction of labour.\",\n",
      "        \"authors\": \"Lyren\\u00e4s S; Clason I; Ulmsten U\",\n",
      "        \"doi\": \"10.1111/j.1471-0528.2001.00039.x\",\n",
      "        \"year\": \"2001\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Lyren\\u00e4s S, et al. In vivo controlled release of PGE2 from a vaginal insert (0.8 mm, 10 mg) during induction of labour. In vivo controlled release of PGE2 from a vaginal insert (0.8 mm, 10 mg) during induction of labour. 2001; 108:169-78. doi: 10.1111/j.1471-0528.2001.00039.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16553177\",\n",
      "        \"title\": \"Randomized study on removable PGE2 vaginal insert versus PGE2 cervical gel for cervical priming and labor induction in low-Bishop-score pregnancy.\",\n",
      "        \"authors\": \"Strobelt N; Meregalli V; Ratti M; Mariani S; Zani G; Morana S\",\n",
      "        \"doi\": \"10.1080/00016340500523685\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Strobelt N, et al. Randomized study on removable PGE2 vaginal insert versus PGE2 cervical gel for cervical priming and labor induction in low-Bishop-score pregnancy. Randomized study on removable PGE2 vaginal insert versus PGE2 cervical gel for cervical priming and labor induction in low-Bishop-score pregnancy. 2006; 85:302-5. doi: 10.1080/00016340500523685\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17071427\",\n",
      "        \"title\": \"Induction of labour at term with vaginal prostaglandins preparations: a randomised controlled trial of Prostin vs Propess.\",\n",
      "        \"authors\": \"El-Shawarby SA; Connell RJ\",\n",
      "        \"doi\": \"10.1080/01443610600903362\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"El-Shawarby SA and Connell RJ. Induction of labour at term with vaginal prostaglandins preparations: a randomised controlled trial of Prostin vs Propess. Induction of labour at term with vaginal prostaglandins preparations: a randomised controlled trial of Prostin vs Propess. 2006; 26:627-30. doi: 10.1080/01443610600903362\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00528060\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"23459496\",\n",
      "        \"title\": \"Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial.\",\n",
      "        \"authors\": \"Parienti JJ; Barrail-Tran A; Duval X; Nembot G; Descamps D; Vigan M; Vrijens B; Panhard X; Taburet AM; Mentr\\u00e9 F; Goujard C\",\n",
      "        \"doi\": \"10.1128/AAC.02605-12\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Parienti JJ, et al. Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial. Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial. 2013; 57:2265-71. doi: 10.1128/AAC.02605-12\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02650427\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04008927\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26806260\",\n",
      "        \"title\": \"Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care.\",\n",
      "        \"authors\": \"Chevaliez S; Poiteau L; Rosa I; Soulier A; Roudot-Thoraval F; Laperche S; H\\u00e9zode C; Pawlotsky JM\",\n",
      "        \"doi\": \"10.1016/j.cmi.2016.01.009\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Evaluation Study\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Chevaliez S, et al. Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care. Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care. 2016; 22:459.e1-6. doi: 10.1016/j.cmi.2016.01.009\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28004616\",\n",
      "        \"title\": \"Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004-2011: model-based estimation from two national cross-sectional serosurveys.\",\n",
      "        \"authors\": \"Leon L; Kasereka S; Barin F; Larsen C; Weill-Barillet L; Pascal X; Chevaliez S; Pillonel J; Jauffret-Roustide M; LE Strat Y\",\n",
      "        \"doi\": \"10.1017/S0950268816002934\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Leon L, et al. Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004-2011: model-based estimation from two national cross-sectional serosurveys. Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004-2011: model-based estimation from two national cross-sectional serosurveys. 2017; 145:895-907. doi: 10.1017/S0950268816002934\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29432973\",\n",
      "        \"title\": \"Using dual capture/recapture studies to estimate the population size of persons who inject drugs (PWID) in the city of Hai Phong, Vietnam.\",\n",
      "        \"authors\": \"Des Jarlais D; Khue PM; Feelemyer J; Arasteh K; Thi Huong D; Thi Hai Oanh K; Thi Giang H; Thi Tuyet Thanh N; Vinh VH; Heckathorn DD; Moles JP; Vallo R; Quillet C; Rapoud D; Michel L; Laureillard D; Hammett T; Nagot N\",\n",
      "        \"doi\": \"10.1016/j.drugalcdep.2017.11.033\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Des Jarlais D, et al. Using dual capture/recapture studies to estimate the population size of persons who inject drugs (PWID) in the city of Hai Phong, Vietnam. Using dual capture/recapture studies to estimate the population size of persons who inject drugs (PWID) in the city of Hai Phong, Vietnam. 2018; 185:106-111. doi: 10.1016/j.drugalcdep.2017.11.033\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27537841\",\n",
      "        \"title\": \"Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.\",\n",
      "        \"authors\": \"Dore GJ; Altice F; Litwin AH; Dalgard O; Gane EJ; Shibolet O; Luetkemeyer A; Nahass R; Peng CY; Conway B; Grebely J; Howe AY; Gendrano IN; Chen E; Huang HC; Dutko FJ; Nickle DC; Nguyen BY; Wahl J; Barr E; Robertson MN; Platt HL; C-EDGE CO-STAR Study Group\",\n",
      "        \"doi\": \"10.7326/M16-0816\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Dore GJ, et al. Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial. Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial. 2016; 165:625-634. doi: 10.7326/M16-0816\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27168667\",\n",
      "        \"title\": \"Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014.\",\n",
      "        \"authors\": \"Blackburn NA; Patel RC; Zibbell JE\",\n",
      "        \"doi\": \"10.1177/00333549161310S214\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Blackburn NA, et al. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014. 2016; 131 Suppl 2:91-7. doi: 10.1177/00333549161310S214\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22310560\",\n",
      "        \"title\": \"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact.\",\n",
      "        \"authors\": \"Curran GM; Bauer M; Mittman B; Pyne JM; Stetler C\",\n",
      "        \"doi\": \"10.1097/MLR.0b013e3182408812\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, U.S. Gov't, Non-P.H.S.\"\n",
      "        ],\n",
      "        \"citation\": \"Curran GM, et al. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. 2012; 50:217-26. doi: 10.1097/MLR.0b013e3182408812\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35774932\",\n",
      "        \"title\": \"Reaching Hard-to-Reach People Who Use Drugs: A Community-Based Strategy for the Elimination of Hepatitis C.\",\n",
      "        \"authors\": \"Nagot N; D'Ottavi M; Quillet C; Debellefontaine A; Castellani J; Langendorfer N; Hanslik B; Guichard S; Baglioni R; Faucherre V; Tuaillon E; Pageaux GP; Laureillard D; Donnadieu-Rigole H\",\n",
      "        \"doi\": \"10.1093/ofid/ofac181\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Nagot N, et al. Reaching Hard-to-Reach People Who Use Drugs: A Community-Based Strategy for the Elimination of Hepatitis C. Reaching Hard-to-Reach People Who Use Drugs: A Community-Based Strategy for the Elimination of Hepatitis C. 2022; 9:ofac181. doi: 10.1093/ofid/ofac181\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27178119\",\n",
      "        \"title\": \"Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.\",\n",
      "        \"authors\": \"Des Jarlais D; Duong HT; Pham Minh K; Khuat OH; Nham TT; Arasteh K; Feelemyer J; Heckathorn DD; Peries M; Moles JP; Laureillard D; Nagot N; (The Drive Study Team)\",\n",
      "        \"doi\": \"10.1080/09540121.2016.1178698\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Des Jarlais D, et al. Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. 2016; 28:1312-5. doi: 10.1080/09540121.2016.1178698\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01022476\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01335529\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"27077673\",\n",
      "        \"title\": \"Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study.\",\n",
      "        \"authors\": \"Poizot-Martin I; Bellissant E; Garraffo R; Colson P; Piroth L; Solas C; Renault A; Bourli\\u00e8re M; Halfon P; Ghosn J; Alric L; Naqvi A; Carrieri P; Molina JM; ANRS HC27 BOCEPREVIH Study Group\",\n",
      "        \"doi\": \"10.1080/15284336.2015.1135553\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Poizot-Martin I, et al. Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study. Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study. 2016; 17:63-71. doi: 10.1080/15284336.2015.1135553\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02014727\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"28947345\",\n",
      "        \"title\": \"Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel\\u00ae in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial.\",\n",
      "        \"authors\": \"Sirima SB; Durier C; Kara L; Houard S; Gansane A; Loulergue P; Bahuaud M; Benhamouda N; Nebi\\u00e9 I; Faber B; Remarque E; Launay O; AMA1-DiCo Study Group\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2017.09.027\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sirima SB, et al. Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel\\u00ae in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial. Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel\\u00ae in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial. 2017; 35:6218-6227. doi: 10.1016/j.vaccine.2017.09.027\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00536627\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"15382173\",\n",
      "        \"title\": \"Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers.\",\n",
      "        \"authors\": \"Mancini-Bourgine M; Fontaine H; Scott-Algara D; Pol S; Br\\u00e9chot C; Michel ML\",\n",
      "        \"doi\": \"10.1002/hep.20408\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mancini-Bourgine M, et al. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. 2004; 40:874-82. doi: 10.1002/hep.20408\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24555998\",\n",
      "        \"title\": \"Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN.\",\n",
      "        \"authors\": \"Fontaine H; Kahi S; Chazallon C; Bourgine M; Varaut A; Buffet C; Godon O; Meritet JF; Sa\\u00efdi Y; Michel ML; Scott-Algara D; Aboulker JP; Pol S; ANRS HB02 study group\",\n",
      "        \"doi\": \"10.1136/gutjnl-2013-305707\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Fontaine H, et al. Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN. Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN. 2015; 64:139-47. doi: 10.1136/gutjnl-2013-305707\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16310901\",\n",
      "        \"title\": \"Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers.\",\n",
      "        \"authors\": \"Mancini-Bourgine M; Fontaine H; Br\\u00e9chot C; Pol S; Michel ML\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2005.08.013\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mancini-Bourgine M, et al. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. 2006; 24:4482-9. doi: 10.1016/j.vaccine.2005.08.013\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24394187\",\n",
      "        \"title\": \"Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analogues.\",\n",
      "        \"authors\": \"Godon O; Fontaine H; Kahi S; Meritet JF; Scott-Algara D; Pol S; Michel ML; Bourgine M; ANRS HB02 study group\",\n",
      "        \"doi\": \"10.1038/mt.2013.274\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Godon O, et al. Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analogues. Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analogues. 2014; 22:675-684. doi: 10.1038/mt.2013.274\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02078076\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02777229\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"31339676\",\n",
      "        \"title\": \"Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1.\",\n",
      "        \"authors\": \"NAMSAL ANRS 12313 Study Group; Kouanfack C; Mpoudi-Etame M; Omgba Bassega P; Eymard-Duvernay S; Leroy S; Boyer S; Peeters M; Calmy A; Delaporte E\",\n",
      "        \"doi\": \"10.1056/NEJMoa1904340\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Equivalence Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"NAMSAL ANRS 12313 Study Group, et al. Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1. Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1. 2019; 381:816-826. doi: 10.1056/NEJMoa1904340\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33355914\",\n",
      "        \"title\": \"Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial).\",\n",
      "        \"authors\": \"Bousmah MA; Nishimwe ML; Tovar-Sanchez T; Lantche Wandji M; Mpoudi-Etame M; Maradan G; Omgba Bassega P; Varloteaux M; Montoyo A; Kouanfack C; Delaporte E; Boyer S; New Antiretroviral\\u00a0and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group\",\n",
      "        \"doi\": \"10.1007/s40273-020-00987-3\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bousmah MA, et al. Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial). Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial). 2021; 39:331-343. doi: 10.1007/s40273-020-00987-3\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"38156046\",\n",
      "        \"title\": \"Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study.\",\n",
      "        \"authors\": \"Mpoudi-Etame M; Tovar Sanchez T; Bousmah MA; Omgba Bassega P; Olinga J; Mimbe E; Foalem M; Chiep C; Edimo S; Varloteaux M; Pelloquin R; Lamare N; Boyer S; Peeters M; Reynes J; Calmy A; Hill A; Delaporte E; Kouanfack C; New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-income countries (NAMSAL-ANRS-12313) study group \",\n",
      "        \"doi\": \"10.1093/ofid/ofad582\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Mpoudi-Etame M, et al. Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study. Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study. 2023; 10:ofad582. doi: 10.1093/ofid/ofad582\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33010241\",\n",
      "        \"title\": \"Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon.\",\n",
      "        \"authors\": \"Calmy A; Tovar Sanchez T; Kouanfack C; Mpoudi-Etame M; Leroy S; Perrineau S; Lantche Wandji M; Tetsa Tata D; Omgba Bassega P; Abong Bwenda T; Varloteaux M; Tongo M; Mpoudi-Ngol\\u00e9 E; Montoyo A; Mercier N; LeMoing V; Peeters M; Reynes J; Delaporte E; New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(20)30238-1\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Calmy A, et al. Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon. Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon. 2020; 7:e677-e687. doi: 10.1016/S2352-3018(20)30238-1\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"37851566\",\n",
      "        \"title\": \"Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial).\",\n",
      "        \"authors\": \"Bousmah MA; Protopopescu C; Mpoudi-Etame M; Omgba Bassega P; Maradan G; Olinga J; Varloteaux M; Tovar-Sanchez T; Delaporte \\u00c9; Kouanfack C; Boyer S; NAMSAL ANRS 12313 Study Group\",\n",
      "        \"doi\": \"10.1097/QAI.0000000000003273\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bousmah MA, et al. Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial). Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial). 2023; 94:262-272. doi: 10.1097/QAI.0000000000003273\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01703962\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"37668523\",\n",
      "        \"title\": \"Neurochemical Differences between 1p/19q Codeleted and Noncodeleted IDH-mutant Gliomas by in Vivo MR Spectroscopy.\",\n",
      "        \"authors\": \"Branzoli F; Liserre R; Deelchand DK; Poliani PL; Bielle F; Nichelli L; Sanson M; Leh\\u00e9ricy S; Marja\\u0144ska M\",\n",
      "        \"doi\": \"10.1148/radiol.223255\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Research Support, N.I.H., Extramural\"\n",
      "        ],\n",
      "        \"citation\": \"Branzoli F, et al. Neurochemical Differences between 1p/19q Codeleted and Noncodeleted IDH-mutant Gliomas by in Vivo MR Spectroscopy. Neurochemical Differences between 1p/19q Codeleted and Noncodeleted IDH-mutant Gliomas by in Vivo MR Spectroscopy. 2023; 308:e223255. doi: 10.1148/radiol.223255\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03546127\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01331876\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02886416\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01188525\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00302822\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01693835\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02978924\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00226434\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22010913\",\n",
      "        \"title\": \"Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.\",\n",
      "        \"authors\": \"Blanc FX; Sok T; Laureillard D; Borand L; Rekacewicz C; Nerrienet E; Madec Y; Marcy O; Chan S; Prak N; Kim C; Lak KK; Hak C; Dim B; Sin CI; Sun S; Guillard B; Sar B; Vong S; Fernandez M; Fox L; Delfraissy JF; Goldfeld AE; CAMELIA (ANRS 1295\\u2013CIPRA KH001) Study Team\",\n",
      "        \"doi\": \"10.1056/NEJMoa1013911\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Blanc FX, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. 2011; 365:1471-81. doi: 10.1056/NEJMoa1013911\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24096631\",\n",
      "        \"title\": \"Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.\",\n",
      "        \"authors\": \"Laureillard D; Marcy O; Madec Y; Chea S; Chan S; Borand L; Fernandez M; Prak N; Kim C; Dim B; Nerrienet E; Sok T; Delfraissy JF; Goldfeld AE; Blanc FX; CAMELIA (ANRS 1295 \\u2013 CIPRA KH001) Study Team\",\n",
      "        \"doi\": \"10.1097/01.aids.0000432456.14099.c7\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Laureillard D, et al. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial. 2013; 27:2577-86. doi: 10.1097/01.aids.0000432456.14099.c7\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17624825\",\n",
      "        \"title\": \"Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials.\",\n",
      "        \"authors\": \"Blanc FX; Havlir DV; Onyebujoh PC; Thim S; Goldfeld AE; Delfraissy JF\",\n",
      "        \"doi\": \"10.1086/518658\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Research Support, U.S. Gov't, P.H.S.\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Blanc FX, et al. Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials. Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials. 2007; 196 Suppl 1:S46-51. doi: 10.1086/518658\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24759827\",\n",
      "        \"title\": \"Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial.\",\n",
      "        \"authors\": \"Marcy O; Laureillard D; Madec Y; Chan S; Mayaud C; Borand L; Prak N; Kim C; Lak KK; Hak C; Dim B; Sok T; Delfraissy JF; Goldfeld AE; Blanc FX; CAMELIA (ANRS 1295-CIPRA KH001) Study Team\",\n",
      "        \"doi\": \"10.1093/cid/ciu283\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Marcy O, et al. Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial. Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial. 2014; 59:435-45. doi: 10.1093/cid/ciu283\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23237982\",\n",
      "        \"title\": \"Plasma concentrations of efavirenz with a 600 mg standard dose in Cambodian HIV-infected adults treated for tuberculosis with a body weight above 50 kg.\",\n",
      "        \"authors\": \"Borand L; Laureillard D; Madec Y; Chou M; Pheng P; Marcy O; Sok T; Goldfeld AE; Taburet AM; Blanc FX; CAMELIA ANRS 1295-CIPRA KH001 Study Team\",\n",
      "        \"doi\": \"10.3851/IMP2483\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Borand L, et al. Plasma concentrations of efavirenz with a 600 mg standard dose in Cambodian HIV-infected adults treated for tuberculosis with a body weight above 50 kg. Plasma concentrations of efavirenz with a 600 mg standard dose in Cambodian HIV-infected adults treated for tuberculosis with a body weight above 50 kg. 2013; 18:419-23. doi: 10.3851/IMP2483\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24608960\",\n",
      "        \"title\": \"Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial).\",\n",
      "        \"authors\": \"Borand L; Madec Y; Laureillard D; Chou M; Marcy O; Pheng P; Prak N; Kim C; Lak KK; Hak C; Dim B; Nerrienet E; Fontanet A; Sok T; Goldfeld AE; Blanc FX; Taburet AM\",\n",
      "        \"doi\": \"10.1371/journal.pone.0090350\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Borand L, et al. Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial). Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial). 2014; 9:e90350. doi: 10.1371/journal.pone.0090350\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00148824\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"20210645\",\n",
      "        \"title\": \"Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults.\",\n",
      "        \"authors\": \"Rabian C; Tsch\\u00f6pe I; Lesprit P; Katlama C; Molina JM; Meynard JL; Delfraissy JF; Ch\\u00eane G; L\\u00e9vy Y; ANRS 114 Pneumovac Study Group\",\n",
      "        \"doi\": \"10.1086/651418\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Rabian C, et al. Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults. Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults. 2010; 50:1174-83. doi: 10.1086/651418\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00670839\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26257021\",\n",
      "        \"title\": \"Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.\",\n",
      "        \"authors\": \"Rey D; Piroth L; Wendling MJ; Miailhes P; Michel ML; Dufour C; Haour G; Sogni P; Rohel A; Ajana F; Billaud E; Molina JM; Launay O; Carrat F; ANRS HB04 B-BOOST study group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(15)00220-0\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Rey D, et al. Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial. Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial. 2015; 15:1283-91. doi: 10.1016/S1473-3099(15)00220-0\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01548586\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"10990547\",\n",
      "        \"title\": \"Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation.\",\n",
      "        \"authors\": \"Nitsche MA; Paulus W\",\n",
      "        \"doi\": \"10.1111/j.1469-7793.2000.t01-1-00633.x\",\n",
      "        \"year\": \"2000\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nitsche MA and Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. 2000; 527 Pt 3:633-9. doi: 10.1111/j.1469-7793.2000.t01-1-00633.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15272049\",\n",
      "        \"title\": \"Demonstration of a second rapidly conducting cortico-diaphragmatic pathway in humans.\",\n",
      "        \"authors\": \"Sharshar T; Hopkinson NS; Jonville S; Prigent H; Carlier R; Dayer MJ; Swallow EB; Lofaso F; Moxham J; Polkey MI\",\n",
      "        \"doi\": \"10.1113/jphysiol.2004.061150\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Sharshar T, et al. Demonstration of a second rapidly conducting cortico-diaphragmatic pathway in humans. Demonstration of a second rapidly conducting cortico-diaphragmatic pathway in humans. 2004; 560:897-908. doi: 10.1113/jphysiol.2004.061150\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19805746\",\n",
      "        \"title\": \"Impact of transcranial direct current stimulation on spinal network excitability in humans.\",\n",
      "        \"authors\": \"Roche N; Lackmy A; Achache V; Bussel B; Katz R\",\n",
      "        \"doi\": \"10.1113/jphysiol.2009.177550\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Roche N, et al. Impact of transcranial direct current stimulation on spinal network excitability in humans. Impact of transcranial direct current stimulation on spinal network excitability in humans. 2009; 587:5653-64. doi: 10.1113/jphysiol.2009.177550\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"8756819\",\n",
      "        \"title\": \"Impairment of central motor conduction to the diaphragm in stroke.\",\n",
      "        \"authors\": \"Similowski T; Catala M; Rancurel G; Derenne JP\",\n",
      "        \"doi\": \"10.1164/ajrccm.154.2.8756819\",\n",
      "        \"year\": \"1996\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Similowski T, et al. Impairment of central motor conduction to the diaphragm in stroke. Impairment of central motor conduction to the diaphragm in stroke. 1996; 154:436-41. doi: 10.1164/ajrccm.154.2.8756819\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"11723286\",\n",
      "        \"title\": \"Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans.\",\n",
      "        \"authors\": \"Nitsche MA; Paulus W\",\n",
      "        \"doi\": \"10.1212/wnl.57.10.1899\",\n",
      "        \"year\": \"2001\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nitsche MA and Paulus W. Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. 2001; 57:1899-901. doi: 10.1212/wnl.57.10.1899\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20161639\",\n",
      "        \"title\": \"Focal and bi-directional modulation of lower limb motor cortex using anodal transcranial direct current stimulation.\",\n",
      "        \"authors\": \"Madhavan S; Stinear JW\",\n",
      "        \"doi\": \"10.1016/j.brs.2009.06.005\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Madhavan S and Stinear JW. Focal and bi-directional modulation of lower limb motor cortex using anodal transcranial direct current stimulation. Focal and bi-directional modulation of lower limb motor cortex using anodal transcranial direct current stimulation. 2010; 3:42. doi: 10.1016/j.brs.2009.06.005\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16002441\",\n",
      "        \"title\": \"Modulating parameters of excitability during and after transcranial direct current stimulation of the human motor cortex.\",\n",
      "        \"authors\": \"Nitsche MA; Seeber A; Frommann K; Klein CC; Rochford C; Nitsche MS; Fricke K; Liebetanz D; Lang N; Antal A; Paulus W; Tergau F\",\n",
      "        \"doi\": \"10.1113/jphysiol.2005.092429\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nitsche MA, et al. Modulating parameters of excitability during and after transcranial direct current stimulation of the human motor cortex. Modulating parameters of excitability during and after transcranial direct current stimulation of the human motor cortex. 2005; 568:291-303. doi: 10.1113/jphysiol.2005.092429\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15634731\",\n",
      "        \"title\": \"Effects of non-invasive cortical stimulation on skilled motor function in chronic stroke.\",\n",
      "        \"authors\": \"Hummel F; Celnik P; Giraux P; Floel A; Wu WH; Gerloff C; Cohen LG\",\n",
      "        \"doi\": \"10.1093/brain/awh369\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Controlled Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hummel F, et al. Effects of non-invasive cortical stimulation on skilled motor function in chronic stroke. Effects of non-invasive cortical stimulation on skilled motor function in chronic stroke. 2005; 128:490-9. doi: 10.1093/brain/awh369\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22085959\",\n",
      "        \"title\": \"Transcranial direct current stimulation--update 2011.\",\n",
      "        \"authors\": \"Nitsche MA; Paulus W\",\n",
      "        \"doi\": \"10.3233/RNN-2011-0618\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Historical Article\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Nitsche MA and Paulus W. Transcranial direct current stimulation--update 2011. Transcranial direct current stimulation--update 2011. 2011; 29:463-92. doi: 10.3233/RNN-2011-0618\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01801618\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29662875\",\n",
      "        \"title\": \"Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study.\",\n",
      "        \"authors\": \"S\\u00e9g\\u00e9ral O; Nerrienet E; Neth S; Spire B; Khol V; Ferradini L; Sarun S; Mom C; Ngin S; Charpentier C; Men P; Mora M; Mean Chhi V; Ly P; Saphonn V\",\n",
      "        \"doi\": \"10.3389/fpubh.2018.00063\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"S\\u00e9g\\u00e9ral O, et al. Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study. Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study. 2018; 6:63. doi: 10.3389/fpubh.2018.00063\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01055873\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22427678\",\n",
      "        \"title\": \"Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study.\",\n",
      "        \"authors\": \"Avettand-Fenoel V; Blanche S; Le Chenadec J; Scott-Algara D; Dollfus C; Viard JP; Bouallag N; Benmebarek Y; Rivi\\u00e8re Y; Warszawski J; Rouzioux C; Buseyne F\",\n",
      "        \"doi\": \"10.1093/infdis/jis233\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Avettand-Fenoel V, et al. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study. 2012; 205:1520-8. doi: 10.1093/infdis/jis233\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00495326\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"24663014\",\n",
      "        \"title\": \"Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment.\",\n",
      "        \"authors\": \"Bhatt NB; Barau C; Amin A; Baudin E; Meggi B; Silva C; Furlan V; Grinsztejn B; Barrail-Tran A; Bonnet M; Taburet AM; ANRS 12146-CARINEMO Study Group\",\n",
      "        \"doi\": \"10.1128/AAC.02379-13\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bhatt NB, et al. Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment. Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment. 2014; 58:3182-90. doi: 10.1128/AAC.02379-13\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23433590\",\n",
      "        \"title\": \"Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial.\",\n",
      "        \"authors\": \"Bonnet M; Bhatt N; Baudin E; Silva C; Michon C; Taburet AM; Ciaffi L; Sobry A; Bastos R; Nunes E; Rouzioux C; Jani I; Calmy A; CARINEMO study group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(13)70007-0\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bonnet M, et al. Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial. Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial. 2013; 13:303-12. doi: 10.1016/S1473-3099(13)70007-0\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02099474\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"32661003\",\n",
      "        \"title\": \"Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial.\",\n",
      "        \"authors\": \"Zheng Y; Hirt D; Delmas S; Lui G; Benaboud S; Lechedanec J; Tr\\u00e9luyer JM; Chenevier-Gobeaux C; Arezes E; Gelley A; Amri I; Urien S; Bouazza N; Foissac F; Warszawski J; Ghosn J\",\n",
      "        \"doi\": \"10.1128/AAC.00759-20\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Zheng Y, et al. Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial. Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial. 2020; 64:(unknown pages). doi: 10.1128/AAC.00759-20\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02592174\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"31755936\",\n",
      "        \"title\": \"Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 Study.\",\n",
      "        \"authors\": \"Makinson A; Dubois J; Eymard-Duvernay S; Leclercq P; Zaegel-Faucher O; Bernard L; Vassallo M; Barbuat C; G\\u00e9ny C; Thouvenot E; Costagliola D; Ozguler A; Zins M; Simony M; Reynes J; Berr C\",\n",
      "        \"doi\": \"10.1093/cid/ciz670\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Makinson A, et al. Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 Study. Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 Study. 2020; 70:2641-2648. doi: 10.1093/cid/ciz670\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00334256\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"19307941\",\n",
      "        \"title\": \"Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1.\",\n",
      "        \"authors\": \"TEmAA ANRS 12109 Study group; Arriv\\u00e9 E; Chaix ML; Nerrienet E; Blanche S; Rouzioux C; Coffie PA; Kruy Leang S; McIntyre J; Avit D; Srey VH; Gray G; N'Dri-Yoman T; Diallo A; Ekou\\u00e9vi DK; Dabis F\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32832949d5\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"TEmAA ANRS 12109 Study group, et al. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1. 2009; 23:825-33. doi: 10.1097/QAD.0b013e32832949d5\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18987623\",\n",
      "        \"title\": \"Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109).\",\n",
      "        \"authors\": \"Hirt D; Urien S; Ekou\\u00e9vi DK; Rey E; Arriv\\u00e9 E; Blanche S; Amani-Bosse C; Nerrienet E; Gray G; Kone M; Leang SK; McIntyre J; Dabis F; Tr\\u00e9luyer JM; ANRS 12109\",\n",
      "        \"doi\": \"10.1038/clpt.2008.201\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hirt D, et al. Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109). Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109). 2009; 85:182-9. doi: 10.1038/clpt.2008.201\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19104016\",\n",
      "        \"title\": \"Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates.\",\n",
      "        \"authors\": \"Hirt D; Urien S; Rey E; Arriv\\u00e9 E; Ekou\\u00e9vi DK; Coffi\\u00e9 P; Leang SK; Lalsab S; Avit D; Nerrienet E; McIntyre J; Blanche S; Dabis F; Tr\\u00e9luyer JM\",\n",
      "        \"doi\": \"10.1128/AAC.00860-08\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hirt D, et al. Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates. 2009; 53:1067-73. doi: 10.1128/AAC.00860-08\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01492985\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"33568510\",\n",
      "        \"title\": \"A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial.\",\n",
      "        \"authors\": \"L\\u00e9vy Y; Lacabaratz C; Lhomme E; Wiedemann A; Bauduin C; Fenwick C; Foucat E; Surenaud M; Guillaumat L; Boilet V; Rieux V; Bouchaud O; Girard PM; Molina JM; Morlat P; Hocqueloux L; Richert L; Pantaleo G; Leli\\u00e8vre JD; Thi\\u00e9baut R\",\n",
      "        \"doi\": \"10.1128/JVI.02165-20\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"L\\u00e9vy Y, et al. A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial. A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial. 2021; 95:(unknown pages). doi: 10.1128/JVI.02165-20\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02125500\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00196599\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"10915095\",\n",
      "        \"title\": \"Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients.\",\n",
      "        \"authors\": \"Molina JM; Ferchal F; Rancinan C; Raffi F; Rozenbaum W; Sereni D; Morlat P; Journot V; Decazes JM; Ch\\u00eane G\",\n",
      "        \"doi\": \"10.1086/315711\",\n",
      "        \"year\": \"2000\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Molina JM, et al. Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients. Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients. 2000; 182:599-602. doi: 10.1086/315711\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15012649\",\n",
      "        \"title\": \"Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial).\",\n",
      "        \"authors\": \"Molina JM; Peytavin G; Perusat S; Lascoux-Combes C; Sereni D; Rozenbaum W; Chene G\",\n",
      "        \"doi\": \"10.1111/j.1468-1293.2004.00194.x\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Molina JM, et al. Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial). Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial). 2004; 5:99-104. doi: 10.1111/j.1468-1293.2004.00194.x\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02906137\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02647632\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29077864\",\n",
      "        \"title\": \"Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study.\",\n",
      "        \"authors\": \"de L\\u00e9dinghen V; Laforest C; H\\u00e9zode C; Pol S; Renault A; Alric L; Larrey D; M\\u00e9tivier S; Tran A; J\\u00e9z\\u00e9quel C; Samuel D; Zoulim F; Tual C; Pailh\\u00e9 A; Gibowski S; Bourli\\u00e8re M; Bellissant E; Pawlotsky JM\",\n",
      "        \"doi\": \"10.1093/cid/cix916\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"de L\\u00e9dinghen V, et al. Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study. Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study. 2018; 66:1013-1018. doi: 10.1093/cid/cix916\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00822315\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"24726095\",\n",
      "        \"title\": \"Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.\",\n",
      "        \"authors\": \"Grinsztejn B; De Castro N; Arnold V; Veloso VG; Morgado M; Pilotto JH; Brites C; Madruga JV; Barcellos NT; Santos BR; Vorsatz C; Fagard C; Santini-Oliveira M; Patey O; Delaugerre C; Ch\\u00eane G; Molina JM; ANRS 12 180 Reflate TB study group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(14)70711-X\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Grinsztejn B, et al. Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial. Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial. 2014; 14:459-67. doi: 10.1016/S1473-3099(14)70711-X\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01413152\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01463956\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00454337\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"21326075\",\n",
      "        \"title\": \"Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia.\",\n",
      "        \"authors\": \"Gallien S; Delaugerre C; Charreau I; Braun J; Boulet T; Barrail-Tran A; de Castro N; Molina JM; Kuritzkes DR\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e3283445834\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Gallien S, et al. Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia. Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia. 2011; 25:665-9. doi: 10.1097/QAD.0b013e3283445834\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19995925\",\n",
      "        \"title\": \"High concentration of raltegravir in semen of HIV-infected men: results from a substudy of the EASIER-ANRS 138 trial.\",\n",
      "        \"authors\": \"Barau C; Delaugerre C; Braun J; de Castro N; Furlan V; Charreau I; G\\u00e9rard L; Lascoux-Combe C; Molina JM; Taburet AM\",\n",
      "        \"doi\": \"10.1128/AAC.01261-09\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Barau C, et al. High concentration of raltegravir in semen of HIV-infected men: results from a substudy of the EASIER-ANRS 138 trial. High concentration of raltegravir in semen of HIV-infected men: results from a substudy of the EASIER-ANRS 138 trial. 2010; 54:937-9. doi: 10.1128/AAC.01261-09\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19757993\",\n",
      "        \"title\": \"Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial.\",\n",
      "        \"authors\": \"De Castro N; Braun J; Charreau I; Pialoux G; Cotte L; Katlama C; Raffi F; Weiss L; Meynard JL; Yazdanpanah Y; Delaugerre C; Madelaine-Chambrin I; Aboulker JP; Molina JM; EASIER ANRS 138 study group\",\n",
      "        \"doi\": \"10.1086/605674\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"De Castro N, et al. Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial. Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial. 2009; 49:1259-67. doi: 10.1086/605674\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22416781\",\n",
      "        \"title\": \"Comparison of resistance mutation patterns in historical plasma HIV RNA genotypes with those in current proviral HIV DNA genotypes among extensively treated patients with suppressed replication.\",\n",
      "        \"authors\": \"Delaugerre C; Braun J; Charreau I; Delarue S; Nere ML; de Castro N; May T; Marchou B; Simon F; Molina JM; Aboulker JP; ANRS 138-EASIER study group\",\n",
      "        \"doi\": \"10.1111/j.1468-1293.2012.01002.x\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Delaugerre C, et al. Comparison of resistance mutation patterns in historical plasma HIV RNA genotypes with those in current proviral HIV DNA genotypes among extensively treated patients with suppressed replication. Comparison of resistance mutation patterns in historical plasma HIV RNA genotypes with those in current proviral HIV DNA genotypes among extensively treated patients with suppressed replication. 2012; 13:517-25. doi: 10.1111/j.1468-1293.2012.01002.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21712241\",\n",
      "        \"title\": \"Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial.\",\n",
      "        \"authors\": \"Gallien S; Braun J; Delaugerre C; Charreau I; Reynes J; Jeanblanc F; Verdon R; de Truchis P; May T; Madelaine-Chambrin I; Aboulker JP; Molina JM; EASIER ANRS 138 Study Group\",\n",
      "        \"doi\": \"10.1093/jac/dkr269\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Gallien S, et al. Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial. Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial. 2011; 66:2099-106. doi: 10.1093/jac/dkr269\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27042193\",\n",
      "        \"title\": \"Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial.\",\n",
      "        \"authors\": \"de Castro N; Braun J; Charreau I; Lafeuillade A; Viard JP; Allavena C; Aboulker JP; Molina JM; EASIER ANRS 138 study group\",\n",
      "        \"doi\": \"10.1186/s12981-016-0101-3\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"de Castro N, et al. Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial. Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial. 2016; 13:17. doi: 10.1186/s12981-016-0101-3\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21576452\",\n",
      "        \"title\": \"Switch from enfuvirtide to raltegravir lowers plasma concentrations of darunavir and tipranavir: a pharmacokinetic substudy of the EASIER-ANRS 138 trial.\",\n",
      "        \"authors\": \"Goldwirt L; Braun J; de Castro N; Charreau I; Barrail-Tran A; Delaugerre C; Raffi F; Lascoux-Combe C; Aboulker JP; Taburet AM; Molina JM\",\n",
      "        \"doi\": \"10.1128/AAC.01827-10\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Goldwirt L, et al. Switch from enfuvirtide to raltegravir lowers plasma concentrations of darunavir and tipranavir: a pharmacokinetic substudy of the EASIER-ANRS 138 trial. Switch from enfuvirtide to raltegravir lowers plasma concentrations of darunavir and tipranavir: a pharmacokinetic substudy of the EASIER-ANRS 138 trial. 2011; 55:3613-5. doi: 10.1128/AAC.01827-10\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20683319\",\n",
      "        \"title\": \"Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen.\",\n",
      "        \"authors\": \"Delaugerre C; Charreau I; Braun J; N\\u00e9r\\u00e9 ML; de Castro N; Yeni P; Ghosn J; Aboulker JP; Molina JM; Simon F; ANRS 138 study group\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32833d214c\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Delaugerre C, et al. Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen. Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen. 2010; 24:2391-5. doi: 10.1097/QAD.0b013e32833d214c\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21126958\",\n",
      "        \"title\": \"Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrug-resistant HIV-1-infected patients: a randomized open-label trial (EASIER-ANRS 138).\",\n",
      "        \"authors\": \"Boulet T; Pavie J; Charreau I; Braun J; Reynes J; Morlat P; Piroth L; Spire B; Molina JM; Aboulker JP; Easier-Anrs 138 Study Group\",\n",
      "        \"doi\": \"10.1310/hct1105-283\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Boulet T, et al. Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrug-resistant HIV-1-infected patients: a randomized open-label trial (EASIER-ANRS 138). Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrug-resistant HIV-1-infected patients: a randomized open-label trial (EASIER-ANRS 138). 2010; 11:283-93. doi: 10.1310/hct1105-283\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01698411\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02214511\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01331811\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26908804\",\n",
      "        \"title\": \"Performance of Xpert MTB/RIF and Alternative Specimen Collection Methods for the Diagnosis of Tuberculosis in HIV-Infected Children.\",\n",
      "        \"authors\": \"Marcy O; Ung V; Goyet S; Borand L; Msellati P; Tejiokem M; Nguyen Thi NL; Nacro B; Cheng S; Eyangoh S; Pham TH; Ouedraogo AS; Tarantola A; Godreuil S; Blanche S; Delacourt C\",\n",
      "        \"doi\": \"10.1093/cid/ciw036\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Marcy O, et al. Performance of Xpert MTB/RIF and Alternative Specimen Collection Methods for the Diagnosis of Tuberculosis in HIV-Infected Children. Performance of Xpert MTB/RIF and Alternative Specimen Collection Methods for the Diagnosis of Tuberculosis in HIV-Infected Children. 2016; 62:1161-1168. doi: 10.1093/cid/ciw036\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29174612\",\n",
      "        \"title\": \"Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study.\",\n",
      "        \"authors\": \"Marcy O; Tejiokem M; Msellati P; Truong Huu K; Do Chau V; Tran Ngoc D; Nacro B; Ateba-Ndongo F; Tetang-Ndiang S; Ung V; Dim B; Neou L; Berteloot L; Borand L; Delacourt C; Blanche S; ANRS 12229 PAANTHER 01 Study Group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(17)30206-0\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Marcy O, et al. Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study. Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study. 2018; 5:e87-e95. doi: 10.1016/S2352-3018(17)30206-0\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30689814\",\n",
      "        \"title\": \"Isolation of Nontuberculous Mycobacteria in Southeast Asian and African Human Immunodeficiency Virus-infected Children With Suspected Tuberculosis.\",\n",
      "        \"authors\": \"Borand L; de Lauzanne A; Nguyen NL; Cheng S; Pham TH; Eyangoh S; Ouedraogo AS; Ung V; Msellati P; Tejiokem M; Nacro B; Inghammar M; Dim B; Delacourt C; Godreuil S; Blanche S; Marcy O; Pediatric Asian African Network for Tuberculosis and HIV Research (PAANTHER) Study Group\",\n",
      "        \"doi\": \"10.1093/cid/ciy897\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Borand L, et al. Isolation of Nontuberculous Mycobacteria in Southeast Asian and African Human Immunodeficiency Virus-infected Children With Suspected Tuberculosis. Isolation of Nontuberculous Mycobacteria in Southeast Asian and African Human Immunodeficiency Virus-infected Children With Suspected Tuberculosis. 2019; 68:1750-1753. doi: 10.1093/cid/ciy897\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31455612\",\n",
      "        \"title\": \"A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis.\",\n",
      "        \"authors\": \"Marcy O; Borand L; Ung V; Msellati P; Tejiokem M; Huu KT; Do Chau V; Ngoc Tran D; Ateba-Ndongo F; Tetang-Ndiang S; Nacro B; Sanogo B; Neou L; Goyet S; Dim B; Pean P; Quillet C; Fournier I; Berteloot L; Carcelain G; Godreuil S; Blanche S; Delacourt C; ANRS 12229 PAANTHER 01 STUDY GROUP\",\n",
      "        \"doi\": \"10.1542/peds.2018-2065\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Marcy O, et al. A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis. A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis. 2019; 144:(unknown pages). doi: 10.1542/peds.2018-2065\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT05090956\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00120185\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"19508157\",\n",
      "        \"title\": \"Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119).\",\n",
      "        \"authors\": \"Molina JM; Levy Y; Fournier I; Hamonic S; Bentata M; Beck-Wirth G; Gougeon ML; Venet A; Madelaine I; Sereni D; Jeanblanc F; Boulet T; Simon F; Aboulker JP; Agence Nationale de Recherches sur le SIDA et les H\\u00e9patites Virales (ANRS) 119 Interstart Study Team\",\n",
      "        \"doi\": \"10.1086/599989\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Molina JM, et al. Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119). Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119). 2009; 200:206-15. doi: 10.1086/599989\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04392388\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"34293141\",\n",
      "        \"title\": \"Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study.\",\n",
      "        \"authors\": \"Carrat F; de Lamballerie X; Rahib D; Blanch\\u00e9 H; Lapidus N; Artaud F; Kab S; Renuy A; Szabo de Edelenyi F; Meyer L; Lydi\\u00e9 N; Charles MA; Ancel PY; Jusot F; Rouquette A; Priet S; Saba Villarroel PM; Fouri\\u00e9 T; Lusivika-Nzinga C; Nicol J; Legot S; Druesne-Pecollo N; Esseddik Y; Lai C; Gagliolo JM; Deleuze JF; Bajos N; Severi G; Touvier M; Zins M;  for the SAPRIS and SAPRIS-SERO study groups\",\n",
      "        \"doi\": \"10.1093/ije/dyab110\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Carrat F, et al. Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study. Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study. 2021; 50:1458-1472. doi: 10.1093/ije/dyab110\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01065207\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02082171\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02052271\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158509\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"17314338\",\n",
      "        \"title\": \"Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus.\",\n",
      "        \"authors\": \"Nagot N; Ou\\u00e9draogo A; Foulongne V; Konat\\u00e9 I; Weiss HA; Vergne L; Defer MC; Djagbar\\u00e9 D; Sanon A; Andonaba JB; Becquart P; Segondy M; Vallo R; Sawadogo A; Van de Perre P; Mayaud P; ANRS 1285 Study Group\",\n",
      "        \"doi\": \"10.1056/NEJMoa062607\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nagot N, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. 2007; 356:790-9. doi: 10.1056/NEJMoa062607\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18593294\",\n",
      "        \"title\": \"Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels.\",\n",
      "        \"authors\": \"Nagot N; Ouedraogo A; Konate I; Weiss HA; Foulongne V; Defer MC; Sanon A; Becquart P; Segondy M; Sawadogo A; Van de Perre P; Mayaud P; ANRS 1285 Study Group\",\n",
      "        \"doi\": \"10.1086/589621\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nagot N, et al. Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels. Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels. 2008; 198:241-9. doi: 10.1086/589621\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16044019\",\n",
      "        \"title\": \"Longitudinal assessment of HIV-1 and HSV-2 shedding in the genital tract of West African women.\",\n",
      "        \"authors\": \"Nagot N; Foulongne V; Becquart P; Mayaud P; Konate I; Ouedraogo A; Defer MC; Weiss H; Van de Perre P; Segondy M\",\n",
      "        \"doi\": null,\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Evaluation Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nagot N, et al. Longitudinal assessment of HIV-1 and HSV-2 shedding in the genital tract of West African women. Longitudinal assessment of HIV-1 and HSV-2 shedding in the genital tract of West African women. 2005; 39:632-4.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18596069\",\n",
      "        \"title\": \"Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women.\",\n",
      "        \"authors\": \"Mayaud P; Nagot N; Konat\\u00e9 I; Ouedraogo A; Weiss HA; Foulongne V; Defer MC; Sawadogo A; Segondy M; Van de Perre P; ANRS 1285 Study Group\",\n",
      "        \"doi\": \"10.1136/sti.2008.030692\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mayaud P, et al. Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women. Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women. 2008; 84:332-7. doi: 10.1136/sti.2008.030692\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02346409\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02656407\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"25955583\",\n",
      "        \"title\": \"Spatiotemporal Clutter Filtering of Ultrafast Ultrasound Data Highly Increases Doppler and fUltrasound Sensitivity.\",\n",
      "        \"authors\": \"Demen\\u00e9 C; Deffieux T; Pernot M; Osmanski BF; Biran V; Gennisson JL; Sieu LA; Bergel A; Franqui S; Correas JM; Cohen I; Baud O; Tanter M\",\n",
      "        \"doi\": \"10.1109/TMI.2015.2428634\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Demen\\u00e9 C, et al. Spatiotemporal Clutter Filtering of Ultrafast Ultrasound Data Highly Increases Doppler and fUltrasound Sensitivity. Spatiotemporal Clutter Filtering of Ultrafast Ultrasound Data Highly Increases Doppler and fUltrasound Sensitivity. 2015; 34:2271-85. doi: 10.1109/TMI.2015.2428634\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02150993\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00657397\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"27770695\",\n",
      "        \"title\": \"Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial).\",\n",
      "        \"authors\": \"Carrieri P; Vilotitch A; Nordmann S; Lions C; Michel L; Mora M; Morel A; Maradan G; Spire B; Roux P; Methaville Study Group\",\n",
      "        \"doi\": \"10.1016/j.drugpo.2016.08.005\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Carrieri P, et al. Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial). Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial). 2017; 39:86-91. doi: 10.1016/j.drugpo.2016.08.005\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25393311\",\n",
      "        \"title\": \"Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville).\",\n",
      "        \"authors\": \"Carrieri PM; Michel L; Lions C; Cohen J; Vray M; Mora M; Marcellin F; Spire B; Morel A; Roux P; Methaville Study Group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0112328\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Pragmatic Clinical Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Carrieri PM, et al. Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville). Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville). 2014; 9:e112328. doi: 10.1371/journal.pone.0112328\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25209306\",\n",
      "        \"title\": \"Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions.\",\n",
      "        \"authors\": \"Roux P; Lions C; Michel L; Mora M; Daulou\\u00e8de JP; Marcellin F; Spire B; Morel A; Carrieri PM; ANRS Methaville study group\",\n",
      "        \"doi\": \"10.1186/1747-597X-9-37\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Roux P, et al. Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions. Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions. 2014; 9:37. doi: 10.1186/1747-597X-9-37\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22741944\",\n",
      "        \"title\": \"Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial.\",\n",
      "        \"authors\": \"Roux P; Michel L; Cohen J; Mora M; Morel A; Aubertin JF; Desenclos JC; Spire B; Carrieri PM; ANRS Methaville Study Group\",\n",
      "        \"doi\": \"10.1186/1471-2458-12-488\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Roux P, et al. Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial. Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial. 2012; 12:488. doi: 10.1186/1471-2458-12-488\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24268548\",\n",
      "        \"title\": \"Predictors of non-prescribed opioid use after one year of methadone treatment: an attributable-risk approach (ANRS-Methaville trial).\",\n",
      "        \"authors\": \"Lions C; Carrieri MP; Michel L; Mora M; Marcellin F; Morel A; Spire B; Roux P; Methaville Study Group\",\n",
      "        \"doi\": \"10.1016/j.drugalcdep.2013.10.018\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Lions C, et al. Predictors of non-prescribed opioid use after one year of methadone treatment: an attributable-risk approach (ANRS-Methaville trial). Predictors of non-prescribed opioid use after one year of methadone treatment: an attributable-risk approach (ANRS-Methaville trial). 2014; 135:1-8. doi: 10.1016/j.drugalcdep.2013.10.018\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27048152\",\n",
      "        \"title\": \"Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study).\",\n",
      "        \"authors\": \"Roux P; Lions C; Vilotitch A; Michel L; Mora M; Maradan G; Marcellin F; Spire B; Morel A; Carrieri PM; ANRS Methaville study group\",\n",
      "        \"doi\": \"10.1186/s12954-016-0100-7\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Roux P, et al. Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study). Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study). 2016; 13:12. doi: 10.1186/s12954-016-0100-7\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03137797\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"24058636\",\n",
      "        \"title\": \"Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 \\u00abCOPANA\\u00bb cohort study.\",\n",
      "        \"authors\": \"Legeai C; Vigouroux C; Souberbielle JC; Bouchaud O; Boufassa F; Bastard JP; Carlier R; Capeau J; Goujard C; Meyer L; Viard JP; ANRS-COPANA Cohort Study Group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0074868\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Legeai C, et al. Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 \\u00abCOPANA\\u00bb cohort study. Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 \\u00abCOPANA\\u00bb cohort study. 2013; 8:e74868. doi: 10.1371/journal.pone.0074868\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27509048\",\n",
      "        \"title\": \"Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset.\",\n",
      "        \"authors\": \"Ploquin MJ; Madec Y; Casrouge A; Huot N; Passaes C; L\\u00e9curoux C; Essat A; Boufassa F; Jacquelin B; Jochems SP; Petitjean G; Angin M; G\\u00e4rtner K; Garcia-Tellez T; No\\u00ebl N; Booiman T; Boeser-Nunnink BD; Roques P; Saez-Cirion A; Vaslin B; Dereudre-Bosquet N; Barr\\u00e9-Sinoussi F; Ghislain M; Rouzioux C; Lambotte O; Albert ML; Goujard C; Kootstra N; Meyer L; M\\u00fcller-Trutwin MC\",\n",
      "        \"doi\": \"10.1371/journal.ppat.1005774\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Ploquin MJ, et al. Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset. Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset. 2016; 12:e1005774. doi: 10.1371/journal.ppat.1005774\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22267473\",\n",
      "        \"title\": \"Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort.\",\n",
      "        \"authors\": \"Boufassa F; Goujard C; Viard JP; Carlier R; Lefebvre B; Yeni P; Bouchaud O; Capeau J; Meyer L; Vigouroux C; ANRS COPANA Cohort Study Group\",\n",
      "        \"doi\": \"10.3851/IMP1916\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Boufassa F, et al. Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort. Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort. 2012; 17:91-100. doi: 10.3851/IMP1916\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23079802\",\n",
      "        \"title\": \"Does pregnancy affect the early response to cART?\",\n",
      "        \"authors\": \"Rachas A; Warszawski J; Le Chenadec J; Legeai C; Teglas JP; Goujard C; Rouzioux C; Mandelbrot L; Tubiana R; Meyer L\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32835ac8bc\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Rachas A, et al. Does pregnancy affect the early response to cART?. Does pregnancy affect the early response to cART?. 2013; 27:357-67. doi: 10.1097/QAD.0b013e32835ac8bc\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22008658\",\n",
      "        \"title\": \"Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use.\",\n",
      "        \"authors\": \"Dray-Spira R; Legeai C; Le Den M; Bou\\u00e9 F; Lascoux-Combe C; Simon A; May T; Goujard C; Meyer L; ANRS-COPANA Cohort Study Group\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32834dcf61\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Dray-Spira R, et al. Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use. Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use. 2012; 26:207-15. doi: 10.1097/QAD.0b013e32834dcf61\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25573889\",\n",
      "        \"title\": \"Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART.\",\n",
      "        \"authors\": \"El Khoury P; Ghislain M; Villard EF; Le Goff W; Lascoux-Combe C; Yeni P; Meyer L; Vigouroux C; Goujard C; Guerin M\",\n",
      "        \"doi\": \"10.1194/jlr.M054510\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"El Khoury P, et al. Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART. Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART. 2015; 56:692-702. doi: 10.1194/jlr.M054510\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26636578\",\n",
      "        \"title\": \"Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities.\",\n",
      "        \"authors\": \"Ghislain M; Bastard JP; Meyer L; Capeau J; Fellahi S; G\\u00e9rard L; May T; Simon A; Vigouroux C; Goujard C; ANRS-COPANA Cohort Study Group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0144317\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Ghislain M, et al. Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities. Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities. 2015; 10:e0144317. doi: 10.1371/journal.pone.0144317\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23936509\",\n",
      "        \"title\": \"Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts.\",\n",
      "        \"authors\": \"Krastinova E; Seng R; Yeni P; Viard JP; Vittecoq D; Lascoux-Combe C; Fourn E; Pahlavan G; Delfraissy JF; Goujard C; Meyer L; ANRS PRIMO and COPANA Cohorts\",\n",
      "        \"doi\": \"10.1371/journal.pone.0071473\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Krastinova E, et al. Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts. Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts. 2013; 8:e71473. doi: 10.1371/journal.pone.0071473\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24465584\",\n",
      "        \"title\": \"Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration.\",\n",
      "        \"authors\": \"Boufassa F; Lechenadec J; Meyer L; Costagliola D; Hunt PW; Pereyra F; Deeks S; Pancino G; Taulera O; Lichterfeld M; Delobel P; Saez-Cirion A; Lambotte O; ANRS CO18 HIV Controllers Cohort; Cascade Collaboration in Eurocoord; SCOPE Cohort; International HIV Controllers Study\",\n",
      "        \"doi\": \"10.1371/journal.pone.0085516\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Boufassa F, et al. Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration. Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration. 2014; 9:e85516. doi: 10.1371/journal.pone.0085516\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01167283\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02014883\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26536893\",\n",
      "        \"title\": \"Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency.\",\n",
      "        \"authors\": \"Mochel F; Hainque E; Gras D; Adanyeguh IM; Caillet S; H\\u00e9ron B; Roubertie A; Kaphan E; Valabregue R; Rinaldi D; Vuillaumier S; Schiffmann R; Ottolenghi C; Hogrel JY; Servais L; Roze E\",\n",
      "        \"doi\": \"10.1136/jnnp-2015-311475\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mochel F, et al. Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency. Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency. 2016; 87:550-3. doi: 10.1136/jnnp-2015-311475\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02931097\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02093754\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00116454\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03954054\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"35012570\",\n",
      "        \"title\": \"Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER).\",\n",
      "        \"authors\": \"Antwerpes S; Costa M; Coste M; Bureau M; Maradan G; Cutarella C; Leloutre J; Riccobono-Soulier O; Hedoire S; Frot E; Vernier F; Vassas-Goyard S; Barr\\u00e9 T; Casanova D; Carrieri P\",\n",
      "        \"doi\": \"10.1186/s12954-021-00587-0\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Antwerpes S, et al. Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER). Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER). 2022; 19:2. doi: 10.1186/s12954-021-00587-0\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02329054\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26930627\",\n",
      "        \"title\": \"Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.\",\n",
      "        \"authors\": \"Sissoko D; Laouenan C; Folkesson E; M'Lebing AB; Beavogui AH; Baize S; Camara AM; Maes P; Shepherd S; Danel C; Carazo S; Conde MN; Gala JL; Colin G; Savini H; Bore JA; Le Marcis F; Koundouno FR; Petitjean F; Lamah MC; Diederich S; Tounkara A; Poelart G; Berbain E; Dindart JM; Duraffour S; Lefevre A; Leno T; Peyrouset O; Irenge L; Bangoura N; Palich R; Hinzmann J; Kraus A; Barry TS; Berette S; Bongono A; Camara MS; Chanfreau Munoz V; Doumbouya L; Souley Harouna; Kighoma PM; Koundouno FR; R\\u00e9n\\u00e9 Lolamou; Loua CM; Massala V; Moumouni K; Provost C; Samake N; Sekou C; Soumah A; Arnould I; Komano MS; Gustin L; Berutto C; Camara D; Camara FS; Colpaert J; Delamou L; Jansson L; Kourouma E; Loua M; Malme K; Manfrin E; Maomou A; Milinouno A; Ombelet S; Sidiboun AY; Verreckt I; Yombouno P; Bocquin A; Carbonnelle C; Carmoi T; Frange P; Mely S; Nguyen VK; Pannetier D; Taburet AM; Treluyer JM; Kolie J; Moh R; Gonzalez MC; Kuisma E; Liedigk B; Ngabo D; Rudolf M; Thom R; Kerber R; Gabriel M; Di Caro A; W\\u00f6lfel R; Badir J; Bentahir M; Deccache Y; Dumont C; Durant JF; El Bakkouri K; Gasasira Uwamahoro M; Smits B; Toufik N; Van Cauwenberghe S; Ezzedine K; D'Ortenzio E; Pizarro L; Etienne A; Guedj J; Fizet A; Barte de Sainte Fare E; Murgue B; Tran-Minh T; Rapp C; Piguet P; Poncin M; Draguez B; Allaford Duverger T; Barbe S; Baret G; Defourny I; Carroll M; Raoul H; Augier A; Eholie SP; Yazdanpanah Y; Levy-Marchal C; Antierrens A; Van Herp M; G\\u00fcnther S; de Lamballerie X; Ke\\u00efta S; Mentre F; Anglaret X; Malvy D; JIKI Study Group\",\n",
      "        \"doi\": \"10.1371/journal.pmed.1001967\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sissoko D, et al. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. 2016; 13:e1001967. doi: 10.1371/journal.pmed.1001967\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28231247\",\n",
      "        \"title\": \"Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted.\",\n",
      "        \"authors\": \"Nguyen TH; Guedj J; Anglaret X; Laou\\u00e9nan C; Madelain V; Taburet AM; Baize S; Sissoko D; Pastorino B; Rodallec A; Piorkowski G; Carazo S; Conde MN; Gala JL; Bore JA; Carbonnelle C; Jacquot F; Raoul H; Malvy D; de Lamballerie X; Mentr\\u00e9 F; JIKI study group\",\n",
      "        \"doi\": \"10.1371/journal.pntd.0005389\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nguyen TH, et al. Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted. Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted. 2017; 11:e0005389. doi: 10.1371/journal.pntd.0005389\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25435054\",\n",
      "        \"title\": \"Dose regimen of favipiravir for Ebola virus disease.\",\n",
      "        \"authors\": \"Mentr\\u00e9 F; Taburet AM; Guedj J; Anglaret X; Ke\\u00efta S; de Lamballerie X; Malvy D\",\n",
      "        \"doi\": \"10.1016/S1473-3099(14)71047-3\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Letter\"\n",
      "        ],\n",
      "        \"citation\": \"Mentr\\u00e9 F, et al. Dose regimen of favipiravir for Ebola virus disease. Dose regimen of favipiravir for Ebola virus disease. 2015; 15:150-1. doi: 10.1016/S1473-3099(14)71047-3\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27046271\",\n",
      "        \"title\": \"Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.\",\n",
      "        \"authors\": \"Sissoko D; Laouenan C; Folkesson E; M'Lebing AB; Beavogui AH; Baize S; Camara AM; Maes P; Shepherd S; Danel C; Carazo S; Conde MN; Gala JL; Colin G; Savini H; Bore JA; Le Marcis F; Koundouno FR; Petitjean F; Lamah MC; Diederich S; Tounkara A; Poelart G; Berbain E; Dindart JM; Duraffour S; Lefevre A; Leno T; Peyrouset O; Irenge L; Bangoura N; Palich R; Hinzmann J; Kraus A; Barry TS; Berette S; Bongono A; Camara MS; Munoz VC; Doumbouya L; Harouna S; Kighoma PM; Koundouno FR; Lolamou R; Loua CM; Massala V; Moumouni K; Provost C; Samake N; Sekou C; Soumah A; Arnould I; Komano MS; Gustin L; Berutto C; Camara D; Camara FS; Colpaert J; Delamou L; Jansson L; Kourouma E; Loua M; Malme K; Manfrin E; Maomou A; Milinouno A; Ombelet S; Sidiboun AY; Verreckt I; Yombouno P; Bocquin A; Carbonnelle C; Carmoi T; Frange P; Mely S; Nguyen VK; Pannetier D; Taburet AM; Treluyer JM; Kolie J; Moh R; Gonzalez MC; Kuisma E; Liedigk B; Ngabo D; Rudolf M; Thom R; Kerber R; Gabriel M; Di Caro A; W\\u00f6lfel R; Badir J; Bentahir M; Deccache Y; Dumont C; Durant JF; El Bakkouri K; Uwamahoro MG; Smits B; Toufik N; Van Cauwenberghe S; Ezzedine K; D'Ortenzio E; Pizarro L; Etienne A; Guedj J; Fizet A; de Sainte Fare EB; Murgue B; Tran-Minh T; Rapp C; Piguet P; Poncin M; Draguez B; Duverger TA; Barbe S; Baret G; Defourny I; Carroll M; Raoul H; Augier A; Eholie SP; Yazdanpanah Y; Levy-Marchal C; Antierrens A; Van Herp M; G\\u00fcnther S; de Lamballerie X; Ke\\u00efta S; Mentre F; Anglaret X; Malvy D; JIKI Study Group\",\n",
      "        \"doi\": \"10.1371/journal.pmed.1002009\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Published Erratum\"\n",
      "        ],\n",
      "        \"citation\": \"Sissoko D, et al. Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. 2016; 13:e1002009. doi: 10.1371/journal.pmed.1002009\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04842851\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00118677\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"20657770\",\n",
      "        \"title\": \"Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy.\",\n",
      "        \"authors\": \"Weiss L; Piketty C; Assoumou L; Didier C; Caccavelli L; Donkova-Petrini V; Levy Y; Girard PM; Burgard M; Viard JP; Rouzioux C; Costagliola D; ANRS 116 SALTO study group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0011659\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Weiss L, et al. Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy. Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy. 2010; 5:e11659. doi: 10.1371/journal.pone.0011659\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01880151\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00495651\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"35093007\",\n",
      "        \"title\": \"Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adults.\",\n",
      "        \"authors\": \"Moh DR; Ntakp\\u00e9 JB; Gabillard D; Yayo-Emieme AA; Badj\\u00e9 A; Kouame GM; d'Aquin TT; Danel C; Anglaret X; Eholi\\u00e9 SP\",\n",
      "        \"doi\": \"10.1186/s12879-022-07082-2\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Moh DR, et al. Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adults. Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adults. 2022; 22:100. doi: 10.1186/s12879-022-07082-2\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24985779\",\n",
      "        \"title\": \"Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24-month prospective study in C\\u00f4te d'Ivoire.\",\n",
      "        \"authors\": \"Jean K; Gabillard D; Moh R; Danel C; Desgr\\u00e9es-du-Lo\\u00fb A; N'takpe JB; Le Carrou J; Badj\\u00e9 A; Eholi\\u00e9 S; Lert F; Anglaret X; Dray-Spira R\",\n",
      "        \"doi\": \"10.7448/IAS.17.1.18977\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Jean K, et al. Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24-month prospective study in C\\u00f4te d'Ivoire. Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24-month prospective study in C\\u00f4te d'Ivoire. 2014; 17:18977. doi: 10.7448/IAS.17.1.18977\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29297443\",\n",
      "        \"title\": \"Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults.\",\n",
      "        \"authors\": \"Moh R; Badj\\u00e9 A; N'takp\\u00e9 JB; Kouam\\u00e9 GM; Gabillard D; Ouassa T; Ouattara E; Le Carrou J; Bohoussou F; Messou E; Eholi\\u00e9 S; Anglaret X; Danel C\",\n",
      "        \"doi\": \"10.5588/ijtld.17.0016\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Moh R, et al. Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults. Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults. 2017; 21:1237-1244. doi: 10.5588/ijtld.17.0016\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26193126\",\n",
      "        \"title\": \"A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.\",\n",
      "        \"authors\": \"TEMPRANO ANRS 12136 Study Group; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakp\\u00e9 JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouam\\u00e9 A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidib\\u00e9 B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouam\\u00e9 E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundz\\u00e9 S; Hawerlander D; Ani A; Demb\\u00e9l\\u00e9 F; Kon\\u00e9 F; Gu\\u00e9hi C; Kanga C; Koule S; S\\u00e9ri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleou\\u00e9 G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semd\\u00e9 C; Kouame A; Massumbuko JM; Ch\\u00eane G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholi\\u00e9 SP; Anglaret X\",\n",
      "        \"doi\": \"10.1056/NEJMoa1507198\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"TEMPRANO ANRS 12136 Study Group, et al. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. 2015; 373:808-22. doi: 10.1056/NEJMoa1507198\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29020361\",\n",
      "        \"title\": \"Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.\",\n",
      "        \"authors\": \"Kouam\\u00e9 GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emi\\u00e8me A; Maylin S; Chekaraou MA; Eholi\\u00e9 SP; Zoulim F; Lacombe K; Anglaret X; Danel C; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 12136 Temprano and ANRS 12240 VarBVA Study Groups\",\n",
      "        \"doi\": \"10.1093/cid/cix747\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kouam\\u00e9 GM, et al. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication. 2018; 66:112-120. doi: 10.1093/cid/cix747\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25330161\",\n",
      "        \"title\": \"Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in C\\u00f4te d'Ivoire, West Africa.\",\n",
      "        \"authors\": \"Danel C; Kabran M; Inwoley A; Badje A; Herrmann JL; Moh R; Lecarrou J; Gabillard D; Ntakpe JB; Deschamps N; Ouattara E; Perronne C; Eholie S; Anglaret X\",\n",
      "        \"doi\": \"10.1371/journal.pone.0107245\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Danel C, et al. Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in C\\u00f4te d'Ivoire, West Africa. Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in C\\u00f4te d'Ivoire, West Africa. 2014; 9:e107245. doi: 10.1371/journal.pone.0107245\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23639243\",\n",
      "        \"title\": \"Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts.\",\n",
      "        \"authors\": \"Ouattara E; Danel C; Moh R; Gabillard D; Peytavin G; Konan R; Carrou JL; Bohoussou F; Eholie SP; Anglaret X\",\n",
      "        \"doi\": \"10.7448/IAS.16.1.18059\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Ouattara E, et al. Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts. Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts. 2013; 16:18059. doi: 10.7448/IAS.16.1.18059\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02481453\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"24975859\",\n",
      "        \"title\": \"Evaluation and construction of diagnostic criteria for inclusion body myositis.\",\n",
      "        \"authors\": \"Lloyd TE; Mammen AL; Amato AA; Weiss MD; Needham M; Greenberg SA\",\n",
      "        \"doi\": \"10.1212/WNL.0000000000000642\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Lloyd TE, et al. Evaluation and construction of diagnostic criteria for inclusion body myositis. Evaluation and construction of diagnostic criteria for inclusion body myositis. 2014; 83:426-33. doi: 10.1212/WNL.0000000000000642\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20413309\",\n",
      "        \"title\": \"International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009.\",\n",
      "        \"authors\": \"Benveniste O; Hilton-Jones D\",\n",
      "        \"doi\": \"10.1016/j.nmd.2010.03.014\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Congress\"\n",
      "        ],\n",
      "        \"citation\": \"Benveniste O and Hilton-Jones D. International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009. International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009. 2010; 20:414-21. doi: 10.1016/j.nmd.2010.03.014\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"38273639\",\n",
      "        \"title\": \"Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial.\",\n",
      "        \"authors\": \"Benveniste O; Hogrel JY; Belin L; Annoussamy M; Bachasson D; Rigolet A; Laforet P; Dzangu\\u00e9-Tchoupou G; Salem JE; Nguyen LS; Stojkovic T; Zahr N; Hervier B; Landon-Cardinal O; Behin A; Guilloux E; Reyngoudt H; Amelin D; Uruha A; Mariampillai K; Marty B; Eymard B; Hulot JS; Greenberg SA; Carlier PG; Allenbach Y\",\n",
      "        \"doi\": \"10.1016/S2665-9913(20)30280-0\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Benveniste O, et al. Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial. Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial. 2021; 3:e40-e48. doi: 10.1016/S2665-9913(20)30280-0\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00421551\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29767684\",\n",
      "        \"title\": \"Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies.\",\n",
      "        \"authors\": \"Lambert-Niclot S; Grude M; Meynard JL; Marcelin AG; Valantin MA; Flandre P; Izopet J; Moinot L; Bouteloup V; Calvez V; Katlama C; Girard PM; Morand-Joubert L\",\n",
      "        \"doi\": \"10.1093/cid/ciy382\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Lambert-Niclot S, et al. Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. 2018; 67:1883-1889. doi: 10.1093/cid/ciy382\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20802297\",\n",
      "        \"title\": \"Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136.\",\n",
      "        \"authors\": \"Katlama C; Valantin MA; Algarte-Genin M; Duvivier C; Lambert-Niclot S; Girard PM; Molina JM; Hoen B; Pakianather S; Peytavin G; Marcelin AG; Flandre P\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32833dec20\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Katlama C, et al. Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136. Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136. 2010; 24:2365-74. doi: 10.1097/QAD.0b013e32833dec20\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22848481\",\n",
      "        \"title\": \"Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks.\",\n",
      "        \"authors\": \"Lambert-Niclot S; Flandre P; Valantin MA; Soulie C; Fourati S; Wirden M; Sayon S; Pakianather S; Bocket L; Masquelier B; Dos Santos G; Katlama C; Calvez V; Marcelin AG\",\n",
      "        \"doi\": \"10.1371/journal.pone.0041390\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Lambert-Niclot S, et al. Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks. Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks. 2012; 7:e41390. doi: 10.1371/journal.pone.0041390\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02658253\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"32032566\",\n",
      "        \"title\": \"PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study.\",\n",
      "        \"authors\": \"Sirima SB; Richert L; Ch\\u00eane A; Konate AT; Campion C; Dechavanne S; Semblat JP; Benhamouda N; Bahuaud M; Loulergue P; Ou\\u00e9draogo A; N\\u00e9bi\\u00e9 I; Kabore M; Kargougou D; Barry A; Ouattara SM; Boilet V; Allais F; Roguet G; Havelange N; Lopez-Perez E; Kuppers A; Konat\\u00e9 E; Roussillon C; Kant\\u00e9 M; Belarbi L; Diarra A; Henry N; Soulama I; Ou\\u00e9draogo A; Esperou H; Leroy O; Batteux F; Tartour E; Viebig NK; Thiebaut R; Launay O; Gamain B\",\n",
      "        \"doi\": \"10.1016/S1473-3099(19)30739-X\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sirima SB, et al. PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study. PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study. 2020; 20:585-597. doi: 10.1016/S1473-3099(19)30739-X\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33717176\",\n",
      "        \"title\": \"Progress and Insights Toward an Effective Placental Malaria Vaccine.\",\n",
      "        \"authors\": \"Gamain B; Ch\\u00eane A; Viebig NK; Tuikue Ndam N; Nielsen MA\",\n",
      "        \"doi\": \"10.3389/fimmu.2021.634508\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Gamain B, et al. Progress and Insights Toward an Effective Placental Malaria Vaccine. Progress and Insights Toward an Effective Placental Malaria Vaccine. 2021; 12:634508. doi: 10.3389/fimmu.2021.634508\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01688453\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29696179\",\n",
      "        \"title\": \"Reducing social inequalities in access to overweight and obesity care management for adolescents: The PRALIMAP-IN\\u00c8S trial protocol and inclusion data analysis.\",\n",
      "        \"authors\": \"Legrand K; Lecomte E; Langlois J; Muller L; Saez L; Quinet MH; B\\u00f6hme P; Spitz E; Omorou AY; Brian\\u00e7on S; PRALIMAP-IN\\u00c8S trial group\",\n",
      "        \"doi\": \"10.1016/j.conctc.2017.05.010\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Legrand K, et al. Reducing social inequalities in access to overweight and obesity care management for adolescents: The PRALIMAP-IN\\u00c8S trial protocol and inclusion data analysis. Reducing social inequalities in access to overweight and obesity care management for adolescents: The PRALIMAP-IN\\u00c8S trial protocol and inclusion data analysis. 2017; 7:141-157. doi: 10.1016/j.conctc.2017.05.010\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32097754\",\n",
      "        \"title\": \"Physical activity rather than sedentary behaviour is socially determined in French adolescents with overweight and obesity.\",\n",
      "        \"authors\": \"Omorou AY; Manneville F; Langlois J; Legrand K; B\\u00f6hme P; Muller L; Guillemin F; Brian\\u00e7on S; Lecomte E; PRALIMAP-IN\\u00c8S Trial Group\",\n",
      "        \"doi\": \"10.1016/j.ypmed.2020.106043\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Omorou AY, et al. Physical activity rather than sedentary behaviour is socially determined in French adolescents with overweight and obesity. Physical activity rather than sedentary behaviour is socially determined in French adolescents with overweight and obesity. 2020; 134:106043. doi: 10.1016/j.ypmed.2020.106043\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29934380\",\n",
      "        \"title\": \"Using facilitator-receiver peer dyads matched according to socioeconomic status to promote behaviour change in overweight adolescents: a feasibility study.\",\n",
      "        \"authors\": \"Saez L; Legrand K; Alleyrat C; Ramisasoa S; Langlois J; Muller L; Omorou AY; De Lavenne R; Kivits J; Lecomte E; Brian\\u00e7on S; PRALIMAP-IN\\u00c8S Trial Group\",\n",
      "        \"doi\": \"10.1136/bmjopen-2017-019731\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Saez L, et al. Using facilitator-receiver peer dyads matched according to socioeconomic status to promote behaviour change in overweight adolescents: a feasibility study. Using facilitator-receiver peer dyads matched according to socioeconomic status to promote behaviour change in overweight adolescents: a feasibility study. 2018; 8:e019731. doi: 10.1136/bmjopen-2017-019731\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29776897\",\n",
      "        \"title\": \"Reach and Acceptability of a Mobile Reminder Strategy and Facebook Group Intervention for Weight Management in Less Advantaged Adolescents: Insights From the PRALIMAP-IN\\u00c8S Trial.\",\n",
      "        \"authors\": \"Saez L; Langlois J; Legrand K; Quinet MH; Lecomte E; Omorou AY; Brian\\u00e7on S; PRALIMAP-IN\\u00c8S Trial Group\",\n",
      "        \"doi\": \"10.2196/mhealth.7657\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Saez L, et al. Reach and Acceptability of a Mobile Reminder Strategy and Facebook Group Intervention for Weight Management in Less Advantaged Adolescents: Insights From the PRALIMAP-IN\\u00c8S Trial. Reach and Acceptability of a Mobile Reminder Strategy and Facebook Group Intervention for Weight Management in Less Advantaged Adolescents: Insights From the PRALIMAP-IN\\u00c8S Trial. 2018; 6:e110. doi: 10.2196/mhealth.7657\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34087324\",\n",
      "        \"title\": \"Sociodemographic and psychological characteristics associated with discrepancy between body satisfaction and weight change among adolescents.\",\n",
      "        \"authors\": \"Manneville F; Omorou AY; Legrand K; Lecomte E; Rydberg JA; Brian\\u00e7on S; Guillemin F; PRALIMAP Trial Group\",\n",
      "        \"doi\": \"10.1016/j.ypmed.2021.106668\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Manneville F, et al. Sociodemographic and psychological characteristics associated with discrepancy between body satisfaction and weight change among adolescents. Sociodemographic and psychological characteristics associated with discrepancy between body satisfaction and weight change among adolescents. 2021; 150:106668. doi: 10.1016/j.ypmed.2021.106668\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35272723\",\n",
      "        \"title\": \"Behavioural risk patterns in adolescents with excess weight participating in the PRALIMAP-IN\\u00c8S trial.\",\n",
      "        \"authors\": \"Julia C; Omorou A; Lecomte E; Langlois J; Touvier M; Hercberg S; Brian\\u00e7on S; Kesse-Guyot E; Guillemin F; PRALIMAP-IN\\u00c8S Trial Group\",\n",
      "        \"doi\": \"10.1017/S136898002200057X\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Julia C, et al. Behavioural risk patterns in adolescents with excess weight participating in the PRALIMAP-IN\\u00c8S trial. Behavioural risk patterns in adolescents with excess weight participating in the PRALIMAP-IN\\u00c8S trial. 2023; 26:96-105. doi: 10.1017/S136898002200057X\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02408354\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"28969699\",\n",
      "        \"title\": \"A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood.\",\n",
      "        \"authors\": \"Hainque E; Caillet S; Leroy S; Flamand-Roze C; Adanyeguh I; Charbonnier-Beaupel F; Retail M; Le Toullec B; Atencio M; Rivaud-P\\u00e9choux S; Brochard V; Habarou F; Ottolenghi C; Cormier F; M\\u00e9neret A; Ruiz M; Doulazmi M; Roubergue A; Corvol JC; Vidailhet M; Mochel F; Roze E\",\n",
      "        \"doi\": \"10.1186/s13023-017-0713-2\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Hainque E, et al. A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood. A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood. 2017; 12:160. doi: 10.1186/s13023-017-0713-2\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02157311\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29186458\",\n",
      "        \"title\": \"Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial.\",\n",
      "        \"authors\": \"de Truchis P; Assoumou L; Landman R; Mathez D; Le D\\u00fb D; Bellet J; Amat K; Katlama C; Gras G; Bouchaud O; Duracinsky M; Abe E; Alvarez JC; Izopet J; Saillard J; Melchior JC; Leibowitch J; Costagliola D; Girard PM; Perronne C; ANRS 162-4D Study Group\",\n",
      "        \"doi\": \"10.1093/jac/dkx434\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"de Truchis P, et al. Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial. Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial. 2018; 73:738-747. doi: 10.1093/jac/dkx434\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04288128\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"38421662\",\n",
      "        \"title\": \"ATXN7-Related Cone-Rod Dystrophy: The Integrated Functional Evaluation of the Cerebellum (CERMOI) Study.\",\n",
      "        \"authors\": \"Nassisi M; Coarelli G; Blanchard B; Dubec-Fleury C; Drine K; Kitic N; Sancho S; Hilab R; Tezenas du Montcel S; Junge C; Lane R; Arnold HM; Durr A; Audo I\",\n",
      "        \"doi\": \"10.1001/jamaophthalmol.2024.0001\",\n",
      "        \"year\": \"2024\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Nassisi M, et al. ATXN7-Related Cone-Rod Dystrophy: The Integrated Functional Evaluation of the Cerebellum (CERMOI) Study. ATXN7-Related Cone-Rod Dystrophy: The Integrated Functional Evaluation of the Cerebellum (CERMOI) Study. 2024; (unknown volume):(unknown pages). doi: 10.1001/jamaophthalmol.2024.0001\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"38419144\",\n",
      "        \"title\": \"Digital Gait Measures Capture 1-Year Progression in Early-Stage Spinocerebellar Ataxia Type 2.\",\n",
      "        \"authors\": \"Seemann J; Daghsen L; Cazier M; Lamy JC; Welter ML; Giese MA; Synofzik M; Durr A; Ilg W; Coarelli G\",\n",
      "        \"doi\": \"10.1002/mds.29757\",\n",
      "        \"year\": \"2024\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Seemann J, et al. Digital Gait Measures Capture 1-Year Progression in Early-Stage Spinocerebellar Ataxia Type 2. Digital Gait Measures Capture 1-Year Progression in Early-Stage Spinocerebellar Ataxia Type 2. 2024; (unknown volume):(unknown pages). doi: 10.1002/mds.29757\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02721745\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01494961\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"34329355\",\n",
      "        \"title\": \"Couple oriented counselling improves male partner involvement in sexual and reproductive health of a couple: Evidence from the ANRS PRENAHTEST randomized trial.\",\n",
      "        \"authors\": \"Kengne-Nde C; Tejiokem MC; Orne-Gliemann J; Melingui B; Koki Ndombo P; Essounga NA; Bissek AC; Cauchemez S; Tchendjou PT\",\n",
      "        \"doi\": \"10.1371/journal.pone.0255330\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kengne-Nde C, et al. Couple oriented counselling improves male partner involvement in sexual and reproductive health of a couple: Evidence from the ANRS PRENAHTEST randomized trial. Couple oriented counselling improves male partner involvement in sexual and reproductive health of a couple: Evidence from the ANRS PRENAHTEST randomized trial. 2021; 16:e0255330. doi: 10.1371/journal.pone.0255330\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23343912\",\n",
      "        \"title\": \"Increasing HIV testing among male partners.\",\n",
      "        \"authors\": \"Orne-Gliemann J; Balestre E; Tchendjou P; Miric M; Darak S; Butsashvili M; Perez-Then E; Eboko F; Plazy M; Kulkarni S; Desgr\\u00e9es du Lo\\u00fb A; Dabis F; Prenahtest ANRS 12127 Study Group\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32835f1d8c\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Orne-Gliemann J, et al. Increasing HIV testing among male partners. Increasing HIV testing among male partners. 2013; 27:1167-77. doi: 10.1097/QAD.0b013e32835f1d8c\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20403152\",\n",
      "        \"title\": \"Couple-oriented prenatal HIV counseling for HIV primary prevention: an acceptability study.\",\n",
      "        \"authors\": \"Orne-Gliemann J; Tchendjou PT; Miric M; Gadgil M; Butsashvili M; Eboko F; Perez-Then E; Darak S; Kulkarni S; Kamkamidze G; Balestre E; du Lo\\u00fb AD; Dabis F\",\n",
      "        \"doi\": \"10.1186/1471-2458-10-197\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Evaluation Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Orne-Gliemann J, et al. Couple-oriented prenatal HIV counseling for HIV primary prevention: an acceptability study. Couple-oriented prenatal HIV counseling for HIV primary prevention: an acceptability study. 2010; 10:197. doi: 10.1186/1471-2458-10-197\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29178852\",\n",
      "        \"title\": \"Couples HIV counselling and couple relationships in India, Georgia and the Dominican Republic.\",\n",
      "        \"authors\": \"Tiendrebeogo T; Plazy M; Darak S; Miric M; Perez-Then E; Butsashvili M; Tchendjou P; Dabis F; Orne-Gliemann J\",\n",
      "        \"doi\": \"10.1186/s12889-017-4901-8\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Tiendrebeogo T, et al. Couples HIV counselling and couple relationships in India, Georgia and the Dominican Republic. Couples HIV counselling and couple relationships in India, Georgia and the Dominican Republic. 2017; 17:901. doi: 10.1186/s12889-017-4901-8\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21857289\",\n",
      "        \"title\": \"Factors associated with history of HIV testing among pregnant women and their partners in Cameroon: baseline data from a Behavioral Intervention Trial (ANRS 12127 Prenahtest).\",\n",
      "        \"authors\": \"Tchendjou PT; Koki PN; Eboko F; Malateste K; Essounga AN; Amassana D; Mossus T; Tejiokem M; Boisier P; Orne-Gliemann J\",\n",
      "        \"doi\": \"10.1097/QAI.0b013e31821ec6e2\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Tchendjou PT, et al. Factors associated with history of HIV testing among pregnant women and their partners in Cameroon: baseline data from a Behavioral Intervention Trial (ANRS 12127 Prenahtest). Factors associated with history of HIV testing among pregnant women and their partners in Cameroon: baseline data from a Behavioral Intervention Trial (ANRS 12127 Prenahtest). 2011; 57 Suppl 1:S9-15. doi: 10.1097/QAI.0b013e31821ec6e2\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02833961\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"36318030\",\n",
      "        \"title\": \"Longitudinal Monitoring of Microstructural Alterations in Cerebral Ischemia with in Vivo Diffusion-weighted MR Spectroscopy.\",\n",
      "        \"authors\": \"Genovese G; Diaz-Fernandez B; Lejeune FX; Ronen I; Marja\\u0144ska M; Yahia-Cherif L; Leh\\u00e9ricy S; Branzoli F; Rosso C\",\n",
      "        \"doi\": \"10.1148/radiol.220430\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Research Support, N.I.H., Extramural\"\n",
      "        ],\n",
      "        \"citation\": \"Genovese G, et al. Longitudinal Monitoring of Microstructural Alterations in Cerebral Ischemia with in Vivo Diffusion-weighted MR Spectroscopy. Longitudinal Monitoring of Microstructural Alterations in Cerebral Ischemia with in Vivo Diffusion-weighted MR Spectroscopy. 2023; 306:e220430. doi: 10.1148/radiol.220430\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02567071\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02453061\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"31381524\",\n",
      "        \"title\": \"Huntington's Disease Clinical Trials Corner: June 2019.\",\n",
      "        \"authors\": \"Rodrigues FB; Ferreira JJ; Wild EJ\",\n",
      "        \"doi\": \"10.3233/JHD-199003\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Rodrigues FB, et al. Huntington's Disease Clinical Trials Corner: June 2019. Huntington's Disease Clinical Trials Corner: June 2019. 2019; 8:363-371. doi: 10.3233/JHD-199003\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01693861\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00272428\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"33738534\",\n",
      "        \"title\": \"The inflammatory potential of the diet is prospectively associated with subjective hearing loss.\",\n",
      "        \"authors\": \"Andreeva VA; P\\u00e9neau S; Julia C; Shivappa N; H\\u00e9bert JR; Wirth MD; Touvier M; Hercberg S; Galan P; Kesse-Guyot E\",\n",
      "        \"doi\": \"10.1007/s00394-021-02531-1\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Andreeva VA, et al. The inflammatory potential of the diet is prospectively associated with subjective hearing loss. The inflammatory potential of the diet is prospectively associated with subjective hearing loss. 2021; 60:3669-3678. doi: 10.1007/s00394-021-02531-1\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26864363\",\n",
      "        \"title\": \"Prospective association between the Dietary Inflammatory Index and mortality: modulation by antioxidant supplementation in the SU.VI.MAX randomized controlled trial.\",\n",
      "        \"authors\": \"Graffouill\\u00e8re L; Deschasaux M; Mariotti F; Neufcourt L; Shivappa N; H\\u00e9bert JR; Wirth MD; Latino-Martel P; Hercberg S; Galan P; Julia C; Kesse-Guyot E; Touvier M\",\n",
      "        \"doi\": \"10.3945/ajcn.115.126243\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Graffouill\\u00e8re L, et al. Prospective association between the Dietary Inflammatory Index and mortality: modulation by antioxidant supplementation in the SU.VI.MAX randomized controlled trial. Prospective association between the Dietary Inflammatory Index and mortality: modulation by antioxidant supplementation in the SU.VI.MAX randomized controlled trial. 2016; 103:878-85. doi: 10.3945/ajcn.115.126243\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24553693\",\n",
      "        \"title\": \"Dietary total and insoluble fiber intakes are inversely associated with prostate cancer risk.\",\n",
      "        \"authors\": \"Deschasaux M; Pouchieu C; His M; Hercberg S; Latino-Martel P; Touvier M\",\n",
      "        \"doi\": \"10.3945/jn.113.189670\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Deschasaux M, et al. Dietary total and insoluble fiber intakes are inversely associated with prostate cancer risk. Dietary total and insoluble fiber intakes are inversely associated with prostate cancer risk. 2014; 144:504-10. doi: 10.3945/jn.113.189670\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31164347\",\n",
      "        \"title\": \"Plasma Metabolomic Signatures Associated with Long-term Breast Cancer Risk in the SU.VI.MAX Prospective Cohort.\",\n",
      "        \"authors\": \"L\\u00e9cuyer L; Dalle C; Lyan B; Demidem A; Rossary A; Vasson MP; Petera M; Lagree M; Ferreira T; Centeno D; Galan P; Hercberg S; Deschasaux M; Partula V; Srour B; Latino-Martel P; Kesse-Guyot E; Druesne-Pecollo N; Durand S; Pujos-Guillot E; Touvier M\",\n",
      "        \"doi\": \"10.1158/1055-9965.EPI-19-0154\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"L\\u00e9cuyer L, et al. Plasma Metabolomic Signatures Associated with Long-term Breast Cancer Risk in the SU.VI.MAX Prospective Cohort. Plasma Metabolomic Signatures Associated with Long-term Breast Cancer Risk in the SU.VI.MAX Prospective Cohort. 2019; 28:1300-1307. doi: 10.1158/1055-9965.EPI-19-0154\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20605091\",\n",
      "        \"title\": \"Incidence of skin cancers during 5-year follow-up after stopping antioxidant vitamins and mineral supplementation.\",\n",
      "        \"authors\": \"Ezzedine K; Latreille J; Kesse-Guyot E; Galan P; Hercberg S; Guinot C; Malvy D\",\n",
      "        \"doi\": \"10.1016/j.ejca.2010.06.008\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Ezzedine K, et al. Incidence of skin cancers during 5-year follow-up after stopping antioxidant vitamins and mineral supplementation. Incidence of skin cancers during 5-year follow-up after stopping antioxidant vitamins and mineral supplementation. 2010; 46:3316-22. doi: 10.1016/j.ejca.2010.06.008\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19828715\",\n",
      "        \"title\": \"Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome.\",\n",
      "        \"authors\": \"Phillips CM; Goumidi L; Bertrais S; Ferguson JF; Field MR; Kelly ED; Peloso GM; Cupples LA; Shen J; Ordovas JM; McManus R; Hercberg S; Portugal H; Lairon D; Planells R; Roche HM\",\n",
      "        \"doi\": \"10.3945/ajcn.2009.28101\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Phillips CM, et al. Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome. Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome. 2009; 90:1665-73. doi: 10.3945/ajcn.2009.28101\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28033414\",\n",
      "        \"title\": \"Effect of Multimorbidity on Health-Related Quality of Life in Adults Aged 55 Years or Older: Results from the SU.VI.MAX 2 Cohort.\",\n",
      "        \"authors\": \"Walker V; Perret-Guillaume C; Kesse-Guyot E; Agrinier N; Hercberg S; Galan P; Assmann KE; Brian\\u00e7on S; Rotonda C\",\n",
      "        \"doi\": \"10.1371/journal.pone.0169282\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Walker V, et al. Effect of Multimorbidity on Health-Related Quality of Life in Adults Aged 55 Years or Older: Results from the SU.VI.MAX 2 Cohort. Effect of Multimorbidity on Health-Related Quality of Life in Adults Aged 55 Years or Older: Results from the SU.VI.MAX 2 Cohort. 2016; 11:e0169282. doi: 10.1371/journal.pone.0169282\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15557412\",\n",
      "        \"title\": \"The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals.\",\n",
      "        \"authors\": \"Hercberg S; Galan P; Preziosi P; Bertrais S; Mennen L; Malvy D; Roussel AM; Favier A; Brian\\u00e7on S\",\n",
      "        \"doi\": \"10.1001/archinte.164.21.2335\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hercberg S, et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. 2004; 164:2335-42. doi: 10.1001/archinte.164.21.2335\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22633793\",\n",
      "        \"title\": \"Adherence to Mediterranean diet reduces the risk of metabolic syndrome: a 6-year prospective study.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Ahluwalia N; Lassale C; Hercberg S; Fezeu L; Lairon D\",\n",
      "        \"doi\": \"10.1016/j.numecd.2012.02.005\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Adherence to Mediterranean diet reduces the risk of metabolic syndrome: a 6-year prospective study. Adherence to Mediterranean diet reduces the risk of metabolic syndrome: a 6-year prospective study. 2013; 23:677-83. doi: 10.1016/j.numecd.2012.02.005\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21955649\",\n",
      "        \"title\": \"Fruit and vegetable intake and cognitive function in the SU.VI.MAX 2 prospective study.\",\n",
      "        \"authors\": \"P\\u00e9neau S; Galan P; Jeandel C; Ferry M; Andreeva V; Hercberg S; Kesse-Guyot E; SU.VI.MAX 2 Research Group\",\n",
      "        \"doi\": \"10.3945/ajcn.111.014712\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"P\\u00e9neau S, et al. Fruit and vegetable intake and cognitive function in the SU.VI.MAX 2 prospective study. Fruit and vegetable intake and cognitive function in the SU.VI.MAX 2 prospective study. 2011; 94:1295-303. doi: 10.3945/ajcn.111.014712\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26962176\",\n",
      "        \"title\": \"The Dietary Inflammatory Index Is Associated with Prostate Cancer Risk in French Middle-Aged Adults in a Prospective Study.\",\n",
      "        \"authors\": \"Graffouill\\u00e8re L; Deschasaux M; Mariotti F; Neufcourt L; Shivappa N; H\\u00e9bert JR; Wirth MD; Latino-Martel P; Hercberg S; Galan P; Julia C; Kesse-Guyot E; Touvier M\",\n",
      "        \"doi\": \"10.3945/jn.115.225623\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Graffouill\\u00e8re L, et al. The Dietary Inflammatory Index Is Associated with Prostate Cancer Risk in French Middle-Aged Adults in a Prospective Study. The Dietary Inflammatory Index Is Associated with Prostate Cancer Risk in French Middle-Aged Adults in a Prospective Study. 2016; 146:785-791. doi: 10.3945/jn.115.225623\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28494135\",\n",
      "        \"title\": \"Prospective association between body mass index at midlife and healthy aging among French adults.\",\n",
      "        \"authors\": \"Ruhunuhewa I; Adjibade M; Andreeva VA; Galan P; Hercberg S; Assmann KE; Kesse-Guyot E\",\n",
      "        \"doi\": \"10.1002/oby.21853\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Ruhunuhewa I, et al. Prospective association between body mass index at midlife and healthy aging among French adults. Prospective association between body mass index at midlife and healthy aging among French adults. 2017; 25:1254-1262. doi: 10.1002/oby.21853\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23284983\",\n",
      "        \"title\": \"Alcohol consumption in midlife and cognitive performance assessed 13 years later in the SU.VI.MAX 2 cohort.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Andreeva VA; Jeandel C; Ferry M; Touvier M; Hercberg S; Galan P\",\n",
      "        \"doi\": \"10.1371/journal.pone.0052311\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Alcohol consumption in midlife and cognitive performance assessed 13 years later in the SU.VI.MAX 2 cohort. Alcohol consumption in midlife and cognitive performance assessed 13 years later in the SU.VI.MAX 2 cohort. 2012; 7:e52311. doi: 10.1371/journal.pone.0052311\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22378736\",\n",
      "        \"title\": \"Modulation of the association between plasma intercellular adhesion molecule-1 and cancer risk by n-3 PUFA intake: a nested case-control study.\",\n",
      "        \"authors\": \"Touvier M; Kesse-Guyot E; Andreeva VA; Fezeu L; Charnaux N; Sutton A; Druesne-Pecollo N; Hercberg S; Galan P; Zelek L; Latino-Martel P; Czernichow S\",\n",
      "        \"doi\": \"10.3945/ajcn.111.027805\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Touvier M, et al. Modulation of the association between plasma intercellular adhesion molecule-1 and cancer risk by n-3 PUFA intake: a nested case-control study. Modulation of the association between plasma intercellular adhesion molecule-1 and cancer risk by n-3 PUFA intake: a nested case-control study. 2012; 95:944-50. doi: 10.3945/ajcn.111.027805\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20176858\",\n",
      "        \"title\": \"Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome.\",\n",
      "        \"authors\": \"Phillips CM; Goumidi L; Bertrais S; Field MR; Cupples LA; Ordovas JM; Defoort C; Lovegrove JA; Drevon CA; Gibney MJ; Blaak EE; Kiec-Wilk B; Karlstrom B; Lopez-Miranda J; McManus R; Hercberg S; Lairon D; Planells R; Roche HM\",\n",
      "        \"doi\": \"10.1194/jlr.M003046\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Phillips CM, et al. Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome. Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome. 2010; 51:1793-800. doi: 10.1194/jlr.M003046\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27000099\",\n",
      "        \"title\": \"Prospective association between a dietary quality index based on a nutrient profiling system and cardiovascular disease risk.\",\n",
      "        \"authors\": \"Adriouch S; Julia C; Kesse-Guyot E; M\\u00e9jean C; Ducrot P; P\\u00e9neau S; Donnenfeld M; Deschasaux M; Menai M; Hercberg S; Touvier M; Fezeu LK\",\n",
      "        \"doi\": \"10.1177/2047487316640659\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Adriouch S, et al. Prospective association between a dietary quality index based on a nutrient profiling system and cardiovascular disease risk. Prospective association between a dietary quality index based on a nutrient profiling system and cardiovascular disease risk. 2016; 23:1669-76. doi: 10.1177/2047487316640659\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26409628\",\n",
      "        \"title\": \"Are different vascular risk scores calculated at midlife uniformly associated with subsequent poor cognitive performance?\",\n",
      "        \"authors\": \"Kesse-Guyot E; Lassale C; Assmann KE; Andreeva VA; Julia C; Blacher J; Fezeu L; Hercberg S; Galan P\",\n",
      "        \"doi\": \"10.1016/j.atherosclerosis.2015.09.023\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Are different vascular risk scores calculated at midlife uniformly associated with subsequent poor cognitive performance?. Are different vascular risk scores calculated at midlife uniformly associated with subsequent poor cognitive performance?. 2015; 243:286-92. doi: 10.1016/j.atherosclerosis.2015.09.023\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21775560\",\n",
      "        \"title\": \"French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Fezeu L; Jeandel C; Ferry M; Andreeva V; Amieva H; Hercberg S; Galan P\",\n",
      "        \"doi\": \"10.3945/ajcn.110.007815\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial. French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial. 2011; 94:892-9. doi: 10.3945/ajcn.110.007815\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26817718\",\n",
      "        \"title\": \"Weight Status and Alcohol Intake Modify the Association between Vitamin D and Breast Cancer Risk.\",\n",
      "        \"authors\": \"Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M\",\n",
      "        \"doi\": \"10.3945/jn.115.221481\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Deschasaux M, et al. Weight Status and Alcohol Intake Modify the Association between Vitamin D and Breast Cancer Risk. Weight Status and Alcohol Intake Modify the Association between Vitamin D and Breast Cancer Risk. 2016; 146:576-85. doi: 10.3945/jn.115.221481\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31927670\",\n",
      "        \"title\": \"Untargeted plasma metabolomic profiles associated with overall diet in women from the SU.VI.MAX cohort.\",\n",
      "        \"authors\": \"L\\u00e9cuyer L; Dalle C; Micheau P; P\\u00e9t\\u00e9ra M; Centeno D; Lyan B; Lagree M; Galan P; Hercberg S; Rossary A; Demidem A; Vasson MP; Partula V; Deschasaux M; Srour B; Latino-Martel P; Druesne-Pecollo N; Kesse-Guyot E; Durand S; Pujos-Guillot E; Manach C; Touvier M\",\n",
      "        \"doi\": \"10.1007/s00394-020-02177-5\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"L\\u00e9cuyer L, et al. Untargeted plasma metabolomic profiles associated with overall diet in women from the SU.VI.MAX cohort. Untargeted plasma metabolomic profiles associated with overall diet in women from the SU.VI.MAX cohort. 2020; 59:3425-3439. doi: 10.1007/s00394-020-02177-5\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27055851\",\n",
      "        \"title\": \"Long-term association between the dietary inflammatory index and cognitive functioning: findings from the SU.VI.MAX study.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Assmann KE; Andreeva VA; Touvier M; Neufcourt L; Shivappa N; H\\u00e9bert JR; Wirth MD; Hercberg S; Galan P; Julia C\",\n",
      "        \"doi\": \"10.1007/s00394-016-1211-3\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Observational Study\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Long-term association between the dietary inflammatory index and cognitive functioning: findings from the SU.VI.MAX study. Long-term association between the dietary inflammatory index and cognitive functioning: findings from the SU.VI.MAX study. 2017; 56:1647-1655. doi: 10.1007/s00394-016-1211-3\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23082222\",\n",
      "        \"title\": \"Cross-sectional and longitudinal associations of different sedentary behaviors with cognitive performance in older adults.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Charreire H; Andreeva VA; Touvier M; Hercberg S; Galan P; Oppert JM\",\n",
      "        \"doi\": \"10.1371/journal.pone.0047831\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Cross-sectional and longitudinal associations of different sedentary behaviors with cognitive performance in older adults. Cross-sectional and longitudinal associations of different sedentary behaviors with cognitive performance in older adults. 2012; 7:e47831. doi: 10.1371/journal.pone.0047831\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25651444\",\n",
      "        \"title\": \"Overall and abdominal adiposity in midlife and subsequent cognitive function.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Andreeva VA; Touvier M; Jeandel C; Ferry M; Hercberg S; Galan P; SU.VI.MAX 2 Research Group\",\n",
      "        \"doi\": \"10.1007/s12603-014-0508-2\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Overall and abdominal adiposity in midlife and subsequent cognitive function. Overall and abdominal adiposity in midlife and subsequent cognitive function. 2015; 19:183-9. doi: 10.1007/s12603-014-0508-2\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21490142\",\n",
      "        \"title\": \"Dietary intake of 337 polyphenols in French adults.\",\n",
      "        \"authors\": \"P\\u00e9rez-Jim\\u00e9nez J; Fezeu L; Touvier M; Arnault N; Manach C; Hercberg S; Galan P; Scalbert A\",\n",
      "        \"doi\": \"10.3945/ajcn.110.007096\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"P\\u00e9rez-Jim\\u00e9nez J, et al. Dietary intake of 337 polyphenols in French adults. Dietary intake of 337 polyphenols in French adults. 2011; 93:1220-8. doi: 10.3945/ajcn.110.007096\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23283500\",\n",
      "        \"title\": \"Mediterranean diet and cognitive function: a French study.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Andreeva VA; Lassale C; Ferry M; Jeandel C; Hercberg S; Galan P; SU.VI.MAX 2 Research Group\",\n",
      "        \"doi\": \"10.3945/ajcn.112.047993\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Mediterranean diet and cognitive function: a French study. Mediterranean diet and cognitive function: a French study. 2013; 97:369-76. doi: 10.3945/ajcn.112.047993\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24027184\",\n",
      "        \"title\": \"Intakes of PUFAs were inversely associated with plasma C-reactive protein 12 years later in a middle-aged population with vitamin E intake as an effect modifier.\",\n",
      "        \"authors\": \"Julia C; Touvier M; Meunier N; Papet I; Galan P; Hercberg S; Kesse-Guyot E\",\n",
      "        \"doi\": \"10.3945/jn.113.180943\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Julia C, et al. Intakes of PUFAs were inversely associated with plasma C-reactive protein 12 years later in a middle-aged population with vitamin E intake as an effect modifier. Intakes of PUFAs were inversely associated with plasma C-reactive protein 12 years later in a middle-aged population with vitamin E intake as an effect modifier. 2013; 143:1760-6. doi: 10.3945/jn.113.180943\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21106918\",\n",
      "        \"title\": \"Adherence to nutritional recommendations and subsequent cognitive performance: findings from the prospective Supplementation with Antioxidant Vitamins and Minerals 2 (SU.VI.MAX 2) study.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Amieva H; Castetbon K; Henegar A; Ferry M; Jeandel C; Hercberg S; Galan P; SU.VI.MAX 2 Research Group\",\n",
      "        \"doi\": \"10.3945/ajcn.2010.29761\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Adherence to nutritional recommendations and subsequent cognitive performance: findings from the prospective Supplementation with Antioxidant Vitamins and Minerals 2 (SU.VI.MAX 2) study. Adherence to nutritional recommendations and subsequent cognitive performance: findings from the prospective Supplementation with Antioxidant Vitamins and Minerals 2 (SU.VI.MAX 2) study. 2011; 93:200-10. doi: 10.3945/ajcn.2010.29761\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30517725\",\n",
      "        \"title\": \"Unsaturated Fatty Acid Intakes During Midlife Are Positively Associated with Later Cognitive Function in Older Adults with Modulating Effects of Antioxidant Supplementation.\",\n",
      "        \"authors\": \"Assmann KE; Adjibade M; Hercberg S; Galan P; Kesse-Guyot E\",\n",
      "        \"doi\": \"10.1093/jn/nxy206\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Assmann KE, et al. Unsaturated Fatty Acid Intakes During Midlife Are Positively Associated with Later Cognitive Function in Older Adults with Modulating Effects of Antioxidant Supplementation. Unsaturated Fatty Acid Intakes During Midlife Are Positively Associated with Later Cognitive Function in Older Adults with Modulating Effects of Antioxidant Supplementation. 2018; 148:1938-1945. doi: 10.1093/jn/nxy206\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19491388\",\n",
      "        \"title\": \"Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults.\",\n",
      "        \"authors\": \"Czernichow S; Vergnaud AC; Galan P; Arnaud J; Favier A; Faure H; Huxley R; Hercberg S; Ahluwalia N\",\n",
      "        \"doi\": \"10.3945/ajcn.2009.27635\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Czernichow S, et al. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. 2009; 90:329-35. doi: 10.3945/ajcn.2009.27635\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26156743\",\n",
      "        \"title\": \"Prospective association between dietary folate intake and skin cancer risk: results from the Suppl\\u00e9mentation en Vitamines et Min\\u00e9raux Antioxydants cohort.\",\n",
      "        \"authors\": \"Donnenfeld M; Deschasaux M; Latino-Martel P; Diallo A; Galan P; Hercberg S; Ezzedine K; Touvier M\",\n",
      "        \"doi\": \"10.3945/ajcn.115.109041\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Donnenfeld M, et al. Prospective association between dietary folate intake and skin cancer risk: results from the Suppl\\u00e9mentation en Vitamines et Min\\u00e9raux Antioxydants cohort. Prospective association between dietary folate intake and skin cancer risk: results from the Suppl\\u00e9mentation en Vitamines et Min\\u00e9raux Antioxydants cohort. 2015; 102:471-8. doi: 10.3945/ajcn.115.109041\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29649036\",\n",
      "        \"title\": \"Association Between Alexithymia and Risk of Incident Cardiovascular Diseases in the SUppl\\u00e9mentation en VItamines et Min\\u00e9raux AntioXydants (SU.VI.MAX) Cohort.\",\n",
      "        \"authors\": \"Wiernik E; Lemogne C; Fezeu L; Arnault N; Hercberg S; Kesse-Guyot E; Galan P\",\n",
      "        \"doi\": \"10.1097/PSY.0000000000000592\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Wiernik E, et al. Association Between Alexithymia and Risk of Incident Cardiovascular Diseases in the SUppl\\u00e9mentation en VItamines et Min\\u00e9raux AntioXydants (SU.VI.MAX) Cohort. Association Between Alexithymia and Risk of Incident Cardiovascular Diseases in the SUppl\\u00e9mentation en VItamines et Min\\u00e9raux AntioXydants (SU.VI.MAX) Cohort. 2018; 80:460-467. doi: 10.1097/PSY.0000000000000592\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20431391\",\n",
      "        \"title\": \"Associations between dietary patterns and arterial stiffness, carotid artery intima-media thickness and atherosclerosis.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Vergnaud AC; Fezeu L; Zureik M; Blacher J; P\\u00e9neau S; Hercberg S; Galan P; Czernichow S\",\n",
      "        \"doi\": \"10.1097/HJR.0b013e32833a197f\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Associations between dietary patterns and arterial stiffness, carotid artery intima-media thickness and atherosclerosis. Associations between dietary patterns and arterial stiffness, carotid artery intima-media thickness and atherosclerosis. 2010; 17:718-24. doi: 10.1097/HJR.0b013e32833a197f\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22158670\",\n",
      "        \"title\": \"Long-term antioxidant supplementation has no effect on health-related quality of life: the randomized, double-blind, placebo-controlled, primary prevention SU.VI.MAX trial.\",\n",
      "        \"authors\": \"Brian\\u00e7on S; Boini S; Bertrais S; Guillemin F; Galan P; Hercberg S\",\n",
      "        \"doi\": \"10.1093/ije/dyr161\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Brian\\u00e7on S, et al. Long-term antioxidant supplementation has no effect on health-related quality of life: the randomized, double-blind, placebo-controlled, primary prevention SU.VI.MAX trial. Long-term antioxidant supplementation has no effect on health-related quality of life: the randomized, double-blind, placebo-controlled, primary prevention SU.VI.MAX trial. 2011; 40:1605-16. doi: 10.1093/ije/dyr161\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28356432\",\n",
      "        \"title\": \"The Inflammatory Potential of the Diet Is Associated with Depressive Symptoms in Different Subgroups of the General Population.\",\n",
      "        \"authors\": \"Adjibade M; Andreeva VA; Lemogne C; Touvier M; Shivappa N; H\\u00e9bert JR; Wirth MD; Hercberg S; Galan P; Julia C; Assmann KE; Kesse-Guyot E\",\n",
      "        \"doi\": \"10.3945/jn.116.245167\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Adjibade M, et al. The Inflammatory Potential of the Diet Is Associated with Depressive Symptoms in Different Subgroups of the General Population. The Inflammatory Potential of the Diet Is Associated with Depressive Symptoms in Different Subgroups of the General Population. 2017; 147:879-887. doi: 10.3945/jn.116.245167\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26812508\",\n",
      "        \"title\": \"Consumption of Dairy Products and Cognitive Functioning: Findings from the SU.VI.MAX 2 Study.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Assmann KE; Andreeva VA; Ferry M; Hercberg S; Galan P; SU.VI.MAX 2 Research Group\",\n",
      "        \"doi\": \"10.1007/s12603-015-0593-x\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Consumption of Dairy Products and Cognitive Functioning: Findings from the SU.VI.MAX 2 Study. Consumption of Dairy Products and Cognitive Functioning: Findings from the SU.VI.MAX 2 Study. 2016; 20:128-37. doi: 10.1007/s12603-015-0593-x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24089418\",\n",
      "        \"title\": \"Midlife iron status is inversely associated with subsequent cognitive performance, particularly in perimenopausal women.\",\n",
      "        \"authors\": \"Andreeva VA; Galan P; Arnaud J; Julia C; Hercberg S; Kesse-Guyot E\",\n",
      "        \"doi\": \"10.3945/jn.113.177089\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Andreeva VA, et al. Midlife iron status is inversely associated with subsequent cognitive performance, particularly in perimenopausal women. Midlife iron status is inversely associated with subsequent cognitive performance, particularly in perimenopausal women. 2013; 143:1974-81. doi: 10.3945/jn.113.177089\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24527713\",\n",
      "        \"title\": \"Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values.\",\n",
      "        \"authors\": \"Touvier M; Deschasaux M; Montourcy M; Sutton A; Charnaux N; Kesse-Guyot E; Fezeu LK; Latino-Martel P; Druesne-Pecollo N; Malvy D; Galan P; Hercberg S; Ezzedine K; Souberbielle JC\",\n",
      "        \"doi\": \"10.1210/jc.2013-3349\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Touvier M, et al. Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values. Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values. 2014; 99:1196-203. doi: 10.1210/jc.2013-3349\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26447153\",\n",
      "        \"title\": \"Prospective associations between vitamin D status, vitamin D-related gene polymorphisms, and risk of tobacco-related cancers.\",\n",
      "        \"authors\": \"Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M\",\n",
      "        \"doi\": \"10.3945/ajcn.115.110510\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Deschasaux M, et al. Prospective associations between vitamin D status, vitamin D-related gene polymorphisms, and risk of tobacco-related cancers. Prospective associations between vitamin D status, vitamin D-related gene polymorphisms, and risk of tobacco-related cancers. 2015; 102:1207-15. doi: 10.3945/ajcn.115.110510\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29546305\",\n",
      "        \"title\": \"The Inflammatory Potential of the Diet at Midlife Is Associated with Later Healthy Aging in French Adults.\",\n",
      "        \"authors\": \"Assmann KE; Adjibade M; Shivappa N; H\\u00e9bert JR; Wirth MD; Touvier M; Akbaraly T; Hercberg S; Galan P; Julia C; Kesse-Guyot E\",\n",
      "        \"doi\": \"10.1093/jn/nxx061\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Assmann KE, et al. The Inflammatory Potential of the Diet at Midlife Is Associated with Later Healthy Aging in French Adults. The Inflammatory Potential of the Diet at Midlife Is Associated with Later Healthy Aging in French Adults. 2018; 148:437-444. doi: 10.1093/jn/nxx061\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25994566\",\n",
      "        \"title\": \"Prospective association between alcohol intake and hormone-dependent cancer risk: modulation by dietary fiber intake.\",\n",
      "        \"authors\": \"Chhim AS; Fassier P; Latino-Martel P; Druesne-Pecollo N; Zelek L; Duverger L; Hercberg S; Galan P; Deschasaux M; Touvier M\",\n",
      "        \"doi\": \"10.3945/ajcn.114.098418\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Chhim AS, et al. Prospective association between alcohol intake and hormone-dependent cancer risk: modulation by dietary fiber intake. Prospective association between alcohol intake and hormone-dependent cancer risk: modulation by dietary fiber intake. 2015; 102:182-9. doi: 10.3945/ajcn.114.098418\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01534728\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04409405\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"38043556\",\n",
      "        \"title\": \"Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study.\",\n",
      "        \"authors\": \"Nkuba-Ndaye A; Dilu-Keti A; Tovar-Sanchez T; Diallo MSK; Mukadi-Bamuleka D; Kitenge R; Formenty P; Legand A; Edidi-Atani F; Thaurignac G; Pelloquin R; Mbala-Kingebeni P; Toure A; Ayouba A; Muyembe-Tamfum JJ; Delaporte E; Peeters M; Ahuka-Mundeke S; Les Vainqueurs d\\u2019Ebola Study Group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(23)00552-2\",\n",
      "        \"year\": \"2024\",\n",
      "        \"publication_types\": [\n",
      "          \"Observational Study\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Nkuba-Ndaye A, et al. Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study. Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study. 2024; 24:266-274. doi: 10.1016/S1473-3099(23)00552-2\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02976298\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00647205\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02960698\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01842477\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01037777\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"32822634\",\n",
      "        \"title\": \"Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.\",\n",
      "        \"authors\": \"Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Sch\\u00f6ls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; B\\u00fcrk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T\",\n",
      "        \"doi\": \"10.1016/S1474-4422(20)30235-0\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Jacobi H, et al. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study. 2020; 19:738-747. doi: 10.1016/S1474-4422(20)30235-0\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35264424\",\n",
      "        \"title\": \"Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1.\",\n",
      "        \"authors\": \"Wilke C; Mengel D; Sch\\u00f6ls L; Hengel H; Rakowicz M; Klockgether T; Durr A; Filla A; Melegh B; Sch\\u00fcle R; Reetz K; Jacobi H; Synofzik M\",\n",
      "        \"doi\": \"10.1212/WNL.0000000000200257\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Wilke C, et al. Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1. Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1. 2022; 98:e1985-e1996. doi: 10.1212/WNL.0000000000200257\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24780882\",\n",
      "        \"title\": \"Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6.\",\n",
      "        \"authors\": \"Tezenas du Montcel S; Durr A; Rakowicz M; Nanetti L; Charles P; Sulek A; Mariotti C; Rola R; Schols L; Bauer P; Dufaure-Gar\\u00e9 I; Jacobi H; Forlani S; Schmitz-H\\u00fcbsch T; Filla A; Timmann D; van de Warrenburg BP; Marelli C; Kang JS; Giunti P; Cook A; Baliko L; Melegh B; Boesch S; Szymanski S; Berciano J; Infante J; Buerk K; Masciullo M; Di Fabio R; Depondt C; Ratka S; Stevanin G; Klockgether T; Brice A; Golmard JL\",\n",
      "        \"doi\": \"10.1136/jmedgenet-2013-102200\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Tezenas du Montcel S, et al. Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6. Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6. 2014; 51:479-86. doi: 10.1136/jmedgenet-2013-102200\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23707147\",\n",
      "        \"title\": \"Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.\",\n",
      "        \"authors\": \"Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Sch\\u00f6ls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; B\\u00fcrk K; Peltz A; Schulz JB; Dufaure-Gar\\u00e9 I; Klockgether T\",\n",
      "        \"doi\": \"10.1016/S1474-4422(13)70104-2\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Jacobi H, et al. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data. 2013; 12:650-8. doi: 10.1016/S1474-4422(13)70104-2\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02172677\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02101398\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01495897\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00463983\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"16883006\",\n",
      "        \"title\": \"Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis.\",\n",
      "        \"authors\": \"Lebtahi R; Moreau S; Marchand-Adam S; Debray MP; Brauner M; Soler P; Marchal J; Raguin O; Gruaz-Guyon A; Reubi JC; Le Guludec D; Crestani B\",\n",
      "        \"doi\": null,\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Lebtahi R, et al. Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis. Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis. 2006; 47:1281-7.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22379151\",\n",
      "        \"title\": \"Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study.\",\n",
      "        \"authors\": \"Crestani B; Chapron J; Wallaert B; Bergot E; Delaval P; Israel-Biet D; Lacronique J; Monnet I; Reynaud-Gaubert M; Tazi A; Lebtahi R; Debray MP; Brauner M; Dehoux M; Dornic Q; Aubier M; Mentr\\u00e9 F; Duval X\",\n",
      "        \"doi\": \"10.1183/09031936.00113011\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Letter\",\n",
      "          \"Multicenter Study\"\n",
      "        ],\n",
      "        \"citation\": \"Crestani B, et al. Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study. Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study. 2012; 39:772-5. doi: 10.1183/09031936.00113011\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158483\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"19530940\",\n",
      "        \"title\": \"Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial.\",\n",
      "        \"authors\": \"Mayaud P; Legoff J; Weiss HA; Gr\\u00e9senguet G; Nzambi K; Bouhlal H; Frost E; P\\u00e9pin J; Malkin JE; Hayes RJ; Mabey DC; B\\u00e9lec L; ANRS 1212 Study Group\",\n",
      "        \"doi\": \"10.1086/599991\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mayaud P, et al. Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial. Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial. 2009; 200:216-26. doi: 10.1086/599991\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18385443\",\n",
      "        \"title\": \"Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2.\",\n",
      "        \"authors\": \"LeGoff J; Mayaud P; Gresenguet G; Weiss HA; Nzambi K; Frost E; Pepin J; Belec L; ANRS 12-12 Study Group\",\n",
      "        \"doi\": \"10.1128/JCM.02332-07\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Evaluation Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"LeGoff J, et al. Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2. Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2. 2008; 46:1914-8. doi: 10.1128/JCM.02332-07\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16455895\",\n",
      "        \"title\": \"Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV.\",\n",
      "        \"authors\": \"Legoff J; Bouhlal H; Gr\\u00e9senguet G; Weiss H; Khonde N; Hocini H; D\\u00e9sir\\u00e9 N; Si-Mohamed A; de Dieu Longo J; Chemin C; Frost E; P\\u00e9pin J; Malkin JE; Mayaud P; B\\u00e9lec L\",\n",
      "        \"doi\": \"10.1128/JCM.44.2.423-432.2006\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Evaluation Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Legoff J, et al. Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV. Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV. 2006; 44:423-32. doi: 10.1128/JCM.44.2.423-432.2006\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00301561\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"21831714\",\n",
      "        \"title\": \"Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial.\",\n",
      "        \"authors\": \"Laurent C; Kouanfack C; Laborde-Balen G; Aghokeng AF; Mbougua JB; Boyer S; Carrieri MP; Mben JM; Dontsop M; Kaz\\u00e9 S; Molinari N; Bourgeois A; Mpoudi-Ngol\\u00e9 E; Spire B; Koulla-Shiro S; Delaporte E; Stratall ANRS 12110/ESTHER study group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(11)70168-2\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Laurent C, et al. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial. 2011; 11:825-33. doi: 10.1016/S1473-3099(11)70168-2\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35248123\",\n",
      "        \"title\": \"Non-inferiority test for a continuous variable with a flexible margin in an active controlled trial: an application to the \\\"Stratall ANRS 12110 / ESTHER\\\" trial.\",\n",
      "        \"authors\": \"Sandie AB; Molinari N; Wanjoya A; Kouanfack C; Laurent C; Tchatchueng-Mbougua JB\",\n",
      "        \"doi\": \"10.1186/s13063-022-06118-x\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Sandie AB, et al. Non-inferiority test for a continuous variable with a flexible margin in an active controlled trial: an application to the \\\"Stratall ANRS 12110 / ESTHER\\\" trial. Non-inferiority test for a continuous variable with a flexible margin in an active controlled trial: an application to the \\\"Stratall ANRS 12110 / ESTHER\\\" trial. 2022; 23:202. doi: 10.1186/s13063-022-06118-x\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01075061\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158405\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"16152755\",\n",
      "        \"title\": \"Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in C\\u00f4te d'Ivoire.\",\n",
      "        \"authors\": \"Moh R; Danel C; Sorho S; Sauvageot D; Anzian A; Minga A; Gomis OB; Konga C; Inwoley A; Gabillard D; Bissagnene E; Salamon R; Anglaret X\",\n",
      "        \"doi\": \"10.1177/135965350501000510\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Moh R, et al. Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in C\\u00f4te d'Ivoire. Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in C\\u00f4te d'Ivoire. 2005; 10:615-24. doi: 10.1177/135965350501000510\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16782488\",\n",
      "        \"title\": \"CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial.\",\n",
      "        \"authors\": \"Danel C; Moh R; Minga A; Anzian A; Ba-Gomis O; Kanga C; Nzunetu G; Gabillard D; Rouet F; Sorho S; Chaix ML; Eholi\\u00e9 S; Menan H; Sauvageot D; Bissagnene E; Salamon R; Anglaret X; Trivacan ANRS 1269 trial group\",\n",
      "        \"doi\": \"10.1016/S0140-6736(06)68887-9\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Danel C, et al. CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial. CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial. 2006; 367:1981-9. doi: 10.1016/S0140-6736(06)68887-9\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18986246\",\n",
      "        \"title\": \"Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults.\",\n",
      "        \"authors\": \"Danel C; Moh R; Chaix ML; Gabillard D; Gnokoro J; Diby CJ; Toni T; Dohoun L; Rouzioux C; Bissagnene E; Salamon R; Anglaret X; Trivacan ANRS 1269 Trial Group\",\n",
      "        \"doi\": \"10.1086/595298\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Danel C, et al. Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults. Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults. 2009; 199:66-76. doi: 10.1086/595298\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00623051\",\n",
      "    \"publications\": []\n",
      "  }\n",
      "]\n"
     ]
    }
   ],
   "source": [
    "print(json.dumps(total_publications_list, indent=2))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 339,
   "id": "e319963c-1e2c-4dde-aae6-c86f161be7ba",
   "metadata": {},
   "outputs": [],
   "source": [
    "# The number of NCTId didn't change\n",
    "assert(len(total_publications_list) == len(studies_list))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "22ec89f9-6196-4a75-b71f-ef5b6aad595d",
   "metadata": {},
   "source": [
    "### Import dans Pandas"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 340,
   "id": "eef6d4fe-795d-447a-8184-61e8f6522c0d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>publications</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT01895920</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02486731</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02116374</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT03537196</td>\n",
       "      <td>[{'pmid': '26298331', 'title': 'Hepatitis C vi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT01899196</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>281</th>\n",
       "      <td>NCT00158483</td>\n",
       "      <td>[{'pmid': '19530940', 'title': 'Impact of acyc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>282</th>\n",
       "      <td>NCT00301561</td>\n",
       "      <td>[{'pmid': '21831714', 'title': 'Monitoring of ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>283</th>\n",
       "      <td>NCT01075061</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>284</th>\n",
       "      <td>NCT00158405</td>\n",
       "      <td>[{'pmid': '16152755', 'title': 'Haematological...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>285</th>\n",
       "      <td>NCT00623051</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>286 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                       publications\n",
       "0    NCT01895920                                                 []\n",
       "1    NCT02486731                                                 []\n",
       "2    NCT02116374                                                 []\n",
       "3    NCT03537196  [{'pmid': '26298331', 'title': 'Hepatitis C vi...\n",
       "4    NCT01899196                                                 []\n",
       "..           ...                                                ...\n",
       "281  NCT00158483  [{'pmid': '19530940', 'title': 'Impact of acyc...\n",
       "282  NCT00301561  [{'pmid': '21831714', 'title': 'Monitoring of ...\n",
       "283  NCT01075061                                                 []\n",
       "284  NCT00158405  [{'pmid': '16152755', 'title': 'Haematological...\n",
       "285  NCT00623051                                                 []\n",
       "\n",
       "[286 rows x 2 columns]"
      ]
     },
     "execution_count": 340,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_pubmed = pd.DataFrame.from_records(total_publications_list)\n",
    "df_pubmed"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c8f8e322-5468-427d-951a-52769f39d215",
   "metadata": {},
   "source": [
    "#### On \"explose\" la colonne \"publications\":\n",
    "\n",
    "Pour chaque NCTId, la colonne 'publications' contient potentiellement une liste de plusieurs publications.  \n",
    "Si par exemple, on a 3 publications, on veut se retrouver avec 3 lignes, chacune indexée par le même NCTId et contenant une unique publication.  \n",
    "\n",
    "*Avant*:  \n",
    "**`NCTId    Reference`**  \n",
    "`NCT0001, [Pub1, Pub2, Pub3]`   \n",
    "\n",
    "*Après*:  \n",
    "**`NCTId    Reference`**  \n",
    "`NCT0001,   Pub1`  \n",
    "`NCT0001,   Pub2`  \n",
    "`NCT0001,   Pub3`   "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 341,
   "id": "2d2b41c7-a86c-40d8-804a-dc5fe197aca1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>publications</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT01895920</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02486731</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02116374</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT03537196</td>\n",
       "      <td>{'pmid': '26298331', 'title': 'Hepatitis C vir...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT03537196</td>\n",
       "      <td>{'pmid': '23172780', 'title': 'Global epidemio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>678</th>\n",
       "      <td>NCT01075061</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>679</th>\n",
       "      <td>NCT00158405</td>\n",
       "      <td>{'pmid': '16152755', 'title': 'Haematological ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>680</th>\n",
       "      <td>NCT00158405</td>\n",
       "      <td>{'pmid': '16782488', 'title': 'CD4-guided stru...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>681</th>\n",
       "      <td>NCT00158405</td>\n",
       "      <td>{'pmid': '18986246', 'title': 'Two-months-off,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>682</th>\n",
       "      <td>NCT00623051</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>683 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                       publications\n",
       "0    NCT01895920                                                NaN\n",
       "1    NCT02486731                                                NaN\n",
       "2    NCT02116374                                                NaN\n",
       "3    NCT03537196  {'pmid': '26298331', 'title': 'Hepatitis C vir...\n",
       "4    NCT03537196  {'pmid': '23172780', 'title': 'Global epidemio...\n",
       "..           ...                                                ...\n",
       "678  NCT01075061                                                NaN\n",
       "679  NCT00158405  {'pmid': '16152755', 'title': 'Haematological ...\n",
       "680  NCT00158405  {'pmid': '16782488', 'title': 'CD4-guided stru...\n",
       "681  NCT00158405  {'pmid': '18986246', 'title': 'Two-months-off,...\n",
       "682  NCT00623051                                                NaN\n",
       "\n",
       "[683 rows x 2 columns]"
      ]
     },
     "execution_count": 341,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_pubmed = df_pubmed.explode('publications', ignore_index = True)\n",
    "df_pubmed"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f9457360-7404-4027-a392-4f0f72e765fa",
   "metadata": {},
   "source": [
    "On vérifie que l'on a retrouvé plus de publications avec PubMed + CT que CT tout seul:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 342,
   "id": "9439fcc7-84f2-4cbe-ace4-b278cf26bac9",
   "metadata": {},
   "outputs": [],
   "source": [
    "assert(len(df_pubmed) >= len(df_ct))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6d4bd8f4-3e7b-4845-8016-ce08f3d86aa3",
   "metadata": {},
   "source": [
    "Pour chaque NCTId, la colonne 'publications' contient maintenant un dictionnaire de la forme:  \n",
    "`{  \n",
    "\"pmid\": \"17545707\",  \n",
    "\"title\": \"Haematological ...\",  \n",
    "\"authors\": \"Smith DJ; ...\",  \n",
    "}`\n",
    "\n",
    "Dont on veut extraire de nouvelles colonnes en utilant les clés du dictionnaire:  \n",
    "**`pmid      title                 authors`**  \n",
    "`17545707, \"Haematological ...\", \"Smith DJ; ...\"`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 343,
   "id": "de0d46f5-ad8f-47ba-9cb2-900c74ceda72",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pmid</th>\n",
       "      <th>title</th>\n",
       "      <th>authors</th>\n",
       "      <th>doi</th>\n",
       "      <th>year</th>\n",
       "      <th>publication_types</th>\n",
       "      <th>citation</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>26298331</td>\n",
       "      <td>Hepatitis C virus (HCV) disease progression in...</td>\n",
       "      <td>Smith DJ; Combellick J; Jordan AE; Hagan H</td>\n",
       "      <td>10.1016/j.drugpo.2015.07.004</td>\n",
       "      <td>2015</td>\n",
       "      <td>[Journal Article, Meta-Analysis, Research Supp...</td>\n",
       "      <td>Smith DJ, et al. Hepatitis C virus (HCV) disea...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>23172780</td>\n",
       "      <td>Global epidemiology of hepatitis C virus infec...</td>\n",
       "      <td>Mohd Hanafiah K; Groeger J; Flaxman AD; Wiersm...</td>\n",
       "      <td>10.1002/hep.26141</td>\n",
       "      <td>2013</td>\n",
       "      <td>[Journal Article, Meta-Analysis, Review, Syste...</td>\n",
       "      <td>Mohd Hanafiah K, et al. Global epidemiology of...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>678</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>679</th>\n",
       "      <td>16152755</td>\n",
       "      <td>Haematological changes in adults receiving a z...</td>\n",
       "      <td>Moh R; Danel C; Sorho S; Sauvageot D; Anzian A...</td>\n",
       "      <td>10.1177/135965350501000510</td>\n",
       "      <td>2005</td>\n",
       "      <td>[Clinical Trial, Journal Article, Randomized C...</td>\n",
       "      <td>Moh R, et al. Haematological changes in adults...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>680</th>\n",
       "      <td>16782488</td>\n",
       "      <td>CD4-guided structured antiretroviral treatment...</td>\n",
       "      <td>Danel C; Moh R; Minga A; Anzian A; Ba-Gomis O;...</td>\n",
       "      <td>10.1016/S0140-6736(06)68887-9</td>\n",
       "      <td>2006</td>\n",
       "      <td>[Journal Article, Multicenter Study, Randomize...</td>\n",
       "      <td>Danel C, et al. CD4-guided structured antiretr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>681</th>\n",
       "      <td>18986246</td>\n",
       "      <td>Two-months-off, four-months-on antiretroviral ...</td>\n",
       "      <td>Danel C; Moh R; Chaix ML; Gabillard D; Gnokoro...</td>\n",
       "      <td>10.1086/595298</td>\n",
       "      <td>2009</td>\n",
       "      <td>[Journal Article, Multicenter Study, Randomize...</td>\n",
       "      <td>Danel C, et al. Two-months-off, four-months-on...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>682</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>683 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "         pmid                                              title  \\\n",
       "0         NaN                                                NaN   \n",
       "1         NaN                                                NaN   \n",
       "2         NaN                                                NaN   \n",
       "3    26298331  Hepatitis C virus (HCV) disease progression in...   \n",
       "4    23172780  Global epidemiology of hepatitis C virus infec...   \n",
       "..        ...                                                ...   \n",
       "678       NaN                                                NaN   \n",
       "679  16152755  Haematological changes in adults receiving a z...   \n",
       "680  16782488  CD4-guided structured antiretroviral treatment...   \n",
       "681  18986246  Two-months-off, four-months-on antiretroviral ...   \n",
       "682       NaN                                                NaN   \n",
       "\n",
       "                                               authors  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3           Smith DJ; Combellick J; Jordan AE; Hagan H   \n",
       "4    Mohd Hanafiah K; Groeger J; Flaxman AD; Wiersm...   \n",
       "..                                                 ...   \n",
       "678                                                NaN   \n",
       "679  Moh R; Danel C; Sorho S; Sauvageot D; Anzian A...   \n",
       "680  Danel C; Moh R; Minga A; Anzian A; Ba-Gomis O;...   \n",
       "681  Danel C; Moh R; Chaix ML; Gabillard D; Gnokoro...   \n",
       "682                                                NaN   \n",
       "\n",
       "                               doi  year  \\\n",
       "0                              NaN   NaN   \n",
       "1                              NaN   NaN   \n",
       "2                              NaN   NaN   \n",
       "3     10.1016/j.drugpo.2015.07.004  2015   \n",
       "4                10.1002/hep.26141  2013   \n",
       "..                             ...   ...   \n",
       "678                            NaN   NaN   \n",
       "679     10.1177/135965350501000510  2005   \n",
       "680  10.1016/S0140-6736(06)68887-9  2006   \n",
       "681                 10.1086/595298  2009   \n",
       "682                            NaN   NaN   \n",
       "\n",
       "                                     publication_types  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3    [Journal Article, Meta-Analysis, Research Supp...   \n",
       "4    [Journal Article, Meta-Analysis, Review, Syste...   \n",
       "..                                                 ...   \n",
       "678                                                NaN   \n",
       "679  [Clinical Trial, Journal Article, Randomized C...   \n",
       "680  [Journal Article, Multicenter Study, Randomize...   \n",
       "681  [Journal Article, Multicenter Study, Randomize...   \n",
       "682                                                NaN   \n",
       "\n",
       "                                              citation  \n",
       "0                                                  NaN  \n",
       "1                                                  NaN  \n",
       "2                                                  NaN  \n",
       "3    Smith DJ, et al. Hepatitis C virus (HCV) disea...  \n",
       "4    Mohd Hanafiah K, et al. Global epidemiology of...  \n",
       "..                                                 ...  \n",
       "678                                                NaN  \n",
       "679  Moh R, et al. Haematological changes in adults...  \n",
       "680  Danel C, et al. CD4-guided structured antiretr...  \n",
       "681  Danel C, et al. Two-months-off, four-months-on...  \n",
       "682                                                NaN  \n",
       "\n",
       "[683 rows x 7 columns]"
      ]
     },
     "execution_count": 343,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_pubmed_publications = pd.json_normalize(df_pubmed.pop('publications'))\n",
    "df_pubmed_publications"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7d9d8656-c1b0-459b-aebb-7846b57288a6",
   "metadata": {},
   "source": [
    "On réassemble la dataFrame complète:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 344,
   "id": "cce27392-459f-45e0-b262-300df63184b2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>pmid</th>\n",
       "      <th>title</th>\n",
       "      <th>authors</th>\n",
       "      <th>doi</th>\n",
       "      <th>year</th>\n",
       "      <th>publication_types</th>\n",
       "      <th>citation</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT01895920</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02486731</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02116374</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT03537196</td>\n",
       "      <td>26298331</td>\n",
       "      <td>Hepatitis C virus (HCV) disease progression in...</td>\n",
       "      <td>Smith DJ; Combellick J; Jordan AE; Hagan H</td>\n",
       "      <td>10.1016/j.drugpo.2015.07.004</td>\n",
       "      <td>2015</td>\n",
       "      <td>[Journal Article, Meta-Analysis, Research Supp...</td>\n",
       "      <td>Smith DJ, et al. Hepatitis C virus (HCV) disea...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT03537196</td>\n",
       "      <td>23172780</td>\n",
       "      <td>Global epidemiology of hepatitis C virus infec...</td>\n",
       "      <td>Mohd Hanafiah K; Groeger J; Flaxman AD; Wiersm...</td>\n",
       "      <td>10.1002/hep.26141</td>\n",
       "      <td>2013</td>\n",
       "      <td>[Journal Article, Meta-Analysis, Review, Syste...</td>\n",
       "      <td>Mohd Hanafiah K, et al. Global epidemiology of...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>678</th>\n",
       "      <td>NCT01075061</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>679</th>\n",
       "      <td>NCT00158405</td>\n",
       "      <td>16152755</td>\n",
       "      <td>Haematological changes in adults receiving a z...</td>\n",
       "      <td>Moh R; Danel C; Sorho S; Sauvageot D; Anzian A...</td>\n",
       "      <td>10.1177/135965350501000510</td>\n",
       "      <td>2005</td>\n",
       "      <td>[Clinical Trial, Journal Article, Randomized C...</td>\n",
       "      <td>Moh R, et al. Haematological changes in adults...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>680</th>\n",
       "      <td>NCT00158405</td>\n",
       "      <td>16782488</td>\n",
       "      <td>CD4-guided structured antiretroviral treatment...</td>\n",
       "      <td>Danel C; Moh R; Minga A; Anzian A; Ba-Gomis O;...</td>\n",
       "      <td>10.1016/S0140-6736(06)68887-9</td>\n",
       "      <td>2006</td>\n",
       "      <td>[Journal Article, Multicenter Study, Randomize...</td>\n",
       "      <td>Danel C, et al. CD4-guided structured antiretr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>681</th>\n",
       "      <td>NCT00158405</td>\n",
       "      <td>18986246</td>\n",
       "      <td>Two-months-off, four-months-on antiretroviral ...</td>\n",
       "      <td>Danel C; Moh R; Chaix ML; Gabillard D; Gnokoro...</td>\n",
       "      <td>10.1086/595298</td>\n",
       "      <td>2009</td>\n",
       "      <td>[Journal Article, Multicenter Study, Randomize...</td>\n",
       "      <td>Danel C, et al. Two-months-off, four-months-on...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>682</th>\n",
       "      <td>NCT00623051</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>683 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId      pmid                                              title  \\\n",
       "0    NCT01895920       NaN                                                NaN   \n",
       "1    NCT02486731       NaN                                                NaN   \n",
       "2    NCT02116374       NaN                                                NaN   \n",
       "3    NCT03537196  26298331  Hepatitis C virus (HCV) disease progression in...   \n",
       "4    NCT03537196  23172780  Global epidemiology of hepatitis C virus infec...   \n",
       "..           ...       ...                                                ...   \n",
       "678  NCT01075061       NaN                                                NaN   \n",
       "679  NCT00158405  16152755  Haematological changes in adults receiving a z...   \n",
       "680  NCT00158405  16782488  CD4-guided structured antiretroviral treatment...   \n",
       "681  NCT00158405  18986246  Two-months-off, four-months-on antiretroviral ...   \n",
       "682  NCT00623051       NaN                                                NaN   \n",
       "\n",
       "                                               authors  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3           Smith DJ; Combellick J; Jordan AE; Hagan H   \n",
       "4    Mohd Hanafiah K; Groeger J; Flaxman AD; Wiersm...   \n",
       "..                                                 ...   \n",
       "678                                                NaN   \n",
       "679  Moh R; Danel C; Sorho S; Sauvageot D; Anzian A...   \n",
       "680  Danel C; Moh R; Minga A; Anzian A; Ba-Gomis O;...   \n",
       "681  Danel C; Moh R; Chaix ML; Gabillard D; Gnokoro...   \n",
       "682                                                NaN   \n",
       "\n",
       "                               doi  year  \\\n",
       "0                              NaN   NaN   \n",
       "1                              NaN   NaN   \n",
       "2                              NaN   NaN   \n",
       "3     10.1016/j.drugpo.2015.07.004  2015   \n",
       "4                10.1002/hep.26141  2013   \n",
       "..                             ...   ...   \n",
       "678                            NaN   NaN   \n",
       "679     10.1177/135965350501000510  2005   \n",
       "680  10.1016/S0140-6736(06)68887-9  2006   \n",
       "681                 10.1086/595298  2009   \n",
       "682                            NaN   NaN   \n",
       "\n",
       "                                     publication_types  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3    [Journal Article, Meta-Analysis, Research Supp...   \n",
       "4    [Journal Article, Meta-Analysis, Review, Syste...   \n",
       "..                                                 ...   \n",
       "678                                                NaN   \n",
       "679  [Clinical Trial, Journal Article, Randomized C...   \n",
       "680  [Journal Article, Multicenter Study, Randomize...   \n",
       "681  [Journal Article, Multicenter Study, Randomize...   \n",
       "682                                                NaN   \n",
       "\n",
       "                                              citation  \n",
       "0                                                  NaN  \n",
       "1                                                  NaN  \n",
       "2                                                  NaN  \n",
       "3    Smith DJ, et al. Hepatitis C virus (HCV) disea...  \n",
       "4    Mohd Hanafiah K, et al. Global epidemiology of...  \n",
       "..                                                 ...  \n",
       "678                                                NaN  \n",
       "679  Moh R, et al. Haematological changes in adults...  \n",
       "680  Danel C, et al. CD4-guided structured antiretr...  \n",
       "681  Danel C, et al. Two-months-off, four-months-on...  \n",
       "682                                                NaN  \n",
       "\n",
       "[683 rows x 8 columns]"
      ]
     },
     "execution_count": 344,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_pubmed = df_pubmed.join(df_pubmed_publications)\n",
    "df_pubmed"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cb881be8-1255-4040-bad6-6e2952e20a06",
   "metadata": {},
   "source": [
    "### Jointure des DataFrame de CT et Pubmed:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 370,
   "id": "f4df0c6f-686a-4553-b2c4-de58040349af",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>pmid</th>\n",
       "      <th>type</th>\n",
       "      <th>citation_x</th>\n",
       "      <th>title</th>\n",
       "      <th>authors</th>\n",
       "      <th>doi</th>\n",
       "      <th>year</th>\n",
       "      <th>publication_types</th>\n",
       "      <th>citation_y</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT01895920</td>\n",
       "      <td>Viral Biofilms: Hijacking T Cell Extracellular...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2013-07-11</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02486731</td>\n",
       "      <td>Hormonal Sensitivity in Patients With Noonan a...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2015-07-01</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02116374</td>\n",
       "      <td>Physiopathology Study of the Microbiota Biodiv...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2014-04-16</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT03537196</td>\n",
       "      <td>DRug Use &amp; Infections in ViEtnam - Hepatitis C...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2018-05-25</td>\n",
       "      <td>26298331</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Smith DJ, Combellick J, Jordan AE, Hagan H. He...</td>\n",
       "      <td>Hepatitis C virus (HCV) disease progression in...</td>\n",
       "      <td>Smith DJ; Combellick J; Jordan AE; Hagan H</td>\n",
       "      <td>10.1016/j.drugpo.2015.07.004</td>\n",
       "      <td>2015</td>\n",
       "      <td>[Journal Article, Meta-Analysis, Research Supp...</td>\n",
       "      <td>Smith DJ, et al. Hepatitis C virus (HCV) disea...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT03537196</td>\n",
       "      <td>DRug Use &amp; Infections in ViEtnam - Hepatitis C...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2018-05-25</td>\n",
       "      <td>23172780</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersm...</td>\n",
       "      <td>Global epidemiology of hepatitis C virus infec...</td>\n",
       "      <td>Mohd Hanafiah K; Groeger J; Flaxman AD; Wiersm...</td>\n",
       "      <td>10.1002/hep.26141</td>\n",
       "      <td>2013</td>\n",
       "      <td>[Journal Article, Meta-Analysis, Review, Syste...</td>\n",
       "      <td>Mohd Hanafiah K, et al. Global epidemiology of...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>678</th>\n",
       "      <td>NCT01075061</td>\n",
       "      <td>Study of a Large Family With Congenital Mirror...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2010-02-24</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>679</th>\n",
       "      <td>NCT00158405</td>\n",
       "      <td>Randomised Trial of Structured Treatment Inter...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>Bristol-Myers Squibb</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-09-12</td>\n",
       "      <td>16152755</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Moh R, Danel C, Sorho S, Sauvageot D, Anzian A...</td>\n",
       "      <td>Haematological changes in adults receiving a z...</td>\n",
       "      <td>Moh R; Danel C; Sorho S; Sauvageot D; Anzian A...</td>\n",
       "      <td>10.1177/135965350501000510</td>\n",
       "      <td>2005</td>\n",
       "      <td>[Clinical Trial, Journal Article, Randomized C...</td>\n",
       "      <td>Moh R, et al. Haematological changes in adults...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>680</th>\n",
       "      <td>NCT00158405</td>\n",
       "      <td>Randomised Trial of Structured Treatment Inter...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>Bristol-Myers Squibb</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-09-12</td>\n",
       "      <td>16782488</td>\n",
       "      <td>RESULT</td>\n",
       "      <td>Danel C, Moh R, Minga A, Anzian A, Ba-Gomis O,...</td>\n",
       "      <td>CD4-guided structured antiretroviral treatment...</td>\n",
       "      <td>Danel C; Moh R; Minga A; Anzian A; Ba-Gomis O;...</td>\n",
       "      <td>10.1016/S0140-6736(06)68887-9</td>\n",
       "      <td>2006</td>\n",
       "      <td>[Journal Article, Multicenter Study, Randomize...</td>\n",
       "      <td>Danel C, et al. CD4-guided structured antiretr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>681</th>\n",
       "      <td>NCT00158405</td>\n",
       "      <td>Randomised Trial of Structured Treatment Inter...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>Bristol-Myers Squibb</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-09-12</td>\n",
       "      <td>18986246</td>\n",
       "      <td>RESULT</td>\n",
       "      <td>Danel C, Moh R, Chaix ML, Gabillard D, Gnokoro...</td>\n",
       "      <td>Two-months-off, four-months-on antiretroviral ...</td>\n",
       "      <td>Danel C; Moh R; Chaix ML; Gabillard D; Gnokoro...</td>\n",
       "      <td>10.1086/595298</td>\n",
       "      <td>2009</td>\n",
       "      <td>[Journal Article, Multicenter Study, Randomize...</td>\n",
       "      <td>Danel C, et al. Two-months-off, four-months-on...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>682</th>\n",
       "      <td>NCT00623051</td>\n",
       "      <td>Evaluation of the Extension at Community Level...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2008-02-25</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>683 rows × 17 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                         BriefTitle  \\\n",
       "0    NCT01895920  Viral Biofilms: Hijacking T Cell Extracellular...   \n",
       "1    NCT02486731  Hormonal Sensitivity in Patients With Noonan a...   \n",
       "2    NCT02116374  Physiopathology Study of the Microbiota Biodiv...   \n",
       "3    NCT03537196  DRug Use & Infections in ViEtnam - Hepatitis C...   \n",
       "4    NCT03537196  DRug Use & Infections in ViEtnam - Hepatitis C...   \n",
       "..           ...                                                ...   \n",
       "678  NCT01075061  Study of a Large Family With Congenital Mirror...   \n",
       "679  NCT00158405  Randomised Trial of Structured Treatment Inter...   \n",
       "680  NCT00158405  Randomised Trial of Structured Treatment Inter...   \n",
       "681  NCT00158405  Randomised Trial of Structured Treatment Inter...   \n",
       "682  NCT00623051  Evaluation of the Extension at Community Level...   \n",
       "\n",
       "                                       LeadSponsorName      CollaboratorName  \\\n",
       "0                   ANRS, Emerging Infectious Diseases                  <NA>   \n",
       "1    Institut National de la Santé Et de la Recherc...                  <NA>   \n",
       "2                   ANRS, Emerging Infectious Diseases                  <NA>   \n",
       "3                   ANRS, Emerging Infectious Diseases                  <NA>   \n",
       "4                   ANRS, Emerging Infectious Diseases                  <NA>   \n",
       "..                                                 ...                   ...   \n",
       "678  Institut National de la Santé Et de la Recherc...                  <NA>   \n",
       "679  French National Agency for Research on AIDS an...  Bristol-Myers Squibb   \n",
       "680  French National Agency for Research on AIDS an...  Bristol-Myers Squibb   \n",
       "681  French National Agency for Research on AIDS an...  Bristol-Myers Squibb   \n",
       "682  French National Agency for Research on AIDS an...                  <NA>   \n",
       "\n",
       "    OverallStatus       StudyType  HasResults StudyFirstPostDate      pmid  \\\n",
       "0       COMPLETED  INTERVENTIONAL       False         2013-07-11      <NA>   \n",
       "1       COMPLETED   OBSERVATIONAL       False         2015-07-01      <NA>   \n",
       "2       COMPLETED   OBSERVATIONAL       False         2014-04-16      <NA>   \n",
       "3       COMPLETED  INTERVENTIONAL       False         2018-05-25  26298331   \n",
       "4       COMPLETED  INTERVENTIONAL       False         2018-05-25  23172780   \n",
       "..            ...             ...         ...                ...       ...   \n",
       "678     COMPLETED  INTERVENTIONAL       False         2010-02-24      <NA>   \n",
       "679     COMPLETED  INTERVENTIONAL       False         2005-09-12  16152755   \n",
       "680     COMPLETED  INTERVENTIONAL       False         2005-09-12  16782488   \n",
       "681     COMPLETED  INTERVENTIONAL       False         2005-09-12  18986246   \n",
       "682     COMPLETED  INTERVENTIONAL       False         2008-02-25      <NA>   \n",
       "\n",
       "           type                                         citation_x  \\\n",
       "0          <NA>                                               <NA>   \n",
       "1          <NA>                                               <NA>   \n",
       "2          <NA>                                               <NA>   \n",
       "3    BACKGROUND  Smith DJ, Combellick J, Jordan AE, Hagan H. He...   \n",
       "4    BACKGROUND  Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersm...   \n",
       "..          ...                                                ...   \n",
       "678        <NA>                                               <NA>   \n",
       "679  BACKGROUND  Moh R, Danel C, Sorho S, Sauvageot D, Anzian A...   \n",
       "680      RESULT  Danel C, Moh R, Minga A, Anzian A, Ba-Gomis O,...   \n",
       "681      RESULT  Danel C, Moh R, Chaix ML, Gabillard D, Gnokoro...   \n",
       "682        <NA>                                               <NA>   \n",
       "\n",
       "                                                 title  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3    Hepatitis C virus (HCV) disease progression in...   \n",
       "4    Global epidemiology of hepatitis C virus infec...   \n",
       "..                                                 ...   \n",
       "678                                                NaN   \n",
       "679  Haematological changes in adults receiving a z...   \n",
       "680  CD4-guided structured antiretroviral treatment...   \n",
       "681  Two-months-off, four-months-on antiretroviral ...   \n",
       "682                                                NaN   \n",
       "\n",
       "                                               authors  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3           Smith DJ; Combellick J; Jordan AE; Hagan H   \n",
       "4    Mohd Hanafiah K; Groeger J; Flaxman AD; Wiersm...   \n",
       "..                                                 ...   \n",
       "678                                                NaN   \n",
       "679  Moh R; Danel C; Sorho S; Sauvageot D; Anzian A...   \n",
       "680  Danel C; Moh R; Minga A; Anzian A; Ba-Gomis O;...   \n",
       "681  Danel C; Moh R; Chaix ML; Gabillard D; Gnokoro...   \n",
       "682                                                NaN   \n",
       "\n",
       "                               doi  year  \\\n",
       "0                              NaN   NaN   \n",
       "1                              NaN   NaN   \n",
       "2                              NaN   NaN   \n",
       "3     10.1016/j.drugpo.2015.07.004  2015   \n",
       "4                10.1002/hep.26141  2013   \n",
       "..                             ...   ...   \n",
       "678                            NaN   NaN   \n",
       "679     10.1177/135965350501000510  2005   \n",
       "680  10.1016/S0140-6736(06)68887-9  2006   \n",
       "681                 10.1086/595298  2009   \n",
       "682                            NaN   NaN   \n",
       "\n",
       "                                     publication_types  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3    [Journal Article, Meta-Analysis, Research Supp...   \n",
       "4    [Journal Article, Meta-Analysis, Review, Syste...   \n",
       "..                                                 ...   \n",
       "678                                                NaN   \n",
       "679  [Clinical Trial, Journal Article, Randomized C...   \n",
       "680  [Journal Article, Multicenter Study, Randomize...   \n",
       "681  [Journal Article, Multicenter Study, Randomize...   \n",
       "682                                                NaN   \n",
       "\n",
       "                                            citation_y  \n",
       "0                                                  NaN  \n",
       "1                                                  NaN  \n",
       "2                                                  NaN  \n",
       "3    Smith DJ, et al. Hepatitis C virus (HCV) disea...  \n",
       "4    Mohd Hanafiah K, et al. Global epidemiology of...  \n",
       "..                                                 ...  \n",
       "678                                                NaN  \n",
       "679  Moh R, et al. Haematological changes in adults...  \n",
       "680  Danel C, et al. CD4-guided structured antiretr...  \n",
       "681  Danel C, et al. Two-months-off, four-months-on...  \n",
       "682                                                NaN  \n",
       "\n",
       "[683 rows x 17 columns]"
      ]
     },
     "execution_count": 370,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_final = df_ct.merge(df_pubmed, on = ['NCTId', 'pmid'], how='right')\n",
    "df_final"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f4de1f05-1852-441a-801f-0af220d03f0d",
   "metadata": {},
   "source": [
    "Suppression des colonnes 'citation':"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 371,
   "id": "663a60db-5ccb-4fdd-873a-4d4bc82a3033",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_final.drop(['citation_x', 'citation_y'], axis = 1, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 487,
   "id": "a9dad762-522c-4483-b9b8-01ff3033beb2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>pmid</th>\n",
       "      <th>type</th>\n",
       "      <th>title</th>\n",
       "      <th>authors</th>\n",
       "      <th>doi</th>\n",
       "      <th>year</th>\n",
       "      <th>publication_types</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT01895920</td>\n",
       "      <td>Viral Biofilms: Hijacking T Cell Extracellular...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2013-07-11</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02486731</td>\n",
       "      <td>Hormonal Sensitivity in Patients With Noonan a...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2015-07-01</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02116374</td>\n",
       "      <td>Physiopathology Study of the Microbiota Biodiv...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2014-04-16</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT03537196</td>\n",
       "      <td>DRug Use &amp; Infections in ViEtnam - Hepatitis C...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2018-05-25</td>\n",
       "      <td>26298331</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Hepatitis C virus (HCV) disease progression in...</td>\n",
       "      <td>Smith DJ; Combellick J; Jordan AE; Hagan H</td>\n",
       "      <td>10.1016/j.drugpo.2015.07.004</td>\n",
       "      <td>2015</td>\n",
       "      <td>[Journal Article, Meta-Analysis, Research Supp...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT03537196</td>\n",
       "      <td>DRug Use &amp; Infections in ViEtnam - Hepatitis C...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2018-05-25</td>\n",
       "      <td>23172780</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Global epidemiology of hepatitis C virus infec...</td>\n",
       "      <td>Mohd Hanafiah K; Groeger J; Flaxman AD; Wiersm...</td>\n",
       "      <td>10.1002/hep.26141</td>\n",
       "      <td>2013</td>\n",
       "      <td>[Journal Article, Meta-Analysis, Review, Syste...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>678</th>\n",
       "      <td>NCT01075061</td>\n",
       "      <td>Study of a Large Family With Congenital Mirror...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2010-02-24</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>679</th>\n",
       "      <td>NCT00158405</td>\n",
       "      <td>Randomised Trial of Structured Treatment Inter...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>Bristol-Myers Squibb</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-09-12</td>\n",
       "      <td>16152755</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Haematological changes in adults receiving a z...</td>\n",
       "      <td>Moh R; Danel C; Sorho S; Sauvageot D; Anzian A...</td>\n",
       "      <td>10.1177/135965350501000510</td>\n",
       "      <td>2005</td>\n",
       "      <td>[Clinical Trial, Journal Article, Randomized C...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>680</th>\n",
       "      <td>NCT00158405</td>\n",
       "      <td>Randomised Trial of Structured Treatment Inter...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>Bristol-Myers Squibb</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-09-12</td>\n",
       "      <td>16782488</td>\n",
       "      <td>RESULT</td>\n",
       "      <td>CD4-guided structured antiretroviral treatment...</td>\n",
       "      <td>Danel C; Moh R; Minga A; Anzian A; Ba-Gomis O;...</td>\n",
       "      <td>10.1016/S0140-6736(06)68887-9</td>\n",
       "      <td>2006</td>\n",
       "      <td>[Journal Article, Multicenter Study, Randomize...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>681</th>\n",
       "      <td>NCT00158405</td>\n",
       "      <td>Randomised Trial of Structured Treatment Inter...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>Bristol-Myers Squibb</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-09-12</td>\n",
       "      <td>18986246</td>\n",
       "      <td>RESULT</td>\n",
       "      <td>Two-months-off, four-months-on antiretroviral ...</td>\n",
       "      <td>Danel C; Moh R; Chaix ML; Gabillard D; Gnokoro...</td>\n",
       "      <td>10.1086/595298</td>\n",
       "      <td>2009</td>\n",
       "      <td>[Journal Article, Multicenter Study, Randomize...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>682</th>\n",
       "      <td>NCT00623051</td>\n",
       "      <td>Evaluation of the Extension at Community Level...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2008-02-25</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>683 rows × 15 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                         BriefTitle  \\\n",
       "0    NCT01895920  Viral Biofilms: Hijacking T Cell Extracellular...   \n",
       "1    NCT02486731  Hormonal Sensitivity in Patients With Noonan a...   \n",
       "2    NCT02116374  Physiopathology Study of the Microbiota Biodiv...   \n",
       "3    NCT03537196  DRug Use & Infections in ViEtnam - Hepatitis C...   \n",
       "4    NCT03537196  DRug Use & Infections in ViEtnam - Hepatitis C...   \n",
       "..           ...                                                ...   \n",
       "678  NCT01075061  Study of a Large Family With Congenital Mirror...   \n",
       "679  NCT00158405  Randomised Trial of Structured Treatment Inter...   \n",
       "680  NCT00158405  Randomised Trial of Structured Treatment Inter...   \n",
       "681  NCT00158405  Randomised Trial of Structured Treatment Inter...   \n",
       "682  NCT00623051  Evaluation of the Extension at Community Level...   \n",
       "\n",
       "                                       LeadSponsorName      CollaboratorName  \\\n",
       "0                   ANRS, Emerging Infectious Diseases                  <NA>   \n",
       "1    Institut National de la Santé Et de la Recherc...                  <NA>   \n",
       "2                   ANRS, Emerging Infectious Diseases                  <NA>   \n",
       "3                   ANRS, Emerging Infectious Diseases                  <NA>   \n",
       "4                   ANRS, Emerging Infectious Diseases                  <NA>   \n",
       "..                                                 ...                   ...   \n",
       "678  Institut National de la Santé Et de la Recherc...                  <NA>   \n",
       "679  French National Agency for Research on AIDS an...  Bristol-Myers Squibb   \n",
       "680  French National Agency for Research on AIDS an...  Bristol-Myers Squibb   \n",
       "681  French National Agency for Research on AIDS an...  Bristol-Myers Squibb   \n",
       "682  French National Agency for Research on AIDS an...                  <NA>   \n",
       "\n",
       "    OverallStatus       StudyType  HasResults StudyFirstPostDate      pmid  \\\n",
       "0       COMPLETED  INTERVENTIONAL       False         2013-07-11      <NA>   \n",
       "1       COMPLETED   OBSERVATIONAL       False         2015-07-01      <NA>   \n",
       "2       COMPLETED   OBSERVATIONAL       False         2014-04-16      <NA>   \n",
       "3       COMPLETED  INTERVENTIONAL       False         2018-05-25  26298331   \n",
       "4       COMPLETED  INTERVENTIONAL       False         2018-05-25  23172780   \n",
       "..            ...             ...         ...                ...       ...   \n",
       "678     COMPLETED  INTERVENTIONAL       False         2010-02-24      <NA>   \n",
       "679     COMPLETED  INTERVENTIONAL       False         2005-09-12  16152755   \n",
       "680     COMPLETED  INTERVENTIONAL       False         2005-09-12  16782488   \n",
       "681     COMPLETED  INTERVENTIONAL       False         2005-09-12  18986246   \n",
       "682     COMPLETED  INTERVENTIONAL       False         2008-02-25      <NA>   \n",
       "\n",
       "           type                                              title  \\\n",
       "0          <NA>                                               <NA>   \n",
       "1          <NA>                                               <NA>   \n",
       "2          <NA>                                               <NA>   \n",
       "3    BACKGROUND  Hepatitis C virus (HCV) disease progression in...   \n",
       "4    BACKGROUND  Global epidemiology of hepatitis C virus infec...   \n",
       "..          ...                                                ...   \n",
       "678        <NA>                                               <NA>   \n",
       "679  BACKGROUND  Haematological changes in adults receiving a z...   \n",
       "680      RESULT  CD4-guided structured antiretroviral treatment...   \n",
       "681      RESULT  Two-months-off, four-months-on antiretroviral ...   \n",
       "682        <NA>                                               <NA>   \n",
       "\n",
       "                                               authors  \\\n",
       "0                                                 <NA>   \n",
       "1                                                 <NA>   \n",
       "2                                                 <NA>   \n",
       "3           Smith DJ; Combellick J; Jordan AE; Hagan H   \n",
       "4    Mohd Hanafiah K; Groeger J; Flaxman AD; Wiersm...   \n",
       "..                                                 ...   \n",
       "678                                               <NA>   \n",
       "679  Moh R; Danel C; Sorho S; Sauvageot D; Anzian A...   \n",
       "680  Danel C; Moh R; Minga A; Anzian A; Ba-Gomis O;...   \n",
       "681  Danel C; Moh R; Chaix ML; Gabillard D; Gnokoro...   \n",
       "682                                               <NA>   \n",
       "\n",
       "                               doi  year  \\\n",
       "0                             <NA>  <NA>   \n",
       "1                             <NA>  <NA>   \n",
       "2                             <NA>  <NA>   \n",
       "3     10.1016/j.drugpo.2015.07.004  2015   \n",
       "4                10.1002/hep.26141  2013   \n",
       "..                             ...   ...   \n",
       "678                           <NA>  <NA>   \n",
       "679     10.1177/135965350501000510  2005   \n",
       "680  10.1016/S0140-6736(06)68887-9  2006   \n",
       "681                 10.1086/595298  2009   \n",
       "682                           <NA>  <NA>   \n",
       "\n",
       "                                     publication_types  \n",
       "0                                                  NaN  \n",
       "1                                                  NaN  \n",
       "2                                                  NaN  \n",
       "3    [Journal Article, Meta-Analysis, Research Supp...  \n",
       "4    [Journal Article, Meta-Analysis, Review, Syste...  \n",
       "..                                                 ...  \n",
       "678                                                NaN  \n",
       "679  [Clinical Trial, Journal Article, Randomized C...  \n",
       "680  [Journal Article, Multicenter Study, Randomize...  \n",
       "681  [Journal Article, Multicenter Study, Randomize...  \n",
       "682                                                NaN  \n",
       "\n",
       "[683 rows x 15 columns]"
      ]
     },
     "execution_count": 487,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_final"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7d497973-5788-41e4-a541-c326b32ffb83",
   "metadata": {},
   "source": [
    "Les nouveaux PMIDs trouvés via Pubmed, n'ont aucune des infos associées avec CT présents: BriefTitle, LeadSponsorName, etc ...\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 382,
   "id": "e83f92d2-39b0-4653-8ab5-9766b16f4da4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>pmid</th>\n",
       "      <th>type</th>\n",
       "      <th>title</th>\n",
       "      <th>authors</th>\n",
       "      <th>doi</th>\n",
       "      <th>year</th>\n",
       "      <th>publication_types</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>NCT03078439</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38408861</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Birth weight and head circumference discordanc...</td>\n",
       "      <td>Guellec I; Brunet A; Lapillonne A; Taine M; To...</td>\n",
       "      <td>10.1136/archdischild-2023-326336</td>\n",
       "      <td>2024</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>NCT02057796</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36883573</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>High performance of systematic combined urine ...</td>\n",
       "      <td>Bonnet M; Gabillard D; Domoua S; Muzoora C; Me...</td>\n",
       "      <td>10.1093/cid/ciad125</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>NCT00640263</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>34425825</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>The prevalence and socio-behavioural and clini...</td>\n",
       "      <td>Birungi N; Fadnes LT; Engebretsen IMS; Tumwine...</td>\n",
       "      <td>10.1186/s12955-021-01844-3</td>\n",
       "      <td>2021</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>NCT02212379</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>31269208</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Dual therapy combining raltegravir with etravi...</td>\n",
       "      <td>Katlama C; Assoumou L; Valantin MA; Soulié C; ...</td>\n",
       "      <td>10.1093/jac/dkz224</td>\n",
       "      <td>2019</td>\n",
       "      <td>[Journal Article, Multicenter Study, Research ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>124</th>\n",
       "      <td>NCT01473472</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36601747</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Hepatitis A and B vaccine uptake and immunisat...</td>\n",
       "      <td>Le Turnier P; Charreau I; Gabassi A; Carette D...</td>\n",
       "      <td>10.1136/sextrans-2022-055634</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Clinical Trial, Research Support, Non-U.S. Go...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>143</th>\n",
       "      <td>NCT03335995</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>37497675</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>One-Year Outcomes in Patients With Acute Strok...</td>\n",
       "      <td>Sonneville R; Mazighi M; Collet M; Gayat E; De...</td>\n",
       "      <td>10.1161/STROKEAHA.123.042910</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Multicenter Study, Journal Article, Research ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161</th>\n",
       "      <td>NCT01426243</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>26314624</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Molecular characterization of the 17D-204 yell...</td>\n",
       "      <td>Salmona M; Gazaignes S; Mercier-Delarue S; Gar...</td>\n",
       "      <td>10.1016/j.vaccine.2015.08.055</td>\n",
       "      <td>2015</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>277</th>\n",
       "      <td>NCT03005652</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38100477</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Effects of a mindfulness-based intervention an...</td>\n",
       "      <td>Schlosser M; Demnitz-King H; Barnhofer T; Coll...</td>\n",
       "      <td>10.1371/journal.pone.0295175</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Randomized Controlled Trial, Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>283</th>\n",
       "      <td>NCT03215732</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>37143029</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Hepatitis B prevention and treatment needs in ...</td>\n",
       "      <td>Djaogol T; Périères L; Marcellin F; Diouf A; C...</td>\n",
       "      <td>10.1186/s12889-023-15710-y</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>284</th>\n",
       "      <td>NCT02405013</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36686592</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Patient-reported outcomes with direct-acting a...</td>\n",
       "      <td>Marcellin F; Mourad A; Lemoine M; Kouanfack C;...</td>\n",
       "      <td>10.1016/j.jhepr.2022.100665</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>298</th>\n",
       "      <td>NCT01089387</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>26439886</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Safety of Intracavernous Bone Marrow-Mononucle...</td>\n",
       "      <td>Yiou R; Hamidou L; Birebent B; Bitari D; Lecor...</td>\n",
       "      <td>10.1016/j.eururo.2015.09.026</td>\n",
       "      <td>2016</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>364</th>\n",
       "      <td>NCT05311865</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>37795682</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>A randomised controlled trial to study the tra...</td>\n",
       "      <td>Luong Nguyen LB; Goupil de Bouillé J; Menant L...</td>\n",
       "      <td>10.1093/cid/ciad603</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>365</th>\n",
       "      <td>NCT05311865</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36438274</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Transmission of SARS-CoV-2 during indoor clubb...</td>\n",
       "      <td>Goupil de Bouillé J; Luong Nguyen LB; Crépey P...</td>\n",
       "      <td>10.3389/fpubh.2022.981213</td>\n",
       "      <td>2022</td>\n",
       "      <td>[Clinical Trial Protocol, Journal Article, Res...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>384</th>\n",
       "      <td>NCT04315948</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36695483</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Remdesivir for the treatment of COVID-19.</td>\n",
       "      <td>Grundeis F; Ansems K; Dahms K; Thieme V; Metze...</td>\n",
       "      <td>10.1002/14651858.CD014962.pub2</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Review, Research Support, No...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>448</th>\n",
       "      <td>NCT05349162</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36735263</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Epicardial vs. transvenous implantable cardiov...</td>\n",
       "      <td>Le Bos PA; Pontailler M; Maltret A; Kraiche D;...</td>\n",
       "      <td>10.1093/europace/euad015</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Clinical Trial, Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>455</th>\n",
       "      <td>NCT01453192</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>30688008</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Low incidence of acute rejection within 6 mont...</td>\n",
       "      <td>Matignon M; Lelièvre JD; Lahiani A; Abbassi K;...</td>\n",
       "      <td>10.1111/hiv.12700</td>\n",
       "      <td>2019</td>\n",
       "      <td>[Journal Article, Multicenter Study, Research ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>481</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38156046</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Durability of the Efficacy and Safety of Dolut...</td>\n",
       "      <td>Mpoudi-Etame M; Tovar Sanchez T; Bousmah MA; O...</td>\n",
       "      <td>10.1093/ofid/ofad582</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>483</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>37851566</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Improvements in Patient-Reported Outcomes Foll...</td>\n",
       "      <td>Bousmah MA; Protopopescu C; Mpoudi-Etame M; Om...</td>\n",
       "      <td>10.1097/QAI.0000000000003273</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Randomized Controlled Trial, Journal Article,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>484</th>\n",
       "      <td>NCT01703962</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>37668523</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Neurochemical Differences between 1p/19q Codel...</td>\n",
       "      <td>Branzoli F; Liserre R; Deelchand DK; Poliani P...</td>\n",
       "      <td>10.1148/radiol.223255</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Observational Study, Researc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>509</th>\n",
       "      <td>NCT01801618</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>29662875</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Positive Virological Outcomes of HIV-Infected ...</td>\n",
       "      <td>Ségéral O; Nerrienet E; Neth S; Spire B; Khol ...</td>\n",
       "      <td>10.3389/fpubh.2018.00063</td>\n",
       "      <td>2018</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>544</th>\n",
       "      <td>NCT04392388</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>34293141</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Antibody status and cumulative incidence of SA...</td>\n",
       "      <td>Carrat F; de Lamballerie X; Rahib D; Blanché H...</td>\n",
       "      <td>10.1093/ije/dyab110</td>\n",
       "      <td>2021</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>592</th>\n",
       "      <td>NCT02481453</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38273639</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Sirolimus for treatment of patients with inclu...</td>\n",
       "      <td>Benveniste O; Hogrel JY; Belin L; Annoussamy M...</td>\n",
       "      <td>10.1016/S2665-9913(20)30280-0</td>\n",
       "      <td>2021</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>603</th>\n",
       "      <td>NCT01688453</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>35272723</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Behavioural risk patterns in adolescents with ...</td>\n",
       "      <td>Julia C; Omorou A; Lecomte E; Langlois J; Touv...</td>\n",
       "      <td>10.1017/S136898002200057X</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>606</th>\n",
       "      <td>NCT04288128</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38421662</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>ATXN7-Related Cone-Rod Dystrophy: The Integrat...</td>\n",
       "      <td>Nassisi M; Coarelli G; Blanchard B; Dubec-Fleu...</td>\n",
       "      <td>10.1001/jamaophthalmol.2024.0001</td>\n",
       "      <td>2024</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>607</th>\n",
       "      <td>NCT04288128</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38419144</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Digital Gait Measures Capture 1-Year Progressi...</td>\n",
       "      <td>Seemann J; Daghsen L; Cazier M; Lamy JC; Welte...</td>\n",
       "      <td>10.1002/mds.29757</td>\n",
       "      <td>2024</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>614</th>\n",
       "      <td>NCT02833961</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36318030</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Longitudinal Monitoring of Microstructural Alt...</td>\n",
       "      <td>Genovese G; Diaz-Fernandez B; Lejeune FX; Rone...</td>\n",
       "      <td>10.1148/radiol.220430</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>659</th>\n",
       "      <td>NCT04409405</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38043556</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Effect of anti-Ebola virus monoclonal antibodi...</td>\n",
       "      <td>Nkuba-Ndaye A; Dilu-Keti A; Tovar-Sanchez T; D...</td>\n",
       "      <td>10.1016/S1473-3099(23)00552-2</td>\n",
       "      <td>2024</td>\n",
       "      <td>[Observational Study, Journal Article]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId BriefTitle LeadSponsorName CollaboratorName OverallStatus  \\\n",
       "43   NCT03078439       <NA>            <NA>             <NA>          <NA>   \n",
       "54   NCT02057796       <NA>            <NA>             <NA>          <NA>   \n",
       "70   NCT00640263       <NA>            <NA>             <NA>          <NA>   \n",
       "88   NCT02212379       <NA>            <NA>             <NA>          <NA>   \n",
       "124  NCT01473472       <NA>            <NA>             <NA>          <NA>   \n",
       "143  NCT03335995       <NA>            <NA>             <NA>          <NA>   \n",
       "161  NCT01426243       <NA>            <NA>             <NA>          <NA>   \n",
       "277  NCT03005652       <NA>            <NA>             <NA>          <NA>   \n",
       "283  NCT03215732       <NA>            <NA>             <NA>          <NA>   \n",
       "284  NCT02405013       <NA>            <NA>             <NA>          <NA>   \n",
       "298  NCT01089387       <NA>            <NA>             <NA>          <NA>   \n",
       "364  NCT05311865       <NA>            <NA>             <NA>          <NA>   \n",
       "365  NCT05311865       <NA>            <NA>             <NA>          <NA>   \n",
       "384  NCT04315948       <NA>            <NA>             <NA>          <NA>   \n",
       "448  NCT05349162       <NA>            <NA>             <NA>          <NA>   \n",
       "455  NCT01453192       <NA>            <NA>             <NA>          <NA>   \n",
       "481  NCT02777229       <NA>            <NA>             <NA>          <NA>   \n",
       "483  NCT02777229       <NA>            <NA>             <NA>          <NA>   \n",
       "484  NCT01703962       <NA>            <NA>             <NA>          <NA>   \n",
       "509  NCT01801618       <NA>            <NA>             <NA>          <NA>   \n",
       "544  NCT04392388       <NA>            <NA>             <NA>          <NA>   \n",
       "592  NCT02481453       <NA>            <NA>             <NA>          <NA>   \n",
       "603  NCT01688453       <NA>            <NA>             <NA>          <NA>   \n",
       "606  NCT04288128       <NA>            <NA>             <NA>          <NA>   \n",
       "607  NCT04288128       <NA>            <NA>             <NA>          <NA>   \n",
       "614  NCT02833961       <NA>            <NA>             <NA>          <NA>   \n",
       "659  NCT04409405       <NA>            <NA>             <NA>          <NA>   \n",
       "\n",
       "    StudyType  HasResults StudyFirstPostDate      pmid    type  \\\n",
       "43       <NA>        <NA>               <NA>  38408861  PUBMED   \n",
       "54       <NA>        <NA>               <NA>  36883573  PUBMED   \n",
       "70       <NA>        <NA>               <NA>  34425825  PUBMED   \n",
       "88       <NA>        <NA>               <NA>  31269208  PUBMED   \n",
       "124      <NA>        <NA>               <NA>  36601747  PUBMED   \n",
       "143      <NA>        <NA>               <NA>  37497675  PUBMED   \n",
       "161      <NA>        <NA>               <NA>  26314624  PUBMED   \n",
       "277      <NA>        <NA>               <NA>  38100477  PUBMED   \n",
       "283      <NA>        <NA>               <NA>  37143029  PUBMED   \n",
       "284      <NA>        <NA>               <NA>  36686592  PUBMED   \n",
       "298      <NA>        <NA>               <NA>  26439886  PUBMED   \n",
       "364      <NA>        <NA>               <NA>  37795682  PUBMED   \n",
       "365      <NA>        <NA>               <NA>  36438274  PUBMED   \n",
       "384      <NA>        <NA>               <NA>  36695483  PUBMED   \n",
       "448      <NA>        <NA>               <NA>  36735263  PUBMED   \n",
       "455      <NA>        <NA>               <NA>  30688008  PUBMED   \n",
       "481      <NA>        <NA>               <NA>  38156046  PUBMED   \n",
       "483      <NA>        <NA>               <NA>  37851566  PUBMED   \n",
       "484      <NA>        <NA>               <NA>  37668523  PUBMED   \n",
       "509      <NA>        <NA>               <NA>  29662875  PUBMED   \n",
       "544      <NA>        <NA>               <NA>  34293141  PUBMED   \n",
       "592      <NA>        <NA>               <NA>  38273639  PUBMED   \n",
       "603      <NA>        <NA>               <NA>  35272723  PUBMED   \n",
       "606      <NA>        <NA>               <NA>  38421662  PUBMED   \n",
       "607      <NA>        <NA>               <NA>  38419144  PUBMED   \n",
       "614      <NA>        <NA>               <NA>  36318030  PUBMED   \n",
       "659      <NA>        <NA>               <NA>  38043556  PUBMED   \n",
       "\n",
       "                                                 title  \\\n",
       "43   Birth weight and head circumference discordanc...   \n",
       "54   High performance of systematic combined urine ...   \n",
       "70   The prevalence and socio-behavioural and clini...   \n",
       "88   Dual therapy combining raltegravir with etravi...   \n",
       "124  Hepatitis A and B vaccine uptake and immunisat...   \n",
       "143  One-Year Outcomes in Patients With Acute Strok...   \n",
       "161  Molecular characterization of the 17D-204 yell...   \n",
       "277  Effects of a mindfulness-based intervention an...   \n",
       "283  Hepatitis B prevention and treatment needs in ...   \n",
       "284  Patient-reported outcomes with direct-acting a...   \n",
       "298  Safety of Intracavernous Bone Marrow-Mononucle...   \n",
       "364  A randomised controlled trial to study the tra...   \n",
       "365  Transmission of SARS-CoV-2 during indoor clubb...   \n",
       "384          Remdesivir for the treatment of COVID-19.   \n",
       "448  Epicardial vs. transvenous implantable cardiov...   \n",
       "455  Low incidence of acute rejection within 6 mont...   \n",
       "481  Durability of the Efficacy and Safety of Dolut...   \n",
       "483  Improvements in Patient-Reported Outcomes Foll...   \n",
       "484  Neurochemical Differences between 1p/19q Codel...   \n",
       "509  Positive Virological Outcomes of HIV-Infected ...   \n",
       "544  Antibody status and cumulative incidence of SA...   \n",
       "592  Sirolimus for treatment of patients with inclu...   \n",
       "603  Behavioural risk patterns in adolescents with ...   \n",
       "606  ATXN7-Related Cone-Rod Dystrophy: The Integrat...   \n",
       "607  Digital Gait Measures Capture 1-Year Progressi...   \n",
       "614  Longitudinal Monitoring of Microstructural Alt...   \n",
       "659  Effect of anti-Ebola virus monoclonal antibodi...   \n",
       "\n",
       "                                               authors  \\\n",
       "43   Guellec I; Brunet A; Lapillonne A; Taine M; To...   \n",
       "54   Bonnet M; Gabillard D; Domoua S; Muzoora C; Me...   \n",
       "70   Birungi N; Fadnes LT; Engebretsen IMS; Tumwine...   \n",
       "88   Katlama C; Assoumou L; Valantin MA; Soulié C; ...   \n",
       "124  Le Turnier P; Charreau I; Gabassi A; Carette D...   \n",
       "143  Sonneville R; Mazighi M; Collet M; Gayat E; De...   \n",
       "161  Salmona M; Gazaignes S; Mercier-Delarue S; Gar...   \n",
       "277  Schlosser M; Demnitz-King H; Barnhofer T; Coll...   \n",
       "283  Djaogol T; Périères L; Marcellin F; Diouf A; C...   \n",
       "284  Marcellin F; Mourad A; Lemoine M; Kouanfack C;...   \n",
       "298  Yiou R; Hamidou L; Birebent B; Bitari D; Lecor...   \n",
       "364  Luong Nguyen LB; Goupil de Bouillé J; Menant L...   \n",
       "365  Goupil de Bouillé J; Luong Nguyen LB; Crépey P...   \n",
       "384  Grundeis F; Ansems K; Dahms K; Thieme V; Metze...   \n",
       "448  Le Bos PA; Pontailler M; Maltret A; Kraiche D;...   \n",
       "455  Matignon M; Lelièvre JD; Lahiani A; Abbassi K;...   \n",
       "481  Mpoudi-Etame M; Tovar Sanchez T; Bousmah MA; O...   \n",
       "483  Bousmah MA; Protopopescu C; Mpoudi-Etame M; Om...   \n",
       "484  Branzoli F; Liserre R; Deelchand DK; Poliani P...   \n",
       "509  Ségéral O; Nerrienet E; Neth S; Spire B; Khol ...   \n",
       "544  Carrat F; de Lamballerie X; Rahib D; Blanché H...   \n",
       "592  Benveniste O; Hogrel JY; Belin L; Annoussamy M...   \n",
       "603  Julia C; Omorou A; Lecomte E; Langlois J; Touv...   \n",
       "606  Nassisi M; Coarelli G; Blanchard B; Dubec-Fleu...   \n",
       "607  Seemann J; Daghsen L; Cazier M; Lamy JC; Welte...   \n",
       "614  Genovese G; Diaz-Fernandez B; Lejeune FX; Rone...   \n",
       "659  Nkuba-Ndaye A; Dilu-Keti A; Tovar-Sanchez T; D...   \n",
       "\n",
       "                                  doi  year  \\\n",
       "43   10.1136/archdischild-2023-326336  2024   \n",
       "54                10.1093/cid/ciad125  2023   \n",
       "70         10.1186/s12955-021-01844-3  2021   \n",
       "88                 10.1093/jac/dkz224  2019   \n",
       "124      10.1136/sextrans-2022-055634  2023   \n",
       "143      10.1161/STROKEAHA.123.042910  2023   \n",
       "161     10.1016/j.vaccine.2015.08.055  2015   \n",
       "277      10.1371/journal.pone.0295175  2023   \n",
       "283        10.1186/s12889-023-15710-y  2023   \n",
       "284       10.1016/j.jhepr.2022.100665  2023   \n",
       "298      10.1016/j.eururo.2015.09.026  2016   \n",
       "364               10.1093/cid/ciad603  2023   \n",
       "365         10.3389/fpubh.2022.981213  2022   \n",
       "384    10.1002/14651858.CD014962.pub2  2023   \n",
       "448          10.1093/europace/euad015  2023   \n",
       "455                 10.1111/hiv.12700  2019   \n",
       "481              10.1093/ofid/ofad582  2023   \n",
       "483      10.1097/QAI.0000000000003273  2023   \n",
       "484             10.1148/radiol.223255  2023   \n",
       "509          10.3389/fpubh.2018.00063  2018   \n",
       "544               10.1093/ije/dyab110  2021   \n",
       "592     10.1016/S2665-9913(20)30280-0  2021   \n",
       "603         10.1017/S136898002200057X  2023   \n",
       "606  10.1001/jamaophthalmol.2024.0001  2024   \n",
       "607                 10.1002/mds.29757  2024   \n",
       "614             10.1148/radiol.220430  2023   \n",
       "659     10.1016/S1473-3099(23)00552-2  2024   \n",
       "\n",
       "                                     publication_types  \n",
       "43                                   [Journal Article]  \n",
       "54                                   [Journal Article]  \n",
       "70                                   [Journal Article]  \n",
       "88   [Journal Article, Multicenter Study, Research ...  \n",
       "124  [Clinical Trial, Research Support, Non-U.S. Go...  \n",
       "143  [Multicenter Study, Journal Article, Research ...  \n",
       "161  [Journal Article, Research Support, Non-U.S. G...  \n",
       "277     [Randomized Controlled Trial, Journal Article]  \n",
       "283  [Journal Article, Research Support, Non-U.S. G...  \n",
       "284                                  [Journal Article]  \n",
       "298  [Journal Article, Research Support, Non-U.S. G...  \n",
       "364                                  [Journal Article]  \n",
       "365  [Clinical Trial Protocol, Journal Article, Res...  \n",
       "384  [Journal Article, Review, Research Support, No...  \n",
       "448                  [Clinical Trial, Journal Article]  \n",
       "455  [Journal Article, Multicenter Study, Research ...  \n",
       "481                                  [Journal Article]  \n",
       "483  [Randomized Controlled Trial, Journal Article,...  \n",
       "484  [Journal Article, Observational Study, Researc...  \n",
       "509                                  [Journal Article]  \n",
       "544                                  [Journal Article]  \n",
       "592                                  [Journal Article]  \n",
       "603  [Journal Article, Research Support, Non-U.S. G...  \n",
       "606                                  [Journal Article]  \n",
       "607                                  [Journal Article]  \n",
       "614  [Journal Article, Research Support, Non-U.S. G...  \n",
       "659             [Observational Study, Journal Article]  "
      ]
     },
     "execution_count": 382,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_final[df_final.loc[:, 'BriefTitle'].isna()]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fc08104a-116a-4a29-9212-2e5b60fbee3f",
   "metadata": {},
   "source": [
    "On va remplir ces colonnes avec les infos contenus dans la DataFrame CT:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 413,
   "id": "0bfe7359-376b-45fb-b36b-7246db7f1543",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Index of empty rows we need to fill \n",
    "change_index = df_final.loc[:, 'BriefTitle'].isna()\n",
    "\n",
    "# Columns we wish to copy\n",
    "columns_to_copy = [\n",
    "    'BriefTitle',\n",
    "    'LeadSponsorName',\n",
    "    'CollaboratorName',\n",
    "    'OverallStatus',\n",
    "    'StudyType',\n",
    "    'HasResults',\n",
    "    'StudyFirstPostDate',\n",
    "]\n",
    "\n",
    "# We copy the data from the CT dataframe to the final dataframe\n",
    "df_final.loc[change_index, columns_to_copy] = df_ct.loc[change_index, columns_to_copy]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "50dcc465-0689-42e3-8276-77fa51ea2782",
   "metadata": {},
   "source": [
    "On rajoute un type 'PUBMED' pour les PMIDs issues de PubMed uniquement:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 417,
   "id": "f4a60897-c005-4158-8508-70938415aa3a",
   "metadata": {},
   "outputs": [],
   "source": [
    "# We add a 'PUBMED' type to the PMIDs extracted from Pubmed exclusively\n",
    "df_final.loc[change_index, 'type'] = 'PUBMED'"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d5132e99-076f-46b6-9007-fa34d0abef35",
   "metadata": {},
   "source": [
    "### Resultat final:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 438,
   "id": "7deedf6e-17bd-49b9-803c-a76561b36f18",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<StringArray>\n",
       "['NCT01605890', 'NCT00928187', 'NCT02573948', 'NCT02453048', 'NCT01882062']\n",
       "Length: 5, dtype: string"
      ]
     },
     "execution_count": 438,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_final.loc[df_final['HasResults'] == True, 'NCTId'].unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 444,
   "id": "f025478b-ab6b-4adc-ab71-bbfe11020351",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>pmid</th>\n",
       "      <th>type</th>\n",
       "      <th>title</th>\n",
       "      <th>authors</th>\n",
       "      <th>doi</th>\n",
       "      <th>year</th>\n",
       "      <th>publication_types</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>NCT01605890</td>\n",
       "      <td>Trial Evaluating a First Line Combination Ther...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Gilead Sciences | Merck Sharp &amp; Dohme LLC</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2012-05-25</td>\n",
       "      <td>29590335</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>First-line Raltegravir/Emtricitabine/Tenofovir...</td>\n",
       "      <td>Matheron S; Descamps D; Gallien S; Besseghir A...</td>\n",
       "      <td>10.1093/cid/ciy245</td>\n",
       "      <td>2018</td>\n",
       "      <td>[Clinical Trial, Phase II, Journal Article, Mu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>300</th>\n",
       "      <td>NCT00928187</td>\n",
       "      <td>Evaluation of Three Strategies of Second-line ...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Gilead Sciences | Janssen Pharmaceutica</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2009-06-25</td>\n",
       "      <td>31273686</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Cost-Effectiveness of Three Alternative Booste...</td>\n",
       "      <td>Boyer S; Nishimwe ML; Sagaon-Teyssier L; March...</td>\n",
       "      <td>10.1007/s41669-019-0157-9</td>\n",
       "      <td>2020</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>404</th>\n",
       "      <td>NCT02573948</td>\n",
       "      <td>Feasibility of Interventions on People Who Inj...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-10-12</td>\n",
       "      <td>27006257</td>\n",
       "      <td>RESULT</td>\n",
       "      <td>Prospects for ending the HIV epidemic among pe...</td>\n",
       "      <td>Des Jarlais DC; Thi Huong D; Thi Hai Oanh K; K...</td>\n",
       "      <td>10.1016/j.drugpo.2016.02.021</td>\n",
       "      <td>2016</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>405</th>\n",
       "      <td>NCT02573948</td>\n",
       "      <td>Feasibility of Interventions on People Who Inj...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-10-12</td>\n",
       "      <td>25540950</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>AIDS, people who use drugs, and altruism: refl...</td>\n",
       "      <td>Des Jarlais DC</td>\n",
       "      <td>10.3109/10826084.2015.978185</td>\n",
       "      <td>2015</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>406</th>\n",
       "      <td>NCT02573948</td>\n",
       "      <td>Feasibility of Interventions on People Who Inj...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-10-12</td>\n",
       "      <td>28800503</td>\n",
       "      <td>RESULT</td>\n",
       "      <td>Intravenous heroin use in Haiphong, Vietnam: N...</td>\n",
       "      <td>Michel L; Des Jarlais DC; Duong Thi H; Khuat T...</td>\n",
       "      <td>10.1016/j.drugalcdep.2017.07.004</td>\n",
       "      <td>2017</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>407</th>\n",
       "      <td>NCT02573948</td>\n",
       "      <td>Feasibility of Interventions on People Who Inj...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-10-12</td>\n",
       "      <td>26050614</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>An international perspective on using opioid s...</td>\n",
       "      <td>Perlman DC; Jordan AE; Uuskula A; Huong DT; Ma...</td>\n",
       "      <td>10.1016/j.drugpo.2015.04.015</td>\n",
       "      <td>2015</td>\n",
       "      <td>[Journal Article, Research Support, N.I.H., Ex...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>408</th>\n",
       "      <td>NCT02573948</td>\n",
       "      <td>Feasibility of Interventions on People Who Inj...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-10-12</td>\n",
       "      <td>26075647</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Can HIV and Hepatitis C Virus Infection be Eli...</td>\n",
       "      <td>Perlman DC; Des Jarlais DC; Feelemyer J</td>\n",
       "      <td>10.1080/10550887.2015.1059111</td>\n",
       "      <td>2015</td>\n",
       "      <td>[Journal Article, Research Support, N.I.H., Ex...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>409</th>\n",
       "      <td>NCT02573948</td>\n",
       "      <td>Feasibility of Interventions on People Who Inj...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-10-12</td>\n",
       "      <td>28612212</td>\n",
       "      <td>RESULT</td>\n",
       "      <td>Risk Behaviors for HIV and HCV Infection Among...</td>\n",
       "      <td>Duong HT; Jarlais DD; Khuat OHT; Arasteh K; Fe...</td>\n",
       "      <td>10.1007/s10461-017-1814-6</td>\n",
       "      <td>2018</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>410</th>\n",
       "      <td>NCT02573948</td>\n",
       "      <td>Feasibility of Interventions on People Who Inj...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-10-12</td>\n",
       "      <td>26032121</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Design and baseline findings of a large-scale ...</td>\n",
       "      <td>Hatzakis A; Sypsa V; Paraskevis D; Nikolopoulo...</td>\n",
       "      <td>10.1111/add.12999</td>\n",
       "      <td>2015</td>\n",
       "      <td>[Journal Article, Research Support, N.I.H., Ex...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>411</th>\n",
       "      <td>NCT02573948</td>\n",
       "      <td>Feasibility of Interventions on People Who Inj...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-10-12</td>\n",
       "      <td>27178119</td>\n",
       "      <td>RESULT</td>\n",
       "      <td>Integrated respondent-driven sampling and peer...</td>\n",
       "      <td>Des Jarlais D; Duong HT; Pham Minh K; Khuat OH...</td>\n",
       "      <td>10.1080/09540121.2016.1178698</td>\n",
       "      <td>2016</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>412</th>\n",
       "      <td>NCT02573948</td>\n",
       "      <td>Feasibility of Interventions on People Who Inj...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-10-12</td>\n",
       "      <td>26080690</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>HIV, Hepatitis C, and Abstinence from Alcohol ...</td>\n",
       "      <td>Elliott JC; Hasin DS; Stohl M; Des Jarlais DC</td>\n",
       "      <td>10.1007/s10461-015-1113-z</td>\n",
       "      <td>2016</td>\n",
       "      <td>[Journal Article, Research Support, N.I.H., Ex...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>414</th>\n",
       "      <td>NCT02453048</td>\n",
       "      <td>Study of BPZE1 (High Dose) Nasal Live Attenuat...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-05-25</td>\n",
       "      <td>24950361</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Heterologous prime-boost immunization with liv...</td>\n",
       "      <td>Feunou PF; Kammoun H; Debrie AS; Locht C</td>\n",
       "      <td>10.1016/j.vaccine.2014.06.019</td>\n",
       "      <td>2014</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>415</th>\n",
       "      <td>NCT02453048</td>\n",
       "      <td>Study of BPZE1 (High Dose) Nasal Live Attenuat...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-05-25</td>\n",
       "      <td>19625486</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>A live attenuated Bordetella pertussis candida...</td>\n",
       "      <td>Skerry CM; Cassidy JP; English K; Feunou-Feuno...</td>\n",
       "      <td>10.1128/CVI.00082-09</td>\n",
       "      <td>2009</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>416</th>\n",
       "      <td>NCT02453048</td>\n",
       "      <td>Study of BPZE1 (High Dose) Nasal Live Attenuat...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-05-25</td>\n",
       "      <td>31945015</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Live attenuated pertussis vaccine BPZE1 induce...</td>\n",
       "      <td>Lin A; Apostolovic D; Jahnmatz M; Liang F; Ols...</td>\n",
       "      <td>10.1172/JCI135020</td>\n",
       "      <td>2020</td>\n",
       "      <td>[Journal Article, Randomized Controlled Trial,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>417</th>\n",
       "      <td>NCT02453048</td>\n",
       "      <td>Study of BPZE1 (High Dose) Nasal Live Attenuat...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-05-25</td>\n",
       "      <td>22814407</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Dual mechanism of protection by live attenuate...</td>\n",
       "      <td>Kammoun H; Feunou PF; Foligne B; Debrie AS; Ra...</td>\n",
       "      <td>10.1016/j.vaccine.2012.07.005</td>\n",
       "      <td>2012</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>418</th>\n",
       "      <td>NCT02453048</td>\n",
       "      <td>Study of BPZE1 (High Dose) Nasal Live Attenuat...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-05-25</td>\n",
       "      <td>24793938</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>B-cell responses after intranasal vaccination ...</td>\n",
       "      <td>Jahnmatz M; Amu S; Ljungman M; Wehlin L; Chiod...</td>\n",
       "      <td>10.1016/j.vaccine.2014.04.048</td>\n",
       "      <td>2014</td>\n",
       "      <td>[Clinical Trial, Phase I, Journal Article, Ran...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>419</th>\n",
       "      <td>NCT02453048</td>\n",
       "      <td>Study of BPZE1 (High Dose) Nasal Live Attenuat...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-05-25</td>\n",
       "      <td>24421886</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>A phase I clinical study of a live attenuated ...</td>\n",
       "      <td>Thorstensson R; Trollfors B; Al-Tawil N; Jahnm...</td>\n",
       "      <td>10.1371/journal.pone.0083449</td>\n",
       "      <td>2014</td>\n",
       "      <td>[Clinical Trial, Phase I, Journal Article, Ran...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>420</th>\n",
       "      <td>NCT02453048</td>\n",
       "      <td>Study of BPZE1 (High Dose) Nasal Live Attenuat...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-05-25</td>\n",
       "      <td>18762220</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Genetic stability of the live attenuated Borde...</td>\n",
       "      <td>Feunou PF; Ismaili J; Debrie AS; Huot L; Hot D...</td>\n",
       "      <td>10.1016/j.vaccine.2008.08.018</td>\n",
       "      <td>2008</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>421</th>\n",
       "      <td>NCT02453048</td>\n",
       "      <td>Study of BPZE1 (High Dose) Nasal Live Attenuat...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-05-25</td>\n",
       "      <td>32687804</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Safety and immunogenicity of the live attenuat...</td>\n",
       "      <td>Jahnmatz M; Richert L; Al-Tawil N; Storsaeter ...</td>\n",
       "      <td>10.1016/S1473-3099(20)30274-7</td>\n",
       "      <td>2020</td>\n",
       "      <td>[Clinical Trial, Phase I, Journal Article, Ran...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>422</th>\n",
       "      <td>NCT02453048</td>\n",
       "      <td>Study of BPZE1 (High Dose) Nasal Live Attenuat...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-05-25</td>\n",
       "      <td>20419113</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>T- and B-cell-mediated protection induced by n...</td>\n",
       "      <td>Feunou PF; Bertout J; Locht C</td>\n",
       "      <td>10.1371/journal.pone.0010178</td>\n",
       "      <td>2010</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>423</th>\n",
       "      <td>NCT02453048</td>\n",
       "      <td>Study of BPZE1 (High Dose) Nasal Live Attenuat...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-05-25</td>\n",
       "      <td>20708998</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Long-term immunity against pertussis induced b...</td>\n",
       "      <td>Feunou PF; Kammoun H; Debrie AS; Mielcarek N; ...</td>\n",
       "      <td>10.1016/j.vaccine.2010.08.017</td>\n",
       "      <td>2010</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>424</th>\n",
       "      <td>NCT02453048</td>\n",
       "      <td>Study of BPZE1 (High Dose) Nasal Live Attenuat...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-05-25</td>\n",
       "      <td>21147936</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>A live, attenuated Bordetella pertussis vaccin...</td>\n",
       "      <td>Skerry CM; Mahon BP</td>\n",
       "      <td>10.1128/CVI.00371-10</td>\n",
       "      <td>2011</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>425</th>\n",
       "      <td>NCT02453048</td>\n",
       "      <td>Study of BPZE1 (High Dose) Nasal Live Attenuat...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-05-25</td>\n",
       "      <td>21430219</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Attenuated Bordetella pertussis vaccine candid...</td>\n",
       "      <td>Fedele G; Bianco M; Debrie AS; Locht C; Ausiel...</td>\n",
       "      <td>10.4049/jimmunol.1003765</td>\n",
       "      <td>2011</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>426</th>\n",
       "      <td>NCT02453048</td>\n",
       "      <td>Study of BPZE1 (High Dose) Nasal Live Attenuat...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2015-05-25</td>\n",
       "      <td>20107007</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Dose response of attenuated Bordetella pertuss...</td>\n",
       "      <td>Mielcarek N; Debrie AS; Mahieux S; Locht C</td>\n",
       "      <td>10.1128/CVI.00322-09</td>\n",
       "      <td>2010</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>449</th>\n",
       "      <td>NCT01882062</td>\n",
       "      <td>Proof of Concept of an Anaplerotic Study Using...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2013-06-20</td>\n",
       "      <td>25568297</td>\n",
       "      <td>RESULT</td>\n",
       "      <td>Triheptanoin improves brain energy metabolism ...</td>\n",
       "      <td>Adanyeguh IM; Rinaldi D; Henry PG; Caillet S; ...</td>\n",
       "      <td>10.1212/WNL.0000000000001214</td>\n",
       "      <td>2015</td>\n",
       "      <td>[Clinical Trial, Journal Article, Research Sup...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                         BriefTitle  \\\n",
       "90   NCT01605890  Trial Evaluating a First Line Combination Ther...   \n",
       "300  NCT00928187  Evaluation of Three Strategies of Second-line ...   \n",
       "404  NCT02573948  Feasibility of Interventions on People Who Inj...   \n",
       "405  NCT02573948  Feasibility of Interventions on People Who Inj...   \n",
       "406  NCT02573948  Feasibility of Interventions on People Who Inj...   \n",
       "407  NCT02573948  Feasibility of Interventions on People Who Inj...   \n",
       "408  NCT02573948  Feasibility of Interventions on People Who Inj...   \n",
       "409  NCT02573948  Feasibility of Interventions on People Who Inj...   \n",
       "410  NCT02573948  Feasibility of Interventions on People Who Inj...   \n",
       "411  NCT02573948  Feasibility of Interventions on People Who Inj...   \n",
       "412  NCT02573948  Feasibility of Interventions on People Who Inj...   \n",
       "414  NCT02453048  Study of BPZE1 (High Dose) Nasal Live Attenuat...   \n",
       "415  NCT02453048  Study of BPZE1 (High Dose) Nasal Live Attenuat...   \n",
       "416  NCT02453048  Study of BPZE1 (High Dose) Nasal Live Attenuat...   \n",
       "417  NCT02453048  Study of BPZE1 (High Dose) Nasal Live Attenuat...   \n",
       "418  NCT02453048  Study of BPZE1 (High Dose) Nasal Live Attenuat...   \n",
       "419  NCT02453048  Study of BPZE1 (High Dose) Nasal Live Attenuat...   \n",
       "420  NCT02453048  Study of BPZE1 (High Dose) Nasal Live Attenuat...   \n",
       "421  NCT02453048  Study of BPZE1 (High Dose) Nasal Live Attenuat...   \n",
       "422  NCT02453048  Study of BPZE1 (High Dose) Nasal Live Attenuat...   \n",
       "423  NCT02453048  Study of BPZE1 (High Dose) Nasal Live Attenuat...   \n",
       "424  NCT02453048  Study of BPZE1 (High Dose) Nasal Live Attenuat...   \n",
       "425  NCT02453048  Study of BPZE1 (High Dose) Nasal Live Attenuat...   \n",
       "426  NCT02453048  Study of BPZE1 (High Dose) Nasal Live Attenuat...   \n",
       "449  NCT01882062  Proof of Concept of an Anaplerotic Study Using...   \n",
       "\n",
       "                                       LeadSponsorName  \\\n",
       "90                  ANRS, Emerging Infectious Diseases   \n",
       "300                 ANRS, Emerging Infectious Diseases   \n",
       "404                 ANRS, Emerging Infectious Diseases   \n",
       "405                 ANRS, Emerging Infectious Diseases   \n",
       "406                 ANRS, Emerging Infectious Diseases   \n",
       "407                 ANRS, Emerging Infectious Diseases   \n",
       "408                 ANRS, Emerging Infectious Diseases   \n",
       "409                 ANRS, Emerging Infectious Diseases   \n",
       "410                 ANRS, Emerging Infectious Diseases   \n",
       "411                 ANRS, Emerging Infectious Diseases   \n",
       "412                 ANRS, Emerging Infectious Diseases   \n",
       "414  Institut National de la Santé Et de la Recherc...   \n",
       "415  Institut National de la Santé Et de la Recherc...   \n",
       "416  Institut National de la Santé Et de la Recherc...   \n",
       "417  Institut National de la Santé Et de la Recherc...   \n",
       "418  Institut National de la Santé Et de la Recherc...   \n",
       "419  Institut National de la Santé Et de la Recherc...   \n",
       "420  Institut National de la Santé Et de la Recherc...   \n",
       "421  Institut National de la Santé Et de la Recherc...   \n",
       "422  Institut National de la Santé Et de la Recherc...   \n",
       "423  Institut National de la Santé Et de la Recherc...   \n",
       "424  Institut National de la Santé Et de la Recherc...   \n",
       "425  Institut National de la Santé Et de la Recherc...   \n",
       "426  Institut National de la Santé Et de la Recherc...   \n",
       "449  Institut National de la Santé Et de la Recherc...   \n",
       "\n",
       "                              CollaboratorName OverallStatus       StudyType  \\\n",
       "90   Gilead Sciences | Merck Sharp & Dohme LLC     COMPLETED  INTERVENTIONAL   \n",
       "300    Gilead Sciences | Janssen Pharmaceutica     COMPLETED  INTERVENTIONAL   \n",
       "404    National Institute on Drug Abuse (NIDA)     COMPLETED   OBSERVATIONAL   \n",
       "405    National Institute on Drug Abuse (NIDA)     COMPLETED   OBSERVATIONAL   \n",
       "406    National Institute on Drug Abuse (NIDA)     COMPLETED   OBSERVATIONAL   \n",
       "407    National Institute on Drug Abuse (NIDA)     COMPLETED   OBSERVATIONAL   \n",
       "408    National Institute on Drug Abuse (NIDA)     COMPLETED   OBSERVATIONAL   \n",
       "409    National Institute on Drug Abuse (NIDA)     COMPLETED   OBSERVATIONAL   \n",
       "410    National Institute on Drug Abuse (NIDA)     COMPLETED   OBSERVATIONAL   \n",
       "411    National Institute on Drug Abuse (NIDA)     COMPLETED   OBSERVATIONAL   \n",
       "412    National Institute on Drug Abuse (NIDA)     COMPLETED   OBSERVATIONAL   \n",
       "414                                       <NA>     COMPLETED  INTERVENTIONAL   \n",
       "415                                       <NA>     COMPLETED  INTERVENTIONAL   \n",
       "416                                       <NA>     COMPLETED  INTERVENTIONAL   \n",
       "417                                       <NA>     COMPLETED  INTERVENTIONAL   \n",
       "418                                       <NA>     COMPLETED  INTERVENTIONAL   \n",
       "419                                       <NA>     COMPLETED  INTERVENTIONAL   \n",
       "420                                       <NA>     COMPLETED  INTERVENTIONAL   \n",
       "421                                       <NA>     COMPLETED  INTERVENTIONAL   \n",
       "422                                       <NA>     COMPLETED  INTERVENTIONAL   \n",
       "423                                       <NA>     COMPLETED  INTERVENTIONAL   \n",
       "424                                       <NA>     COMPLETED  INTERVENTIONAL   \n",
       "425                                       <NA>     COMPLETED  INTERVENTIONAL   \n",
       "426                                       <NA>     COMPLETED  INTERVENTIONAL   \n",
       "449                                       <NA>     COMPLETED  INTERVENTIONAL   \n",
       "\n",
       "     HasResults StudyFirstPostDate      pmid        type  \\\n",
       "90         True         2012-05-25  29590335     DERIVED   \n",
       "300        True         2009-06-25  31273686     DERIVED   \n",
       "404        True         2015-10-12  27006257      RESULT   \n",
       "405        True         2015-10-12  25540950  BACKGROUND   \n",
       "406        True         2015-10-12  28800503      RESULT   \n",
       "407        True         2015-10-12  26050614  BACKGROUND   \n",
       "408        True         2015-10-12  26075647  BACKGROUND   \n",
       "409        True         2015-10-12  28612212      RESULT   \n",
       "410        True         2015-10-12  26032121  BACKGROUND   \n",
       "411        True         2015-10-12  27178119      RESULT   \n",
       "412        True         2015-10-12  26080690  BACKGROUND   \n",
       "414        True         2015-05-25  24950361  BACKGROUND   \n",
       "415        True         2015-05-25  19625486  BACKGROUND   \n",
       "416        True         2015-05-25  31945015     DERIVED   \n",
       "417        True         2015-05-25  22814407  BACKGROUND   \n",
       "418        True         2015-05-25  24793938  BACKGROUND   \n",
       "419        True         2015-05-25  24421886  BACKGROUND   \n",
       "420        True         2015-05-25  18762220  BACKGROUND   \n",
       "421        True         2015-05-25  32687804     DERIVED   \n",
       "422        True         2015-05-25  20419113  BACKGROUND   \n",
       "423        True         2015-05-25  20708998  BACKGROUND   \n",
       "424        True         2015-05-25  21147936  BACKGROUND   \n",
       "425        True         2015-05-25  21430219  BACKGROUND   \n",
       "426        True         2015-05-25  20107007  BACKGROUND   \n",
       "449        True         2013-06-20  25568297      RESULT   \n",
       "\n",
       "                                                 title  \\\n",
       "90   First-line Raltegravir/Emtricitabine/Tenofovir...   \n",
       "300  Cost-Effectiveness of Three Alternative Booste...   \n",
       "404  Prospects for ending the HIV epidemic among pe...   \n",
       "405  AIDS, people who use drugs, and altruism: refl...   \n",
       "406  Intravenous heroin use in Haiphong, Vietnam: N...   \n",
       "407  An international perspective on using opioid s...   \n",
       "408  Can HIV and Hepatitis C Virus Infection be Eli...   \n",
       "409  Risk Behaviors for HIV and HCV Infection Among...   \n",
       "410  Design and baseline findings of a large-scale ...   \n",
       "411  Integrated respondent-driven sampling and peer...   \n",
       "412  HIV, Hepatitis C, and Abstinence from Alcohol ...   \n",
       "414  Heterologous prime-boost immunization with liv...   \n",
       "415  A live attenuated Bordetella pertussis candida...   \n",
       "416  Live attenuated pertussis vaccine BPZE1 induce...   \n",
       "417  Dual mechanism of protection by live attenuate...   \n",
       "418  B-cell responses after intranasal vaccination ...   \n",
       "419  A phase I clinical study of a live attenuated ...   \n",
       "420  Genetic stability of the live attenuated Borde...   \n",
       "421  Safety and immunogenicity of the live attenuat...   \n",
       "422  T- and B-cell-mediated protection induced by n...   \n",
       "423  Long-term immunity against pertussis induced b...   \n",
       "424  A live, attenuated Bordetella pertussis vaccin...   \n",
       "425  Attenuated Bordetella pertussis vaccine candid...   \n",
       "426  Dose response of attenuated Bordetella pertuss...   \n",
       "449  Triheptanoin improves brain energy metabolism ...   \n",
       "\n",
       "                                               authors  \\\n",
       "90   Matheron S; Descamps D; Gallien S; Besseghir A...   \n",
       "300  Boyer S; Nishimwe ML; Sagaon-Teyssier L; March...   \n",
       "404  Des Jarlais DC; Thi Huong D; Thi Hai Oanh K; K...   \n",
       "405                                     Des Jarlais DC   \n",
       "406  Michel L; Des Jarlais DC; Duong Thi H; Khuat T...   \n",
       "407  Perlman DC; Jordan AE; Uuskula A; Huong DT; Ma...   \n",
       "408            Perlman DC; Des Jarlais DC; Feelemyer J   \n",
       "409  Duong HT; Jarlais DD; Khuat OHT; Arasteh K; Fe...   \n",
       "410  Hatzakis A; Sypsa V; Paraskevis D; Nikolopoulo...   \n",
       "411  Des Jarlais D; Duong HT; Pham Minh K; Khuat OH...   \n",
       "412      Elliott JC; Hasin DS; Stohl M; Des Jarlais DC   \n",
       "414           Feunou PF; Kammoun H; Debrie AS; Locht C   \n",
       "415  Skerry CM; Cassidy JP; English K; Feunou-Feuno...   \n",
       "416  Lin A; Apostolovic D; Jahnmatz M; Liang F; Ols...   \n",
       "417  Kammoun H; Feunou PF; Foligne B; Debrie AS; Ra...   \n",
       "418  Jahnmatz M; Amu S; Ljungman M; Wehlin L; Chiod...   \n",
       "419  Thorstensson R; Trollfors B; Al-Tawil N; Jahnm...   \n",
       "420  Feunou PF; Ismaili J; Debrie AS; Huot L; Hot D...   \n",
       "421  Jahnmatz M; Richert L; Al-Tawil N; Storsaeter ...   \n",
       "422                      Feunou PF; Bertout J; Locht C   \n",
       "423  Feunou PF; Kammoun H; Debrie AS; Mielcarek N; ...   \n",
       "424                                Skerry CM; Mahon BP   \n",
       "425  Fedele G; Bianco M; Debrie AS; Locht C; Ausiel...   \n",
       "426         Mielcarek N; Debrie AS; Mahieux S; Locht C   \n",
       "449  Adanyeguh IM; Rinaldi D; Henry PG; Caillet S; ...   \n",
       "\n",
       "                                  doi  year  \\\n",
       "90                 10.1093/cid/ciy245  2018   \n",
       "300         10.1007/s41669-019-0157-9  2020   \n",
       "404      10.1016/j.drugpo.2016.02.021  2016   \n",
       "405      10.3109/10826084.2015.978185  2015   \n",
       "406  10.1016/j.drugalcdep.2017.07.004  2017   \n",
       "407      10.1016/j.drugpo.2015.04.015  2015   \n",
       "408     10.1080/10550887.2015.1059111  2015   \n",
       "409         10.1007/s10461-017-1814-6  2018   \n",
       "410                 10.1111/add.12999  2015   \n",
       "411     10.1080/09540121.2016.1178698  2016   \n",
       "412         10.1007/s10461-015-1113-z  2016   \n",
       "414     10.1016/j.vaccine.2014.06.019  2014   \n",
       "415              10.1128/CVI.00082-09  2009   \n",
       "416                 10.1172/JCI135020  2020   \n",
       "417     10.1016/j.vaccine.2012.07.005  2012   \n",
       "418     10.1016/j.vaccine.2014.04.048  2014   \n",
       "419      10.1371/journal.pone.0083449  2014   \n",
       "420     10.1016/j.vaccine.2008.08.018  2008   \n",
       "421     10.1016/S1473-3099(20)30274-7  2020   \n",
       "422      10.1371/journal.pone.0010178  2010   \n",
       "423     10.1016/j.vaccine.2010.08.017  2010   \n",
       "424              10.1128/CVI.00371-10  2011   \n",
       "425          10.4049/jimmunol.1003765  2011   \n",
       "426              10.1128/CVI.00322-09  2010   \n",
       "449      10.1212/WNL.0000000000001214  2015   \n",
       "\n",
       "                                     publication_types  \n",
       "90   [Clinical Trial, Phase II, Journal Article, Mu...  \n",
       "300                                  [Journal Article]  \n",
       "404  [Journal Article, Research Support, Non-U.S. G...  \n",
       "405                                  [Journal Article]  \n",
       "406                                  [Journal Article]  \n",
       "407  [Journal Article, Research Support, N.I.H., Ex...  \n",
       "408  [Journal Article, Research Support, N.I.H., Ex...  \n",
       "409                                  [Journal Article]  \n",
       "410  [Journal Article, Research Support, N.I.H., Ex...  \n",
       "411                                  [Journal Article]  \n",
       "412  [Journal Article, Research Support, N.I.H., Ex...  \n",
       "414  [Journal Article, Research Support, Non-U.S. G...  \n",
       "415  [Journal Article, Research Support, Non-U.S. G...  \n",
       "416  [Journal Article, Randomized Controlled Trial,...  \n",
       "417  [Journal Article, Research Support, Non-U.S. G...  \n",
       "418  [Clinical Trial, Phase I, Journal Article, Ran...  \n",
       "419  [Clinical Trial, Phase I, Journal Article, Ran...  \n",
       "420  [Journal Article, Research Support, Non-U.S. G...  \n",
       "421  [Clinical Trial, Phase I, Journal Article, Ran...  \n",
       "422  [Journal Article, Research Support, Non-U.S. G...  \n",
       "423  [Journal Article, Research Support, Non-U.S. G...  \n",
       "424  [Journal Article, Research Support, Non-U.S. G...  \n",
       "425  [Journal Article, Research Support, Non-U.S. G...  \n",
       "426  [Journal Article, Research Support, Non-U.S. G...  \n",
       "449  [Clinical Trial, Journal Article, Research Sup...  "
      ]
     },
     "execution_count": 444,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_final[df_final.loc[:, 'NCTId'].isin(['NCT01605890', 'NCT00928187', 'NCT02573948', 'NCT02453048', 'NCT01882062'])]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 424,
   "id": "d31b1848-6436-4ac9-a8bd-bd3d63558aa3",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 683 entries, 0 to 682\n",
      "Data columns (total 15 columns):\n",
      " #   Column              Non-Null Count  Dtype   \n",
      "---  ------              --------------  -----   \n",
      " 0   NCTId               683 non-null    object  \n",
      " 1   BriefTitle          683 non-null    string  \n",
      " 2   LeadSponsorName     683 non-null    string  \n",
      " 3   CollaboratorName    357 non-null    string  \n",
      " 4   OverallStatus       683 non-null    category\n",
      " 5   StudyType           683 non-null    category\n",
      " 6   HasResults          683 non-null    boolean \n",
      " 7   StudyFirstPostDate  683 non-null    string  \n",
      " 8   pmid                547 non-null    object  \n",
      " 9   type                547 non-null    string  \n",
      " 10  title               547 non-null    object  \n",
      " 11  authors             547 non-null    object  \n",
      " 12  doi                 542 non-null    object  \n",
      " 13  year                547 non-null    object  \n",
      " 14  publication_types   547 non-null    object  \n",
      "dtypes: boolean(1), category(2), object(7), string(5)\n",
      "memory usage: 67.1+ KB\n"
     ]
    }
   ],
   "source": [
    "df_final.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 425,
   "id": "8debbfa2-f680-45e1-b62b-0b2c09fa4026",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 683 entries, 0 to 682\n",
      "Data columns (total 15 columns):\n",
      " #   Column              Non-Null Count  Dtype   \n",
      "---  ------              --------------  -----   \n",
      " 0   NCTId               683 non-null    string  \n",
      " 1   BriefTitle          683 non-null    string  \n",
      " 2   LeadSponsorName     683 non-null    string  \n",
      " 3   CollaboratorName    357 non-null    string  \n",
      " 4   OverallStatus       683 non-null    category\n",
      " 5   StudyType           683 non-null    category\n",
      " 6   HasResults          683 non-null    boolean \n",
      " 7   StudyFirstPostDate  683 non-null    string  \n",
      " 8   pmid                547 non-null    string  \n",
      " 9   type                547 non-null    string  \n",
      " 10  title               547 non-null    string  \n",
      " 11  authors             547 non-null    string  \n",
      " 12  doi                 542 non-null    string  \n",
      " 13  year                547 non-null    string  \n",
      " 14  publication_types   547 non-null    object  \n",
      "dtypes: boolean(1), category(2), object(1), string(11)\n",
      "memory usage: 67.1+ KB\n"
     ]
    }
   ],
   "source": [
    "df_final = df_final.convert_dtypes()\n",
    "# df_final = df_final.astype({\"OverallStatus\" : 'category', \"StudyType\" : 'category'})\n",
    "df_final.info()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "52dafbcd-284c-4aa4-81f5-e2f6506a8105",
   "metadata": {},
   "source": [
    "### Export en CSV: "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 488,
   "id": "062a8821-b680-4e5a-823e-256adda183e0",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_final.to_csv('Data/outputs/extract_df_final.csv', sep=\";\", index=False, encoding='utf-8-sig')"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
